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1. INTRODUCTION & STUDY AIMS 
“The three most common forms of micronutrient malnutrition worldwide are iron, 
vitamin A and iodine deficiency. Together they affect at least one third of the 
world‟s population (Allen et al., 2006)”. The World Health Organization (WHO) 
estimates that about two billion people in the world have inadequate iodine 
nutrition. The majority of them live in developing countries (de Benoist et al., 
2008). In Europe however, iodine deficiency (ID) also forms an ongoing public 
health problem (Andersson et al., 2007). 
Iodine is an essential component of the thyroid hormones (T3/T4) (Delange and 
Dunn, 2005). These hormones are required for normal growth, development 
and metabolism throughout life, beginning with the fetal stadium (Delange, 
1994; Yen, 2001; Zimmermann, 2009). When dietary iodine intake is 
insufficient, thyroid hormone synthesis is impaired. This results in a series of 
functional and developmental abnormalities termed “iodine deficiency disorders” 
(Delange, 1994; Zimmermann et al., 2008). ID during pregnancy or infancy 
increases the risk of stunted growth as well as neuromotor and neurocognitive 
impairment of the child. In extremis, this results in cretinism (Glinoer, 2007; 
Zimmermann, 2007a). Worldwide, ID is the most common cause of preventable 
brain damage (World Health Organization et al., 2007; Zimmermann et al., 
2008).  
The reason for the high prevalence of ID is that soils in many regions in the 
world (especially inland and mountainous regions) are poor in iodine. Hence, 
crops that are grown on these soils are also poor in iodine and do not provide 
adequate amounts of iodine to the population (Haldimann et al., 2005; 
Zimmermann et al., 2008). In order to eliminate iodine deficiency disorders, 
universal salt iodization is the recommended and best long-term strategy that 
supplies iodine to a population (World Health Organization et al., 2007). In the 
first year of life, infants1 rely on the iodine content of breast milk as well as 
iodine fortification of formula and complementary food. Salt should not be given 
to the infant during this time period (Swiss pediatric society, 2002).  
Urinary iodine concentration (UIC) reflects recent iodine intake as most of 
                                               
1
 Several definitions of “infant” exist. In this thesis, it describes children up to two years of age. 
2 Introduction 
 
 
 
 
University of Vienna  Nadja Wüst 
 
 
ingested iodine is finally excreted in urine (Vought and London, 1967; World 
Health Organization et al., 2007). Therefore, the most commonly used indicator 
to assess the iodine status of a population is the median UIC of spot urine 
specimens from a representative sample of the target group (Zimmermann, 
2008b). Median UIC could also be a good indicator for monitoring iodine 
nutrition in infants. However, no well-established reference range for UIC exists 
in this age group because only few studies have been carried out. The main 
difficulty is the urine collection in infants (WHO Secretariat on behalf of the 
participants to the Consultation et al., 2007). The WHO presently recommends 
an iodine intake of 90 μg/day for children less than two years of age and 
proposes that a median UIC ≥ 100 µg/l reflects an adequate iodine intake in this 
population group (World Health Organization et al., 2007). In 2007, however, a 
Technical Consultation of the WHO concluded that the median UIC value that 
indicates iodine-sufficiency in infants should be revised based on further 
studies. Additionally, the Consultation proposed studies on UIC in lactating 
women and on breast milk iodine concentration (WHO Secretariat on behalf of 
the participants to the Consultation et al., 2007).   
Switzerland has a well-monitored and long established national salt iodization 
program. The latest national monitoring on UIC in school age children and 
pregnant women showed adequate iodine intake in these population groups 
(Zimmermann et al., 2005). Measurement of thyroid-stimulating hormone (TSH) 
and of UIC in newborns in a recent national study also showed iodine 
sufficiency (Dorey and Zimmermann, 2008). Thus, Switzerland could be an 
ideal country for establishing a reference range of UIC in infants. 
 
Therefore, the overall aim of the study was to assess the urinary iodine 
excretion of 6- and 12-month-old infants in Switzerland by measuring UIC in 
spot urine specimens from a nationally representative sample. This study could 
serve as a basis for establishment of a reference range of median UIC in 
infants, which is required for monitoring the iodine status in infants on a national 
and international level. 
For a more precise evaluation of the iodine status, the dietary iodine intake of 
the infants was estimated by a dietary questionnaire. Moreover, the iodine 
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concentration in breast milk of their mothers was analyzed. The UIC of the 
mothers was also determined for comparison with the UIC of the infants to 
confirm their iodine-sufficiency. 
Another aim of the study was to examine if the iodine status of infants varied 
with the feeding practice. Kersting made the assumption that infants who mainly 
consume home-made food have a lower iodine status compared with those who 
mainly eat commercial infant food (Kersting, 2001). 
 
The tasks of this diploma thesis during the study were: 
1) Set-up and execution of the study during the first months of sampling, which 
specifically included: 
- Contacting and selecting pediatric practices for the study 
- Preparing information material for practices and study participants 
- Creating a registration form for collection of required personal data on 
study participants including infant feeding practices 
- Arranging materials for urine and breast milk sample collection 
- Developing a dietary questionnaire to determine the iodine intake of 
infants and preparing the evaluation of the dietary questionnaires (i.e. 
development of an infant food database for EBISpro, definition of standard 
portion sizes) 
- Visiting pediatric practices to give them study instructions, staying in touch 
with them during sampling and being contact person for questions from 
study participants and practices 
- Managing incoming samples and their storage and input of data from 
subject registration forms 
2) Examination and evaluation of iodine status in infants and their mothers in 
Switzerland (with focus on infants) based on an interim analysis of the 
incoming study data, which included: 
- Analysis of iodine concentration in collected urine samples of infants and 
their mothers (modified Sandell-Kolthoff method) and in breast milk 
samples (ICP-MS method) 
- Evaluation of the data looking at various aspects (gender, anthropometry, 
nationality, pediatric practices, regions, urban/rural area, season, feeding 
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mode, supplements, salt use, social demographics, correlations) and 
comparison with reference values/ recommendations and previous studies 
- Analysis and evaluation of iodine content in selected commonly consumed 
Swiss infant/follow-on formulae and commercial infant foods 
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2. BACKGROUND 
2.1. Physiology & deficiency disorders of iodine 
2.1.1. The role of iodine in the body 
Iodine is an integral component of the hormones T3 (Triiodothyronin) and T4 
(Thyroxin), which are produced by the thyroid gland. T3 and T4 contain three 
(59% of hormone weight) and four (65% of hormone weight) iodine atoms, 
respectively (Oetting and Yen, 2007; Rousset and Dunn, 2004). These 
hormones are the only iodine-containing molecules in the human body with 
established physiologic relevance (Rousset and Dunn, 2004). Thyroid 
hormones and therefore iodine are essential for human life. They are important 
for the differentiation, growth, metabolism, and physiological function of many 
tissues in the body. Their major target organs and tissues are the brain, bones, 
muscles, heart, fat tissue, liver, kidney and pituitary. In these, thyroid hormones 
regulate various important biochemical reactions (Institute of Medicine et al., 
2001; Yen, 2001). Thyroid hormones induce and stimulate RNA-/protein 
synthesis and enzymatic activity. Thereby, they mainly influence growth and 
maturation of the brain and bones and control metabolic processes in the body. 
For example, thyroid hormones elevate O2-usage and basic metabolic rate with 
increased caloric production in the body. They are also known to increase 
lipolysis in fat tissue and liver and regulate gluconeogenesis and glycogenolysis 
in the liver (Elmadfa and Leitzmann, 2004; FAO and WHO, 2004; Thews et al., 
2007; Yen, 2001). Furthermore, they have influence on other hormones of the 
body through direct stimulation of adenylatcyclase (Elmadfa and Leitzmann, 
2004).  
 
2.1.2. Bioavailability, metabolism and excretion of dietary iodine 
Most of ingested iodine (e.g. iodate in salt) is reduced to iodide before 
absorption in the gut, predominantly in the small intestine (FAO and WHO, 
2004; Institute of Medicine et al., 2001). Iodide is almost completely absorbed 
(Nath et al., 1992). Iodinated amino acids including T3 and T4 are absorbed 
intact (FAO and WHO, 2004; Institute of Medicine et al., 2001). Iodide enters 
the plasma and is transported in the circulation as free plasma iodide. It is 
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cleared form the circulation mainly by the thyroid gland and kidney, besides the 
salivary glands and stomach. During lactation, the breast clears some iodide 
from the circulation as well (Rousset and Dunn, 2004).  
Plasma iodide has usually a concentration < 10 µg/l (DeGroot, 1966; Rousset 
and Dunn, 2004) and a half-life of about 10h under normal circumstances 
(Zimmermann et al., 2008).  
Under normal conditions, the thyroid clears iodide from 10 - 25 ml of serum per 
minute (DeGroot, 1966; Rousset and Dunn, 2004), which can increase to over 
100 ml/min during iodine deficiency (Rousset and Dunn, 2004). The renal 
clearance of iodide is about 30 – 50 ml plasma/min and is widely independent of 
the iodide load (DeGroot, 1966; Rousset and Dunn, 2004).  
The amount of excreted iodine in urine is a good indicator of iodine intake (FAO 
and WHO, 2004). More than 90% of ingested iodine is finally excreted in urine 
(Nath et al., 1992; Vought and London, 1967; Zimmermann et al., 2008). The 
rest (~10%) is mainly excreted in feces (Glinoer, 2007). 
 
A healthy adult has 15 to 20 mg of iodine in the body most of which is in the 
thyroid gland (70 – 80%). To maintain an adequate thyroid hormone synthesis 
and to balance iodine losses, the thyroid has to collect about 60 µg of iodide per 
day (Clugston and Hetzel, 1994; DeGroot, 1966). Iodide is actively transported 
through the thyroidal membrane via Na+/Iodide-symporter (NIS) against a 
concentration gradient of 20:1 up to 50:1 (Eskandari et al., 1997; Rousset and 
Dunn, 2004). At the apical membrane, thyroidal iodide is oxidized by 
thyroperoxidase (TPO) in the presence of H2O2 and bound to the tyrosine 
residues of thyroglobulin (Tg) to build the hormone precursors MIT 
(monoiodothyrosine) and DIT (diiodothyrosine). T3 is formed by one MIT and 
one DIT molecule and two DIT molecules form T4. Both reactions are catalyzed 
by TPO (+ H2O2). The iodinated Tg (containing MIT, DIT, T3 and T4) is stored in 
the follicle lumen. When required, T3 and T4 are released into the circulation 
after proteolytic cleavage from Tg in the thyrocytes (Rousset and Dunn, 2004; 
Thews et al., 2007; Yen, 2001). Most of secreted thyroid hormones are in the 
form of T4 (Yen, 2001). Bound to transport proteins, thyroid hormones arrive at 
target tissues where most T4 is deiodinated to T3, the major bioactive form. The 
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7 
deiodinase contains selenium. Therefore, selenium deficiency can impair iodine 
metabolism (Institute of Medicine et al., 2001; Oetting and Yen, 2007). Thyroid 
hormones (mainly T3) form a hormone-receptor-complex in the cell nucleus of 
the target cell and influence thereby the gene expression (Oetting and Yen, 
2007; Thews et al., 2007; Yen, 2001). 
The half-life of T3 and T4 is about 1.5 - 3 days and 5 days, respectively. After 
release into the plasma, iodine is either trapped by the thyroid again or is 
excreted by the kidney (Zimmermann et al., 2008). 
 
TSH (thyrotropin) is able to influence almost every stage of thyroid hormone 
synthesis and release (Delange and Dunn, 2005; Dunn and Dunn, 2001). It also 
plays an important role in growth and development of the thyroid gland (Yen, 
2001). If not enough iodine is available, thyroid hormone production is reduced 
and TSH is released from the pituitary stimulating the thyroid (Rousset and 
Dunn, 2004). In most individuals, the TSH level starts to increase when the 
iodine intake falls below 100 µg/day (Zimmermann, 2009). TSH stimulates the 
expression of NIS and some other thyroid genes by binding to the trans-
membrane TSH-receptor and activating an intracellular signal transduction. 
Consequently, the uptake load of iodide from the thyroid increases to maintain 
an adequate thyroid hormone production and the thyroidal iodine content (Yen, 
2001; Zimmermann, 2009). More T3 is produced relative to T4 (Dunn and Dunn, 
2001). Renal iodine excretion is progressively reduced as a greater part of 
plasma iodide is cleared by the thyroid (Zimmermann, 2009). If the iodine intake 
falls below the critical threshold of about 50 µg/day, the iodine content of the 
thyroid decreases and many people develop goiter (Delange and Dunn, 2005). 
The formation of goiter is an attempt by the thyroid gland to compensate for the 
lower iodine availability and to keep the thyroid hormones, especially T3, at the 
required level (Clugston and Hetzel, 1994; Delange and Dunn, 2005). TSH itself 
is regulated by a “feedback” mechanism (Clugston and Hetzel, 1994). 
 
Substances called goitrogens can interfere with iodine metabolism and have 
clinical effects especially when iodine deficiency coexists (Vanderpas, 2006; 
Zimmermann et al., 2008). They are present in some foods such as cassava, 
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linseed and sorghum (cyanogenic glycosides and their metabolite thiocyanate), 
cruciferous vegetables (glucosinolates), soy and millet (flavonoids) 
(Zimmermann et al., 2008). Glucosinolates and thiocyanates compete with 
iodine for thyroidal uptake. Perchlorate and thiocyanate from smoking also 
negatively affect iodine metabolism (Vanderpas, 2006). Deficiencies of other 
essential nutrients aggravate iodine deficiency: Selenium, which is part of TPO 
and deiodinase (Vanderpas, 2006), iron (Zimmermann et al., 2007a) and 
vitamin A (Zimmermann et al., 2007c). 
 
2.1.3. Iodine deficiency disorders 
Insufficient iodine intake results in inadequate production of thyroid hormones. 
This has multiple adverse health effects grouped under the heading of “Iodine 
Deficiency Disorders” (IDD) (Delange and Dunn, 2005; Hetzel, 1983; 
Zimmermann, 2009). Table 1 shows an overview of the health consequences of 
IDD in different life stages (Hetzel, 1983; World Health Organization et al., 
2007).  
 
Table 1: The health consequences of iodine deficiency, by life stage (adapted from 
(Hetzel, 1983; World Health Organization et al., 2007)) 
Life stage Health consequences of iodine deficiency 
All ages  Goitre 
 Hypothyroidism 
 Increased susceptibility to nuclear radiation 
Fetus  Spontaneous abortion 
 Stillbirth 
 Congenital anomalies 
 Perinatal mortality 
Neonate  Endemic cretinism including mental deficiency with a mixture 
of mutism, spastic diplegia, squint, hypothyroidism and short 
stature 
 Infant mortality 
Child and  
adolescent 
 Impaired mental function 
 Delayed physical development 
 Iodine-induced hyperthyroidism  
Adults  Impaired mental function 
 Iodine-induced hyperthyroidism  
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The best-known and most visible IDD is goiter, which can occur throughout life. 
The most critical periods of IDD are pregnancy and infancy as in these stages 
the most severe and irreversible consequences of IDD occur with its extreme 
manifestation, cretinism (World Health Organization et al., 2007).  
Iodine deficiency (ID) is the greatest cause of preventable brain damage 
worldwide. In this context, more subtle degrees of mental impairment, which 
lead to reduced intellectual ability, are even more important than cretinism (de 
Benoist et al., 2008; World Health Organization et al., 2007). 
Most IDD that occur in adults are reversible with adequate iodine treatment. On 
the contrary, during development, especially in fetus and infant, ID may lead to 
irreversible damage (Bernal, 2009). 
 
In the past, the likely occurrence of IDD in a region was defined by its 
geographical situation (e.g. iodine deplete mountainous regions) confirmed by 
the prevalence of goiter in the population. Today, better assessment methods 
(e.g. urinary iodine excretion) are available. Hence, it was shown that IDD also 
occurred in areas where the above-mentioned factors were not present. Iodine 
deficiency (ID) was detected, for example, where goiter prevalence was low, in 
coastal areas, in large cities, in highly developed countries and where ID was 
thought to have been eliminated. Therefore, it is important that the iodine status 
in populations is monitored periodically (World Health Organization et al., 2007). 
Most iodine monitoring is done in school age children (SAC). The WHO 
estimates that about one third of SAC worldwide have an insufficient iodine 
intake. The highest proportion of SAC with insufficient iodine intake (UIC < 100 
µg/l) is found in Europe (52%) and the Eastern Mediterranean (49%), the lowest 
in Western Pacific (23%) and the Americas (11%). Extrapolating the data of 
SAC, it is estimated that about 2 billion people worldwide have an insufficient 
iodine intake (de Benoist et al., 2008). Also in Europe, ID is an ongoing public 
health concern (Andersson et al., 2007). Worldwide, the WHO classified iodine 
intake as insufficient in 47 countries, as adequate in 49 countries, as more than 
adequate in 27 and as excessive in 7 countries (no data from 63 countries). 
Since the last survey in 2003, an improvement of the global iodine status was 
observed. Switzerland was classified as a country with optimal iodine intake (de 
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Benoist et al., 2008). 
 
2.1.4. Fetal period and infancy 
Fetal thyroid hormonogenesis is detected in the 11th - 12th week of gestation 
together with the appearance of TSH in the fetal plasma (Brown et al., 2005; 
Kratzsch and Pulzer, 2008; Polk, 1995). Other authors suggest that fetal thyroid 
hormone secretion does not start until midgestation (de Escobar et al., 2008). 
However, during the first half of pregnancy, fetal thyroid hormone levels are low 
and the fetus is entirely dependent on maternal thyroid hormones (Bernal, 2009; 
Brown et al., 2005). After that period, fetal thyroid hormone secretion increases 
(Polk, 1995) and the placenta has under normal circumstances limited 
permeability for maternal thyroid hormones. Hence, the fetal hypothalamic-
pituitary-thyroid system develops relatively independently from maternal 
influence. Nevertheless, the iodine for thyroid hormone synthesis has to be 
provided by the mother (Brown, 2009; Kratzsch and Pulzer, 2008). Maternal 
TSH and Tg do not cross the placenta (Brown, 2009).  
Thyroid hormone receptors and T3 are already present in the fetal brain around 
the 10th week of gestation. Thenceforward, the receptor concentration increases 
constantly parallel to rapid brain growth (Bernal and Pekonen, 1984), which 
indicates the early influence of thyroid hormones on brain development 
(Obregon et al., 2007). In other organs, thyroid hormone receptors are detected 
a few weeks later (liver, heart and lung) (Bernal and Pekonen, 1984; Brown et 
al., 2005). 
If the infant has an inborn error in thyroid hormone production, the placental 
permeability for thyroid hormones increases and the infant may have a normal 
clinical appearance at birth (e.g. in case of congenital hypothyroidism). If both 
mother and infant are hypothyroid due to iodine deficiency, the infant shows 
impairment in neurointellectual development (Brown et al., 2005; Obregon et al., 
2007). 
 
At birth, the thyroid gland weighs about 1 g and grows approximately 1 g per 
year until it reaches a size of 15 – 20 g at about 15 years of age (Brown, 2009; 
Brown et al., 2005; Kratzsch and Pulzer, 2008). Thyroid hormone stores and 
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iodine content of the thyroid are low at birth and increase progressively 
thenceforward (van den Hove et al., 1999). The thyroidal iodine content is about 
0.3 mg at birth and increases to 16 mg in adolescents and adults in iodine-
sufficient areas (Brown et al., 2005).  
The iodide space in the body increases progressively in volume, but the relative 
size (liter/kg, expressed as percentage of body weight) decreases from about 
50% of body weight at birth to about 35 % of body weight in adults (Brown et al., 
2005; DeGroot, 1966).  
Within the first day after birth, TSH increases rapidly and decreases again (see 
Figure 1) (Vanderpas, 2006), followed by an increase in T4 and T3 levels  in the 
newborn (Abuid et al., 1973; Brown et al., 2005; Kratzsch and Pulzer, 2008). 
 
 
Figure 1: Development of the central nervous system from pregnancy until two years of 
age and critical periods of cretinism development. The TSH (thyrotropin) profile shown 
is from a population with normal iodine supply. Source: (Vanderpas, 2006).  
 
Infants have a markedly higher T4 turnover compared with adults. It is estimated 
that T4 production rates range from 5 - 6 µg/kg/day in infancy and that they 
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decrease to 2 – 3 µg/kg/day at 3 to 9 years of age. In adults, the T4 production 
rate is about 1.5 µg/kg/day (Brown, 2009). Serum T3 concentration reaches the 
level of adults within a few weeks after birth which indicates that deiodinase 
maturation is completed by then (Brown et al., 2005). Serum Tg levels reach the 
concentration of adults by 6 months of age (Brown, 2009). 
 
Thyroid hormones are essential for growth and development of the brain and 
central nervous system from the 15th week of gestation to three years of age 
(FAO and WHO, 2004). In this period, thyroid hormones provide the induction 
signal for differentiation and maturation programs of the central nervous system 
and mediate neuronal differentiation, neurite outgrowth, synaptogenesis, 
cerebellar neurogenesis, cell migration, gliogenesis and myelinization of 
neurons (Bernal, 2009; Porterfield and Hendrich, 1993). Thyroid hormones 
directly act on the brain through regulation of gene expression (e.g. expression 
of myelin gene, neuronal growth factor gene, genes for proteins in terminal cell 
differentiation and genes for cell signaling) (Bernal, 2005; Kohrle, 2000; Yen, 
2001). Thyroid hormones also regulate normal growth and bone development 
through direct (e.g. endochondral ossification and chondrocyte differentiation in 
the growth plate) and indirect (e.g. growth hormone gene expression) 
mechanisms (Brown et al., 2005). Besides these, thyroid hormones are 
important for various other metabolic processes in infants (Yen, 2001). This 
shows the importance of reliable methods to assess the iodine status in order to 
enable optimal iodine nutrition and thus, optimal development in the specified 
age group.  
 
Iodine and consequently thyroid hormone deficiency (hypothyroidism) during 
the critical period of fetal and infant development may result in stillbirth, abortion 
or in irreversible damages of physical and mental development (FAO and WHO, 
2004; Hetzel, 1983; Porterfield and Hendrich, 1993). The severity of impairment 
depends on the grade and timing of iodine deficiency (Bernal, 2009; Delange, 
2000). The most serious damage due to severe iodine deficiency2 is (endemic) 
                                               
2
 Severe iodine deficiency in a population is defined as a median urinary iodine concentration < 
20 µg/l in adults/school age children of the respective population (see chapter 2.4.1.2) (World 
Health Organization et al., 2007). 
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cretinism (FAO and WHO, 2004; Hetzel, 1983). However, the more subtle forms 
of brain damage and cognitive capacity are of even greater importance for 
public health because they might reduce the potential of a whole population 
(World Health Organization et al., 2007).  
Figure 1 shows the stages of brain development from pregnancy until two years 
of age and the critical periods of cretinism development (Vanderpas, 2006). 
There are two forms of endemic cretinism. Neurological cretinism, in which 
damage to the child due to ID of the mother already occurs in the first/second 
trimester of pregnancy, is characterized by severe mental retardation with 
squint, deaf mutism and motor spasticity. Myxedematous cretinism, in which 
damage occurs during the last trimester of pregnancy and postnatal period, is 
characterized by a less severe degree of mental retardation, but with all signs of 
severe hypothyroidism present since early life such as severe growth 
retardation, myxedema, craniofacial abnormalities, delayed sexual development 
(Bernal, 2009; Vanderpas, 2006; Zimmermann, 2009). Based on several 
intervention studies in regions with severe ID, Zimmermann concluded in a 
recent review that iodine supplementation during pregnancy could prevent 
neurological damages, especially when applied in early pregnancy 
(Zimmermann, 2009). 
 
It remains unclear whether mild-to-moderate3  ID in pregnancy/neonatal life 
causes more subtle impairment of cognitive and/or neurological capacity in the 
progeny as only a few studies have been conducted that measured 
neurocognitive performance of infants in areas with mild-to-moderate ID (Vitti et 
al., 1992; Zimmermann, 2009). A recent intervention study in a Spanish area 
with moderate ID compared the neurocognitive development of infants (3 – 18 
months) whose mothers received 300 µg KI per day during their pregnancy (n = 
133) with infants whose mothers did not receive any supplement (n = 61) 
(Velasco et al., 2009). The study showed that infants whose mothers were 
                                               
3
 Mild or moderate iodine deficiency in a population is defined as a median urinary iodine 
concentration of 50-99 µg/l or 20-49 µg/l in adults/school age children of the respective 
population (see chapter 2.4.1.2) (World Health Organization et al., 2007). 
For pregnant women mild-to-moderate ID can also be defined as a median urinary iodine 
concentration of 50-150 µg/l (Zimmermann, 2007a). 
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supplemented with iodine had a better psychomotor evaluation. The 
supplementation during pregnancy also resulted in significantly higher iodine 
levels in breast milk (BM), which was beneficial for the infants as well (Velasco 
et al., 2009). Another recent Spanish intervention study found that a delay of 6 – 
10 weeks in iodine supplementation of women with mild ID increased the risk 
for permanent alterations in motor coordination and social development in their 
children (measured at 18 months of age) (Berbel et al., 2009). 
 
ID may also increase infant mortality. Zimmermann recently reviewed that 
several studies suggested that iodine supplementation during pregnancy and 
infancy could reduce infant mortality rate by 50% (Zimmermann, 2009). 
 
Postnatal effects of ID on cognitive function are less clear than the effects 
during the fetal period (Zimmermann, 2007a). The neonatal brain, however, is 
just one third of the adult‟s brain size. ID during brain development after birth 
could lead to irreversible brain damage (Sethi and Kapil, 2004). It was assumed 
from several studies that chronic ID reduces IQ in populations. However, the 
studies could not differentiate whether this effect already originated from fetal 
development or resulted from iodine status thereafter (Zimmermann, 2007a). A 
recent intervention study (24 weeks) on moderately iodine-deficient 
schoolchildren in Albania (n = 310, 10 – 12-year-old) showed that iodine 
supplementation (single dose of 400 mg iodine as iodized oil) improved 
cognitive performance (e.g. information processing and fine motor skills) 
(Zimmermann et al., 2006a). 
 
Also less clear are the effects of ID on postnatal growth (Zimmermann, 2009). 
Survey data from Asian countries with mild ID indicated that the use of iodized 
salt was significantly correlated with higher weight-for-age and mid-upper-arm 
circumference, especially in the second year of life (Mason et al., 2002). An 
intervention study in schoolchildren showed that iodine supplementation 
increased the IGF-I and IGF-binding protein-3 levels in body and also showed 
higher z-scores for weight-for-age and height-for-age (Zimmermann et al., 
2007b).  
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2.1.5. Lactation 
During pregnancy, renal iodine clearance and thyroid hormone production are 
increased (Glinoer, 2007). During lactation, renal iodine clearance and thyroid 
hormone production return to normal even though the iodine requirement is 
increased during this time for secretion into breast milk (WHO Secretariat on 
behalf of the participants to the Consultation et al., 2007). Glinoer et al. (Glinoer 
et al., 1992) and Eltom et al. (Eltom et al., 2000) observed normalization of the 
thyroid function six months respectively nine months post-partum. The studies 
neither measured iodine concentration in breast milk nor assessed if the women 
increased their iodine intake during lactation (Eltom et al., 2000; Glinoer et al., 
1992). 
 
During lactation, the mammary gland concentrates iodide actively to ensure an 
adequate iodine supply to the infant (Azizi and Smyth, 2009; Rousset and 
Dunn, 2004). The concentration of iodide in breast milk is 20 – 50 times higher 
in relation to the plasma concentration (Azizi and Smyth, 2009). Almost 80% of 
total iodine in breast milk is in the form of iodide (Semba and Delange, 2001). 
Iodide is transported to the mammary gland in the same way as to the thyroid 
gland, by a Na+/Iodide-symporter (NIS). NIS expression increases during 
lactation (Tazebay et al., 2000). The secretion of iodide into breast milk is 
influenced by several hormones (prolactin, oestradiol, oxytocin) (Azizi and 
Smyth, 2009). 
Thyroid hormones and metabolites are also found in breast milk in various 
concentrations as reviewed by Dorea (Dorea, 2002). 
 
The iodine intake level of the mother influences the iodine content of breast 
milk. Mothers who use iodized salt or iodine-containing supplements usually 
have higher breast milk iodine concentrations compared with non-users (Azizi 
and Smyth, 2009; Zimmermann, 2007b). However, some studies found no 
influence of iodized salt or supplements (Azizi and Smyth, 2009).  
 
It has been shown that maternal smoking interferes with the iodine transport to 
breast milk. This is probably mediated by thiocyanate from smoke that inhibits 
the NIS (Laurberg et al., 2004). 
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2.2. Dietary iodine requirements  
2.2.1. Overview 
Dietary iodine requirement is based on adequate synthesis of thyroid hormones 
in order to meet physiological needs and to avoid iodine deficiency disorders 
(D-A-CH, 2008; Zimmermann, 2008a). 
Various factors need to be considered to determine recommendations of iodine 
intake such as iodine uptake rate, reutilization, storage, excretion in urine and 
stool, variations in iodine content of food, goitrogens and cooking losses (D-A-
CH, 2008; Prentice et al., 2004). Iodine turnover studies and balance studies 
are methods to define iodine requirements and recommendations of iodine 
intake. Another approach is epidemiological studies that observe correlations 
between iodine supply, urinary iodine concentration and goiter frequency (D-A-
CH, 2008; FAO and WHO, 2004; Zimmermann, 2007b). 
For adults, WHO/ICCIDD (> 12 yr), D-A-CH (Switzerland, > 15 yr), US Institute 
of Medicine (≥ 14 yr, RDA) and the Nordic Nutrition Recommendations (> 10 yr) 
recommend an iodine intake of 150 µg/day (Becker et al., 2004; D-A-CH, 2008; 
Institute of Medicine et al., 2001; World Health Organization et al., 2007). The 
Scientific Committee for Food (SCF) of the European Commission recommends 
only 130 µg/day (SCF (Scientific Committee for Food), 1993). 
The iodine requirements for infants, young children, pregnant and lactating 
women are different from adults‟ requirements due to varying physiological 
situations. Consequently, the recommendations for iodine intake differ (D-A-CH, 
2008; Institute of Medicine et al., 2001; World Health Organization et al., 2007). 
The recommendations for infants and lactating women are described in the 
following sections.  
 
2.2.2. Recommendations for infants 
The recommendations of iodine intake for adults are rather consistent in 
different organizations and countries. In contrast, there is a large variation 
among recommendations for infants. Table 2 shows recommendations for 
infants.  
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Table 2: Recommendations for iodine intake: Infants 
Infants Age group 
Recommended 
iodine intake 
[µg/day] 
Source 
UNICEF, ICCIDD, 
WHO 
≤ 2 yr 90 
(World Health Organization 
et al., 2007) 
D-A-CH  
Germany, Austria 
 
 
Switzerland 
 
 
 
0 to < 4 mo a 
4 to < 12 mo 
1 to < 4 yr 
0 to < 4 mo a 
4 to < 12 mo 
1 to < 4 yr 
 
40 
80 
100 
50 
50 
90 
(D-A-CH, 2008) 
US Institute of 
Medicine 
AI 
 
EAR/RDA 
 
 
0 to 6 mo 
7 to 12 mo 
1 to 3 yr 
 
 
110 
130 
65/90 
(Institute of Medicine et al., 
2001) 
SCF European 
Commission (PRI) 
6 to 11 mo 
1 to 3 yr 
50 
70 
(SCF (Scientific Committee 
for Food), 1993) 
COMA (United 
Kingdom) (RNI) 
0 to 3 mo 
4 to 12 mo 
1 to 3 yr 
50 
60 
70 
Recommendations of the 
Department of Health, UK, 
1991, data from (Thomson, 
2002) 
Nordic Nutrition 
Recommendations 
< 6 mo 
6 to 11 mo 
12 to 23 mo 
-- 
50 
70 
(Becker et al., 2004) 
AFSSA (France) 
0 to 6 mo 
7 to 12 mo 
40 
50 
Recommendations of 
Agencie Française de 
Sécurité Sanitaire des 
Aliments (AFSSA), France, 
2001, data from (EU 
Scientific Committee on 
Food, 2003)  
CSH (Belgium) 0 to 1 yr 90 
Recommendations of 
Conseil supérieur d‟Hygiéne 
(CSH), Belgium, 2000, data 
from (EU Scientific 
Committee on Food, 2003) 
Spanish Dietetic and 
Food Science 
Association 
0 to 1 yr 35 
Data from (EU Scientific 
Committee on Food, 2003) 
a 
Estimated value 
Abbreviations: AI = Adequate intake, EAR = Estimated average requirement, RDA = Recommended 
dietary allowance, PRI = Population reference intake, RNI = Reference nutrient intake 
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Compared to adults, infants and children need nutrients not only for 
maintenance of body functions and stores, but also for growth and 
development. These aspects need to be considered in recommendations of 
dietary intakes for infants and children (Prentice et al., 2004). 
 
Explanations on recommendations: 
UNICEF, ICCIDD, WHO: The currently recommended iodine intake for infants 
was updated in 2001 (FAO and WHO, 2004) from the earlier recommendation 
of WHO/UNICEF/ICCIDD (50 µg/day in the first 12 months of age) (WHO et al., 
1996) and the earlier recommended dietary allowances (RDAs) of the Food and 
Nutrition Board of the United States National Academy of Sciences 
(Subcommittee on the tenth edition of the RDAs et al., 1989).  
Gushurst et al. and Delange et al. reported that the iodine recommendation of 
40 - 50 µg/day for infants in the 1980‟s edition of the RDAs was derived from 
breast milk iodine concentration (equates to about 50 µg/l) because it was 
assumed that normally growing infants have an adequate nutrient intake. 
Nevertheless, Gushurst et al. and Delange et al. expressed their uncertainty 
about the adequacy of that earlier recommendation (Delange et al., 1988; 
Gushurst et al., 1984).  
In 1984, Gushurst et al. measured a mean breast milk iodine concentration 
(BMIC) of 178 µg/l in US women (median 146 µg/l) (Gushurst et al., 1984). In a 
revision of the RDAs in year 1989, based on the study of Gushurst et al. 
(Gushurst et al., 1984) it was stated that the BMIC of North American women 
was much higher than the infants‟ needs for iodine due to elevated iodine 
intakes of the women. Therefore, BMIC was not a good basis for the 
recommendations. Thus, relative energy requirements of adults were used as a 
basis for the revised recommendations in 1989 (Subcommittee on the tenth 
edition of the RDAs et al., 1989). However, the recommended dietary 
allowances for iodine were basically the same as before: 40 µg/day for 0 – 6-
month-old infants and 50 µg/day for 7 – 12-month-old infants (approximately 7.5 
µg/kg/day) (Subcommittee on the tenth edition of the RDAs et al., 1989).  
FAO and WHO explained the last update of their recommendation in 2001 as 
follows (FAO and WHO, 2004): Infants have an iodine intake of about 60 µg/day 
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in Europe and about 120 µg/day in the USA. These assumptions were based on 
several studies on BMIC and an average breast milk intake of 750 ml/day  (FAO 
and WHO, 2004). FAO and WHO also considered a balance study of Delange 
et al. conducted with one month old infants (n = 20) in 1983 (Delange et al., 
1988). Delange et al. concluded from this study that a positive iodine balance, 
which is required in infants for building up iodine stores, is only achieved with an 
iodine intake of 15 µg/kg/day (for full term infants) (Delange et al., 1993). The 
infants had a mean iodine retention of 7.3 µg/kg/day in this balance study 
(mean intake 20 µg/kg/day, excretion in feces 1.3 respectively in urine 11.4 
µg/kg/day) (Delange et al., 1988). On the basis of Delange et al.‟s study, FAO 
and WHO concluded that a 6-month-old infant of 6 kg body weight has an 
iodine requirement of approximately 90 µg/day (6 kg * 15 µg/kg/day) (FAO and 
WHO, 2004). Based on the estimated iodine intakes in Europe and the USA 
and Delange et al.‟s study, the updated recommendation for iodine intake was 
set at 90 µg/day for children ≤ 2 yr  (FAO and WHO, 2004; World Health 
Organization et al., 2007). 
D-A-CH: No detailed explanation for the iodine recommendations for infants is 
given by D-A-CH (D-A-CH, 2008). In general, it is indicated, however, that the 
reference values for infants in the first four months of life apply to exclusively 
breast-fed infants. It is referred to Souci et al. for the nutrient contents of breast 
milk. Souci et al. specified an average BMIC of 5.1 µg/100g (Souci and 
Deutsche Forschungsanstalt für Lebensmittelchemie (Garching), 2008). 
Furthermore, an average BM quantity of 750 ml/day (CV about 12.5%) is 
indicated for infants after two months of age (D-A-CH, 2008). This would result 
in a daily iodine intake of 38.25 µg (51 µg/l * 0.75 l), which is very close to the 
recommended 40 µg/day for infants aged 0 to < 4 months in Germany and 
Austria. It is emphasized, however, that the recommendations, which were 
extrapolated from breast milk, are just estimated values due to variations in 
nutrient content of BM and lack of systematic investigations on requirements of 
infants for most of the essential nutrients (D-A-CH, 2008).  
For infants aged 4 to < 12 months and 1 to < 4 years in Austria and Germany 
the iodine recommendations are higher compared with Switzerland. According 
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to the explanation for adults, this is because iodine supply in Germany is still not 
adequate in some regions and age groups and because several interfering 
factors were considered (variations in iodine content of food, iodine losses in 
food preparation, potentially low selenium supply and goitrogenic substances) 
(D-A-CH, 2008). Switzerland has a better iodine nutrition than Austria and 
Germany due to a salt iodization program which has existed for decades (D-A-
CH, 2008). Therefore, the iodine recommendations for Switzerland were 
derived from the WHO/UNICEF/ICCIDD recommendations of 1996 (50 µg/day 
in the first 12 months of age; 90 µg/day for 2 – 6 years of age) (WHO et al., 
1996). 
US Institute of Medicine (IOM): The AI for infants (0 – 12 months) represents 
the observed mean iodine intake of exclusively breast-fed infants. The IOM 
used Gushurst‟s study (Gushurst et al., 1984) which measured a median BMIC 
of 146 µg/l in US women and calculated an iodine intake of 114 µg/day for 
infants fed with 0.78 l breast milk per day. Additionally, they considered Delange 
et al.‟s iodine balance study (see above UNICEF, ICCIDD, WHO) (Delange et 
al., 1988) and calculated a total iodine excretion of 90 µg/day for a 6-month-old 
infant with a body weight of 7 kg (12.7 µg/kg/day iodine excretion in urine and 
feces * 7 kg). Based on these two calculations they set the AI of 110 µg/day for 
infants aged 0 - 6 months. The AI of 130 µg/day for infants aged 7 - 12 months 
was extrapolated from data of younger infants (AI 7-12mo = AI 0-6mo * (weight 7-
12mo/weight 0-6mo)
0.75 ; weight 0-6mo = 7 kg, weight 7-12mo = 9 kg) (Institute of 
Medicine et al., 2001). 
The EAR (estimated average requirement) for children aged 1 - 3 years was 
based on a 4-day balance study that was performed with seven Senegalese 
infants (aged 1.5 to 2.5 yr). These had recovered from protein-calorie 
malnutrition one month before. Their mean iodine intake was 63.5 µg/day and 
they had a positive iodine balance (+ 19 µg/day) (Ingenbleek and Malvaux, 
1974). As no better data were available, the EAR for children aged 1 - 3 years 
was derived from Ingenbleek and Malvaux‟s balance study and set at 65 µg/day 
(Ingenbleek and Malvaux, 1974; Institute of Medicine et al., 2001). If the EAR 
for children of this age group had been extrapolated from the adults EAR 
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(based on body weight), it would have been only 36 µg/day (Institute of 
Medicine et al., 2001). 
The RDA is: EAR + 2 * CV( 20%) (Institute of Medicine et al., 2001). 
SCF: The recommendations for infants were calculated from the 
recommendation for adults (130 µg/day) based on energy requirements (SCF 
(Scientific Committee for Food), 1993). 
COMA (United Kingdom): The UK recommendations for infants up to 12 
months of age were based on the observation that infants who received breast 
milk containing 30-40 µg iodine per liter did not show signs of deficiency 
(Gushurst et al., 1984). A margin of safety was added to the recommendations 
(data from: (Thomson, 2002)).  
For older infants and children recommendations were extrapolated from adults‟ 
recommendations using estimated average requirements (EAR) for energy 
(data from: (Thomson, 2002)). 
Nordic Nutrition Recommendations: No detailed information was found as 
only an excerpt of the recommendations (Becker et al., 2004) was available 
online.  
AFSSA, CSH (Belgium), Spanish Dietetic and Food Science Association 
(data from (EU Scientific Committee on Food, 2003)) no detailed explanation for 
recommendations could be found.  
 
The “Swiss regulation of infant food” specifies 80 µg of iodine as reference 
value for daily iodine intake on labels of infant food. No further explanations are 
given in the regulation (EDI, 2005b). 
 
2.2.3. Recommendations for lactating women 
Lactating women have higher recommendations for iodine intake compared to 
non-pregnant, non-lactating women because of iodine secretion into breast milk 
(D-A-CH, 2008; Institute of Medicine et al., 2001; WHO Secretariat on behalf of 
the participants to the Consultation et al., 2007). Table 3 shows 
recommendations of several organizations.  
 
22 Background 
 
 
 
 
University of Vienna  Nadja Wüst 
 
 
Table 3: Recommendations for iodine intake: Lactating women 
Lactating women 
Recommended iodine 
intake [µg/day] 
Source 
UNICEF, ICCIDD, WHO 250 
(World Health Organization et al., 
2007) 
D-A-CH  
Germany, Austria 
Switzerland 
 
260 
200 
(D-A-CH, 2008) 
US Institute of Medicine 
EAR 
RDA 
 
209 
290 
(Institute of Medicine et al., 2001) 
SCF (PRI) 160 
(SCF (Scientific Committee for 
Food), 1993) 
Nordic Nutrition 
Recommendations 
200 (Becker et al., 2004) 
Abbreviations: EAR = Estimated average requirement, RDA = Recommended dietary 
allowance, PRI = Population reference intake 
 
The US Institute of medicine assumed an average daily loss of 114 µg iodine 
through breast milk (Institute of Medicine et al., 2001). Delange estimated that 
the daily iodine excretion via breast milk is 75 – 200 µg (in iodine-sufficient 
women) depending on the amount of breast milk produced (0.5 – 1.1 l) 
(Delange, 2007).  
The WHO recently increased the recommendation for iodine intake from 200 
µg/day to 250 µg/day for lactating women (which is the same recommendation 
as for pregnant women) (WHO Secretariat on behalf of the participants to the 
Consultation et al., 2007). 
 
2.2.4. Upper limits of intake 
According to WHO/FAO, the save upper limit of iodine intake is 150 µg/kg/day 
for infants aged 0 – 6 months, 140 µg/kg/day for infants aged 7 – 12 months, 50 
µg/kg/day for 1 - 6 year old children and 40 µg/kg/day for lactating women (FAO 
and WHO, 2004). 
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2.3. Dietary iodine sources 
2.3.1. Iodine in the food chain – salt iodization 
The iodine content of plants depends on the iodine content of soils in which they 
are grown. Therefore, the iodine content of foods in the food chain can vary 
markedly. European inland soils are depleted in iodine presumably mainly due 
to glaciations (Haldimann et al., 2005). The most depleted areas in the world 
are the Himalayas, the Andes, the European Alps and the mountains of China 
(Clugston and Hetzel, 1994). Soils in coastal areas and seawater, on the 
contrary, contain higher amounts of iodine.  
 
Marine fish, shellfish and seaweed have the highest natural iodine 
concentrations (up to 1100 µg/kg) (FAO and WHO, 2004; Haldimann et al., 
2005). Iodine concentrations of plant foods, in contrast, are usually very low 
(see Table 4). Milk and eggs have a rather high iodine concentration which is 
due to the use of iodine-containing feed supplements (Haldimann et al., 2005). 
Als et al. reported that in Switzerland cow milk has a higher iodine concentration 
in winter compared with summer because in winter, cows are fed indoors with 
processed iodine-enriched food (Als et al., 2003). Dahl et al. made the same 
finding for Norwegian milk (Dahl et al., 2003). Muscle flesh only contains very 
small amounts of iodine even after feed supplementation (Franke et al., 2008; 
Haldimann et al., 2005). The iodine content of cheese and bread depends on 
the use of iodized salt during production and processing (Haldimann et al., 
2005). Iodine content of tap water can vary much as shown in a Danish study, < 
1.0 - 139 µg/l (Pedersen et al., 1999). 
 
Table 4 shows mean iodine contents which were measured in Swiss foods 
(Haldimann et al., 2005). Iodine contents of Swiss foods can be found also in 
the Swiss food composition table (SwissFIR, 2008) (available online: 
www.swissfir.ethz.ch/datenbank). 
 
Thomson et al. recently found in a New Zealand study that 65% of analyzed 
foods had an iodine content of less than 0.02 µg/g (n = 121, about 70% of the 
most commonly consumed foods in New Zealand) (Thomson et al., 2008). 
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Table 4: Iodine contents in Swiss food samples [µg/kg] (adapted from (Haldimann et 
al., 2005)) 
Food Iodine content in fresh weight samples [µg/kg] 
Marine fish 486 (89 – 1593) a 
Freshwater fish 98 (3 – 408) 
Meat 17 (2 – 155) 
Poultry 18 (10 – 169) 
Milk (winter) 124 (59 – 199) 
Eggs 324 (247 – 428) 
Wholemeal 33 (11 – 47) 
Bread 310 (20 – 815) 
Fruits 3 (0.3 – 13) 
Vegetables 5 (1 – 22) 
a
 Mean (range) (all such values) 
 
Populations living in iodine-depleted areas suffer from iodine deficiency and its 
consequences. Strategies to eliminate iodine deficiency are fortification of foods 
and feed, use of iodine in fertilizers and irrigation water and dietary 
diversification with foods from iodine-sufficient areas (Zimmermann et al., 
2008).  
The recommended strategy to bring iodine into the food chain and to eradicate 
IDDs is universal salt iodization (iodization of all salt for food industry, 
households and animal food). Salt is a good vehicle for iodine because nearly 
everybody uses salt throughout the year. Iodized salt is technically easy to 
produce and cost effective (World Health Organization et al., 2007; 
Zimmermann et al., 2008). WHO recommends adding 20-40 mg iodine/kg salt 
(Allen et al., 2006).  In Switzerland, salt currently has an iodization level of 20 
mg/kg (since 1998) (Zimmermann, 2005). Salt producers and retailers must 
offer iodized and non-iodized salt (Zimmermann, 2008c). In Switzerland, there 
are only two salt producers, and they supply the whole of the country (Bürgi, 
2005). It is estimated that about 95% of the salt used in Swiss households is 
iodized (Zimmermann, 2005). In the USA, household salt only contributes 15% 
to daily salt intake, whereas the major part of salt comes from processed foods 
(Pearce, 2007). A recent study in Switzerland (Geneva) calculated that 
discretionary salt delivers 35% and 41% of total salt intake to women and men, 
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respectively. Consequently, the remaining part comes from processed foods 
(Beer-Borst et al., 2009). The use of iodized salt by food industries in 
Switzerland is voluntary (Zimmermann et al., 2005). It is estimated that about 50 
– 70% of salt in processed foods is iodized (Haldimann et al., 2005; 
Zimmermann, 2008c).  
 
2.3.2. Major dietary iodine sources – general population 
In Switzerland, Haldimann et al. estimated per capita exposure to iodine from 
Swiss foods based on food consumption statistics and measurements of iodine 
content in Swiss foods. Bread (with iodized salt) (41%) and milk (21%) were 
identified as the major iodine sources in Switzerland followed by cheese (9%) 
and eggs (7%). Other food groups contributed only to a minor extent to iodine 
exposure. This study excluded the use of iodized kitchen salt (Haldimann et al., 
2005).  
The following studies assessed the major iodine sources in some other 
countries. 
Manz et al. identified bakery products and milk products as main iodine sources 
for adults in Germany (n = 2500, > 13 yr), followed by iodized table salt, cold 
water fish and meat products (specialized FFQ) (Manz et al., 2002). In another 
German study, which was performed in school children, milk, fish, egg, meat 
and sodium intake were significant predictors of iodine status (Remer et al., 
2006). 
A study in Norway (n > 2500) reported that the main iodine sources for 
Norwegian adults were milk and dairy products, fish and fish products (80% of 
iodine intake). The study used an FFQ (iodized salt not included) and measured 
iodine concentration in food with ICP-MS (Dahl et al., 2004).  
Pearce et al. regarded milk and dairy products and bread and iodized salt as 
the most important iodine sources in the USA. Moreover, multivitamins were 
suggested as possible important source for the US population (Pearce, 2007; 
Pearce et al., 2004). New results of the US Total Diet Study showed that dairy 
and grain products were the most important iodine sources for US adults 
(Murray et al., 2008). 
26 Background 
 
 
 
 
University of Vienna  Nadja Wüst 
 
 
A recent study examined dietary iodine exposure with typical simulated diets in 
New Zealand. Dairy foods were the dominant iodine source in all population 
groups except in 6 - 12-month-old infants. For them, iodine in infant formulae 
and weaning foods contributed to 60% of the iodine exposure. Eggs, mussels, 
fresh fish and oysters were also important for most population groups. Use of 
household salt was not taken into account (Thomson et al., 2008). 
In a Korean study, seaweed contributed to 66% of iodine intake in adults (Kim 
et al., 1998) and in fact the iodine intake solely by seaweed consumption was 
1200 µg/day (Nagataki, 2008). 
 
2.3.3. Infants 
Infants have different food sources compared to adults and therefore different 
iodine sources. 
 
2.3.3.1. Infant nutrition 
The WHO recommends exclusive breast-feeding for the first six months of life. 
Thereafter, complementary foods (CF)4 should be introduced while continuing 
breast-feeding (World Health Organization, 2001). In Switzerland, the “Nutrition 
Commission of the Swiss Pediatric Society” (EK SGP) recommends exclusive 
breast-feeding during the first four to six months of life (ideally six months). If 
breast-feeding is not possible, infant formula should be used during this time. 
Afterwards, starting from the 5th to 7th month of life, feeding with breast milk 
(BM) or formula (FM)5 together with CF is recommended 
(Ernährungskommission der Schweizerischen Gesellschaft für Pädiatrie, 2008). 
CF should be introduced at the latest from the 7th month onwards as breast milk 
does not thereafter deliver enough nutrients (Agostoni et al., 2008; 
Ernährungskommission der Schweizerischen Gesellschaft für Pädiatrie, 2008). 
A feeding plan is included in Appendix 2 (Swiss pediatric society, 2002). 
The Swiss Nutrition Society (SGE) and EKSGP recommend replacing one daily 
                                               
4 Complementary food is defined as follows: Any food (solid or liquid) suitable as a complement 
to breast milk or infant/follow-on formula. Other terms used to describe CF are „„weaning foods‟‟ 
and „„Beikost‟‟ (WHO, 2003; Agostoni et al., 2008). 
5
 Formula (FM) = Breast milk substitutes, usually cow milk based, sometimes soy protein based, 
including infant formulae and follow-on formulae (EDI, 2005b).  
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BM/FM meal by a CF meal (porridge/puree) month by month. Finally, the infant 
receives 3 – 4 CF meals per day and BM or FM at the remaining meal 
occasions. The typical dish to start with CF is vegetable puree. New foods 
should be introduced stepwise with at least 3 – 4 days in between before 
introducing the next one. Continuously, potatoes, oil and meat/egg are added to 
the vegetable meals. Alternatively, complementary feeding can be started by a 
milk-cereal-porridge; otherwise, it usually is the second introduced meal. Next, a 
fruit-cereal-porridge is introduced (Dähler et al., 2007; Ernährungskommission 
der Schweizerischen Gesellschaft für Pädiatrie, 2008).  The selection of CF is 
influenced by various individual, traditional and cultural factors 
(Ernährungskommission der Schweizerischen Gesellschaft für Pädiatrie, 2008).  
Between the end of the first and beginning of the second year, infants 
continuously start eating family foods. CF meals slowly start adapting to adult 
meals (e.g. fruit-cereal-porridge becomes a snack composed of bread and fruit) 
considering specific needs of the growing young child (Ernährungskommission 
der Schweizerischen Gesellschaft für Pädiatrie, 2008; Forschungsinstitut für 
Kinderernährung, 2007; Tönz et al.).  
The SGE gives examples of typical daily meal sequences for infants in their 
recommendations (Dähler et al., 2007):  
- For a 6-month-old infant: first meal: BM/FM  second meal: vegetable-potato-
meat-puree  third meal: BM/FM  fourth meal: milk-cereal-porridge.  
- For a 10- to 12-month-old infant: first meal: BM/FM and bread  second meal 
(snack): bread and fruit juice (1:1 diluted with water) or muesli  third meal: 
vegetable-potato-meat meal  fourth meal: same as second  fifth meal: milk-
cereal-porridge maybe with fruits.  
Examples of meal compositions are given in the nutrition recommendations of 
Dähler et al. and Kersting (Dähler et al., 2007; Kersting, 2001). 
In Switzerland, undiluted cow milk is recommended for infants at the earliest 
from the second year of life (Ernährungskommission der Schweizerischen 
Gesellschaft für Pädiatrie, 2008). Before this, diluted cow milk can be added to 
cereal-milk-porridges if desired even though FM is preferable to cow milk during 
the whole first year of life (Tönz et al.). 
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During the periods of breast-/formula-feeding and complementary feeding, salt 
is not the ideal vehicle for providing iodine as salt intake should be limited 
during these periods (Glinoer, 2007). EK SGP and SGE recommend not giving 
salt to infants below one year of age and, even until 36 months of age, only tiny 
quantities and only iodized and fluoridated salt should be given (Dähler et al., 
2007; Ernährungskommission der Schweizerischen Gesellschaft für Pädiatrie, 
2008; Swiss pediatric society, 2002).  
 
A Swiss study on feeding practices of infants up to 9 months of age was 
conducted in 2003 (n = 2868). A self-administered 24h-dietary-recall 
questionnaire was used, but no frequencies or quantities were inquired (Dratva 
et al., 2006; Merten et al., 2005). Table 5 shows the percentage of infants by 
age [mo] who were exclusively/fully (= predominantly) breast-fed and the 
percentage of infants who had received BM, FM and CF at least once (Merten 
et al., 2005).  
 
Table 5: Infant feeding in different months of age (modified after (Merten et al., 2005)) 
Month of life 
[mo] 
Exclusive 
BF [%] 
Full/ 
predominant 
BF [%] 
Within the last 24h at least [%] 
BF once FM once CF once 
1
st
 and 2
nd
 58 73 83 23 5 
3
rd
 and 4
th
 53 64 76 34 5 
5
th
 and 6
th
 21 27 60 51 57 
7
th
, 8
th
, 9
th
 2 2 40 61 97 
≥ 10
th
 0 0 29 60 99 
Abbreviations: BF = breast-fed; FM = formula milk; CF = complementary food; mo = months 
 
Figure 2 shows the prevalence of different milk types by month of life (Dratva et 
al., 2006). The study found that > 50% of infants were introduced to CF by the 
age of 6 months. The first introduced foods were vegetables and fruits, followed 
by cereals. Figure 3 shows the prevalence of different types of CF by month of 
life (Dratva et al., 2006). A high percentage of mothers cooked infant food 
themselves at least once in the last 24 hours. 81% of fruit, vegetable, meat or 
fish meals and 17% of cereal meals were home-made (Merten et al., 2005). 
 
No other studies on infant feeding in Switzerland were found. 
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Figure 2: Milk feeding in different months of life. Source: (Dratva et al., 2006) 
 
 
Figure 3: Complementary foods in different months of life. Source: (Dratva et al., 2006) 
 
 
In the German DONALD study, the contribution of different foods to the total 
food intake (g/d) of 6- respectively 12-month-old infants was: 25% resp. 1% BM, 
33% resp. 13% FM, 10% resp. 9% commercial infant cereals, 10% resp. 15% 
commercial baby foods and 13% resp. 62% other foods (homemade infant food, 
family food, cow milk) (Kersting et al., 1998).  
In the US Feeding Infants and Toddlers Study, the most important energy 
sources for 6- to 11-month-old infants were infant formula (43%), BM (11%) and 
infant cereals (6.5%). For 12- to 24-month-old infants it was milk (cow/goat/soy, 
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24%), juice (6%), sweetened beverages (5%), cheese (4%) and bread (various 
kinds, 4%) (Fox et al., 2006). 
 
2.3.3.2. Iodine sources for infants 
Infants depend completely on the iodine concentration of BM or FM in their first 
months of life, then gradually also on iodine content in CF and by the end of the 
first year, progressively on iodine content in family foods. 
To our knowledge no study on iodine intake of Swiss infants has been 
conducted before this study.  
According to Kersting (2001), the major iodine source for infants is FM (about 
55%), followed by milk-cereal-porridges (about 22%), vegetable-potato-meat-
purees (about 15%) and fruit-cereal-porridges (about 8%) (estimation is based 
on home-made CF) (Kersting, 2001). 
A national British study assessed food intake of 6- to 12-month-old infants (n = 
488) by a 7-day dietary record in 1986 (Mills and Tyler, 1992). The median daily 
iodine intake was 164 µg/day for 6 – 9-month-old infants and 236 µg/day for 9 – 
12-month-old infants. The highest percentage of iodine was observed from milk: 
71% for 6 – 9-month-old infants (46% cow milk, 22% FM, 3% BM) and 68% for 
9 – 12-month-old infants (62% cow milk, 5% FM, 1% BM). Family foods 
contributed to 19% respectively 28% of the iodine intake of 6 – 9- respectively 9 
– 12-month-old infants. Commercial infant food (jars, instant foods, rusks) 
supplied 10% respectively 4% of iodine to 6 – 9- respectively 9 – 12-month-old 
infants. No further details were given about iodine intake. Salt use was not 
taken into account in the calculations. The contribution of foods to energy intake 
was: 6% resp. 1% BM, 23% resp. 7% FM, 18% resp. 28% cow milk, 30% resp. 
53% family foods and 23% resp. 11% infant foods for 6 – 9-month resp. 9 – 12-
month-old infants. Within family foods, bread and cereals delivered the highest 
percentage of energy (Mills and Tyler, 1992).  
In a more recent study in south-west England, which assessed food intake in  8-
month-old infants (n = 1130) by a 3-day unweighed dietary record, a median 
iodine intake of 75.3 µg/day was found (Noble and Emmett, 2001). Milk 
accounted for 52% of the energy intake (13% BM, 30% FM, 9% cow milk). The 
contribution of foods to iodine intake was not indicated (Noble and Emmett, 
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2001). 
In the New Zealand Total Diet study (Thomson et al., 2008) typical diets were 
simulated. In non-breast-fed 6- to 12-month-old infants, exposure to iodine was 
dominated by iodine content of infant and follow-on formula. The contribution (in 
%) of food groups to dietary iodine exposure in 6 – 12-month-old infants was: 
60% infant formulae and weaning foods (cereal based/custard and fruit 
dish/savoury), 25% dairy, 7 % chicken/eggs/fish/meat, 3% grains, 2% take-
aways, 3% other foods. For a 1 – 3-year-old toddler it was: 67% dairy, 13% 
chicken/eggs/fish/meat, 7% grains, 4% take-aways, 3% infant formulae and 
weaning foods, 6% other foods. This study estimated an exposure to iodine of 
49 µg/day for infants and 47 µg/day for toddlers (iodized salt was not taken into 
account) (Thomson et al., 2008). 
In the US FDA Total Diet Studies (1982 – 1991) the major contributors to iodine 
intake in 6 – 11-month-old infants were milk and cheese (59%) and grain 
products (18%) (Pennington and Schoen, 1996a) with an estimated daily iodine 
intake of 131 µg (Pennington and Schoen, 1996b). Household salt was not 
taken into account (Pennington and Schoen, 1996a). New results of the US 
Total Diet Study showed that 90% of iodine intake in 6 – 11-month-old non-
breast-fed infants is provided by baby foods (including all baby foods and FM, 
no adult foods consumed by the infant) and dairy products. Their estimated total 
daily iodine intake was 144-155 µg (around 85 µg from baby foods and 50 µg 
from dairy) (Murray et al., 2008). 
 
2.3.3.3. Iodine in formula and commercial infant food 
Swiss legislation regulates the iodine contents of infant formula and follow-on 
formula (definition see Appendix 1) and of cereal-based and other 
complementary food (“Beikost”, definition see Appendix 1) in the regulation on 
“special foods” of the Federal Department of Home Affairs (“Eidgenössisches 
Department des Inneren”) (EDI, 2005b). In March 2008, the required minimum 
iodine content of infant and follow-on formula was elevated from 5 μg/100 kcal 
(1.2 μg/100 kJ) to 10 μg/100 kcal (2.5 μg/100 kJ). The upper level of iodine was 
set at 50 μg/100 kcal (10 μg/100 kJ). The allowed energy value for formula was 
reduced from 75 respectively 80 kcal/100 ml for infant respectively follow-on 
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formula to 60 – 70 kcal/100ml (250 – 295 kJ/100 ml) for both in 2008 (all values 
refer to the ready-to-eat product) (EDI, 2005b). The regulation restricts the 
forms of iodine which are allowed  for fortification (EDI, 2005b). The new 
regulations for iodine content of infant and follow-on formulae were made based 
on the recommendations of the European Commission in 2003 (EU Scientific 
Committee on Food, 2003) and the European Society of Pediatric 
Gastroenterology, Hepatology and Nutrition (ESPGHAN) in 2005 (Koletzko et 
al., 2005). The 31st March 2010 was set as date of implementation of the new 
regulations. Permission was given to launch, produce and label products 
according to the former regulations up to this date and the products can still be 
sold until depletion of stocks (EDI, 2005b).  
For cereal-based and other complementary foods, there is no regulation in 
Switzerland and the EU requiring a minimum iodine content in the products. In 
case of fortification, the allowed upper level is 35 μg iodine/100 kcal product 
(ready-to-eat) (Commission of the European Communities, 2006; EDI, 2005b). 
Concerning fortification of CF through iodized salt, Swiss regulation only allows 
the addition of sodium salts to cereal-based CF if necessary for technical 
reasons and in this case, a sodium content of maximally 100 mg/100 kcal (25 
mg/100 kJ) is allowed. For other CF (e.g. vegetable-meat-purees), a sodium 
content of maximally 200 mg/100 kcal (48 mg/100 kJ) or 200 mg/100g is 
allowed in the finished product. It is not allowed to add sodium salts to fruit 
dishes, desserts and puddings except for technological purposes (EDI, 2005b). 
According to SGE (Dähler et al., 2007) and Kersting (Kersting, 2001), the 
recommended iodine intake for infants is often only fulfilled by feeding them 
fortified commercially available CF because home-made food has low amounts 
of iodine.  
In a recent German market survey for infant foods, 64% of products (n = 305) 
were fortified with iodine, 51% of CF products and all formulae (min. 7 μg/100g). 
Most milk-cereal-porridges were fortified with iodine (83%). A minor part of 
menus (37%) and fruit-cereal-porridges (13%) was fortified with iodine (Alexy et 
al., 2009). In a scenario, the survey compared the iodine intake of an 8-month-
old breast-fed infant, who received home-made CF, with a formula-fed infant, 
Background 
 
 
 
University of Vienna  Nadja Wüst 
 
33 
who received commercial CF. The breast-fed infant had an estimated iodine 
intake of about 40 μg/day (BMIC 6.4 - 9.1 μg/100g) and the formula-fed infant 
had an intake ranging from 125 – 187 μg/day. Accordingly, the breast-fed infant 
reached only about half of the recommended iodine intake in Germany (80 
μg/day) and the formula-fed infant had an intake of 50 – 130% above the 
recommendation (Alexy et al., 2009). 
 
2.3.4. Supplements 
The Nutrition Commission of the Swiss Pediatric Society states in its 
recommendations for infant feeding in 2008 that infants and children who have 
a well-balanced diet do not need iodine supplementation as struma prophylaxis 
(Ernährungskommission der Schweizerischen Gesellschaft für Pädiatrie, 2008). 
The Federal Office of Public Health in Switzerland does not recommend iodine 
supplementation of lactating mothers either (Camenzind-Frey and Hesse-
Lamm, 2008). 
 
The WHO does not recommend iodine supplementation for infants and lactating 
women living in countries where iodized salt is used in > 90% of households 
and universal salt iodization is achieved and where iodine intake is adequate 
(according to WHO criteria (World Health Organization et al., 2007)). The WHO 
recommends, however, ensuring that complementary foods are fortified with 
iodine. If iodine intake in a country is insufficient, WHO suggests 
supplementation with potassium iodide (daily) or iodized oil (annual dose) for 
women of reproductive age, pregnant and lactating women in order that their 
recommended daily iodine intake is met. In this case, breast-fed infants receive 
supplementation through BM or fortified weaning foods (WHO Secretariat on 
behalf of the participants to the Consultation et al., 2007).  
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2.4. Assessment of a population’s iodine status 
SAC are an easily accessible population group and are particularly vulnerable 
to IDDs. Therefore, they are the “golden standard” for determination of a 
population‟s iodine status (World Health Organization et al., 2007). Most studies 
on iodine status in the WHO “Global Database on ID” (a database that lists the 
iodine status in countries based on available studies) were performed in SAC 
(WHO Nutrition, 2008b). The other recommended target groups are women of 
childbearing age and pregnant women (15 - 44 yr) because ID particularly in 
fetus and neonates is dangerous (World Health Organization et al., 2007). 
The WHO recommends two survey methods for monitoring the iodine status in 
a population: 1) cross-sectional surveys, which are usually performed to obtain 
representative population data, 2) sentinel surveillance, which is useful to see 
trends in iodine nutrition (World Health Organization et al., 2007). In cross-
sectional surveys there are often two stages of selection. In the first stage, 
clusters (e.g. schools) are selected by “probability proportion to 
size”/”proportionate to population size” (PPS) method, simple random sampling 
or systematic sampling. In the second stage, individuals are selected randomly 
or systematically. Usually, 30 clusters are used (Sullivan et al., 2000; World 
Health Organization et al., 2007). 
 
2.4.1. Recommended methods to assess iodine status 
2.4.1.1. Overview  
Four recommended parameters exist to assess the iodine status in a 
population. These are urinary iodine concentration (UIC), goiter rate, serum 
thyroid stimulating hormone (TSH) and thyroglobulin (Tg) (Zimmermann, 
2008b). 
UIC (µg/l) is a short-term measure of the iodine status (days) and reflects the 
current dietary iodine intake. It is well established for SAC, adults and pregnant 
women (World Health Organization et al., 2007). UIC analysis is the most 
widespread method worldwide to assess the iodine status biochemically 
(Caldwell et al., 2005) and is also the recommended method by the WHO 
(World Health Organization et al., 2007). For a more detailed description of the 
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method, see below. 
Goiter rate (%) is a long-term measure of iodine status (months to years) and is 
usually examined in SAC (Zimmermann, 2008b). It can be assessed either by 
palpation or by ultrasound. A goiter rate < 5% in a population indicates iodine 
sufficiency. This method is not applicable for infants (World Health Organization 
et al., 2007; Zimmermann et al., 2004). 
In many countries, TSH is assessed in newborn screening by blood spots to 
detect congenital hypothyroidism (Zimmermann, 2008b). Measuring TSH to 
determine iodine status is only valuable in newborns, as TSH increases only in 
newborns to a distinguishable level between iodine sufficiency and deficiency. 
The measurement is expensive and only feasible if a sufficiently sensitive TSH 
assay is available. Therefore, the WHO does not recommend it universally as 
an assessment method for iodine status (World Health Organization et al., 
2007). If less than 3% of newborns (3 – 4 days old) have a TSH value > 5 mU/l 
whole blood, this indicates iodine sufficiency in a population (Zimmermann et 
al., 2005). 
Tg reflects the iodine intake over the last weeks to months (Zimmermann, 
2008b). Tg measured in dried whole blood spots of SAC is a sensitive indicator 
of the iodine status in a population (reference range 4 - 40 µg/l) (World Health 
Organization et al., 2007; Zimmermann et al., 2006b). 
 
2.4.1.2. Urinary iodine concentration (UIC) 
Over 90% of ingested iodine finally appears in urine. Therefore, UIC is a good 
indicator of recent iodine intake (Zimmermann, 2008b).  
For an individual, a single urine specimen does not reflect the iodine status, 
because there is a high variation of UIC within a day (Als et al., 2000a; 
Rasmussen et al., 1999). The only reliable specimen is a 24-hour urine sample 
and even this shows a marked variation from day to day (Dunn, 1993). For 
better results more than one 24-hour urine sample should be analyzed for an 
individual (Rasmussen et al., 1999). 
However, spot urine samples have been shown to be an accurate measure in 
assessing the iodine status of a population(-group) when a sufficient number of 
samples are collected to compensate for varying degrees of subject hydration 
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and other biological differences between subjects and to attain a narrow 
confidence interval (Andersen et al., 2008; World Health Organization et al., 
2007).  
A spot urine sample is usually easy to obtain in field conditions. Iodine in urine 
is stable even without refrigeration and the measurement is generally simpler 
and cheaper compared with other biomarkers (Dunn, 1993; World Health 
Organization et al., 2007). 
 
2.4.1.2.1. Measurement 
Many analytical techniques for assessing UIC exist. Most of them are based on 
the Sandell-Kolthoff reaction (Sandell and Kolthoff, 1937), which is a 
quantitative colorimetric method. In this reaction, iodide acts as catalyst in the 
reduction of ceric ammonium sulfate (yellow) to the colorless cerous form in the 
presence of arsenious acid (Gnat et al., 2003). A modification of the Sandell-
Kolthoff method (Pino et al., 1996) was successfully implemented at the 
laboratory of human nutrition at ETH Zurich some time ago (for a description of 
the method, see chapter 3.6.1). This modified method (with ammonium 
persulfate digestion) is also the recommended technique of the WHO (World 
Health Organization et al., 2007). 
Another analytical method is ICP-MS (inductively coupled plasma mass 
spectrometry). This technique provides a high degree of accuracy and 
precision. It has become popular as a reliable method for the determination of 
trace elements in biological samples (Caldwell et al., 2005; Haldimann et al., 
1998). However, the equipment costs for ICP-MS are very high and therefore it 
is only used as a reference method in specialized laboratories (Vanderpas, 
2006).  
The CDC (Centers for Disease Control and Prevention) compared the ICP-MS 
method (used in NHANES 2000) with the modified Sandell-Kolthoff method 
(used in NHANES III) and found a strong correlation between the two methods 
(r2 = 0.980). There was no significant difference between the results of the ICP-
MS and the Sandell-Kolthoff method (Caldwell et al., 2003). 
EQUIP (Programme for Ensuring the Quality of Iodine Procedures) is an 
international external quality control program for UIC measurements (World 
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Health Organization et al., 2007). 
 
2.4.1.2.2. Interpretation 
Since analyzed UICs of study subjects are usually not normally distributed, the 
median UIC value is used for data interpretation. It is usually indicated as µg 
iodine per liter urine (µg/l) (World Health Organization et al., 2007). 
 
Table 6: Epidemiological criteria for assessing iodine nutrition based on median urinary 
iodine concentration (World Health Organization et al., 2007) 
Population 
group 
Median UIC 
[µg/l] 
Iodine intake Iodine nutrition 
School-age 
children (≥ 6yr) 
and adults 
< 20 Insufficient Severe ID 
20 – 49 Insufficient Moderate ID 
50 – 99 Insufficient Mild ID 
100 – 199 Adequate Optimal 
200 – 299 Above 
requirements 
Likely to provide adequate 
intake for pregnant/lactating 
women, but may pose a slight 
risk in the overall population. 
≥ 300 Excessive Risk of adverse health 
consequences 
Pregnant women < 150 Insufficient  
150 – 249 Adequate  
250 – 499 More than 
adequate  
≥ 500 Excessive  
Lactating women < 100 Insufficient  
≥ 100 Adequate  
Infants < 2 yr < 100 Insufficient  
≥ 100 Adequate  
Abbreviations: UIC = urinary iodine concentration; ID = iodine deficiency; yr = years 
 
A median UIC below 100 µg/l in a population has been associated with an 
increase in median thyroid size (FAO and WHO, 2004) and it has been shown 
in school-age children that the largest thyroid sizes are associated with the 
lowest UICs (Delange et al., 1997). Studies which associated low UICs with 
high goiter prevalence, high radioiodine uptake and low thyroidal organic iodine 
38 Background 
 
 
 
 
University of Vienna  Nadja Wüst 
 
 
content showed a steady-state as soon as UIC reached ≥ 100 µg/l (Delange et 
al., 1993; FAO and WHO, 2004). 
The epidemiological criteria for assessing iodine nutrition in a population are 
shown in Table 6. In children and non-pregnant women, a median UIC between 
100 and 299 µg/l defines a population without ID. Additionally, less than 20% of 
samples should have a UIC < 50 µg/l to categorize a population as iodine-
sufficient (World Health Organization et al., 2007).  
 
The daily iodine intake of a population can be estimated based on extrapolation 
from median UIC (for SAC or adults). For the extrapolation, mean 24-h urine 
volume (0.0009 l/h/kg for ages 7 – 15 years and about 1.5 l for adults) was 
estimated and an iodine bioavailability of approximately 92% was assumed, 
resulting in the following formula: UIC (µg/l) * 0.0235 * body weight (kg) = iodine 
intake per day (Institute of Medicine et al., 2001). With this formula, a median 
UIC of 100 µg/l corresponds to an average iodine intake of approximately 150 
µg per day in adults (Zimmermann, 2009). 
 
2.4.1.2.3. Infants 
Following the reliability of UIC as a biomarker for iodine status in SAC, a WHO 
Consultation recently proposed that the median UIC could also be a good 
indicator for infants. However, they admitted that further studies are required to 
better support this theory (WHO Secretariat on behalf of the participants to the 
Consultation et al., 2007).  
Currently, WHO/UNICEF/ICCIDD define a median UIC of ≥ 100 µg/l as 
adequate for children below two years of age. No other categories of UIC could 
be defined due to lack of data (see Table 6) (World Health Organization et al., 
2007). In 2007, a Technical Consultation of the WHO recommended that the 
median UIC value that indicates iodine-sufficiency in infants should be revised 
based on further studies (WHO Secretariat on behalf of the participants to the 
Consultation et al., 2007). 
Based on their current recommended iodine intake of 90 µg/day, FAO/WHO 
reported that UIC should be between 150 – 220 µg/l for an iodine-sufficient 
infant aged 0 - 3 yr (assumed urine volume: 4 - 6 dl/day) (FAO and WHO, 
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2004). This calculation was made using the formula for adults (see 2.4.1.2.2) 
and ignores the fact that iodine should be partially retained by infants to build up 
iodine stores (Delange, 2007). Moreover, the calculated UIC range is much 
higher than the current cut-off (≥ 100 µg/l) (Zimmermann, 2009).  
Delange et al. supplemented 111 Belgian infants aged 6 - 36 months with 90 µg 
iodine per day and found that their UIC plateaued between 220-240 µg/l after 30 
weeks of supplementation (Delange et al., 2001). Their median UIC was 101 
µg/l at baseline, which Delange et al. classified as clearly iodine-deficient, 
especially since it took several weeks until the infants reached a plateau of 
iodine excretion. This observation was suspected to be due to refilling of iodine 
stores (Delange et al., 2001).  
Dorey and Zimmermann recently performed a study to establish UIC reference 
values for newborns in Switzerland. They indicated that the current UIC cut-off 
was probably set too high and suggested a reference range of 70 – 100 µg/l to 
define iodine sufficiency in the first 4 – 5 days after birth (Dorey and 
Zimmermann, 2008). They also recognized increasing UIC in newborns from 
day 0 to day 5 after birth indicating that UIC might be lower in the first few days 
after birth due to lower breast milk intake (Dorey and Zimmermann, 2008). In 
our study, this UIC increase should be further examined and new information 
gathered about UIC in the course of the first year of life. 
 
The main problem in assessing UIC in infants is that they are more difficult to 
reach than SAC or newborns. Moreover, the urine collection itself is difficult 
(WHO Secretariat on behalf of the participants to the Consultation et al., 2007). 
Possible methods for urine collection in infants are clean catch method, urine 
bags and pads (Liaw et al., 2000). The “pad method” was recently applied in the 
Swiss newborn study (Dorey and Zimmermann, 2008). 
 
2.4.1.2.4. Lactating women 
In lactating women, iodine metabolism, which is altered during pregnancy 
(Glinoer, 2007), returns to that of non-pregnant women, except that iodine is 
excreted in breast milk. Therefore, despite having the same iodine intake 
recommendation as pregnant women, the cut-off for adequate iodine status in 
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lactating women is ≥ 100 µg/l (= median UIC) (WHO Secretariat on behalf of the 
participants to the Consultation et al., 2007). Similar to infants, no other 
categories of UIC could be defined (see Table 6) (World Health Organization et 
al., 2007).  
 
2.4.2. Alternative methods to assess iodine status in infants 
2.4.2.1. Iodine concentration in breast milk (BMIC) 
The WHO has not made a recommendation on the level of BMIC which 
indicates iodine sufficiency as there is no consensus (Zimmermann, 2009).  
In a recent publication, Azizi and Smyth (Azizi and Smyth, 2009) reported that in 
conditions of iodine sufficiency BMIC is between 150 – 180 µg/l based on 
studies reviewed by Dorea and Semba and Delange (Dorea, 2002; Semba and 
Delange, 2001). Based on studies reviewed by themselves, Azizi and Smyth 
indicated that BMIC should be between 100 - 150 µg/l in iodine-sufficient areas 
(Azizi and Smyth, 2009). Zimmermann reviewed studies on BMIC in iodine-
sufficient countries and found medians/means between 50 µg/l and 270 µg/l. He 
stated, however, that it was difficult to specify the adequate BMIC from this 
data, as the sample size of the studies was very small (Zimmermann, 2007b; 
Zimmermann, 2009). Semba and Delange suggested in 2001 that BMIC could 
be another indicator for the iodine status of a population. This could be the 
proportion of lactating women with BMIC ≥ 100 µg/l (Semba and Delange, 
2001). Bazrafshan et al. used a cut-off of ≥ 50 µg/l for BMIC to define BM as 
iodine-sufficient in their study in Iran (Bazrafshan et al., 2005). Azizi and Smyth 
proposed that values > 75 µg/l might be considered as an index of sufficient 
iodine nutrition (Azizi and Smyth, 2009). 
 
The daily breast milk intake of 6-month-old exclusively breast-fed infants is 
about 854 ± 118 ml (mean ± SD) (Butte et al., 2002) and 95% of the BM‟s 
iodine is assumed to be absorbed (Zimmermann, 2009). Based on these 
assumptions and the recommended iodine intake of 90 µg/day (World Health 
Organization et al., 2007), BMIC would need to be at a minimum of 111 µg/l to 
fulfill the infants‟ needs (calculation by N Wüst). 
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A recent study of Boston women found no intrafeed variation in BMIC (Pearce 
et al., 2007). Kirk et al. found considerable within day and day-to-day variation 
of iodide concentration in breast milk (Kirk et al., 2007). 
 
2.4.2.1.1. Measurement 
Contrary to UIC, the WHO does not recommend a method for the determination 
of BMIC. Many different methods and methodic variations used for the sample 
preparation and determination of BMIC exist, which also makes it more difficult 
to compare different studies. 
Hedayati et al. gave a short overview of the various determination methods in 
use (Hedayati et al., 2007). Two main methodic ways of determination were 
specified: 1) instrumental methods such as X-ray fluorescence, ICP-MS, 
polarography, atomic absorption spectrometry and 2) colorimetric methods 
based on the Sandell-Kolthoff reaction. The instrumental methods require 
expensive high-tech equipment and are time consuming (Hedayati et al., 2007). 
In all the methods, the iodine must be released from organic compounds in a 
first step and interfering substances must be eliminated from the breast milk. 
Three sample preparation methods exist: alkaline ashing, alkaline digestion and 
acid digestion. The sample preparation is the critical step as iodine can be lost 
by volatilization (Haldimann et al., 1998; Hedayati et al., 2007).  
 
In the laboratory of human nutrition at ETH Zurich, iodine was analyzed in cow 
milk by a modified Sandell-Kolthoff reaction which included an alkali ashing 
digestion step with potassium hydroxide. However, high iodine losses occurred 
with this method and this problem has not yet been solved (Richard, 2008). 
Therefore, this method could not be used for the analysis of breast milk 
samples in the present study.  
The analysis of iodine in human and cow milk has been successfully performed 
by isotope dilution analysis with ICP-MS at the Swiss Federal Office of Public 
Health (FOPH, Liebefeld) (Facheinheit Lebensmittel und 
Gebrauchsgegenstände des Bundesamtes für Gesundheit, 2000; Haldimann et 
al., 2000). ICP-MS has been proven to be a very precise method for iodine 
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determination in biological samples (Haldimann et al., 2000). A recently 
ameliorated version of the method, which was already used for analysis of cow 
milk at FOPH (Crnkic et al., 2006), has been used for analysis of breast milk 
samples in the present study (for method description see method section). 
Several recent studies on BMIC used a method based on ICP-MS for their 
analysis (see Appendix 4) (Bader et al., 2005; Chan et al., 2003; Dasgupta et 
al., 2008; Facheinheit Lebensmittel und Gebrauchsgegenstände des 
Bundesamtes für Gesundheit, 2000; Fernandez-Sanchez et al., 2007). 
 
There is no external control program for BMIC in place. The only possibility is to 
use cow milk reference material as a control (Gills, 1993). Studies, which used 
ICP-MS for milk analysis, showed good results measuring the reference 
material (Crnkic et al., 2006; Fernandez-Sanchez et al., 2007; Haldimann et al., 
2005; Sturup and Buchert, 1996). 
 
2.4.2.2. Dietary assessment of iodine status in infants 
2.4.2.2.1. Methods 
The WHO does not indicate the dietary assessment as a method to determine 
the iodine status. Only few studies were found which assessed the dietary 
iodine intake in infants.  
A national British survey in 6 – 12-month-old infants (n = 488) used a 7-day 
unweighed structured food diary to assess total daily iodine intake and iodine 
intake in different food categories (Mills and Tyler, 1992). Another regional 
British study assessed daily iodine intake in 8-month-old infants (n = 1131 ) by a 
3-day unweighed dietary record (Noble and Emmett, 2001).  
A Dutch study group recently developed a simulation model to estimate dietary 
iodine intake in a population (1 to ≥ 18yr) based on a 2-day food record. The 
model included the iodine intake from natural sources, industrially added 
iodized salt, discretionary added iodized salt and iodine-containing 
supplements. Finally, the total iodine intake was calculated and statistical 
modeling for within/between-person variability was performed. The measured 
urinary iodine excretion values were compared with the calculated iodine intake 
values from the model and good associations were found (Verkaik-Kloosterman 
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et al., 2009). 
A recent New Zealand study indirectly calculated the daily iodine exposure for 
non-breast-fed 6 – 12-month-old infants, 1 – 3-year-old toddlers and other age 
groups by simulating typical diets (14d) and measuring the iodine content in 
foods (Thomson et al., 2008).  
The US Total Diet Study (TDS) has been monitoring food intake for 46 years 
and regularly calculates the dietary iodine intake of 6 – 11-month-old non-
breast-fed infants with the help of specially developed TDS diets and by 
measuring iodine in foods (Murray et al., 2008). 
For adults, some studies developed special iodine questionnaires that 
contained only questions regarding the intake of iodine rich foods (Leung et al., 
2007; Manz et al., 2002). 
The US Feeding Infants and Toddlers Study (FITS) assessed dietary intake (not 
iodine) in 3022 subjects. This study used an interviewed 24-hour dietary recall 
and a second 24-hour dietary recall in a subsample (n = 703) (Devaney et al., 
2004). The 24-hour dietary recall method was chosen as it provided a 
standardized methodology, minimal respondent burden, detailed brand names 
as well as types and quantities of consumed foods and beverages. It was 
assumed that parents are usually familiar with their infant‟s food intake schedule 
and know the amount they feed to their infants (Ziegler et al., 2006). 
A recent study compared a 24-hour dietary recall with a 3-day weighed food 
record in 7 – 11-month-old infants and 12 – 24-month-old toddlers. The study 
found an overestimation in energy intake in 13% of infants respectively in 29% 
of toddlers by the 24-hour dietary recall method (Fisher et al., 2008). 
Accordingly, higher macro- and micronutrient intakes were measured with the 
24-hour dietary recall. The overestimation of portion sizes in the 24-hour dietary 
recall was seen as major error source, especially driven by overestimation of 
dairy and grain food intakes. However, eating patterns (frequency and location) 
did not differ in the two methods (Fisher et al., 2008). 
 
For the present study, it was necessary to assess the dietary iodine intake of 
the day before the urine collection was carried out as UIC examines short-term 
iodine intake. However, it was not possible to inform the subjects about the 
44 Background 
 
 
 
 
University of Vienna  Nadja Wüst 
 
 
dietary assessment before urine collection. Therefore, the dietary questionnaire 
had to be filled out on the day of sampling. It was also not possible to carry out 
interviewed questionnaires due to lack of human resources. Thus, a 
retrospective method with a self-administered questionnaire had to be used. 
However, detailed data was required to calculate the iodine intake of the infants 
accurately. Among existing dietary assessment methods (Elmadfa and 
Leitzmann, 2004; Gibson, 2005), the diet history and the food frequency 
questionnaire method were considered to be not suitable for infants as their 
food intake changes constantly during the first year of life. Weighed or 
unweighed dietary food records are probably the most precise methods to 
assess dietary iodine intake in infants. However, these methods are 
prospective, rather time consuming, need clear personal instructions and could 
lead to changes in infant feeding practices either to make recording easier or to 
demonstrate good feeding practices (Elmadfa and Leitzmann, 2004; Gibson, 
2005). The 24-hour dietary recall is retrospective and usually interviewer based. 
It is less time consuming than other methods, but it requires good memory of 
the interviewed subject and the ability to estimate portion sizes accurately. Also 
in the 24-hour dietary recall, it is possible that respondents report only “good 
feeding habits” (Elmadfa and Leitzmann, 2004; Gibson, 2005).  
In accordance with our study purpose, it was therefore necessary to use a 
method based on a 24-hour dietary recall, but it had to be self-administered 
and, hence, well structured in order to help parents to remember as accurately 
as possible what they fed their infant. It also had to be assumed that parents 
usually know quite well what and how much they feed their infants (Ziegler et 
al., 2006). 
 
No data about day-to-day variation of iodine intake in infants were found in 
literature. 
 
2.4.2.2.2. Estimation of breast milk intake 
“The golden standard” for measuring daily breast milk intake is weighing infants 
before and after each breast-feeding during 24 hours. This method was used, 
for example, in the German DONALD study (Alexy et al., 1998) and the 
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Copenhagen Cohort study (Michaelsen et al., 1994). 
Two options for estimation of breast milk intake without weighing are given in 
literature. Two British studies on infant nutrition assessed dietary intake of 6 – 
12-month-old infants by a 3-day unweighed dietary record and asked mothers 
to record number of daily breast-feeds and minutes per feed (Emmett et al., 
2000; Mills and Tyler, 1992). These studies used the following method for 
estimation of breast milk intake. The estimated amount of breast milk per full 
feed was 135 g for 6 – 7-month-old infants and 100 g for 8 – 12-month-olds (the 
amounts were estimated based on the study of Paul et al. (Paul et al., 1988)). A 
feed of 10 minutes or longer was assumed a full feed. For feeds of shorter 
duration, the amount of BM was calculated proportionally (Emmett et al., 2000; 
Mills and Tyler, 1992).  
In the national US FITS study, dietary intake of infants and toddlers (4 – 24 
months of age) was assessed by telephone-interviewed 24-hour dietary recall. 
In this study, a daily breast milk intake of 780 ml was assumed for exclusively 
breast-fed infants < 7 months of age. If the infants were fed breast milk and 
formula, the volume of formula was subtracted from 780 ml to obtain the 
quantity of consumed breast milk. For infants ≥ 7 months a daily quantity of 600 
ml breast milk was assumed and the corresponding volume of consumed 
formula or cow milk was subtracted from 600 ml (Devaney et al., 2004). The 
assumed breast milk quantities (780 ml, 600 ml) were estimated from the 
DARLING study, in which infants were weighed before and after feeding (Heinig 
et al., 1993). The authors of the FITS study pointed out the problem of 
overestimating the breast milk intake in infants who already consumed more 
non-milk foods than other infants (Devaney et al., 2004).  
A recent study in 7 – 24-month-old children compared the results of dietary 
assessment from a single telephone 24-hour dietary recall with a 3-day weighed 
food record (Fisher et al., 2008). This study used the weighing method for food 
records and combined both estimation methods mentioned above for the 24-
hour recall. For 7 – 11-month-old infants an intake of 600 ml breast milk was 
assumed and other types of milk were subtracted. For children above 12-
months of age a breast milk intake of 29.6 ml (1 fluid ounce) for every 5 min of 
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feeding was assumed. The evaluation of both questionnaire types revealed that 
breast milk intake was overestimated by 24-hour recall. However, it was 
concluded that the extent of the overestimation was small regarding the total 
sample and that the method used in the 24-hour recall still delivered good 
estimates (Fisher et al., 2008). 
Other studies excluded breast-fed infants from data evaluation. In a study from 
New Zealand, which assessed dietary intake of 6 – 24-month-old infants using a 
3-day weighed food record, breast-fed infants were excluded from questionnaire 
evaluation as breast milk intake was not quantified (Soh et al., 2002). Breast 
milk intake was also not assessed in the Euro-Growth study and not quantified 
for data evaluation (Freeman et al., 2000). 
 
In a WHO publication in 2002, measured daily breast milk intake from several 
studies was compared. The studies were conducted in developed countries and 
used the test-weighing method. The mean ± SD daily breast milk intake in these 
studies was 854 ± 118 ml for 6-month-old exclusively breast-fed infants 
respectively 612 ± 180 ml for 6-month-old partially breast-fed infants and 497 ± 
238 ml for 12-month-old partially breast-fed infants (intake volumes weighted for 
sample size of studies) (Butte et al., 2002). 
 
2.4.2.2.3. Measurement of iodine content in formula and infant food 
Hammer and Andrey recently gave a short overview of published methods for 
iodine determination in food products. These are based on X-ray fluorescence, 
spectrophotometry, HPLC, GC, ion-selective electrode (ISE) or ICP-MS 
(Hammer and Andrey, 2008). In 2007, the “European Committee for 
Standardization” had adopted ICP-MS as EN15111:2007 for determination of 
iodine in foodstuffs (European Committee for Standardization, 2007; Hammer 
and Andrey, 2008). Hammer and Andrey recently compared ICP-MS (internal 
standard, TMAH extraction; see method section) and ISE by measuring formula 
products and whole milk reference material. They found that the results were 
accurate for both methods. However, ICP-MS was more precise. Therefore, 
they also recommended the ICP-MS technique as international standard for 
controlling labeled iodine concentration in milk-based nutritional products 
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(Hammer and Andrey, 2008).  
Earlier, Rädlinger and Heumann had already tested an ICP-MS method that 
was similar to the one used in the present study (isotope dilution analysis with 
TMAH extraction, see method section) and showed accurate results in 
measuring iodine in infant food and milk powder reference samples (Radlinger 
and Heumann, 1998). Sturup and Buchert (Sturup and Buchert, 1996) (standard 
addition calibration, samples diluted in TMAH/KOH solution) and Fernandez-
Sanchez et al. (Fernandez-Sanchez et al., 2007) (standard addition, digestion 
with ammonia solution) measured formula milk samples with ICP-MS. They 
showed good accuracy of the method by measuring the certified iodine 
concentration of milk powder reference samples (Fernandez-Sanchez et al., 
2007; Sturup and Buchert, 1996).  
Haldimann et al. measured iodine in Swiss foods (Haldimann et al., 2005) and 
in infant formulae (Facheinheit Lebensmittel und Gebrauchsgegenstände des 
Bundesamtes für Gesundheit, 2000) using ICP-MS (isotope dilution analysis 
with nitric acid digestion). They found that the method was accurate according 
to the results of reference materials and in comparison with measurement by 
neutron activation analysis (Haldimann et al., 2005; Haldimann et al., 2000). For 
the present study, a modification of Haldimann‟s method was applied (the same 
as used for the breast milk). This modification also showed accurate results by 
determination of certified iodine concentration in milk powder reference material 
(Crnkic et al., 2006). A description of the isotope dilution ICP-MS method with 
TMAH extraction is given in the method section (chapter 3.6.2). 
Reference material is available for infant formula (Wise and Watters, 2007), but 
not for cereal-based infant food. 
 
In 1999, the Swiss Federal Office of Public Health measured iodine in Swiss 
formula products (n = 31, bought in 1997 and 1999) to check if the minimum 
level of required iodine was present. 13% of the products (one on cow milk 
basis and three on soy milk basis) had an iodine content below the required 
minimum level (Facheinheit Lebensmittel und Gebrauchsgegenstände des 
Bundesamtes für Gesundheit, 2000). Some of the measured iodine values were 
as much as 10 times lower than the labeled value and others were as much as 
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five times higher (unpublished data, personal communication M. Haldimann). 
A US study also compared labeled with measured iodine contents in eight 
formula products (spectrophotometrical method). Slightly higher iodine contents 
were measured in the samples compared with the labeled contents. In two 
samples a four to seven times higher iodine content was observed (Pearce et 
al., 2004). 
 
2.5. Urinary iodine concentration in infants –  
previous studies   
No representative Swiss studies on UIC in infants are available. In fact, only a 
few studies at all have examined UIC in infants (excluding newborns) 
worldwide.  
 
A list of studies which examined UIC in infants in the age range of our study 
infants is given in the Appendix 3. The list includes data on country, date and 
level of study (local, regional, national), studied age group, sample description 
(e.g. gender, sub-groups), sample size, median/mean UIC [µg/l], prevalence 
below/above specified UIC levels [%], UIC of mothers [µg/l] (if available), UIC 
analysis method, comments concerning the study and classification of iodine 
intake in the country (see below).  
The studies were carried out or published between 1989 and 2009. In total, 23 
studies were found (all in Pubmed), which were carried out in 19 different 
countries. The majority were performed in Europe (12 studies: one in 
Switzerland, Armenia, Austria, Belgium, Czech Republic, Italy and Turkey, two 
in Germany and three in France), followed by the Western-Pacific area (4 
studies: one in Malaysia and New Zealand and two in China). Studies in two 
countries of the Americas (Mexico and Venezuela), Africa (Nigeria and Reunion 
Island) and South-East Asia (India and Indonesia) were found and one in an 
Eastern-Mediterranean country (Sudan). In Switzerland, only one small regional 
study was carried out in our studied age group (Als et al., 2000b), see also 
chapter 2.7 “Iodine in Switzerland”. 
Just one study (in Indonesia) included only infants of our studied age 
groups/range (Wijaya-Erhardt et al., 2007). However, the study included only 
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boys and it was an intervention study (data taken from baseline). All other 
studies also included either younger or older children than our target group. In 
most of the studies the exact age of the participating children was not indicated 
or UIC values were only given for a wider age range or for the full sample. 
Only three studies were performed on a national level, in Armenia (Rossi and 
Branca, 2003), in Czech Republic (Bilek et al., 2005) and in Germany (Thamm 
et al., 2007). The other studies were carried out on a local or regional level. 
Sample sizes ranged from 18 to about 2500. Most studies, however, had small 
sample sizes. 
 
The lowest measured median UIC value was 10.6 µg/l in 0- to 6-year-old 
Malaysian children living in a goitrous area (Foo et al., 1996). The highest 
median UIC was found in 1- to 12-month-old French infants 328 µg/l (Pouessel 
et al., 2008). 
In seven studies, a median/mean UIC < 100 µg/l was found either in the full 
sample or in a specified subgroup (Akanji et al., 1996; Elnour et al., 2000; Foo 
et al., 1996; Manz et al., 1993; Rapa et al., 1999; Skeaff et al., 2005; Thamm et 
al., 2007). 
 
Only three studies looked at differences in UIC depending on infant feeding 
practices (Manz et al., 1993; Pouessel et al., 2003; Skeaff et al., 2005). 
 
In two studies, it was clearly stated that UIC of matched pairs of mother and 
infant were examined (Akanji et al., 1996; Gupta et al., 2006). Some studies 
also looked at women of childbearing age or lactating women but it was not 
clear whether these women were the mothers of the examined infants in the 
studies (Foo et al., 1996; Jaffiol et al., 1997; Rapa et al., 1999; Wang et al., 
2009; Yan et al., 2005). 
 
The studies measured iodine in spot urine samples. None of the studies 
indicated that pads were used for urine collection in infants. Most of the studies 
used a method based on the Sandell-Kolthoff reaction for UIC analysis. 
 
Appendix 3 further includes the WHO classification of iodine intake of the above 
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mentioned countries (de Benoist et al., 2008; WHO Nutrition, 2008a; WHO 
Nutrition, 2008b). Twelve studies were performed in countries which were 
classified as having adequate or more than adequate iodine nutrition 
(Switzerland, Austria, Czech Republic, Germany, Mexico, Venezuela, Nigeria, 
India, Indonesia and China). One study was carried out in a country with 
“excessive” iodine intake (Armenia). In 11 of these studies a median/mean UIC 
≥ 100 µg/l was measured in the infants (Switzerland, Armenia, Austria, Czech 
Republic, in one of the German studies (Thamm et al., 2007), Mexico, 
Venezuela, India, Indonesia, China). Nine studies were performed in countries 
that were classified as having insufficient iodine nutrition (Belgium, France, Italy, 
Turkey, Sudan, Malaysia and New Zealand). Only in three of these studies was 
a median/mean UIC < 100 µg/l measured in the infants (Italy, Malaysia and 
New Zealand). Reunion Island was not classified by the WHO (WHO Nutrition, 
2008b).  
 
2.6. Breast milk iodine concentration – previous studies 
In 2001, Semba and Delange reviewed existing studies on BMIC that were 
performed between 1926 and 1999 (Semba and Delange, 2001). In those 
studies, very low mean BMICs were found in women living in goitrous areas (9 
– 32 µg/l) and in women with goiter (13 – 18 µg/l). Summarized BMICs from 
areas with a salt iodization program were higher ranging from 90 – 150 µg/l. 
The authors pointed out that most of the studies had too small a sample size to 
determine adequate iodine intake and to interpret the data (n = 2 - 143). They 
suggested that the well baby visit/vaccination appointment of the child (at a 
pediatric practice or clinic) would be a good occasion to come into contact with 
women and to select them for studies (Semba and Delange, 2001). 
Another review was performed by Dorea (Dorea, 2002). In those studies, BMIC 
ranged from 5 µg/l in Ethiopia to 660 µg/l in Japan (the Japanese population is 
known to have a high seaweed intake, which is rich in iodine). In studies which 
were performed in a goitrous area, BMIC was between 17.5 and 40 µg/l. No 
sample size was given for the studies (Dorea, 2002). 
The most recent review was done by Azizi and Smyth in 2009 (Azizi and Smyth, 
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2009). This review added four studies performed between 2005 and 2007 and 
included only studies with a sample size > 40. A recent study in China had the 
largest sample size (n = 710) (Yan et al., 2005). The four new studies were all 
conducted in regions with a salt iodization program and measured a median 
BMIC between 117 and 155 µg/l (Azizi and Smyth, 2009). 
 
In Switzerland, four small regional studies on BMIC have been performed so 
far. See chapter 2.7 “Iodine in Switzerland” and Appendix 4: Studies on BMIC – 
in Switzerland and worldwide (selection) - conducted between 1998 and 2009. 
 
In Appendix 4 an overview of studies on BMIC which were performed between 
1998 and 2009 is given. This is not a complete overview of studies in this time 
frame, but a selection. The following information about the studies is listed: 
country, date and level of study, age of women, description of BM samples, 
sample size, median/mean BMIC [µg/l] or [µg/kg], BM analysis method, 
comments and the country‟s classification of iodine intake (WHO Nutrition, 
2008a; WHO Nutrition, 2008b). If available, median/mean UIC of women and 
their infants was also added.  
Besides the four Swiss studies, 17 studies are listed, which were conducted in 9 
different countries. Five were performed in Europe (in Belgium, Denmark, 
Germany (two) and Spain), five in the USA, two in Iran, two in China, one in 
Australia and one in New Zealand. All studies were conducted either on a local 
or a regional level. Most studies had a small sample size (n = 14 - 710). Only in 
five studies was it stated that the BM was mature (> 12th day postpartum). All 
other analyses were done in colostral or transitory milk. The lowest BMIC was 
measured in New Zealand (mean 22 µg/l) (Skeaff et al., 2005), the highest in 
China (median 163 µg/l) (Wang et al., 2009). New Zealand is classified by the 
WHO as iodine insufficient and China as more than adequate (WHO Nutrition, 
2008a). 
In the countries that the WHO classified as iodine-sufficient (iodine nutrition 
adequate or more than adequate: Switzerland, Germany, Spain, USA, Iran, 
Australia and China) (WHO Nutrition, 2008a), the studies measured a 
median/mean BMIC between 43 and 163 µg/l. In the countries that the WHO 
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classified as iodine-deficient (iodine nutrition insufficient: Belgium, Denmark, 
New Zealand) (WHO Nutrition, 2008a), the studies measured a median/mean 
BMIC between 22 and 78 µg/l. 
The studies used various different methods for analysis of BMIC; some did not 
indicate the method. Five studies used a method based on ICP-MS. 
Eight studies also measured UIC in the women (Bazrafshan et al., 2005; Chan 
et al., 2003; Dasgupta et al., 2008; Laurberg et al., 2004; Ordookhani et al., 
2007; Pearce et al., 2007; Wang et al., 2009; Yan et al., 2005) and seven 
studies included UIC of the infants or newborns (Ciardelli et al., 2002; Hoang 
Truong et al., 1997; Laurberg et al., 2004; Ordookhani et al., 2007; Skeaff et al., 
2005; Wang et al., 2009; Yan et al., 2005). 
 
2.7. Iodine in Switzerland 
Before the introduction of iodized salt, Switzerland was severely iodine-deficient 
due to its geographical situation in the iodine-deplete Alp region of Europe 
(Clugston and Hetzel, 1994; Zimmermann, 2008c). Many people had goitres; 
some infants were born as cretins (Bürgi et al., 1990). In 1922 a Swiss Goiter 
Committee was formed and recommended iodization of Swiss salt to cantons 
first at a quite low level from 1.9 to 3.75 mg/kg salt and sale of it on a voluntary 
basis (Bürgi et al., 1990; Zimmermann, 2008c). By 1952 iodized salt was 
available nationwide and the level of iodization was adapted continuously (see 
Table 7) (Bürgi, 2005; Bürgi et al., 1990). The former Goiter Commission has 
now been replaced by the Fluorine-Iodine Commission of the Swiss Academy of 
the Medical Sciences which meets annually to discuss further adaptations of 
salt iodization (Bürgi, 2005). The last elevation of salt iodization was carried out 
in 1998 to the current level of 20 mg/kg (Bürgi, 2005) because in 1997 it was 
recognized that UIC in SAC had started to fall (Zimmermann et al., 1998).  
 
Table 7: Salt iodine concentration (ppm) and UIC in SAC in Switzerland from 1923 to 
2004 (Bürgi, 2005) 
 
a 
µg/day; 
b
 µg/g creatinine; 
c
 µg/l 
a b b c c c c 
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Many surveys showed that the iodization of salt has been the reason for 
eradication of goitre and cretinism in Switzerland (Bürgi et al., 1990). Over 90% 
of Swiss households use iodized salt, which is provided by only two producers 
(Schweizer Rheinsalinen and saline de Bex) (Bürgi et al., 1990; Zimmermann et 
al., 2005). 
 
Since 1999, an iodine monitoring program on UIC of SAC and pregnant women 
is performed every five years in Switzerland (Bürgi, 2005). In the first two 
national monitoring studies in 1999 and 2004, the median UIC of SAC showed a 
sufficient iodine status (115 respectively 141 µg/l). Additionally, the frequency of 
UIC values < 50 µg/l in SAC showed iodine sufficiency (8.5% respectively 5%). 
Pregnant women had a marginal status in 1999 (138 µg/l) but had a clearly 
sufficient status in 2004 (249 µg/l) (Hess et al., 2001; Zimmermann et al., 2005). 
Newborn TSH levels showed iodine sufficiency in both monitoring studies (< 3% 
of newborns with TSH > 5 mU/l) (Hess et al., 2001; Zimmermann et al., 2005).  
Based on these study results and the long-standing Swiss salt iodization 
program which covers nearly all households (Zimmermann, 2008c), Switzerland 
is categorized as a country with optimal iodine nutrition by WHO (Andersson et 
al., 2007; de Benoist et al., 2008). 
Parallel to our infant study, the next national monitoring study on iodine status in 
SAC and pregnant women was started in 2009. First results showed a sufficient 
iodine status for school age children (n = 916) with a median UIC of 120 µg/l. 
Pregnant women seemed to have a marginal sufficient iodine status (interim 
analysis, n = 318) with a median UIC of 151 µg/l (personal communication I 
Henschen and A Piacenza, ETH Zurich, 2009). 
 
Between 2005 and 2007, a nationally representative study to set reference 
values for spot urinary iodine concentrations in newborns was conducted. Two 
urine samples were collected from newborns (on day 0 – 5, n = 634) and their 
median UIC showed a value of 77 µg/l (Dorey and Zimmermann, 2008). Even 
though the value was below the current WHO cut-off for iodine sufficiency (≥ 
100 µg/l), it was stated as sufficient because TSH levels in the newborns 
showed iodine sufficiency (Dorey and Zimmermann, 2008). Moreover, pregnant 
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women had a sufficient iodine status in the monitoring study which was 
performed in Switzerland in 2004 (Zimmermann et al., 2005). The authors 
suggested that the current WHO cut-off might be set too high for newborns 
(Dorey and Zimmermann, 2008).  
In three earlier regional Swiss studies on newborns conducted in 1984, 1985 
and 1994 (n total = 237), similar median UIC values were found (62 µg/l, 70 
µg/l, 66 µg/l) (Hoang Truong et al., 1997). 
 
No study has analyzed UIC in 6- and 12-month-old infants in Switzerland, 
except one regional study in 1997 which looked at 31 children aged between 0 
and 5 years (Als et al., 2000b). No information about the exact age of the 
children was given. Their median UIC was 108 µg/l. 
 
Iodine status in women was investigated in a regional Swiss study in 1997 
(Bernese region). The median UIC of women from 13 – 20 years (n = 13), 21 – 
35 years (n = 31) and 36 – 50 years (n = 35) was 90 µg/l, 91 µg/l and 93 µg/l. In 
this study SAC (6 – 12 yr) had a UIC of 110 µg/l (n = 47) (Als et al., 2000b).  
A longitudinal study was conducted between 1996 and 2000 including 11 
women between 35 – 65 years of age. UIC before and after increase of salt 
iodization in year 1998 was measured (2128 urine samples). A median UIC of 
92 µg/l was measured before the increase of salt iodine level and a median of 
93 µg/l was measured after the increase. In comparison, children (3 – 15 yr, n = 
12) had a median UIC of 141 µg/l before salt iodine increase and after 1998 
their median UIC increased to a value of 162 µg/l (Als et al., 2004).  
Two recent Swiss studies on UIC in non-pregnant, non-lactating women 
showed a median UIC of 79.1 µg/l in women from Zurich area (n = 567, 18-42 
yr) (personal communication, M Andersson, 2007) and a median UIC of 81.0 
µg/l (n = 144) in women from several regions in Switzerland (personal 
communication, M Kammermann, 2009).  
 
No studies on UIC in lactating women have been performed in Switzerland. 
 
Four small regional studies on the iodine concentration in breast milk have been 
carried out in Switzerland: 1992/93 in Berne median BMIC 98 µg/l (n = 38, 5th – 
Background 
 
 
 
University of Vienna  Nadja Wüst 
 
55 
12th day after birth); 1993/94 in Basel median BMIC 82 µg/l (n = 23, 5th – 12th 
day after birth); 1998/99 in Basel median BMIC 68 µg/l (n = 52, > 12th day after 
birth, ICP-MS analysis method, personal communication M. Haldimann) 
(Facheinheit Lebensmittel und Gebrauchsgegenstände des Bundesamtes für 
Gesundheit, 2000). Another study was carried out in 1994 in Solothurn with a 
mean BMIC of 78 ± 59 µg/l (n = 30, 3 – 6 days after birth) (Hoang Truong et al., 
1997). 
 
No direct dietary assessment to determine the iodine intake in the Swiss 
population or in one of our examined population groups has been performed. 
Only per capita exposure to iodine has been estimated based on the food 
consumption statistics (Camenzind-Frey et al., 2005; Haldimann et al., 2005; 
Jacob, 2005; Schlotke and Sieber, 1998). In the most recent estimation of 
Haldimann et al., who also measured the iodine contents in Swiss foods, it was 
estimated that the overall dietary iodine exposure to (average) consumers was 
140 µg/day. The use of iodized kitchen salt was excluded from the estimation 
(Haldimann et al., 2005). 
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3. SUBJECTS & METHODS 
3.1. Study population 
The study was conducted in 6- and 12-month-old infants (± 6 weeks) and their 
mothers. The study subjects were enrolled at pediatric practices.   
The inclusion criteria were: 1) Full-term birth of the infant (between the 38th and 
42nd week of pregnancy); 2) No infantile or maternal history of recent thyroid 
disorders; 3) Intact health of infant; 4) No application of iodine-containing 
disinfectants in the infant within the last month and no use of (iodine-containing) 
contrast media in the infant since birth; 5) Mother resident in Switzerland for at 
least 12 months before and since the infant‟s birth (together with the infant); 6) 
No intake or injection of (iodine-containing) radiologic/CT-contrast media or 
drugs (amiodarone [anti-arrhythmic]) by the mother since pregnancy.  
Based on earlier studies in Switzerland that were carried out in school age 
children, pregnant women and newborns (Dorey and Zimmermann, 2008; Hess 
et al., 2001; Zimmermann et al., 2005) (see chapter 2.7.) it was assumed that 
the infants should be iodine-sufficient, which is an essential condition to be 
fulfilled to develop reference values. Nevertheless, to prove this assumption, 
iodine status in mothers was also assessed by measuring UIC and BMIC. 
 
3.2. Study design 
The study was designed as a national cross-sectional survey. A 2-stage 
population-based cluster sampling was performed to obtain a representative 
sample of infants. In the first stage, 20 pediatric practices (clusters) had to be 
selected distributed throughout the seven “greater Swiss regions” (Swiss 
Federal Statistical Office, 2008a). The selected number of pediatric practices 
per region had to be proportional to the number of annual births in the regions 
(% live births in relation to all annual births in Switzerland) (see Table 8). In the 
second stage, pediatricians at the selected practices had to enroll infants and 
their mothers.  
For the selection, pediatricians were initially contacted by letter and invited to 
participate in the study (addresses from “Forum für Praxispädiatrie”, “Swiss 
pediatric society” and phone book). Out of all positive answers, a convenience 
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selection of the pediatric practices (single or group practices) was made 
according to the required number of practices per “greater Swiss region” (see 
above and Table 8) with specific regard to the practices with the greater number 
of infants visiting the practice per week. This method was chosen in order to 
reach the required number of infants within good time under the assumption 
that the iodine intake is uniform across the country (Hess et al., 2001; 
Zimmermann et al., 2005).  
 
Table 8: Population data, live births and number of pediatric practices per greater 
Swiss region 
Greater Swiss 
regions 
Swiss 
population 
(31.12.2006) 
a 
% 
population 
per region 
Live 
births 
(2006) 
a 
% live 
births 
per 
region 
Required 
clusters 
(practices)  
per region 
Total 7'508'739 100 73'371 100 20 
Lake Geneva region 1'389'988  18.5  14'868  20.3  4.1 
Espace Mittelland 1'703'966  22.7  15'909  21.7  4.3 
Northwestern 
Switzerland 
1'026'801  13.7    9'388  12.8  2.6 
Zurich 1'284'052  17.1  13'533  18.4  3.7 
Eastern Switzerland 1'065'253  14.2    9'659  13.2  2.6 
Central Switzerland    713'828    9.5    7'222    9.8  2.0 
Ticino    324'851    4.3    2'792    3.8  0.8 
a
 Source: (Swiss Federal Statistical Office, 2006) 
 
The enrollment of mother-infant pairs at the pediatric practices took place at the 
“routine check-up”/vaccination occasion of the infants. The routine check-
ups/vaccinations are not mandatory in Switzerland, but they are covered by the 
health insurance. 85% to 95% of infants and children in Switzerland are 
vaccinated depending on the kind of vaccination (Lang et al., 2008).  
At each pediatric practice, 30 mother-infant pairs of each age group had to be 
enrolled. The pediatricians were allowed to perform a convenient sampling of 
the study subjects, but were asked to enroll every eligible subject when 
possible. As the pediatric practices had varying numbers of infants per week, no 
fixed timeframe was defined to reach the required number of subjects at the 
beginning of the study. 
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The study was approved by the ethical committee of the Swiss Federal Institute 
of Technology Zurich (ETH) [reference number EK 2008-08]. The participating 
mothers provided written consent before the study started and had the option to 
withdraw from the study at any time. Study participants and doctors were not 
remunerated for study participation.  
 
The study was financed by the “Swiss Foundation of Nutrition Research” of the 
ETH Zurich, Switzerland. The obtained funding was dedicated to material costs 
for the study. The Laboratory of Human Nutrition (ETH, Zurich) provided 
equipment/chemicals for urine sample analysis and for breast milk analysis, 
equipment/chemicals were supplied by the Swiss Federal Office of Public 
Health (FOPH, Liebefeld). 
 
3.3. Sample size calculation 
The estimation of the sample size was based on currently available data on 
iodine-sufficient infants (Zimmermann, 2007b). A standard deviation (SD) of 
UIC of 40 μg/l was used to estimate the length of the total reference range for 
UIC (4 x SD). The required relative precision at the upper and lower limit of the 
reference range was specified as 3% of this range. The required sample size 
was calculated using the formula: 2 27.14 /n    , where 2  is the variance of 
UIC and 2  the specified precision for the 97.5th percentile being estimated 
(Armitage et al., 2002). Based on this calculation, a sample size of at least 1200 
infants was required to obtain the specified precision level. This calculation was 
originally meant for a study population including infants from 6 - 12 months of 
age. Due to the fact that healthy infants visit the pediatric practice only at 6 and 
at 12 months of age (and not in between) for routine check-up/vaccination, it 
was decided to split the sample size into two age groups and include 600 
infants of each age group (6 and 12 months). 
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3.4. Data collection 
3.4.1. Overview 
The required personal data of infants and mothers (including infant feeding 
practices) were gathered using individual registration forms. A spot urine 
sample was collected from each infant and each mother and in addition, a 
breast milk sample was obtained from lactating mothers. Furthermore, a dietary 
questionnaire (self-administered), which assessed the infants‟ food intake on 
the day before sample collection, was filled out by the mothers on the sampling 
day (retrospective) and a second dietary questionnaire was filled out three to 
four days afterwards. 
 
3.4.2. Study procedure at pediatric practices 
All participating pediatric practices were visited once by the study coordinator of 
the ETH to instruct them personally about the study procedure and to give them 
written study instructions (see Appendix 5 - German). 
The eligible mothers were informed about the study at the pediatric practice by 
a written information sheet (see Appendix 6 - German) which was handed out to 
them at the day of the routine check-up or during an earlier visit. The 
information sheet outlined the study purposes and objectives, the study 
procedure, the required inclusion criteria and included information about the 
risks, financing, insurance, withdrawal option, the anonymity of the data and the 
study contacts. Mothers were also orally informed about the study by the 
pediatrician or the pediatrician‟s medical assistant. The pediatrician ensured the 
fulfillment of the inclusion criteria and the subscription of the consent form.  
An individual registration form for each mother-infant pair was filled out by the 
pediatrician (see 3.4.3 Individual registration form and Appendix 7 - German). 
Mothers could optionally provide their phone numbers so that ETH could 
contact them for any further questions. It was also possible to participate 
anonymously in the study. The registration and consent form always had to be 
filled out at the pediatric practice. 
The practices had the option either to collect the samples in the practice or to 
instruct the mother about sample collection at home. If the sampling was done 
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at home, the mother additionally received a detailed information leaflet 
explaining in simple instructions how to collect the samples (see Appendix 9 - 
German). Mothers were advised to do the sample collection if feasible on the 
same day they visited the pediatric practice or as soon as possible after the 
visit. A phone number of ETH was indicated on the leaflet for any questions.  
The dietary questionnaires were handed to the mothers with a short explanation 
on the purpose and usage (see also 3.4.8).  
Ten minutes were estimated in total for registration and instruction of each 
participating mother-infant pair at the pediatric practice. 
Each practice listed their study participants on a practice registration form in 
which the place of sample collection was also documented.  
All required study materials and forms were provided to the pediatric 
practices/mothers. They were pre-labeled and packed in plastic bags (one bag 
per mother-infant pair) to allow an easy and rapid handling for the pediatric 
practices and for the mothers.  
After the study was completed by a pediatric practice, the doctor received a 
short questionnaire with some questions about the selection of mother-infant 
pairs and the study procedure at the practice (see Appendix 10 - German). 
 
3.4.3. Individual registration form 
On the individual registration form, fulfillment of the inclusion criteria (see 3.1.), 
subject characteristics and infant feeding practices were documented from each 
mother-infant pair (see Appendix 7: Individual registration form – German). 
 
3.4.3.1. Subject characteristics 
The following subject characteristics were registered.  
 
Infant: gender, date of birth, mode of delivery, body weight and length.  
Weight and length were measured in the pediatric practice on the day of study 
registration using routine measuring instruments of the practice. The weight was 
recorded to the nearest 10 g, the length to the nearest 0.5 cm. 
 
Mother: place of residence, date of birth, body weight and height (indication 
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made by mother), nationality, intake of vitamin/mineral or algae/kelp 
supplements, use of iodized salt. 
 
3.4.3.2. Infant feeding practices 
The following questions were included on the individual registration form to 
obtain an overview of the feeding practices of the infants (in case a mother had 
not filled out the dietary questionnaire): 
o Ever/still breast-fed (exclusively, predominantly or partially; definition 
according to WHO et al. (WHO et al., 1998; WHO et al., 2008)) - times per 
day 
o Ever/still formula-fed (breast milk substitutes including infant-formula, follow-
on formula, junior milk) - times per day/week/month  
o Already fed (semi-)solid foods/nutritious fluids (excl. fruit juices, sweetened 
drinks) in addition to or instead of breast milk/formula; either especially 
prepared for the infant or from the family table - times per day.  
In this diploma thesis, these meals were named complementary/family foods 
(CF/FF). 
o Kinds of (semi-)solid foods/nutritious fluids (milk-cereal porridge/bottle with 
FM or cow milk, diluted/undiluted cow milk (w/o cereals), vegetable-
carbohydrate-(meat)-meals (w/o milk), fruit-(cereal)-meals (w/o milk)) - times 
per day/week 
o Already fed family food (= food given from the family table) 
o Use of (iodized) salt in home-made/ready meals for the infant 
 
Some doctors addressed questions to us about the part on infant feeding after 
the study instruction. Therefore, we provided an explanation sheet to all 
doctors; see Appendix 8 (German). 
 
3.4.3.3. Comparison with WHO child growth standards 
The height and weight of the study infants were compared with the WHO child 
growth standards. These were developed from the growth data of 8440 healthy 
breastfed infants and young children from diverse ethnic and cultural 
backgrounds living in an environment that promotes normal growth in 6 different 
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countries (WHO Multicentre Growth Reference Study Group, 2006). Based on 
weight, length, age (birth date – study registration date) and sex of the study 
infants, the following mean z-scores were calculated with the aid of the “WHO 
Anthro” Software (WHO, 2009): Weight-for-age, length-for-age, weight-for-
length, BMI-for-age. Based on this, we identified the percentage of underweight 
(weight-for-age < -2SD (= z-scores) of the reference median), stunting (length-
for-age < -2SD of the reference median), wasting (weight-for-length, BMI-for-
age < -2SD of the reference median) and overweight (weight-for-length, BMI-
for-age > +2 SD of the reference median) of the studied population in 
comparison with the WHO reference population. The reference population is 
expected to have infants with z-scores < -2 and > +2 with a prevalence of 2.3% 
(WHO Expert Committee on Physical Status, 1995; WHO Statistical Information 
System, 2008; World Health Organization, 2008). 
 
3.4.4. Spot urine sample of infants  
A spot urine sample of 3 ml was collected from each participating infant using 
the “pad collection” method (Euron Uricol Set, sterile, art. no. 310019, Sterisets 
Int. B.V., Oss, NL). This method was chosen because it is simple, fast and not 
painful or uncomfortable for the infant (Crofton et al., 2008; Liaw et al., 2000). 
The method was successfully used for urine collection in the Swiss newborn 
study (Dorey and Zimmermann, 2008).  
The urine sample was collected at the pediatric practice by the 
pediatrician/medical assistant or at home by the mother (as described above). 
Collection procedure: The infant‟s genital area was cleaned without using any 
cream or powder. The pad was then placed in the nappy which was turned 
inside out to make sure that the urine was not absorbed by the nappy. The pad 
was regularly checked if it had become wet. The mother was instructed to 
breast-feed the infant or to give it something to drink to encourage urination.  If 
the pad became soiled with feces, it was replaced by the second pad. As soon 
as the pad was wet with urine, it was removed and laid on a clean surface, with 
the wet side facing up. With a syringe (in the Uricol set; positioned at 45° on the 
pad) the urine was extracted from the pad by slowly pulling up the plunger and 
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emptying the urine into the specially labeled transport-tube (PS 15 ml, art. no. 
2276, Semadeni AG, Switzerland). This procedure was repeated until the tube 
contained at least 3 ml urine (mark on the tube).  
An illustration of the urine extraction was provided to the mothers, see Figure 4.  
 
Figure 4: Illustration of “pad collection method” 
 
The doctors were told that it was very important to avoid direct or even indirect 
(e.g. open disinfectant close to the sample) contact of iodine-containing 
disinfectants with the urine samples. 
 
3.4.5. Spot urine sample of mothers 
A spot urine sample of 10 ml was collected from the mothers either at the 
pediatric practice or at home.  
The urine was collected with a urine collection cup (PP 125 ml, art. no. 5664, 
Semadeni AG, Switzerland) and 10 ml were filled into a specially labeled 
transport-tube (PS 15 ml, art. no. 2276, Semadeni AG, Switzerland). 
 
3.4.6. Breast milk sample 
A breast milk sample of 10 ml was obtained from breastfeeding mothers either 
at the pediatric practice or at home. The mother had the option to collect the 
breast milk sample either manually or by breast-pump. A description of the 
method for manually collecting breast milk was handed out to the mothers 
(provided by the “Swiss Foundation for the Promotion of Breastfeeding”), see 
Figure 5.  
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Mothers were instructed to discard the first few milk drops because of possible 
differences in composition. Therefore, disposable bra pads (Medela AG, 
Medical Technology, Switzerland) were provided. Then, 10 ml of breast milk 
was collected in a collection cup (PP 125 ml, art. no. 5664, Semadeni AG, 
Switzerland) and filled into a specially labeled transport-tube (PS 15 ml, art. no. 
2276, Semadeni AG, Switzerland).  
 
 
Figure 5: Description of the method for manual breast milk expression - German 
Source: (Swiss Foundation for the Promotion of Breastfeeding, 2008) (with permission) 
 
3.4.7. Storage and transport of samples 
In the pediatric practices urine and breast milk were kept refrigerated at 2 to 8°C 
until they were transported to ETH Zürich (to avoid unpleasant odor). The 
samples were sent to ETH by (priority) mail enclosed in plastic bags and in 
special soft envelopes on a weekly basis. If the samples were collected at 
home, mothers were asked to keep them refrigerated and to send them to ETH 
as soon as possible. The pediatric practices/mothers were provided with all 
transport material (pre-stamped). As it was shown that there is no iodine loss in 
well sealed samples (Sullivan et al., 2000), it was not problematic to transport 
the samples to ETH at ambient temperature. 
When arriving at ETH, the samples were instantly refrigerated at 4°C. Within the 
same or next day they were aliquoted into Eppendorf tubes (2 x 1.5 ml for urine, 
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5 x 2 ml for breast milk; Clicklock Microcentrifuge tubes, Simport, Canada) and 
frozen at -25°C until analysis. 
If breast milk samples became coagulated during transport, the tubes were 
placed in an ultrasound bath (Fisher Scientific FB 15061, Germany) for 10 to 15 
minutes to dissolve the coagulation and were subsequently aliquoted. 
 
3.4.8. Dietary questionnaires and social demographics of 
mothers 
More detailed information about the structure and development of the dietary 
questionnaire is given in chapter 3.7. “Dietary assessment” and the 
questionnaire is shown in Appendix 11 (German). 
The first dietary questionnaire was filled out by the mothers either directly at the 
pediatric practice or at home and sent to ETH. At the practice, a folder with 
brochures of commercial infant food products was provided to help mothers 
remember the correct product names. It was emphasized in the questionnaire 
that the mother should try to remember the food intake of her infant as precisely 
as possible. If she had not spent the day before sample collection together with 
her infant, she was asked to fill out the questionnaire on the next possible day. 
If the sample collection took place at home, the mother was instructed to fill out 
the first questionnaire at the day of sample collection. 
The second dietary questionnaire had to be filled out at home three to four days 
after sample collection and was sent to ETH in a pre-stamped envelope.  
The pediatrician had the option to leave out the dietary questionnaires if the 
mother seemed to be incapable of completing the questionnaires because of 
poor language skills. 
The questionnaire also included sociodemographic questions about the mother: 
age, nationality, canton of residence, number of children, single parent, smoker, 
professional activity and education/profession. Contact data of mother for 
further inquiry of ETH was optional.  
Mothers‟ education and profession were classified in nine super groups of 
occupation according to the “Schweizer Berufsnomenklatur, SBN 2000” 
(Bundesamt für Statistik, 2000) (see Appendix 14). They were also categorized 
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according to the UNESCO “International Standard Classification of Education” 
(ISCED) levels (UNESCO Institute for Statistics, 2006). These levels (see 
Appendix 14) are also used by the Swiss Federal Statistical office to classify 
professional education in Switzerland (Bundesamt für Statistik, 2007/2008). 
 
3.4.9. Formula and infant food product samples 
The labeled iodine concentration of formula and commercial infant food 
products was compared with the analyzed concentration. Formula products 
(infant formulae 2x, follow-on formulae 9x, soy-based formula 1x; all instant 
powders) and baby cereal products (10x; 9 instant powders, 1 ready-to-eat 
product) of the eight most common infant food brands in Switzerland were 
bought in several retail stores, pharmacies and health food shops located in 
Zürich, Berne and Sargans. We made a convenient selection of each available 
brand on the Swiss market and particularly of the products that were frequently 
consumed by the infants of our study (as indicated in the dietary 
questionnaires). 
 
3.5. Time schedule 
The estimated time schedule for the study was: 
- April to July 2008: Study preparation and recruitment of pediatric practices 
- August 2008 to August 2009: Data collection  
- January 2009 until study completion: Ongoing data input and laboratory 
analysis 
- September to November 2009: Statistical analysis and data evaluation 
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3.6. Laboratory analyses 
3.6.1. Urinary iodine concentration  
- modified Sandell-Kolthoff method 
The analysis of the urinary iodine concentration (UIC) was performed by a 
modified Sandell-Kolthoff method at the Laboratory of Human Nutrition, Institute 
of Food Science and Nutrition, ETH Zürich. 
 
3.6.1.1. Principle 
This colorimetric method was first described in detail by E.B. Sandell and I.M. 
Kolthoff (Sandell and Kolthoff, 1937) and modified by Pino et al. (Pino et al., 
1996). 
The method is based on the reduction of cerium(IV) ion (yellow) to the colorless 
cerous(III) ion in the presence of arsenious acid (Sandell and Kolthoff, 1937): 
2 Ce4+ + As3+  2 Ce3+ + As5+. 
 
This reaction proceeds slowly in the absence of a catalyst in dilute sulfuric acid 
medium at room temperature. If only a few micrograms of iodide are added, it 
causes a decolorization of the solution from yellow to colorless within a few 
minutes. No other relevant elements were found which also distinctly catalyze 
the reaction (the only elements found were osmium, ruthenium). Iodine must be 
present as iodide ( ) to catalyze the reaction (Sandell and Kolthoff, 1937). 
Iodide is also the main chemical form of iodine in urine (Gnat et al., 2003). If 
iodine is present as iodate ( 3 ), this is reduced to iodide in the presence of 
sulfuric acid and arsenite solution (Sandell and Kolthoff, 1937). For the 
measurement of the iodine concentration, the ceric solution (Ce4+) needs to be 
added to an excess of arsenite solution (As3+) which contains the iodide. The 
amount of iodide is than directly proportional to the rate of decolorization. The 
reaction must take place in a fairly acid medium (dilute sulfuric acid) to prevent 
the precipitation of ceric arsenate (Sandell and Kolthoff, 1937).  
This original method had no digestion step so that interfering substances in 
urine (such as oxidizing and reducing substances) could affect the reaction 
(Sandell and Kolthoff, 1937). Therefore, Pino et al. modified the method in order 
to obtain exact measurements by eliminating interfering substances and the 
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natural color of urine. For this purpose, urine samples are digested by 
ammonium persulfate, an oxidizing agent, before the colorimetric analysis is 
performed (Pino et al., 1996). 
 
3.6.1.2. Acid-washing 
To avoid iodine contamination, all glassware required for the analysis was acid 
washed with the following procedure: The objects were filled in a PE-container 
and washed three times with nanopure water (18MΩ, Nanopure Cartrige 
System, Skan AG, Switzerland). Concentrated nitric acid (HNO3 (65%) pro 
analysi, Merck, Germany) was diluted with nanopure water to a concentration of 
22% and filled in the container with the objects. After shaking the container over 
night on a lab shaker (K5501, IKA Labortechnik, Germany) the acid was 
emptied out and the objects washed three times with nanopure water. Then the 
container was again filled with nanopure water and shaken over night. After 
that, the objects were again washed three times with nanopure water and put in 
an oven (WTC Binder, Germany) at 65°C for drying. 
 
3.6.1.3. Test of collection materials 
Before sample collection, urine collection pads (Euron Uricol Set (sterile), art. 
no. 310019, Sterisets Int. B.V., NL) were tested for iodine contamination and 
iodine recovery. All other materials for the study were also tested for iodine 
contamination: syringes (in Euron Uricol Set, see above), urine collection cups 
(PP 125 ml, art. no. 5664, Semadeni AG, Switzerland), urine transport-tubes 
(PS 15 ml, art. no. 2276, Semadeni AG, Switzerland), disposable bra pads 
(Medela AG, Medical Technology, Switzerland) and the bottle with nanopure 
water that was used during the iodine analysis (Art. no 1165, Semadeni AG, 
Switzerland). As one pediatric practice insisted on using urine collection bags 
instead of pads, two brands of bags were also tested for iodine contamination 
(Pediatric urine collectors (sterile), Ref: PEDUB100, Romed, NL; U-bag 
pediatric (sterile), Urine collectors No. 7511 (Single Specimen), Hollister, Illinois, 
USA). All other plastic materials used for the study had already been assessed 
to have no iodine contamination at an earlier point of time by the laboratory and 
are regularly used for iodine analyses (Eppendorf tubes, Pasteur pipettes and 
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pipette tips). 
Test of the urine collection pads: To verify the absence of iodine contamination, 
the pad was soaked with 10 ml of nanopure water. After half an hour, the water 
was extracted from the pad with a syringe (from the Uricol set) and aliquoted 
into three Eppendorf tubes. This was done for three pads. As a control for 
iodine contamination in the nanopure water, another three Eppendorf tubes 
were filled with nanopure water without extracting it from a pad. Then, all 
aliquots were analyzed in duplicate by the modified Sandell-Kolthoff method in 
the same way as urine samples, see chapter 3.6.1.7.  
The same procedure was applied to control for iodine recovery from the pads. 
Therefore, an iodine solution [100 μg/l] was used instead of nanopure water. 
Test of the other collection materials: To verify the absence of iodine 
contamination, 10 ml of nanopure water was filled in the urine collection cups, 
transport tubes, disposable bra pads and urine bags (each in triplicate), 5 ml of 
nanopure water in the syringes (in triplicate) and one plastic bottle was filled 
completely with nanopure water. All materials were shaken well for 5 minutes. 
After half an hour, three samples of each piece of material were aliquoted into 
Eppendorf tubes (with disposable Pasteur pipettes). To check whether the 
nanopure water that was used for analysis was contaminated, three Eppendorf 
tubes were filled with nanopure water. Then, all aliquots were analyzed in 
duplicate by the modified Sandell-Kolthoff method in the same way as urine 
samples, see chapter 3.6.1.7.  
It was not possible to extract the water after half an hour from the disposable 
bra pads because they contained a super-absorbent gel. Medela assured that 
the disposable bra pads did not contain any iodine (personal communication).  
After analysis, all aliquots were frozen at -25°C for repeat analysis.  
 
3.6.1.4. Reagents 
All reagents that were used for the modified Sandell-Kolthoff method are listed 
in Table 9. For all analyses, nanopure grade water purified by reverse osmosis 
was used (18MΩ, Nanopure Cartrige System, Skan AG, Switzerland). 
 
70 Subjects & Methods 
 
 
 
 
University of Vienna  Nadja Wüst 
 
 
Table 9: Reagents for the modified Sandell-Kolthoff method 
Reagent Chem. formula Art. no Supplier 
 Sodium hydroxide 
    (pellets) 
NaOH puriss. p.a., 71695 Fluka Chemie, 
Switzerland 
 Arsenic (III) oxide As2O3 puriss. p.a., 11100 
Fluka Chemie, 
Switzerland 
 Concentrated sulfuric 
acid (95 -97%) 
H2SO4 puriss. p.a., 84720 
Fluka Chemie, 
Switzerland 
 Sodium chloride NaCl puriss. p.a., 71379 
Fluka Chemie, 
Switzerland 
 Ammonium cerium (IV) 
    sulfate Dihydrate 
Ce(NH4)4(SO4)4
*2H2O 
puriss. p.a., 22269 
Fluka Chemie, 
Switzerland 
 Ammonium 
    peroxodisulfate 
H2N2O8S2 puriss. p.a., 09915  
Fluka Chemie, 
Switzerland 
 Potassium iodate K O3 puriss p.a., 60390 
Fluka Chemie, 
Switzerland 
 
3.6.1.5. Equipment/materials 
All equipment and materials that were used for the modified Sandell-Kolthoff 
method are listed in Table 10. 
 
Table 10: Equipment/materials for the modified Sandell-Kolthoff reaction 
Equipment/material Model Supplier 
 Analytical scale AT 200 Mettler-Toledo, Switzerland 
 Fume hood  Renggli, Switzerland 
 Biohazard-box Skanair VFV 90 Skan AG, Switzerland 
 Heating/Magnetic stirrer FB 15001 Fisher Scientific, Germany 
 Vortex Genie 2TM Bender & Hobein, Switzerland 
 Timer   
 Heating block  Bioblock Scientific, Switzerland 
 Borosilicate glass test tubes  12 x 100 mm Schott Duran®, Germany 
 Micro-pipette (25 μl) single channel, 
Finnpipette 
Thermo Labsystems, Germany 
 Micro-pipette (50-200 μl) single channel Socorex, Switzerland 
 Micro-pipette (100-1000 μl) single channel Eppendorf reference, Germany 
 Multichannel-pipette  
   (20-200 μl) 
Acura 855 Socorex, Switzerland 
 Disposable pipette tips graduated Starlab, Germany 
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Continuation of Table 10:  
Equipment/material Model Supplier 
 96-well micro-plates (PS) Polystyrene, flat 
bottom 
Greiner-bio-one, Germany 
 Micro-plate shaker Titramax 100 Bioblock Scientific/Heidolph, 
Switzerland 
 MRX Micro-plate Reader MR1200 Dynatech Laboratories, Germany 
 Various glassware  
    (acid washed) 
Volumetric 
flasks, beakers, 
reagent 
containers, 
measuring 
cylinders, glass 
measuring 
pipettes 
Schott Duran/Pyrex/Hirschmann, 
Germany 
 
 
3.6.1.6. Solutions 
Sodium hydroxide solution (8.0 mol/l):  
159.4 g of NaOH pellets were dissolved in 300 ml of nanopure water in a 
volumetric flask (500 ml) in an ice bath. After cooling, the solution was adjusted 
to 500 ml with nanopure water. The solution is stable for months. 
Sodium hydroxide solution (0.875 mol/l): 
21.8 g of NaOH solution (8 mol/l, see above) was weighed into a volumetric 
flask (200 ml) and diluted with nanopure water to a volume of 200 ml. 
Arsenious acid solution (0.05 mol/l): 
9.8 g of arsenic (III) oxide (As2O3) was dissolved in 200 ml of NaOH solution 
(0.875 mol/l, see above) in a volumetric flask (1000 ml). In an ice bath under a 
fume hood, 32 ml of concentrated sulfuric acid (H2SO4) was slowly added. After 
cooling to room temperature, 25 g of sodium chloride (NaCl) was dissolved in 
the solution and nanopure water was added to a volume of about 800 ml. The 
solution was heated under stirring (magnetic stirrer) at 85-90°C until complete 
dissolution (about 1 h, flask covered with aluminum foil). After cooling to room 
temperature, the solution was adjusted to 1000ml with nanopure water.  
Stored away from light at room temperature, the solution is stable for at least 
three months. 
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Sulfuric acid solution (1.75 mol/l): 
Under a fume hood in an ice bath, 94.5 ml of concentrated sulfuric acid (H2SO4) 
was slowly added to about 700 ml of nanopure water in a volumetric flask (1000 
ml). After cooling to room temperature, the solution was adjusted to 1000 ml 
with nanopure water. 
Ceric ammonium sulfate solution (0.019 mol/l): 
Under a fume hood, 6 g of ammonium cerium (IV) sulfate dihydrate 
(Ce(NH4)4(SO4)4*2H2O) was dissolved in 400 ml of sulfuric acid solution (1.75 
mol/l) in a volumetric flask (500 ml). The solution was covered with aluminum 
foil and stirred on a magnetic stirrer. When the solution became clear, it was 
adjusted to a final volume of 500 ml with the sulfuric acid solution (1.75 mol/l, 
see above). Stored away from light at room temperature, the solution is stable 
for at least 3 months. 
Ammonium persulfate solution (1.0 mol/l): 
57.05 g of ammonium peroxodisulfate (H2N2O8S2) was dissolved in 
approximately 180 ml of nanopure water in a volumetric flask (250 ml). The 
solution was stirred on a magnetic stirrer until it became clear. Finally, it was 
filled to a volume of 250 ml with nanopure water. The solution was prepared 
freshly every week. 
Iodine stock solution (1 g iodine/l): 
168 mg of potassium iodate (K O3) was dissolved in nanopure water in a 
volumetric flask (100 ml) and adjusted to 100 ml with nanopure water.  
Covered with aluminum foil, the stem solution is stable for at least 3 months at 
room temperature.  
Iodine standard solution A (0.5 mg iodine/l): 
50 μl of iodine stock solution (1 g iodine/l, see above) was pipetted into a 
volumetric flask (100 ml). Nanopure water was added to a final volume of 100 
ml. The iodine standard solution A was freshly prepared every day. 
 
3.6.1.7. Experimental procedure 
For each experiment 26 urine samples (aliquots of 1.5 ml) and two urine control 
samples (X and Z, aliquots of 1.5 ml) were defrosted to room temperature and 
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vortexed to dissolve sediments. In a biohazard-box, 2 x 250 μl of each sample 
(duplicate), 250 μl of each control sample (no duplicate) and 250 μl of nanopure 
water (= blank, no duplicate) were pipetted into borosilicate glass test tubes 
(totally 55 tubes). As the color reaction has no specific endpoint a standard 
curve is required (Pino et al., 1996). For the standard curve the iodine standard 
solution A was pipetted into glass tubes according to the following scheme (no 
duplicate) (S1 – S5 = standard solutions 1 - 5): 
      Iodine conc. [μg/l] 
S1 25 l iodine standard solution A + 225 l H20 * 50 
S2 50 l iodine standard solution A + 200 l H20 100 
S3 100 l iodine standard solution A + 150 l H20 200 
S4 150 l iodine standard solution A + 100 l H20 300 
S5 200l iodine standard solution A + 50 l H20 400 
*(H20 always refers to nanopure water) 
 
1 ml of ammonium persulfate solution (1.0 mol/l) was added to each glass tube. 
All tubes were vortexed. Then, the tubes were heated to 95°C for 60 min in a 
heating block under a fume hood. Heating time and temperature had to be 
identical for all tubes (time stopped). After one hour, the tubes were taken out of 
the heating block and cooled to room temperature (approximately 30 min). 
Subsequently, the glass tubes were vortexed. Then, 50 μl from each tube were 
pipetted into the corresponding well/wells of a 96-well micro-plate according to 
the pipetting scheme in Table 11 (finally, each well on the micro-plate contained 
50 μl of the respective solution/sample).  
 
Table 11: Pipetting scheme on 96-well micro-plate 
 1 2 3 4 5 6 7 8 9 10 11 12 
A 0 0 0 0 0 0 0 0 0 0 0 0 
B S1 S5 S5 S5 S5 S5 S5 S5 S5 S5 S5 S1 
C S2 U1a U3a U5a U8a U11a U14a U17a U20a U23a U25a S2 
D S3 U1b U3b U5b U8b U11b U14b U17b U20b U23b U25b S3 
E S4 U2a U4a U6a U9a U12a U15a U18a U21a U24a U26a S4 
F S5 U2b U4b U6b U9b U12b U15b U18b U21b U24b U26b S5 
G X X X U7a U10a U13a U16a U19a U22a X X X 
H Z Z Z U7b U10b U13b U16b U19b U22b Z Z Z 
Legend: 0 = blank; S1-5 = standard solutions; X and Z = urine control samples; U1-26 = urine samples in 
duplicate (a, b), plate filled column-wise; (A - H = lines; 1 – 12 = columns of the micro-plate) 
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100 μl of arsenious acid solution (0.05 mol/l) was added to each well of the 
micro-plate with a multichannel-pipette (from left to right, column 1-12). The 
plate was shaken on a micro-plate shaker for 15 min (time stopped). Then, 50 μl 
of ceric ammonium sulfate solution (0.019 mol/l) was pipetted to each well of 
the micro-plate within 60 sec using a multichannel-pipette (from left to right, 
column 1-12) and the plate was shaken on the micro-plate shaker for exactly 28 
min (time stopped). The micro-plate was placed in the micro-plate reader and 
the absorbences were measured photometrically at a wavelength of 405 nm, 
against air (settings of micro-plate reader are shown in Table 12).  
 
Table 12: Settings of the micro-plate reader MRX 1.2 
MRX 1.2  Description Setting 
Photometer Test filter 1:  λ= 405nm  
 Reference filter 0 
 Blank (Air/Kavit.) AIR 
 Control well A1 
 Shaking time (sec) 0 
Periphery RS-232-C (COMx:) 1 
 Baudrate 9600 
 Pieps 2 
 
Data processing was performed by the associated MRX-software. The 
absorbences were transferred to a computer for the evaluation with Excel 
(Microsoft, Seattle, WA, 2003). 
 
3.6.1.8. Calculations 
Urinary iodine concentrations were calculated with the help of a standard curve 
by linear regression.  
A “control” standard curve was calculated with the log transformed absorbances 
of the standards in the first and last column (column 1 and 12, see Table 11) of 
the micro-plate (y-axis) versus the standard iodine concentrations (x-axis) 
according to the following regression equation: y = a * x + b (y = log absorption, 
x = iodine concentration [μg/l], a = slope, b = intercept). An example can be 
seen in Figure 6. The coefficient of determination (R2) of the standard curve had 
to be ≥ 0.99 to accept the measurements.  
To compensate for the slight time difference of the color reaction, when the 
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ceric ammonium sulfate solution was pipetted from column 1 to 12 of the micro-
plate, the blank and standard 5 (400 μg/l) were pipetted in each column of the 
micro-plate (see Table 11). The sample concentrations were not calculated with 
the “control” standard curve (Figure 6), but with two-point standard curves 
(using blank and standard 5) for each single column of samples (columns 2-11) 
on the micro-plate.  
 
 
Figure 6: Example of standard curve 
 
For each sample the difference of UIC [in %] between the duplicate was 
determined. A sample was accepted, if the difference was:  
≤ 15% for iodine concentrations < 50 μg/l,  
≤ 10% for iodine concentrations between 50 - 150 μg/l,  
≤ 5% for iodine concentrations > 150 μg/l. 
Otherwise, the sample was repeated until the difference fell in the above-
mentioned range.  
For the data analysis, the average of both measured UI concentrations of a 
duplicate was used. 
 
3.6.1.9. Quality control 
3.6.1.9.1. Internal quality control 
As internal control, two control samples (X and Z) were included in each run (= 
on each micro-plate). The control samples were from a urine pool, one with low 
(X) and one with high (Z) iodine concentration. Before they were set as control 
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samples, they were measured on 20 plates in duplicates against the former 
controls to determine their mean and SD. It was defined for all future 
measurements that a measurement was only accepted if both control samples 
were within 3 SD of the control mean: 
X control sample: 34.1 ± 3.34 μg/l; CV% 9.80; acceptable range 24-44 (3 SD) 
Z control sample: 218 ± 7.05 μg/l; CV% 3.24; acceptable range 197-239 (3 SD) 
X and Z values were also validated by measuring the concentration by ICP-MS 
at FOPH in Berne, Switzerland. See chapter 3.6.2.10.  
X and Z were also used to assess the inter-assay precision of the 
measurements. To assess the intra-assay precision a urine sample was 
measured in several tubes in one single assay (see results). 
 
3.6.1.9.2. External quality control  
For a constant control of the quality of urinary iodine measurements the 
laboratory takes part in a worldwide program “to ensure the quality of urinary 
iodine procedures” (EQUIP) developed by the Centers for Disease Control and 
Prevention (CDC). Currently, more than 80 iodine laboratories in more than 30 
countries participate in the program. In this program, urine specimens with 
unknown iodine concentration are analyzed by the participating laboratories 
three times a year. CDC defines the EQUIP target values of the urine 
specimens by taking the mean of nine individual measurements with ICP-DRC-
MS on at least three different days. Each participating laboratory has to report 
data for each specimen measured three times in duplicate (on three different 
plates) (Caldwell et al., 2005). During our analyses we participated in one round 
and measured four EQUIP samples of different iodine concentrations. 
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3.6.2. Breast milk iodine concentration & iodine in formula and 
infant food - ICP-MS method 
All breast milk, formula and infant food samples were measured by an 
inductively coupled plasma mass spectrometry (ICP-MS) method at the Swiss 
Federal Office of Public Health (FOPH, Liebefeld) in the laboratory of the 
Consumer Protection Directorate in collaboration with M. Haldimann and A. 
Blanc. 
 
3.6.2.1. Principle 
Several modifications of the ICP-MS method for the determination of iodine 
exist. The method which was applied here was developed by Haldimann at 
FOPH based on Adriaens et al., Fecher at al. and Haldimann et al. (Adriaens et 
al., 1993; Fecher et al., 1998; Haldimann et al., 2000; Haldimann et al., 1998). It 
was used before for the analysis of iodine in cow milk samples at the same 
laboratory (Crnkic et al., 2006). 
 
First, iodine has to be quantitatively extracted from the samples and brought 
into solution. Therefore, tetramethylammonium hydroxide (TMAH), a strong 
alkaline reagent, was used at an elevated temperature (90°C) (Fecher et al., 
1998). Furthermore, the measuring of iodine in alkaline solution suppresses the 
development of volatile iodine species such as H  and 2 (Haldimann et al., 
2000). 
In breast milk (BM), iodine is mainly found as iodide ( -) in the aqueous phase 
(milk whey) (Dorea, 2002; Fernandez-Sanchez et al., 2007). Organic iodine like 
thyroid hormones and metabolites is also reported in BM however with large 
concentration differences (Dorea, 2002). In infant and follow-on formula it is 
allowed to add iodine as potassium iodide, sodium iodide and potassium iodate 
and in complementary foods sodium iodate is also allowed (EDI, 2005b). With 
ICP-MS the total concentration of soluble iodine of a sample is measured 
regardless of the chemical form as all molecules are atomized and ionized ( +) 
in the plasma of the spectrometer (Fecher et al., 1998; Thomas, 2001a).  
After the extraction, iodine concentration is measured with ICP-MS using 
isotope dilution analysis (IDA) with 129  (Haldimann et al., 1998). In the method 
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of IDA the sample is spiked with an isotope of the element that is to be 
determined. It must be either an isotope that does not naturally exist in the 
sample or else a low abundance isotope that is enriched (Adriaens et al., 1993). 
In the case of iodine only one stable isotope, 127 , exists naturally in samples 
and its concentration is the searched variable. 129  is a radioactive, β emitting 
isotope of iodine (half-life: 1.57 x 107 years) (Platzner, 1997) and its natural 
abundance is negligible (Muramatsu and Yoshida, 1995). 129  is added to the 
samples as a spike (= tracer) (Haldimann et al., 1998). The ratio of these two 
isotopes is directly measured by ICP-MS. Knowing the 129  concentration in the 
added spike, the 127  concentration in the sample can be determined (Adriaens 
et al., 1993; Haldimann et al., 1998). The method of IDA (in contrast to an 
external standard) is ideal to compensate for plasma fluctuations during ICP-MS 
measurement and to erase matrix effects of the sample such as suppressions 
by other ions (like Ca2+, Mg2+ and Cl-), which play an important role in biological 
samples. The isotope ratio is not affected because the degree of modification is 
the same for both isotopes (Haldimann et al., 1998; Horlick and Montaser, 
1998). For the principle of the ICP-mass spectrometer, see below. 
 
3.6.2.2. Reagents/reference materials 
All reagents and reference materials used for the ICP-MS analysis are listed in 
Table 13.  
Ultrapure water was used (18.2MΩ, Ultra-pure, Purelab ultra, Elga, UK) for all 
analyses. 
 
3.6.2.3. Equipment/materials 
All equipment/materials used for the ICP-MS analysis are listed in Table 14. 
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Table 13: Reagents/reference material for iodine analysis with ICP-MS 
Reagents/reference material Art. no Supplier 
 Tetramethylammonium 
Hydroxide (TMAH) 25% 
(CH3)4NOH 
Tamapure-AA, Lot. No. Z826N01K,  
UN No. 1835,  
Ultrapure analytical reagent,  
Specification (on certificate of 
analysis) < 1000 ppt iodine (pg/mL) 
Tama 
Chemicals, 
Japan 
 Iodine-129 radioactivity 
standard (Gills, 1995) 
 
Standard reference material 4949C NIST, 
Gaithersburg, 
USA 
 Natriumhydroxid-Monohydrat 
 NaOH * H2O 
Suprapur, 99.99%, art. no. 1.06466 Merck, 
Darmstadt, 
Germany 
 Whole milk powder 
(Gills, 1993) 
Reference Material 8435 NIST, 
Gaithersburg, 
USA 
 Infant formula (powder) 
    (Wise and Watters, 2007) 
Standard Reference Material 1846 NIST, 
Gaithersburg, 
USA 
Abbreviation: ICP-MS = Inductively Coupled Plasma Mass Spectrometry 
 
Table 14: Equipment/materials for iodine analysis with ICP-MS 
Equipment / material Model Supplier 
 Heat cabinet Thermocenter TC40 SalvisLab, Switzerland 
 (Drying) oven Durocell 55 MMM, Germany 
 Analytical balance XP205 Mettler Toledo, Switzerland 
 Precision balance PR8002 Delta Range Mettler Toledo, Switzerland 
 Pipette 0.5 – 5 ml Socorex, Switzerland 
 Disposable pipette tips 100 – 5000 μl Eppendorf, Germany 
 Automatic pipette EDOS 5222 Eppendorf, Germany 
 Combitips plus (disposable) 1 ml, 5 ml, 10 ml Eppendorf, Germany 
 PP-tubes with  
red screw cap (HD-PE) 
(disposable) 
50 ml, conical skirted 
base  
Sarstedt, Germany  
 PP-tubes with push cap 
(disposable) 
12 ml, round base Sarstedt, Germany 
 Ultrasound bath TPC-40, Telesonic Ultrasonics Steckmann 
GmbH, Germany 
 Polycarbonate bottles (500 ml) Narrow-mouth square 
bottle, Lexan  
Nalgene, USA 
 Laboratory mixer B-400, titan blades Büchi, Switzerland 
 Mixer sample vessels Borosilicate glass Büchi, Switzerland 
Abbreviation: ICP-MS = Inductively Coupled Plasma Mass Spectrometry 
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3.6.2.4. Spiking solution 
Preparation of the 129  spiking solution (1.41 ppm): 
254.3 mg of the iodine-129 radioactivity standard (189.9 mg/L, (Gills, 1995)) 
was weighed and filled up to 34.16 g with ultrapure water. 134 mg of NaOH 
(hydrate) was then added. This resulted in 1.41 ng/µl (ppm) iodine-129 in a 
0.26% NaOH solution. The 129  spiking solution was stored at 8°C. 
 
3.6.2.5. Experimental procedure 
The samples were generally analyzed once. Some samples were repeated 
(another aliquot) in a second run to test the repeatability of the analysis and 
preparation as well as the homogeneity of the samples. 
 
3.6.2.5.1. Preparation for measurement 
See also preparation scheme, Table 15: 
 
Preparation of breast milk samples: 
The BM samples were transported to Berne for analysis in frozen conditions 
(with dry ice). For the analysis, the desired number of samples (aliquots of 2 ml, 
the number of samples per run varied between 35 and 40) was equilibrated to 
room temperature for about one hour. The samples were agitated carefully to 
homogenize the BM and 1.5 ml of each sample was pipetted into 50ml-PP-
tubes on an analytical scale. The exact weight of each pipetted sample was 
noted and each tube was closed with a cap. If an aliquot contained less than 1.5 
ml, the maximum volume was taken for analysis. The pipetted amount and 
weight were noted. Some BM samples were coagulated to different extents. To 
dissolve the coagulated particles - presumably mainly consisting of fat – the 
corresponding samples were placed in an (drying) oven at 40°C for 15 - 30 
minutes depending on the extent of coagulation. After cooling for 5 minutes, 
they were pipetted in the same way as the rest of the samples. Subsequently, 
0.5 ml of TMAH solution (25%) was added to each PP-tube using an automatic 
pipette (5 ml tip, DISP mode). The tubes were closed again with the caps and 
swayed slightly. The samples were heated in the heat cabinet for 3 hours at 
90°C to extract the iodine. After that, the samples were taken out of the heat 
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cabinet and left to cool to room temperature for 45 minutes. The tubes were 
filled up to the 50 ml mark with ultrapure water, closed with the caps, shaken 
well and left over night for sedimentation at room temperature. The next 
morning, the tubes were handled carefully and not shaken to avoid dispersing of 
sediments. Aliquots of 10 ml were pipetted from the middle of the tubes into 
12ml-PP-tubes using an automatic pipette (10 ml tip, PIP mode). Care was 
taken not to take up any sediment from the bottom of the tube or parts of the fat 
fraction floating on top of the solution as this would have interfered with the ICP-
MS measurement. Then, 25 μl of the 129  spiking solution (shaken well and 
equilibrated to room temperature; 25 μl spiking solution contains 35.25 ng 129 ) 
was added to each sample using an automatic pipette (1 ml tip, DISP mode). 
The 12ml-PP-tubes were closed with caps and shaken well. 
 
Preparation of formula and infant food samples: 
The infant food sample packages were stored at room temperature in dry 
ambiance. Before taking out a sample, the package was shaken well to 
homogenize the content. We always reconstituted full portions of the products 
for the analyses to control for a possible inhomogeneous distribution of iodine in 
the dry product. Some products were additionally analyzed in powder form. The 
number of formula/infant food samples that was included per run varied 
(depending on the time required for sample preparation and the number of 
included BM samples in the same run). 
Preparation of formula and infant food samples in powder form: About 0.25 g of 
a product (powder) was weighed into a 50ml-PP-tube on an analytical scale. 
The exact weight was noted and the cap was closed. 2 ml of ultrapure water 
was added to the tube using an automatic pipette (10 ml tip, DISP mode). 
Subsequently (continuing with the addition of TMAH), the samples were 
prepared for the ICP-MS measurement in the same way as the BM samples 
(see also Table 15). 
Preparation of reconstituted formula: The formula (FM) was prepared freshly on 
the day of experiment according to the instructions described on the package. 
The portion size for an infant of about six months of age was used (between 
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200 and 260 ml depending on the product). The amount which had to be 
prepared was calculated precisely based on the indicated standard resolution of 
the product [g/vol] (defined as: amount of powder (g) + 90 ml of water = 100 ml 
of FM). Polycarbonate bottles were used for the preparation because they are 
commonly used as baby bottles. Before usage, the bottles were rinsed three 
times with ultrapure water and dried. The required amount of ultrapure water 
was weighed directly into a polycarbonate bottle on a precision balance, the cap 
was closed and the bottle heated in the heat cabinet for about one hour at the 
required temperature for preparation (between 40 – 50°C depending on the 
product). After that, the required amount of powder was directly added to the 
water and simultaneously weighed, the bottle closed again and shaken to 
dissolve the powder. After cooling and shaking again, about 40 ml of the 
preparation was transferred to a 50 ml PP-tube (for storage after the analysis at 
-25°C). From this, 1.5 ml was pipetted into another 50ml-PP-tube on an 
analytical scale. The exact weight was noted and the tube was closed with a 
cap. Subsequently (continuing with the addition of TMAH), the reconstituted FM 
samples were prepared for the ICP-MS measurement in the same way as the 
BM samples (see also Table 15). 
Preparation of reconstituted baby cereal porridge: The porridge (one portion per 
product) was prepared freshly on the day of experiment according to the 
instructions described on the package. Ultrapure water was heated in a 
polycarbonate bottle in the heat cabinet for about one hour at the required 
temperature (between 40 – 50°C depending on the product). Then, according to 
the instruction on the package, either firstly the water, then the powder, or vice 
versa were weighed in a borosilicate mixer vessel and the exact weights were 
recorded. The vessel was fixed in the mixer and the porridge was mixed twice 
for about 10 sec. If the porridge was homogeneous, an aliquot of about 40 ml 
was transferred to a 50ml-PP-tube (for storage after the analysis at -25°C). 1.5 
– 2.0 g of the sample was weighed into another 50ml-PP-tube on an analytical 
scale. The exact weight was noted and the tube was closed with a cap. 
Subsequently (continuing with the addition of TMAH), the porridge samples 
were prepared for the ICP-MS measurement in the same way as the BM 
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samples (see also Table 15). 
Before and after usage, the borosilicate vessels were first cleaned with hot 
water and rinsing agent and then rinsed with ultrapure water. They were then 
filled with nitric acid (5%, HNO3 (65%) pro analysi, Merck, Germany) for a few 
minutes and rinsed again three times with ultrapure water and finally left for 
drying. In between mixing different porridges, the mixing blades were rinsed 
well with ultrapure water. Finally, the blades were soaked overnight in 1% RBS 
50 concentrate (art. no. 83462, Fluka Chemie, Switzerland) and then rinsed with 
ultrapure water. 
 
Preparation of the blank: 
The blank solution was freshly prepared for each ICP-MS measurement series. 
For the blank, 2 ml of ultrapure water was pipetted into a 50ml-PP-tube using an 
automatic pipette (10 ml tip, DISP mode) and the cap was closed. Afterwards 
(continuing with the addition of TMAH), the blank was prepared in the same way 
as the BM samples, except that no 129  spiking solution was added (see also 
Table 15). 
 
Preparation of the whole milk powder/infant formula reference samples:  
One to three whole milk/infant formula (IF) reference samples were included in 
each ICP-MS measurement (depending on kind and number of measured 
samples).  
About 0.2 g of whole milk reference powder or 0.25 g of IF reference powder 
was weighed into a 50ml-PP-tube on an analytical scale. The exact weight was 
recorded and the cap was closed. 2 ml of ultrapure water was added to the tube 
using an automatic pipette (10 ml tip, DISP mode). As the IF reference powder 
did not dissolve well, the PP-tubes with the IF reference were put in an 
ultrasound bath for 20 min at 40°C. In the following (continuing with the addition 
of TMAH), the reference samples were prepared in the same way as the BM 
samples, except that after the sedimentation an aliquot of 5 ml was taken from 
the middle of the 50ml-PP-tube (instead of 10 ml for the BM samples) (see also 
Table 15). 
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Table 15: Preparation scheme: Measurement of iodine concentration by ICP-MS 
 BM/FM  
(reconst.) 
Baby 
cereal 
(reconst.) 
Baby 
cereal 
(powder) 
Whole 
milk/IF  
reference 
Blank  
 
Pipetted/ 
weighed sample 
1.5 ml 1.5 - 2.0 g 0.25 g 0.2/0.25 g -- 
5
0
m
l-
P
P
-t
u
b
e
 
Water 
(Nanopure) 
-- -- 2 ml 2 ml 2 ml 
TMAH (25%) 0.5 ml 0.5 ml 0.5 ml 0.5 ml 0.5 ml 
 Swayed slightly 
Heat cabinet 3 h, 90°C 
Equilibration to 
RT 
45 min 
Water 
(Nanopure) 
Filled up to 50 ml 
 Shaken well 
 Sedimentation over night (at RT) 
Aliquot from   
50 ml PP-tube 10 ml 10 ml 10 ml 5 ml 10 ml 
1
2
m
l-
P
P
-
tu
b
e
 
129  spiking 
solution 
25 μl 25 μl 25 μl 25 μl -- 
 Shaken very well 
Abbreviations: ICP-MS = Inductively Coupled Plasma Mass Spectrometry; reconst. = 
reconstituted; BM = breast milk; FM = formula; IF = infant formula; TMAH = 
tetramethylammonium hydroxide; RT = room temperature 
 
Preparation of the spike ratio solution: 
The spike ratio solution was freshly prepared for each ICP-MS measurement 
series. 
About 30 ml of the prepared blank solution (see above) was transferred from 
the 50ml-PP-tube into another 50ml-PP-tube. 75 μl of 129  spiking solution was 
added to the blank solution in the new tube using an automatic pipette (1 ml tip, 
PIP mode). 
 
3.6.2.5.2. Measurement  
The measurements were performed with a double focusing magnetic sector-
field ICP-MS (Finnigan™ ELEMENT 2, Thermo Scientific, USA).  
For the measurement, the 12ml-PP-tubes were placed on a special rack in a 
defined order. The programmed sequence was started and the samples were 
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taken up and measured automatically at fixed operating conditions (Table 16).  
A typical sample sequence of the ICP-MS measurements is shown in Table 17. 
 
Table 16: Operating conditions of ICP-MS 
Operating conditions of ICP-MS 
 Sample flow rate ml/min 0.3  
 Sample take-up time min 2  
 Sample measuring time sec 25  
 Radio frequency power 
 Resolution 
 Mode 
 Runs/passes 
 Settling time 
 Sample time 
 Samples per peak 
 Spectrum range 
 Segment duration 
 Scan type 
 Detection mode 
 Integration type 
W 
m/∆m 
 
 
sec 
sec 
 
u 
sec 
 
 
 
1300 
Low = 300 
1 
9 * 9  
0.001  
0.010  
30 
126.8060 - 129.0050 
0.150  
E-Scan (electric) 
Analog + counting 
Average 
 Wash time with TMAH min 3  
 Monitored ions  m/z
 127 , 129 , 129Xe (impurity) 
 Quantification type cps Intensities  
Abbreviations: ICP-MS = Inductively Coupled Plasma Mass Spectrometry;  
TMAH = tetramethylammonium hydroxide 
 
Table 17: Typical sample sequence of ICP-MS measurements (e.g. breast milk) 
Sample definition 
No. of measurement 
in the sequence 
Blank (TMAH 0.25%) Start 
Spike ratio solution Start 
Whole milk reference  1 
Breast milk samples  1 - 5 
Spike ratio solution 1 
Breast milk samples 6 - 10 
Spike ratio solution 2 
Breast milk samples 11 - 15 
Spike ratio solution 3 
Whole milk reference  2 
Breast milk samples … 
Spike ratio solution … 
Whole milk reference  3 
Blank (TMAH 0.25%) End 
Spike ratio solution End 
Abbreviations: ICP-MS = Inductively Coupled Plasma Mass Spectrometry;  
TMAH = tetramethylammonium hydroxide 
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The washing solution - in between each sample - was TMAH (0.25%, Tama 
Chemicals, Japan). For aerosol generation and sample introduction a Burgener 
Mira Mist nebulizer (low flow, inert Teflon capillaries, Burgener Research Inc., 
Canada) and a Cinnabar spray chamber (20 ml cyclonic, borosilicate glass, 
Glass Expansion P/L., Australia) were used. The plasma gas was argon 
(Alphagaz 1 Argon, ≥ 99.999% mol, Carbagas, Switzerland; cool gas flow ca. 
15.4 l/min, sample gas flow ca. 1.07 l/min and auxiliary gas flow ca. 0.66 l/min, 
argon pressure: middle ca. 2.6 bar, max. ca. 5.8 bar; daily optimized). 
Instrument control and data acquisition was performed by the associated 
Finnigan ELEMENT2 software. 
 
 
Figure 7: Schematic sector field inductively coupled plasma mass spectrometer 
(Source: (Thermo Electron Corporation, 2004)) 
 
The measurement principle of the sector field ICP-MS is the following (see  
Figure 7): The liquid sample is introduced into the plasma with a nebulizer that 
forms an aerosol and with a spray chamber that selects small droplets (carried 
by argon gas) (Montaser et al., 1998; Thomas, 2001b). In the inductively 
coupled plasma (plasma gas: argon) the sample is atomized and then positively 
ionized predominantly by collisions with energetic argon electrons at 6000-7000 
K (Thomas, 2001c; Turner and Montaser, 1998). Then, the ions are transported 
through the interface region (sampler and skimmer metallic cone with very small 
orifices) from the plasma (atmospheric pressure) to the high vacuum of the MS-
Sample 
introduction 
Plasma 
interface 
Ion transfer 
optics 
Magnetic sector 
analyzer 
Electrostatic 
analyzer 
Detection 
system 
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analyzer (Thomas, 2001d; Turner et al., 1998). Before entering the analyzer, 
electrostatic ion optics focus and accelerate positive ions onto the entrance slit 
and stop particulates, neutrals and photons (reduction of background noise) 
(Turner et al., 1998). In the MS-analyzer the mass separation is performed by a 
magnetic field which disperses ions according to their mass and energy. After 
this, the ions enter an electrostatic analyzer for energy focusing. The 
combination of the magnetic and electrostatic sector fields result in the double 
focusing, high-resolution properties of the analyzer. The ions are detected with 
a discrete dynode detector system in which ions generate electrons that are 
quantified simultaneously by analog collection (for high ion concentrations) and 
pulse counting (for low ion concentrations) (Thermo Electron Corporation, 2004; 
Thomas, 2002; Turner et al., 1998). The measured signals are collected and 
they result in a MS-spectrogram with relative abundance (intensity) [cps] versus 
mass to charge ratio [u]. The analyzer constantly switches rapidly between 
measuring 127 - and 129 -signals. An example of the MS-spectrogram is shown in 
Figure 8. 
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Figure 8: Example of a MS-spectrogram of a spiked breast milk sample 
 
3.6.2.6. Calculations 
The formula to calculate the iodine content in the samples was derived from 
Adriaens et al. (Adriaens et al., 1993) and adapted by Haldimann (personal 
communication, used in (Crnkic et al., 2006)): m = n*(RM – RS)*M 
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m is the unknown total mass of 127  in the sample (BM, FM or infant food) [ng]; n 
is the number of moles of 129  in the added spike: n [nmol] = mass of added 
iodine spike [ng]/molar mass of 129  [128.905 ng/nmol] (mass of added iodine 
spike [ng] = 129  concentration of spiking solution  [ng/µl] * volume of added 
spiking solution [µl]) ; RM is the molar 
127 /129  – ratio in the resulting mixture in 
the sample [calculated from measured mean cps (relative) of 127  and 129  in the 
sample: 127  [cps]/129  [cps] = ratio in sample]; RS is the molar 
127 /129  – ratio in 
the spike solution (measured in the spike ratio solution) [calculated from 
measured mean cps (relative) of 127  and 129  in the spike ratio solution: 127  
[cps]/129  [cps] = ratio in spike]. RS was measured at the beginning of each 
measurement sequence and after about five samples it was measured again on 
a regular basis. The RS which was measured closest prior to the sample was 
used for the calculation (see Table 17, spike ratio solution); M is the molar mass 
of 127  [126.904 ng/nmol]. An illustration of the formula can be seen in Figure 9. 
To determine the iodine concentration [ng/g = μg/kg] in the sample, m was 
divided by the weight of the sample [g] in the 12ml-PP-tube (e.g. weighed 
sample amount in 50ml-PP-tube divided by 5 to calculate the sample weight in 
the 10 ml aliquot in the 12ml-PP-tube). 
Calculations were performed with spreadsheet software (Excel, Microsoft, 
Seattle, WA, 2003). 
 
 
Figure 9: Calculation of 127  concentration with 127 /129  – ratio  
(adapted from M. Haldimann, personal communication) 
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3.6.2.7. Limit of detection & limit of quantification 
The limit of detection (LOD) and the limit of quantification (LOQ) for the IDA 
were calculated on the basis of the spike ratio measurements (Heumann, 
1988).  
LOD: RLOD > (
127 /129 )Spike + 3s 
LOQ: RLOQ > (
127 /129 )Spike + 10s 
127  and 129  are the measured intensities [cps] of the iodine isotopes in the spike 
ratio solution; s is the SD of the spike ratio measurements.  
 
3.6.2.8. Quality control 
3.6.2.8.1. Blank 
The blank was used as a control for possible iodine contamination in the used 
solutions and materials. It was always measured at the beginning and end of 
each measurement sequence. 
 
3.6.2.8.2. Reference samples 
One to three whole milk (powder) reference samples with certified iodine 
concentration were included in each run of BM samples as a control for the 
accuracy of the method. BM reference material does not exist. 
Certified iodine content in whole milk reference: 
mg/kg ± 95% CI:   2.3 ± 0.4 
(Gills, 1993) 
 
In each run of FM/infant food samples three to four IF (powder) reference 
samples with certified iodine concentration were included as a control for the 
accuracy of the method. 
Certified iodine content in infant formula reference: 
mg/kg ± 95% CI:   1.11 ± 0.17 
(Wise and Watters, 
2007) 
 
The reference samples were placed at the beginning, in the middle and at the 
end of a measurement sequence (see Table 17). 
The reference powders were stored at room temperature. 
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3.6.2.8.3. Spike ratio solution 
The spike ratio solution was measured regularly during each run to check for 
possible iodine memory effects which could be caused by accumulation of 
iodine in the spray chamber of the ICP-MS (Haldimann et al., 1998). 
 
3.6.2.9. Test of iodine stability in cow milk 
Some BM samples contained coagulated particles when they arrived at ETH. 
Most of the particles disappeared after heat treatment and before ICP-MS 
measurement. Therefore, we concluded that the particles might have mainly 
consisted of fat. However, they could also originate from acidification of the 
milk. Haldimann et al. (Haldimann et al., 2000) reported that a low pH is 
attributed to the formation of volatile iodine species from iodide. To test if there 
had been an iodine loss during the transport of BM samples, a milk iodine 
stability test was performed with pasteurized cow milk (organic whole milk, 
bought at Migros, March 2009) as cow milk has a very similar matrix to BM. The 
cow milk was measured in triplicate on the day of purchase and then 
remeasured after seven days storage at ambient temperature. After this week 
the milk smelled sour and contained coagulations. The measurement procedure 
was the same as for BM. 
 
3.6.2.10. Validation of X and Z urine reference samples 
The two urine reference samples X and Z, which were used as internal control 
for the Sandell-Kolthoff method at ETH Zurich (see chapter 3.6.1.9.1), were 
measured by ICP-MS for validation. Each sample was analyzed in triplicate 
(from three different aliquots).  
1 ml of urine sample was pipetted into a 50ml-PP-tube on an analytical scale 
(three tubes for X and for Z). The exact weight was noted. Then, 25 μl of 129  
spike solution was added to the X samples and 50 μl of 129  spike solution was 
added to the Z samples using an automatic pipette (1 ml tip, DISP mode). The 
tubes were then filled up to 25 ml with TMAH solution (0.1%), shaken well and 
directly measured with ICP-MS.  
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3.7. Dietary assessment of infants 
The purpose of the dietary questionnaire was to assess the infants‟ iodine 
intake, to get a broader insight into the major iodine sources in infancy in 
Switzerland, to examine if iodine intake varies by feeding habits such as 
breastfeeding or formula feeding and to evaluate if fortified industrial infant 
foods are necessary for an adequate iodine intake of infants.  
The first questionnaire assessed the infant‟s food and consequently iodine 
intake on the day before urine sample collection. As UIC is an indicator of short-
term iodine intake (World Health Organization et al., 2007), it was assumed that 
iodine intake on the day before urine collection would be most comparable with 
UIC. 
The day-to-day variability of food and iodine intake was examined by a second 
dietary questionnaire which had to be filled out 3-4 days after the first 
questionnaire. 
 
3.7.1. Development of the dietary questionnaire  
The aim was to develop a self-administered dietary questionnaire which could 
be filled out by mothers at once without detailed oral instructions from the 
pediatric practices or by ETH, but which asked the mothers precisely about their 
infant‟s food intake on the previous day. Mothers had the option to fill out the 
dietary questionnaire at the pediatric practice if the samples were collected 
there or could fill it out at home on the same day as the sampling was 
performed. It was assumed that mothers normally know well what they feed to 
their infants and that food intake in infants is less variable compared with adults. 
Therefore, it was concluded that a retrospective questionnaire (in terms of a 24-
hour recall) was accurate to assess the infants‟ food intake. In any case, it was 
not possible to use a prospective dietary protocol as it was not feasible to give 
the questionnaires to the mothers before they were recruited for the study at the 
routine-check up in the pediatric practice. The questionnaire had to be well-
structured and use precise questions in order to lead the mothers to provide the 
required information without the help of an interviewer. Furthermore, the 
mothers needed to be able to complete the questionnaires within a reasonable 
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time frame. 
 
Before the questionnaire was developed, usual consumer wording and 
recommendations of the most important foods and meals for infants were 
evaluated. Therefore, information brochures about infant feeding designated for 
parents were used. Such brochures were available from the Swiss Society for 
Nutrition (SGE) (Dähler et al., 2007) and the Research Institute of Child 
Nutrition in Dortmund (FKE) (Forschungsinstitut für Kinderernährung, 2007). It 
was also examined what kind of commercial infant food was currently available 
on the Swiss market (in retail shops, pharmacies, health food shops and on web 
pages of infant food producers). Furthermore, the kind of food and meal 
patterns which were observed in previous studies on food intake of infants were 
examined (Fox et al., 2004; Freeman et al., 2000; Kersting et al., 1998; Kudlova 
and Rames, 2007; Merten et al., 2005; Noble and Emmett, 2001; Stocker, 2001; 
Thomson et al., 2008) (see also chapters 2.3.3.1 and 2.3.3.2). 
We had the support of Dr. M. Wälti, a nutrition scientist and in charge of the 
Swiss version of EBISpro (see 3.7.3). She also had an infant at the age of the 
study infants at that time.  
With the help of all this information, a questionnaire consisting of eight sections 
was developed between April and July 2008. The questionnaire was pre-tested 
for comprehension with a group of 22 mothers some who attended public 
mother-child meetings and others who were from a circle of friends (see also 
(Münger, 2008)). Specified problems and unclarities were used to ameliorate 
the questionnaire. Appendix 11 presents the final version of the questionnaire 
(German). 
 
3.7.2. Structure of the dietary questionnaire 
The complete questionnaire (German version) can be found in Appendix 11. 
In the introductory section of the questionnaire, the mother was instructed to 
record foods and drinks that her infant had consumed the previous day (in the 
first questionnaire: the day before the samples were collected). She was 
informed about the importance of mentioning all foods and drinks and was 
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asked to fill out the questionnaire as precisely as possible. In case the mother 
did not know what her infant had eaten the day before (e.g. because the infant 
was in a nursery), she was asked to fill out the questionnaire on the next 
possible day (as a questionnaire with missing or vague data would not be 
possible to evaluate). To help the mother remember the day before, she was 
asked what day that had been and where respectively with whom the infant had 
spent the previous day (from morning through evening; options to cross: at 
home or outside the home with mother, father, grandparents, at nursery, day 
mother/family or other). Furthermore, the mother was asked at what time the 
infant had been fed the first and the last time and she was informed that 
“yesterday” meant 0h to 24h. 
 
After the introduction, the mother had to fill out what she had fed her infant in 
five sections with different meal types. All sections were built up in a similar way 
but with specific adaptations which allowed the collection of particular 
information about each meal type. All sections started with a question about 
how often the infant had received a certain meal type the day before. If the 
infant had not been fed the meal type the day before, the mother could directly 
continue with answering the next section. If the infant had received the meal 
type, the mother was asked to fill out the frequency of consumption on a vertical 
line in which the day was divided into six periods (morning to night). This would 
help the mother to reconstruct the day before and make her think of her infant‟s 
food intake. See Figure 10 (in German) as an example. 
 
 
Figure 10: Example of dietary questionnaire section about frequency of meal 
consumption by the infant (German) 
 
The following information about the different meal types was collected in the five 
sections of the questionnaires: 
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1. Breast milk: The number of breast-feeds per day, the duration per breast-
feed in minutes or the quantity of breast milk fed to infant per feed (if the 
mother expressed the breast milk manually or by pump). 
2. Formula (infant, follow-on and other types of formula; in a bottle or drinking 
cup): The brand and point of purchase of the products, the exact product 
names, number of spoons used for each preparation (if it was a dry powder) 
as well as type and quantity [ml] of fluid for preparation and the fraction or 
amount the infant had actually consumed (from each prepared formula). 
3. Purees/porridges, (semi-)solid food (eaten with a spoon):  
3.1. Home-made meals and snacks (such as fruit, vegetables, bread, biscuits 
or rusks): All ingredients used to prepare the meals with, including the 
quantity and variety/brand of the ingredients, use of salt for the meals, 
method of preparation (e.g. cooked, pureed) and amount (fraction) of the 
prepared meal the infant had actually consumed. 
To help the mothers estimate the quantities of foods, pictures of bread and 
cheese were provided (for weight definition of foods on pictures, see 
Appendix 12) and a list of household measurements that could be used for 
estimation (such as spoon, cup or size). The option for exact quantity 
indication [g or ml] was also mentioned. 
In a separate question, mothers were asked if the salt they had used was 
iodized, non-iodized or unknown and which brand of salt they had used. 
3.2. Ready meals: 
3.2.1. Ready-to-eat meals (e.g. in jars, cups): The brand and point of purchase 
of the products, the exact product names including weight/size of the 
products and age level, the quantity consumed by the infant and 
additional ingredients (added by mother).  
To illustrate and help with the estimation of sizes of available jars in 
Switzerland, a photo with jars and their weight (incl. a yoghurt jar as 
object of comparison) was provided on the questionnaire.  
In a separate question, mothers were asked if the meals contained salt. 
3.2.2. Dry powders prepared with fluid (e.g. baby cereals): The brand and point 
of purchase of the products, the exact product names including number 
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of spoons as well as kind and quantity of fluid used for preparation, 
additional ingredients and the actual quantity (fraction) consumed by the 
infant. 
 
In sections 2 and 3, an example of each meal type was given to show how 
the meals should be indicated in the questionnaire (see Figure 11 as 
example).  
We always asked first for the quantity of ingredients the mother had used for 
the meal preparation and then how much the infant had actually consumed of 
the whole prepared meal. This method was chosen as it was assumed to be 
a good way to receive accurate data on the consumed quantities of the 
infant. 
 
Figure 11: Example of dietary questionnaire (German) 
 
4. Other foods: Foods and meals which could not be allocated to the other 
sections including all necessary information on type and quantity consumed. 
5. Drinks: Other drinks than breast milk/formula consumed by the infant, the 
type of drinks, the consumption frequency and the approximate consumption 
quantity [ml or dl].  
The following drinks could be chosen: tap water, mineral water, tea, juice, 
diluted and undiluted cow milk, others (indication of type of drink). 
 
Following these questions, the mothers were asked if the reported day had 
been a usual day for the infant and if not, the reasons for not being so were 
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inquired on.  
 
The questionnaire finished with some sociodemographic questions about the 
mother (see 3.4.8). 
 
The second questionnaire was identical to the first one with the instruction that it 
should be filled out three to four days after the first questionnaire. Mothers 
should choose a day they had spent together with their infant for the second 
questionnaire. 
 
3.7.3. EBISpro and SwissFIR 
For analysis of dietary data the Swiss version of the nutrition software EBISpro 
for windows (version 8.0, Dr. J Erhardt, University of Hohenheim, Stuttgart, 
Germany) is available at the laboratory of human nutrition at ETH. This software 
can translate the food intake into daily iodine intake. The program contains 
about 680 foods commonly consumed in Switzerland from the Swiss Food 
Composition Database (Version 2003, ETH/BAG, Switzerland (Infanger, 2004)) 
complemented by about 450 foods from the German Food and Nutrition 
Database (BLS 2.3, Federal Health Department, Berlin, Germany) as well as 
about 360 Swiss recipes and products (www.ebis-schweiz.ch). 
The Swiss Food Composition Database is constantly updated by the project 
group SwissFIR, ETH Zürich (SwissFIR, 2008), and is available online 
(www.swissfir.ethz.ch). In one of the next versions of EBISpro, an updated 
Swiss Food Composition Database will be incorporated in the software 
(personal communication M. Wälti). 
 
The iodine content is not available for all foods in the databases (in EBISpro: 
indicated as “0 µg/100g”, which can mean either that the food has no iodine or 
that the iodine content is not available (personal communication, M. Wälti, 
2008); in SwissFIR: if not available, the content is not listed). In such a case a 
similar food with known iodine content needs to be chosen and documented. 
Variations in iodine content of foods and products also need to be considered 
and can depend on where the food crops were grown, seasonality (e.g. milk) or 
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preparation/production (e.g. use of iodized salt or not). EBISpro software does 
not give any information about the sources of the nutrient values; SwissFIR 
indicates the data sources (see www.swissfir.ethz.ch). The mentioned issues 
need to be taken into account for questionnaire analysis and data interpretation. 
As iodine content of some foods have been updated by SwissFIR (version V 
2.11, data retrieved 7.4.09) by iodine measurements in Swiss foods (Haldimann 
et al., 2005), the updated values were adapted in the EBISpro version for the 
questionnaire analysis (changes were documented). 
 
Data entry and evaluation of the dietary questionnaires was not part of this 
diploma thesis, but partly the preparation for data entry, see following chapters. 
 
3.7.4. Infant food database 
Commercial infant food products, which our study population used, as well as 
breast milk had to be entered manually in the database of EBISpro software. 
For data-input, most recent detailed product information of producers was 
ordered or, in case they did not have any (e.g. Coop), the information was 
directly taken from product packages. 
During set-up of the infant food database, it was recognized that producers 
regularly change and improve their formula and infant food products. Therefore, 
iodine content of some infant products could have changed during the study; 
especially because the legislation of iodine content in formula/infant foods had 
been changed in 2008 (see chapter 2.3.3.3). The parents were not asked to 
indicate the date of purchase or charge number of products. This needs to be 
taken into account for data interpretation and has the effect that the database 
regularly needs to be updated for further use. 
Within this thesis, 148 products were entered into the database. 
 
3.7.4.1. Products with labeled iodine concentration 
If the iodine content of a product was labeled on its package or indicated in the 
detailed product information of the producer, the product was directly entered 
into EBISpro as a new food item with all available nutrient data. The iodine 
content was labeled for all products which were fortified with iodine, except for 
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some products with iodized salt. For 72 of the entered products the iodine 
content was labeled. 
 
3.7.4.2. Products without iodine labeling 
For products without iodine labeling the iodine content was calculated with 
EBISpro using the following method: 
- First, all ingredients were listed with their percentage in the product (if 
available) in quantitatively downward order. 
- Percentages were then directly transformed to g/100g.  
- For ingredients without the percentage value, the quantity [g] per 100 g was 
estimated based on the rule that ingredients have to be listed on the product 
in quantitatively downward order (decisive is the mass fraction at time of 
processing) (EDI, 2005a) and in total, the ingredients should not exceed 100 
g per 100 g of the product. Ingredients of very small quantity and containing 
practically no iodine (e.g. food additives or vitamins) were ignored. 
- Then the ingredients of the product were entered into EBISpro as a recipe. 
The summarized nutrient content of the product was displayed and if 
necessary quantities [g] of estimated ingredients were adapted to obtain a 
similar content of macro-/micronutrients as labeled on the product. 
- Finally, the product was entered into EBISpro as a new food item using the 
nutrient contents that were labeled on the product and adding the iodine 
content that was calculated with the recipe. 
 
The iodine content of 73 of the entered products had to be calculated in this 
way. The iodine content of three products was measured with ICP-MS and in 
this case the measured value was used. 
 
3.7.4.3. Breast milk 
Breast milk was entered as a new food item into EBISpro with nutrient 
composition from Souci et al. (Souci and Deutsche Forschungsanstalt für 
Lebensmittelchemie (Garching), 2008). The iodine content was replaced by the 
measured median iodine concentration of breast milk from the present study. 
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3.7.4.4. Infant food categories 
Special codes in EBISpro were chosen for the newly entered infant food 
products to categorize them into the following eight food groups for data 
analysis: 
- Infant and follow-on formula, junior-milk (to prepare with water or ready to 
drink) 
- Instant milk-cereal mixtures (already containing dry FM or cow milk to 
prepare porridges by adding water) 
- Dry/instant milk-free cereal based products and cereal mixtures (to prepare 
porridges by adding water or milk) 
- Ready-to-eat cereal-milk-(fruit/vegetable)-porridges, "Trinkmahlzeiten", baby 
yoghurts and desserts (containing milk) in jars, cups or drink cartons 
- Vegetable and fruit purees in jars or cups (simple recipes, just containing 
fruits/vegetables/potatoes and maybe some cereal/starch/oil, no milk) 
- Baby ready meal menus (vegetable-carbohydrate-(meat)) in jars or cups 
(more complicated recipes, labeled as "menu" by producer) 
- Biscuits, rusks and bars 
- Baby pasta 
 
The categories were chosen according to existing product categories on the 
Swiss market and other studies were therefore considered as well (Kersting et 
al., 1998; Noble and Emmett, 2001). The category codes also showed if a 
product was fortified with iodine or not. 
 
3.7.5. Definition of food measurement units 
As infants often consume small amounts of food, the standard amounts and 
portion sizes given by EBISpro are usually too large. Therefore, measurement 
units for foods, which were indicated by the mothers in the questionnaires, and 
their weight were defined for data entry (e.g. average weight for a tea-
/tablespoon of foods or weight for a piece of pasta or slice of sausage). Small 
measurement units for some foods were available in EBISpro and some were 
taken from Infanger, Wachtel and Zacharias et al. (Infanger, 2004; Wachtel, 
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1990; Zacharias and Deutsche Gesellschaft für Hauswirtschaft, 1992). Some 
were weighed by us at ETH. To define the weight of a measurement unit for a 
food, we weighed a food ten times with the same measurement unit and then 
took the average weight. 128 different measurement units for various foods 
were defined so far of which 46 were weighed by us (see Appendix 13). 
 
3.7.6. Definition of standard portion sizes 
As we recognized that in some questionnaires the quantities of eaten foods 
were not indicated by parents, it was necessary to define standard portion sizes 
for data entry to make it possible to estimate the food intake of the infant. Of 
course these portion sizes can differ greatly from the actual food intake. For the 
definition, recommended standard recipes and quantities of ingredients for 
home-made purees and porridges may be used from SGE and FKE (Dähler et 
al., 2007; Forschungsinstitut für Kinderernährung, 2007) and adapted with the 
actually used ingredients in each case. SGE and FKE recommend very similar 
portion sizes ranging from 140 to 240 g per meal. The standard meals they 
defined are: vegetable-potato-puree, vegetable-potato-meat-puree, milk-cereal-
porridge and fruit-cereal-porridge (Dähler et al., 2007; Forschungsinstitut für 
Kinderernährung, 2007).  
Another option is to use portion sizes of ready-meal products which contain the 
same or a similar type of meal that was fed to the infant and which are intended 
for the respective age group.  
 
3.7.7. Estimation of breast milk intake 
It was not decided in this diploma thesis which method is best for the estimation 
of breast milk intake in the present study. An overview of possible calculation 
methods can be found in the background section (chapter 2.4.2.2.2). The 
golden standard method, which is individual weighing of infants before and after 
each breast-feed during 24 hours, was not applicable in this study for practical 
reasons. 
The method used by Emmett et al. and Mills and Tyler (Emmett et al., 2000; 
Mills and Tyler, 1992) would probably give imprecise results and would over- or 
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underestimate breast milk intake of infants, as mothers in our study only had to 
indicate the approximate breast-feeding duration of each feed on the day before 
assessment. Therefore, the methods applied in the US FITS study (Devaney et 
al., 2004) or by Fisher et al. (Fisher et al., 2008) might be more suitable. As 
assumption of basic daily breast milk intake, the amounts published by Butte et 
al. could be used (Butte et al., 2002). More details are given in chapter 
2.4.2.2.2. 
 
3.7.8. Comparison with energy requirement, over-
/underreporting 
A recent study found an overestimation of energy and nutrient intake in infants 
comparing 24-hour dietary recalls with weighed food records (Fisher et al., 
2008). Therefore, it is important to compare the calculated energy intake of the 
questionnaires with the predicted energy requirement for the infants. 
In a British study on infant food intake (Noble and Emmett, 2001), predicted 
energy expenditure was compared with observed energy intake and based on 
that, infants were categorized as potential under- or over-reporters. The 
following formula was used to calculate the predicted energy expenditure 
(PEE): PEE = body weight (kg) * energy requirement (kJ/kg) (Noble and 
Emmett, 2001). Energy requirements for infants aged six and twelve months 
can be found in publications of Butte and the Joint FAO/WHO/UNU Expert 
Consultation of 2004. Estimated daily energy requirements for boys and girls 
are 337 respectively 341 kJ/kg at 6 months of age and 337 respectively 331 
kJ/kg at 12 months of age (Butte, 2005; Joint FAO/WHO/UNU Expert 
Consultation, 2004). 
 
102 Subjects & Methods 
 
 
 
 
University of Vienna  Nadja Wüst 
 
 
3.8. Statistical analyses 
Data processing and statistical analyses were performed using the statistics 
program SPSS (SPSS inc., Chicago, IL, version 16.0) and Excel (Microsoft, 
Seattle, WA, 2003).  
Kolmogorov-Smirnov (K-S) test (with Lillifores significance correction) was used 
to check for the normality of the data. Normally distributed data were presented 
as mean ± SD, non-normally distributed data were presented as median (95% 
CI or range). UI and BM iodine concentrations were not normally distributed. 
Mann-Whitney U (MWU) test was used to calculate the difference between two 
groups of continuous, non-normally distributed data.  
Kruskal-Wallis (K-W) test was used for group comparisons of continuous, non-
normally distributed variables (with Bonferroni corrected post-hoc tests). 
Pearson‟s chi-square test was performed to compare categorical variables.  
Correlations between continuous, normally distributed data were tested using 
correlation analysis of Pearson (r) and correlations between continuous, non-
normally distributed variables were analyzed using Spearman correlation 
analysis (rs).  
P values < 0.05 were considered significant. 
Box plots: the line in the middle of the box represents the median, the lower end 
of the box the 25th percentile and the upper end the 75th percentile. The 
whiskers represent the lowest/highest value that is not yet an outlier. The 
maximum length of the whiskers is 1.5-fold the height of the box, values outside 
this range are shown as outliers. 
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4. RESULTS 
4.1. Selection of the pediatric practices 
Invitation letters for study participation were sent to 441 pediatricians all over 
Switzerland. The biggest part of the doctors‟ addresses was provided by the 
pediatricians‟ association “Forum für Praxispädiatrie” (n = 411, mainly German-
speaking Switzerland), some by the “Swiss pediatric society” (n = 9, French-
speaking Switzerland) and some were taken from the phone book (n = 21, 
Italian-speaking Switzerland). As there was no positive answer from the region 
“Ticino” to the invitation letter, a reminder letter was sent to the doctors of this 
region. In the Lake Geneva region only one doctor agreed to participate in the 
study. Because of time and translational reasons, it was decided to postpone 
contacting more pediatricians in the French-speaking part of Switzerland (“Lake 
Geneva region”). The total response rate by pediatricians was 30.6% [n=135]. 
13.8% [n=61, in 50 pediatric practices] were positive responses (see Table 18 
for distribution to regions). The number of infants visiting the pediatric practice 
for routine check-up/vaccination per week ranged from < 1 to < 25 for each age 
group. Eighteen pediatric practices were selected and sequentially visited for 
study instruction starting from the end of July to November 2008. Table 18 lists 
the responses and participating pediatric practices (state of May 2009) and 
Figure 12 shows the geographical distribution.  
 
Table 18: Overview of pediatric practices 
Greater Swiss 
regions 
Required 
pediatric 
practices 
[n] 
Positive 
responses 
[n] 
(by practice) 
Participating 
practices   
[n] 
(May 2009) 
Drop-
outs 
[n] 
Need for 
search/ 
replacement 
[n] 
Total 20 50 15 3 5 
Lake Geneva region 3 1 1 0 2 
Espace Mittelland 4 12 2 2 2 
Northwestern 
Switzerland 
3 12 3 0 0 
Zurich 4 11 3 1 1 
Eastern Switzerland 3 6 3 0 0 
Central Switzerland 2 5 2 0 0 
Ticino 1 3 1 0 0 
 
At the beginning of May 2009, fifteen pediatric practices were still participating 
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in the study. Two of them had already completed the study (located in Eastern 
and Central Switzerland) and thirteen were still collecting samples. Three 
pediatric practices decided to quit the study. The reason for drop-outs were 
either relocation (one practice) or too few German-speaking mothers (two 
practices). Due to time constraints their replacement was postponed and is not 
reported in the diploma thesis (Table 18 lists the drop-outs).  
 
 
Figure 12: Geographic distribution of pediatric practices 
Legend: Red rhombus: participating practices (state May 2009); White circle: need to be 
selected; green rectangle: drop-outs (Picture source: (Swiss Federal Statistical Office, 2008a)) 
 
4.2. Status of the study 
The results presented here are an interim evaluation of the study with data 
collected from August 2008 to May 2009. The study is continued until the 
desired number of infants is accomplished. The sampling took a longer time 
than expected, therefore the originally planned time period needed to be 
expanded. Based on communication with the still participating pediatric 
practices and the final questionnaire for the practices, the main reasons for the 
above mentioned issue were: small weekly patient numbers, often a huge work 
load in the practice and therefore they did not always have time to recruit 
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infants, language problems with the parents and therefore it was not possible to 
include all eligible infants. The two pediatric practices having completed the 
study reported to have asked approximately 75% of the mothers of all eligible 
infants for study participation. As a main reason for preliminary study exclusion, 
the two pediatricians indicated non-term birth of the infant (10% of all infants in 
both age groups). One pediatric practice reported that 5% of mothers declined 
study participation and the other practice specified that 15% and 10% of 
mothers of 6- and 12-month-old infants, respectively, refused to participate in 
the study. The main reason mentioned by the mothers was lack of interest in 
the study (data from final questionnaire of the two finished practices). 
 
4.3. Subject description 
4.3.1. Sample size  
The subjects of the interim study evaluation were enrolled for the study from 
mid August 2008 to the beginning of May 2009. The total number of mother-
infant pairs who agreed to participate in the study was n = 379 (6-mo: n = 193, 
12-mo: n = 186, these numbers are based on the number of subscribed consent 
forms we received). Out of those, 40 infants and 36 mothers had to be excluded 
from the study due to the following reasons:  
Twenty-seven mother-infant pairs were excluded because they had not 
provided any samples (6-mo: n = 7; 12-mo: n = 20). One mother withdrew her 
study consent. In four cases, we only received a sample of the infant (12-mo: n 
= 2) or mother (12-mo: n = 2) and included the subject with the sample. Five 
mother-infant pairs had to be excluded because they did not fulfill the following 
inclusion criteria: the mother had not been resident in Switzerland for more than 
one year before the infant‟s birth (6-mo: n = 1), recent history of thyroid disorder 
of the mother (12-mo: n = 1), missing data concerning use of contrast 
media/iodine containing drugs (6-mo: n = 2), various missing data for inclusion 
criteria (6-mo: n = 1). One infant (12-mo) was excluded because the pediatrician 
indicated that its health was not intact (recurrent urinary tract infection). Another 
infant had an unexpected surgery after study consent (12-mo) and was 
therefore excluded. The mothers of these two infants were still included. 
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Two infants (6- and 12-mo) were excluded from the analysis as their UI values 
were considered as outliers. They had a concentration > 1000 μg/l (1504 μg/l, 
1691 μg/l). This was suspected as either contamination of the collection 
material (e.g. by iodine containing disinfectants at the pediatric practice) or 
contamination during the collection (e.g. due to application of iodine containing 
disinfectants to the infant). Their mothers were included. 
One mother-infant pair (6-mo) was excluded because the BM sample was 
considered as outlier. Its iodine concentration was 512 μg/kg (measured twice), 
which was much higher than all other BM samples. The reason for this could be 
a contamination (e.g. by an iodine containing disinfectant), an unusually high 
iodine intake (e.g. iodine tablets or algae) or some metabolic disorder. The UIC 
of this mother was 63 μg/l and the UIC of her infant was 873 μg/l. It was 
decided to exclude mother and infant since the UIC of the infant was also very 
high and their high values could have a metabolic reason. The responsible 
pediatrician was informed. 
 
Finally, 337 mother-infant pairs, two single infants and six single mothers were 
included in the present analysis. 52.8 % of all infants belonged to the 6-mo age 
group (infants n = 179; mothers n = 180) and 47.2% to the 12-mo age group 
(infants n = 160; mothers n = 163). An overview of the included infants in each 
region and pediatric practice is given in Table 19 (if there is no comment, the 
numbers are the same for mothers).  
The mother-infant pairs were enrolled in all seven regions by 17 pediatric 
practices. The practices which dropped out during the study, but had enrolled 
some subjects, were also included in the analysis (practice no. 7 and 13; 
practice no. 15 (Espace Mittelland) did not collect any samples before drop-out 
and was therefore not counted). 
The mean (± SD) number of included infants per pediatric practice was eleven 
(± nine) 6-month-old and nine (± nine) 12-month-old infants (ranging from 0 to 
32 infants). Two practices (no. 4 and 6) had already enrolled the desired 
number of thirty infants per age group (see Table 19). 
Most of the practices were located in urban areas (13 practices). In total, 287 of 
the included urine samples of infants came from practices in urban areas. Only 
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four practices were located in rural areas and they collected 52 urine samples 
from infants (see Table 19; “urban/rural area” was defined according to the 
Swiss Federal Statistical office (Bundesamt für Statistik, 2009a)). 
 
Table 19: Included infants (and mothers) in each region and pediatric practice 
Region 
Practice 
ident. no. 
Urban/ 
rural 
Infants  
6-mo  
[n] a 
Infants  
12-mo  
[n] a 
Total of infants per region 
[n] a [% of total] 
Lake Geneva  12 u   3   1   4 1.2 
Espace 
Mittelland 
13 r   4   1 
35 10.3 14 r 10   6 
17 u 10   4 
Northwestern 
Switzerland 
  2 u   9 b   5 b 
54 e 15.9   3 u 13 18 c 
16 u   5   4 
Zurich 
  1 u 14 11 
46 13.6 
  5 u   8   5 
  7 u   2   0 
11 u   2   4 
Eastern 
Switzerland 
  4 u 31 30 d, b  
92 d, b 27.1   9 r   3 11 
18 r   8   9 
Central 
Switzerland 
  6 u 30 32 d 
91 d 26.8 
10 u 19 10 
Ticino   8 u   8   9 b 17 b 5.0 
TOTAL 
infants 
17 f 
practices 
  179 160 339 100 
TOTAL 
mothers 
17 f 
practices 
 180 163 343  
Abbreviations: practice ident. no. = identification number of practice; u = urban, r = rural
 
a
 If there is no comment, the number is the same for mothers 
b
 Additionally one single mother  
c
 Additionally two single mothers 
d
 Includes one single infant 
e
 Additionally four single mothers  
f
 Including 2 drop-out practices (no. 7 + 13), the third drop-out practice did not collect any samples 
and was therefore not listed (no. 15, Espace Mittelland) 
 
In relation to the number of annual births in Switzerland, the sample included 
about every 180th infant in Switzerland (approximately 1:360 per age group). 
For this calculation the Lake Geneva region was excluded from the number of 
annual births as most pediatric practices were not recruited from there (average 
number of annual births in Switzerland in 2007/08: n = 75‟593; excl. Lake 
Geneva region n = 60‟443 (Swiss Federal Statistical Office, 2008b)).  
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4.3.2. Subject characteristics – Infants and their mothers 
4.3.2.1. Inclusion criteria 
The included study subjects fulfilled the inclusion criteria. All infants had a term 
birth. None had a history of thyroid disorders and the pediatricians indicated 
intact health of the infants. All mothers had lived in Switzerland for at least one 
year before the birth of their infant and since the infant‟s birth, together with the 
infant. No mother had a history of recent thyroid disorders and none had 
received contrast media or iodine-containing drugs since pregnancy. Two 
infants (8.2 month-old and 13.8 month-old) were above the indicated age range 
(± 6 weeks), but it was still decided to include them.  
 
4.3.2.2. Infant characteristics 
Table 20 shows the characteristics of the infants included in the study.  
The age of infants in the 6-mo group ranged from 5.2 to 8.2 months (mean 6.3 
mo). In the 12-mo group, age ranged from 11.4 to 13.8 months (mean 12.3 mo).  
In the 6-mo group there were slightly more girls (51%) and in the 12-mo group 
more boys (58%). Overall, 47% of participants were girls, 53% were boys. 
 
Table 20: Characteristics of the infants  
Infants 
Age group 
Total 
6-mo 12-mo 
n 179 160 339 
Age [mo]     6.3 ± 0.4 a 12.3 ± 0.4 9.3 ± 3.0 
Sex ratio [n girls/boys] 91/88 67/93 158/181 
Body weight [kg]   7.67 ± 0.86  9.73 ± 1.17 8.65 ± 1.45 
Body length [cm] 67.4 ± 2.5 75.7 ± 3.0 71.3 ± 5.0 
Age-specific z-scores b    
WHZ-score  - 0.10 ± 0.96 0.24 ± 0.97 0.06 ± 0.98 
HAZ-score    0.12 ± 1.04 0.13 ± 1.08 0.12 ± 1.06 
WAZ-score  - 0.09 ± 0.90 0.23 ± 0.94 0.06 ± 0.93 
BAZ-score  - 0.21 ± 0.96 0.22 ± 0.99 0.00 ± 1.00 
Delivery mode [n] 
Vaginal 
Cesarean 
136 
43 
118 
42 
254 
85 
a
 mean ± SD (all such values) 
b
 Abbreviations: WHZ-score = Weight-for-height z-score; HAZ-score = Height-for-age z-score;  
WAZ-score = Weight-for-age z-score; BAZ-score = BMI-for-age z-score 
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To ensure the fulfillment of normal growth criteria of the study infants, their age 
specific z-scores were calculated (see Table 20) and compared to the WHO 
child growth standards (see 3.4.3.3 Child growth standards). The calculated 
mean z-scores ranged between - 0.21 and 0.12 in the 6-month-old6 infants and 
between 0.13 and 0.24 in the 12-mo group, which means that the z-scores were 
all very close to the WHO standard median 0.00. All z-scores were normally 
distributed (K-S test). The SDs of all z-scores were either < 1 or slightly > 1 
indicating accurately conducted measurements (WHO, 2009). Figure 13 shows 
the z-score curves for all four indicators and compares the study infants with the 
WHO standard population (displayed by WHO Anthro (WHO, 2009)). All curves 
of the study infants were close to the curves of the standard population. 
 
 
Figure 13: Z-score curves of all study children (n = 339, red curves) and WHO 
standards (green curves): WHZ = Weight-for-height; HAZ = Height-for-age; WAZ = 
Weight-for-age; BAZ = BMI-for-age z-scores 
 
For the four anthropometric indicators, the prevalence of infants with z-scores 
under - 2 or over + 2 (WHO cut-off) was ≤ 2.3% (2.3% = expected prevalence in 
the reference population (WHO Expert Committee on Physical Status, 1995)) 
for 6-month/12-month-old boys and girls, with the following exceptions:  
                                               
6
 6-month-old/12-month-old always refers to the age group and is not an exact age statement. 
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- WHZ-score: 3% of 12-month-old girls < - 2 and 3.3% of 6-month-old girls > + 2  
- HAZ-score: 3% of 12-month-old girls < - 2  
- WAZ-score: 3% of 12-month-old girls < - 2  
- BAZ-score: 4.5% of 12-month-old boys and 3% of 12-month-old girls < - 2, 
3.2% of 12-month-old boys > + 2 and 3.3% of 6-month-old and 3% of 12-month-
old girls > + 2.  
This means that a very low percentage of infants in the present study population 
were considered at risk of being underweight, stunted, wasted or was 
overweight and we could assume that the study infants were growing normally 
according to the WHO child growth standards (WHO Multicentre Growth 
Reference Study Group, 2006). Detailed z-score values are given in Appendix 
15. 
 
4.3.2.3. Maternal characteristics 
Table 21 shows the characteristics of the included mothers. 
 
Table 21: Characteristics of the mothers 
Mothers 
Age group of infants 
Total 
6-mo 12-mo 
n 180 163 343 
Age [yr] 32.4 ± 4.2 a 32.6 ± 5.0 32.5 ± 4.6 
Body weight [kg]   64.6 ± 11.5 b 64.7 ± 12.5 c 64.6 ± 12.0 d 
Height [m] 1.68 ± 0.06 1.66 ± 0.06 c 1.67 ± 0.06 c 
BMI  [kg/m2] 22.9 ± 3.8 b 23.3 ± 4.2 c 23.1 ± 4.0 d 
Lactating [n] 
Yes 
No 
102 
78 
29 
134 
131 
212 
Nationality [n] 
Swiss 
Foreign 
158 
22 
132 
31 
290 
53 
a mean ± SD (all such values); 
 b - d
 Missing data/values: 
b
 n = 4; 
c
 n = 3; 
d 
n = 7 
 
57% of the mothers of 6-month-old infants were lactating and 18% of the 
mothers of 12-month-old infants (mean of all mothers 38%). 
85% of all mothers were Swiss and 15% had a foreign nationality (4% German, 
2% Italian, 1% Kosovar, 8% various nationalities). 
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Table 22 shows the supplement and salt use of mothers by infant age group 
and in total.  
 
Table 22: Supplement/salt use of mothers 
Mothers 
Age group of infants 
Total 
6-mo 12-mo 
n 180 163 343 
Use of multivitamin/mineral 
supplements [n] 
Yes, with iodine 
Yes, unclear if with iodine or not 
Yes, but without iodine 
No 
 
6 
7 
48 
119 
a 
7 
8 
31 
114 
a 
13 
15 
79 
233 
Use of iodized salt at home [n] 
Yes 
No 
Unknown 
b 
157 
9 
12 
c 
138 
11 
13 
a 
295 
20 
25 
a – c 
Missing data/values: 
a
 n = 3; 
b
 n = 2; 
c
 n = 1 
 
In total, about one third of the mothers reported taking multivitamin/mineral 
supplements (Table 22). Of these only 12% specified iodine-containing 
supplements and in 14% of cases, it was unclear if their supplement contained 
iodine. The other supplement users named supplements without iodine. 
Looking at lactating (n = 131, missing data concerning supplement use n = 1) 
and non-lactating mothers (n = 212, missing data concerning supplement use n 
= 2), 40% (n = 52) and 26% (n = 55) were taking a supplement. Nevertheless, 
among these supplement users only 10% (n = 5) and 15% (n = 8) of the 
lactating and non-lactating mothers were taking an iodine-containing 
supplement. For 14% of the supplement users it was unclear if their supplement 
contained iodine (lactating n = 6, non-lactating n = 9) based on the information 
received from them. Five of those users were taking a vitamin/mineral 
supplement containing some kind of algae (mainly sweet water or no clear 
information was available). However, iodine was not displayed in the nutrition 
facts of these products and therefore they were allocated the “unclear” group.  
None of the mothers answered the question concerning the use of algae 
supplements with “yes” (data not displayed). 
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The most frequently used supplement was Elevit pronatal (Bayer (Schweiz) AG, 
Zürich), which is especially meant for pregnant and lactating women or for 
women with the wish to have a child. 56% (n = 29) of lactating and 33% (n = 18) 
of non-lactating supplement users took Elevit pronatal. However, it does not 
contain any iodine. 
The iodine containing supplements that were used by mothers (n) were:  
Allsan (Biomed AG, Dübendorf, Switzerland; 34 μg iodine (as KI) per dragée; 
lactating n = 3, non-lactating n = 2), Gynéfam (EFFIK SA, Nyon, Switzerland; 
150 μg iodine (as KI) per capsule; lactating n = 1, non-lactating n = 1), 
Multivitamin Complex (Herbalife, Darmstadt, Germany; 25 μg iodine (as KI) per 
tablet; non-lactating n = 2), Supradyn (Bayer (Schweiz) AG, Zürich; 75 μg iodine 
per tablet; non-lactating n = 1), Adapta Maman (Adapta, Lenzburg, Switzerland; 
52 μg iodine per daily portion, lactating n = 1), Centrum (Whitehall-Much GmbH, 
Münster, Germany; 100 μg iodine (as KI) per tablet; non-lactating n = 1), Green 
Source (Puritan, UK; 50 μg iodine (as kelp) per tablet; non-lactating n = 1). 
 
87% of the mothers reported use of iodized salt and only 6% acknowledged not 
using iodized salt at home. Seven percent did not know if they were using 
iodized salt or not (three mothers did not answer the question, excluded from 
percentage calculation) (Table 22). 
 
4.3.3. Infant feeding practices 
The results regarding infant feeding practices are based on the data indicated 
on the individual registration forms. If some dietary data was missing on a form, 
we made use of the dietary questionnaire (documented). The indicated 
percentages in the text were always calculated with the total number of valid 
data. Missing data was not included in the percentage calculations (see 
respective tables for number of missing data). Percentages were always 
rounded up or down to integers. 
 
4.3.3.1. Breast milk and formula 
Table 23 gives an overview of the breast milk (BM) and formula (FM) intake of 
the infants (questions 1 and 2 on the individual registration form, Appendix 7).  
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Table 23: Intake of breast milk and formula 
 
Age group 
Total 
6-mo 12-mo 
n 179 160 339 
Breast milk  
BM at some time a [n]  
Yes 
No 
173 
6 
g 
141 
17 
g 
314 
23 
Currently BM 
Yes  - Exclusively [n] 
b 
   (times/day) 
e
 
 - Predominantly [n] 
c 
 (times/day) 
 - Partially [n] 
d 
  (times/day) 
No (incl. never BM) 
9 
(6.7 ± 1.6) 
2 
(6.5 ± 2.1) 
91 
(4.3 ± 1.7) 
77 
0 
 
0 
 
29 
(2.6 ± 1.5) 
131 
9 
(6.7 ± 1.6) 
2 
(6.5 ± 2.1) 
120 
(3.9 ± 1.8) 
208 
Formula 
FM at some time a [n]  
Yes 
No 
f 
116 
62 
g 
135 
23 
h 
251 
85 
Currently FM 
Yes  - Exclusively [n] 
  (times/day) 
e
 
 - Daily [n] 
  (times/day) 
 - Occasionally: weekly 
 monthly 
No (incl. never FM) 
 
 
2 
(4.8 ± 0.4) 
100 
(3.4 ± 1.4) 
8 
0 
69 
 
 
0 
 
88 
(2.0 ± 0.9 
f
) 
4 
1 
67 
2 
(4.8 ± 0.4) 
188 
(2.7 ± 1.3) 
12 
1 
136 
Abbreviations: BM = breast milk; FM = formula 
a
 Infant had at some time received BM/FM since the birth 
b
 Defined as: Only breast milk, no other drinks or foods (except drugs) 
c 
Defined as: Predominantly breast milk, but also water (-based) fluids/fruit juice,  
 no formula or other foods
 
d 
Defined as: Mixed feeding of breast milk and other sources of energy and nutrients 
e 
Mean ± SD (all such values); 
f -h  
Missing data: 
f
 n = 1; 
g
 n = 2; 
h
 n = 3 
 
Ninety-three percent of the infants had at some time received BM (6-mo: 97%; 
12-mo: 89%) and only 75% had at some time received FM (6-mo: 65%; 12-mo: 
85%) since they were born (see also Table 23). 
 
At the time of study participation only 6% of the 6-month-old and none of the 12-
month-old infants were still being exclusively or predominantly breast-fed. 51% 
of the 6-month-old infants were partially breast-fed at an average of four breast-
feeds per day and 18% of the 12-month-old infants still received BM at an 
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average of 3 times daily. 40% of the 6-month-old infants and 71% of the 12-
month-old infants, who were at some time breast-fed, were not receiving BM 
anymore when the study was carried out (see also Table 23). 
 
Two 6-month-old infants (1%) received FM as their only food source. About 
55% of the infants in both age groups received FM on a daily basis when the 
study was carried out and 4.5% of the 6-month-old respectively 3% of the 12-
month-old infants received FM occasionally. The 6-month-old infants received 
FM on average three times a day and the 12-month-old infants just two times a 
day. Forty percent (6-mo: 39%; 12-mo: 42%) of the infants were not fed FM at 
the time of study participation (see also Table 23). 
 
4.3.3.2. (Semi-)solid foods & fluids with nutritional value (CF/FF)  
Table 24 gives an overview of the (semi-)solid foods and fluids with nutritional 
value (other than BM/FM) which were consumed by the infants (questions 3 - 5 
on the individual registration form, Appendix 7). These foods were categorized 
as complementary/family foods here (CF/FF). The data should give an insight 
into the types of food and meals infants already received in addition or instead 
of BM/FM and if they already received them on a daily basis or not. As CF/FF 
intake was suspected to show greater daily variability than BM/FM intake, the 
“frequency per day” was not taken into account for UIC analysis, especially as it 
might not reflect the intake of the day before the urine collection. Therefore, the 
frequency of CF/FF intake per day should give a more general insight into 
current CF/FF feeding habits. Moreover, it might not necessarily correlate with 
the amount the infants actually ate. For more detailed analysis, the data of the 
dietary questionnaires would be required.  
 
During data input it was recognized that the indicated total number of daily 
CF/FF meals (question 3 on the individual registration form, Appendix 7) was 
often not consistent with the accumulated number of the individual types of 
CF/FF meals (question 4). Reasons for this could be: 1) the infant also ate other 
foods which were not listed, 2) in case a food was only given as snack, it was 
not counted as a meal, 3) the consumption of cow milk was not taken into 
account by some doctors. In some cases the same number of daily eaten/drunk 
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FM-cereal porridges/bottles was reported in the question about CF/FF (question 
4.a) as the daily number of FM in the question about FM (question 2.1). This 
indicated a double reporting of FM if any cereal was added to the FM bottle. 
 
88% and 100% of the 6-month-old and 12-month-old infants already received 
CF/FF. Most infants in both age groups were fed the different types of CF/FF 
either daily or did not receive them. Few mothers reported feeding certain types 
of CF/FF on a weekly basis (see Table 24). 
 
Most of 6-month-old infants already received vegetable-carbohydrate-(meat)-
meals (80%) on a daily basis. About half (48%) of 6-month-old infants were fed 
daily a fruit-(cereal)-meal. 28% already received milk-cereal porridges/bottles 
with FM on a daily basis. As mentioned before, there might be a certain 
percentage of double reporting with FM intake in this 28% when the mother 
added some cereal to the FM bottle. Just six 6-month-old infants received daily 
milk-cereal porridges/bottles with cow milk. Ninety-six percent of mothers 
indicated that their 6-month-old infant was not yet fed porridges containing cow 
milk. Only one 6-month-old infant was fed diluted cow milk (w/o cereals) once a 
week and none received undiluted cow milk (see also Table 24). 
 
All 12-month-old infants daily ate vegetable-carbohydrate-(meat)-meals and 
nearly all (93%) consumed fruit-(cereal)-meals on a daily basis. 16% of 12-
month-old infants daily received diluted and 28% even undiluted cow milk (w/o 
cereals). Twenty-six percent of mothers of 12-month-old infants reported 
feeding their infant a milk-cereal porridge/bottle with cow milk daily and 31% 
specified giving a milk-cereal porridge/bottle with FM on a daily basis (see also 
Table 24). 
 
Only few 6-month-old infants already received food from the family table - 
meaning food that was prepared for the whole family -, one daily and twelve 
occasionally (missing data n = 3). At the age of 12 months however, only ten 
infants had not yet received family food. 79% of the 12-month-old infants ate 
family food daily (n = 125) and 15% occasionally (n = 23) (missing data n = 2) 
(data not reported in the table). 
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Table 24: Intake of (semi-)solid foods & fluids with nutritional value (CF/FF) by infants 
(Semi-)solid foods & fluids  
with nutritional value (CF/FF) a 
(excl. fruit juices, sweetened drinks)  
Age group 
Total 
6-mo 12-mo 
n 179 160 339 
Already CF or FF [n] 
Yes 
b 
(times/day) 
No 
158 
(1.7 ± 0.7) 
c 
21 
160 
(3.5 ± 1.2 
d
)
 
0 
318 
(2.6 ± 1.4 
d
)
 
21 
Types of CF/FF 
Milk-cereal porridge/bottle with FM 
Yes  - Daily [n] (times/day) 
  - Weekly [n] (times/week) 
No [n] 
51  (1.5 ± 1.0
 e
) 
4  (1.4 ± 0.5) 
124 
e 
49
 
 (1.4 ± 0.9) 
1  (2.0 ± 0.0) 
108  
e 
100  (1.5 ± 0.9 
e
) 
5  (1.5 ± 0.5) 
232 
Milk-cereal porridge/bottle with cow 
milk (+ water) 
Yes  - Daily [n] (times/day) 
  - Weekly [n] (times/week) 
No [n] 
d 
6  (1.3 ± 0.5) 
0 
172  
e 
41
 
 (1.3 ± 0.8 
d
)
 
1  (2.0 ± 0) 
116
 
 
f
 
47  (1.3 ± 0.8 
d
) 
1  (2.0 ± 0) 
288 
Diluted cow milk (w/o cereals) 
Yes  - Daily [n] (times/day) 
  - Weekly [n] (times/week) 
No [n] 
0 
1  (1.0 ± 0) 
178 
e 
26  (1.5 ± 0.7
 d
) 
2  (3.5 ± 2.1) 
130 
 
e
 
26  (1.5 ± 0.7 
d
) 
3  (2.7 ± 2.1) 
308
 
Undiluted cow milk (w/o cereals) 
Yes  - Daily [n] (times/day) 
  - Weekly [n] (times/week) 
No [n] 
0 
0 
179 
e 
44  (1.7 ± 0.7) 
2 (2.0 ± 1.4) 
112 
 
e
 
44  (1.7 ± 0.7) 
2 (2.0 ± 1.4) 
291 
Vegetable-carbohydrate-(meat) 
-meals (w/o milk) 
Yes  - Daily [n] (times/day) 
  - Weekly [n] (times/week) 
No [n] 
143 (1.0 ± 0.2) 
1 (2.0 ± 0) 
35 
d 
159 (1.5 ± 0.6 
d
) 
0 
0
 
d
 
302 (1.3 ± 0.5 
d
) 
1 (2.0 ± 0) 
35 
Fruit-(cereal)-meals (w/o milk) 
Yes  - Daily [n] (times/day) 
  - Weekly [n] (times/week) 
No [n] 
86 (1.0 ± 0.2 
d
) 
3 (3.2 ± 1.3) 
90 
e 
147 (1.3 ± 0.5) 
3 (3.2 ± 0.3) 
8  
e 
233 (1.2 ± 0.4
 d
) 
6 (3.2 ± 0.8) 
98 
a
 In this thesis these were defined as complementary foods (CF) and family foods (FF). 
b
 Even if the infant already ate completely with the family, he/she was also included in “yes” here. 
c 
Mean ± SD (all such values)
 
 
d - f
 Missing data: 
d
 n = 1; 
e
 n = 2; 
f
 n = 3 
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4.3.3.3. Summary infant feeding practices 
Table 25 summarizes the current infant feeding practice by grouping the infants 
into seven different feeding patterns. 
 
Table 25: Summarized current infant feeding practices 
Σ infant feeding practice 
Age group 
Total 
6-mo 12-mo 
n 179 160 339 
 % (n) % (n) % (n) 
Only BM  
(exclusively or predominantly) 
6 (11) 0 -- 3 (11) 
Only FM 1 (2) 0 -- 1 (2) 
Only BM & FM 4 (8) 0 -- 2 (8) 
BM & CF/FF 32 (58) 11 (17) 22 (75) 
FM & CF/FF 42 (75) 51 (81) 46 (156) 
BM & FM & CF/FF 14 (25) 8 (12) 11 (37) 
No BM, no FM, but CF/FF 0 -- 31 (50) 15 (50) 
Abbreviations: BM = breast milk; FM = formula milk; CF = complementary food; FF = family food 
 
At the age of 6 months, the majority of infants received a combination of FM 
and CF/FF (42%), followed by infants who received BM and CF/FF (32%). Only 
few infants were fed a combination of BM, FM and CF/FF (14%). All 6-month-
old infants received either BM or FM and a low percentage of 6-month-old 
infants did not yet receive CF/FF (12%). 
 
At the age of 12 months, about half of the infants received a combination of FM 
and CF/FF. Nearly one third of them received neither BM nor FM anymore 
(31%). All except two of those infants, however, received either porridges 
containing FM/cow milk or cow milk as a drink (diluted or undiluted) on a daily 
basis (data not shown in table). A rather low percentage (18%) of the 12-month-
old infants still received BM in combination with either CF/FF or FM and CF/FF. 
All 12-month-old infants received CF/FF. 
 
4.3.3.4. Salt use for infants 
Table 26 shows the use of salt in home-made and ready meals. 
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Table 26: Salt use for infants [n] 
Use of salt for infants 
Age group 
Total 
6-mo 12-mo 
n 179 160 339 
 in home-made meals [n]  
Yes  - iodized 
 - not iodized 
 - unknown if iodized 
No salt 
No home-made meals 
No CF/FF yet 
a
  
14 
3 
5 
127  
6 
21 
b
  
111 
6 
20 
20 
2 
0 
c
  
125 
9 
25 
147 
8 
21
 
 in ready meals (e.g. jars) [n] 
Yes   
No 
Unknown 
No ready meals 
No CF/FF 
c
  
24 
93 
5  
32 
21
 
d
  
35 
74 
8 
33 
 0 
e
  
59 
167 
13 
65 
21
 
Abbreviations: CF = complementary food; FF = family food 
a - e
 Missing data: 
a
 n = 3; 
b
 n = 1; 
c
 n = 4; 
d 
n = 10; 
e
 n = 14 
 
Home-made meals 
12.5% of the mothers of 6-month-old infants reported already using salt in 
home-made meals for their infants. 64% of those indicated using iodized salt, 
14% used non-iodized salt and the rest did not know if the salt was iodized or 
not. Most of the mothers specified not yet adding salt to their 6-month-old 
infant‟s home-made meals (72%) or not giving home-made/CF/FF at all (15%) 
(Table 26).  
 
86% of the mothers of 12-month-old infants on the other hand, indicated already 
adding salt to home-made meals, of which 81% specified using iodized salt and 
only six mothers (4%) acknowledged not using iodized salt. 15% did not know 
which salt they use for their infant. Only 14% of the 12-month-old infants did not 
yet receive salt in home-made meals (Table 26).  
 
Ready meals 
14% of 6-month-old infants were fed ready meals containing salt (either added 
by producer or mother) and 23% of 12-month-old infants. 53% and 49% of 
mothers of 6-month-old infants and 12-month-old infants reported not giving 
ready meals with salt to their infants. The rest of the infants either did not 
receive ready meals (20% of all infants) or CF/FF or the mother did not know if 
the ready meals they used contained salt (4%). Fourteen mothers in total did 
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not answer the question (not considered in %-calculation) (Table 26).  
 
General salt use  
It was concluded whether or not the infants generally already received salt 
based on the salt use in home-made and ready meals and the feeding of family 
food, which usually contains a certain amount of salt. About 22% (n = 39) of the 
6-month-old infants already received salt, about 74% did not (n = 132) and for 
4% (n = 8) it was unclear if they received salt or not. For the 12-month-old 
infants, it was concluded that nearly all (96%, n = 153) already received salt and 
that only 2.5% (n = 4) did not. For three 12-month-old infants, we could not 
make a conclusion (data are not reported in the table). 
 
4.3.4. Social demographics of mothers  
As an additional characterization of the mothers, Table 27 presents the 
sociodemographic data, which was obtained from the mothers through the 
dietary questionnaires. The percentages in the table and text are in relation to 
the number of mothers who answered the question in the questionnaire. 
 
Table 27: Social demographics of mothers (from dietary questionnaires) 
Social demographics  
of mothers i 
Age group of infants 
Total 
6-mo 12-mo 
Mothers  [n] 180 163 343 
Questionnaire [n] 175 148 323 
Number of children [n] 1.8 (1 - 4) a, b 1.6 (1 - 4) e 1.7 (1 - 4) f 
Single parent [%] 
Yes 
No 
b
  
2 
98 
 
e
  
2 
98  
f
 
2 
98 
Smoker [%] 
Yes 
No 
c
  
7 
93
 
 
e
  
12 
 88  
g
 
9 
91 
Professional activity [%] 
Full time (90-100%) 
Part time (20-80%) 
By the hour  
Not working 
d
  
3 
39 
13 
44  
e
  
4 
53 
15 
 28  
h
 
4 
46 
14 
37 
a
 mean (range) (all such values) 
b  - e
 Data from: 
b
 n = 175; 
c
 n = 173; 
d
 n = 174; 
e 
n = 147; 
f
 n = 322; 
g
 n = 320; 
h
 n = 321.  
Percentages are in relation to number of answers in questionnaire (not in relation to all mothers), 
rounded up or down to integers. 
i
 Data if possible taken from 1
st
 questionnaire, if missing there from 2
nd
. 
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The average number of children per mother was 1.7. Fifty-three percent of the 
mothers had more than one child.  
Only 2% of the mothers were single parents. Nine percent acknowledged being 
a smoker. More mothers of 12-month-old infants smoked (n = 18, one of those 
lactating) compared with mothers of 6-month-old infants (n = 12, four of those 
lactating).  
44% and 28% of mothers of 6-month-old infants respectively 12-month-old 
infants did not work. The others worked either full, part time or by the hour. 
 
In Table 28, mothers were classified into eight different occupational categories. 
 
Table 28: Classification of occupation of the mothers 
Classification of occupation a  [%] (n) 
Age group of infants 
Total 
6-mo 12-mo 
Mothers  [n] 180 163 343 
Questionnaire 1./2. [n] 175 / 163 148 / 143 323 / 306 
1. Agriculture, forestry, stock-breeding 
%
 e
 (n) % (n) % (n) 
2 
b 
(4) 1 
c
 
(2) 2 
d 
(6) 
2. Production in industry & commerce  
(excl. construction) 
2 (4) 3 (5) 3 (9) 
3. Technical & computer science 3 (5) 3 (5) 3 (10) 
4. Construction industry & mining 0 (0)
 
0 (0)
 
0 (0) 
5. Trade and transport 7 (12) 11 (16) 9 (28) 
6. Hotel/restaurant industry & provision of 
personal services 
8 (14) 9 (13) 8 (27) 
7. Management & administration, banking 
& insurance industry & legal system 
29 (49) 26 (39) 28 (88) 
8. Health, education & culture, scientists 48 (81) 45 (67) 47 (148) 
9. Non-classifiable data 1 (1) 1 (1) 1 (2) 
a
 The educations/professions indicated by the mothers on the questionnaire were classified in 
different occupational categories (see methods). 
b - d
 Data from: 
b
 n = 170; 
c
 n = 148; 
d
 n = 318 (total missing n = 25) 
e
 The percentages indicated are related to the total number of valid data, missing data were  
not included in the %-calculation. Percentages were rounded up or down to integers. 
 
Nearly half of all mothers in each infant age group had an occupation in the 
category 8 “health, education & culture, scientists”, followed by 28% in the 
category 7 “management & administration, banking & insurance industry & legal 
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system”. Minor percentages were distributed between the other categories (see 
Table 28). 
 
Classifying mothers according to their educational background, about half of the 
mothers had a compulsory school/secondary education level, about one quarter 
had a higher vocational education and one quarter had a university education 
(see Table 29). 
 
Table 29: Educational background of the mothers 
Educational background a [%] (n) 
Age group of infants 
Total 
6-mo 12-mo 
Mothers  [n] 180 163 343 
Questionnaire 1./2. [n] 175 / 163 148 / 143 323 / 306 
 %
 e
 (n) % (n) % (n) 
Compulsory school/secondary education level 52 
b 
(88) 53 
c
 
(78) 52 
d
 
(166) 
Higher vocational education 24 (41) 26 (38) 25 (79) 
University level 24 (41) 22 (32) 23 (73) 
a
 Definition of the ISCED-levels: Compulsory school/secondary education level (ISCED 1-4);   
Higher vocational education (“Höhere Berufsbildung”) (ISCED 5B); University/university of  
applied sciences (“Hochschule”) (ISCED 5A,6) (see also methods). 
b - d
 Data from: 
b
 n = 170; 
c
 n = 148; 
d
 n = 318 (total missing n = 25) 
e
 The percentages indicated are related to the total number of valid data, missing data were not 
included in the %-calculation. Percentages were rounded up or down to integers. 
 
122 Results 
 
 
 
 
University of Vienna  Nadja Wüst 
 
 
4.4. Urinary iodine concentration 
4.4.1. Collection materials 
The iodine concentration in the pads, urine bags and other collection materials 
was below the detection limit of the method (≈ 2 μg/l). They were therefore not 
considered to be contaminated with iodine. 
In the iodine recovery test, with an iodine concentration of 100 μg/l, no change 
in iodine concentration was found in the urine collection pads compared to the 
“no-pad” reference. For detailed results see the B.Sc. thesis of C. Piccapietra 
(Piccapietra, 2008).  
 
4.4.2. Sample collection 
The samples for this interim study evaluation were collected between mid 
August 2008 and beginning of May 2009 (according to dates of study 
registration).  
The main place of sample collection differed from practice to practice. The 
majority of pediatricians instructed parents to carry out sample collection at 
home. Some doctors collected practically all samples in the practice. Some 
doctors did both. The relation based on currently available information was 
about 2 : 0.5 : 1. More detailed information about the sample collection location 
was not available for this evaluation as the required data was on the practice 
registration form, which was not returned to us from the pediatric practices 
before study completion.  
The approximate median (range) number of days between the registration of 
the infant and the sample arrival at ETH (date of postmark) was 3 (0 - 53) days. 
76.3% of samples (infants) arrived at ETH (by post) within one week after study 
registration and 91% arrived within two weeks. For 5.4% and 3% of the samples 
it took more than three and four weeks until arrival at ETH. It is possible 
however, that those samples were collected earlier but not sent to us directly 
after collection.  
The pad collection method was applied for the first time for urine collection in all 
pediatric practices. Earlier, the practices used urine bags for collection. The 
pediatricians were generally content with this new urine collection method even 
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if most found it time consuming to extract the urine from the pad (oral 
communication). One of the two pediatric practices which had already finished 
sampling could imagine using this method regularly for urine collection in 
infants; the other still preferred using urine bags (final questionnaire to doctors). 
One pediatric practice insisted on using urine bags for the study sample 
collection because they considered the pad collection method too time 
consuming (region Ticino; bags tested for iodine contamination, see methods). 
None of the parents reported any problems with the method; also, the doctors 
did not mention any problems encountered by parents. 
 
4.4.3. Infants - Overview 
Table 30 gives an overview of the measured urinary iodine concentrations of 
the infants by age group and for the total sample. 
The UIC values of the infants (total sample and both age groups separately) 
were not normally distributed, but positively skewed (mean ± SD = 122.4 ± 
102.5 μg/l; median = 93.2 μg/l). Figure 14 shows the UIC distribution of all 
infants. 
The median (95% CI) UIC of infants together (n = 339, total sample) was 93.2 
μg/l (85.6, 104.3). This is just below the currently available WHO cut-off for 
iodine sufficiency of 100 μg/l (World Health Organization et al., 2007).  
For 6-month-old infants, the median UIC of 88.4 μg/l was clearly below 100 μg/l. 
12-month-old infants had a median UIC of 104.0 μg/l. Nevertheless, the two age 
groups were not significantly different (MWU, p = 0.078). Box plots of UIC of 
both age groups are shown in Figure 15. Furthermore, infant age [months] did 
also not significantly correlate with UIC (all n = 339: rs = .10, p = 0.06; 6-mo n = 
179: rs = -.02, p = 0.75; 12-mo n = 160: rs = 0.13, p = .11). 
In the total sample, the included UICs ranged from 6.4 to 763.1 μg/l. The 
interquartile range was 104.0 μg/l (from 53.4 to 157.4 μg/l). Ninety-five percent 
of all UICs lay between 20.3 and 371.6 μg/l. 
53% of all infants had a UIC below the WHO cut-off 100 μg/l and 23% < 50 μg/l. 
In school age children or adults this would indicate mild iodine deficiency (World 
Health Organization et al., 2007). In 5.3% of all infants a UIC ≥ 300 μg/l (6.1% 
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6-mo, 4.3% 12-mo) was measured. In school age children or adults a UIC ≥ 300 
μg/l indicates an excessive iodine intake (World Health Organization et al., 
2007). Three 6-month-old and one 12-month-old infant even had a UIC ≥ 500 
μg/l. 
 
Table 30: Overview of urinary iodine concentrations [μg/l] of infants 
UIC a of infants 
Age group 
Total 
6-mo 12-mo 
n 179 160 339 
Median [μg/l] 88.4 
(67.8, 99.8) 
b 
104.0 
(88.1, 125.5) 
b 
93.2 
(85.6, 104.3) 
b 
Minimum [μg/l] 10.9 6.4 6.4 
Maximum [μg/l] 763.1 504.0 763.1 
Percentiles [μg/l] 
2.5th 
25th 
50th 
75th 
97.5th 
20.6 
49.4 
88.4 
153.1 
434.6 
18.5 
61.4 
104.0 
161.0 
347.0 
20.3 (11.4, 22.6) c 
53.4 
93.2 
157.4 
371.6 (329.9, 550.5) c 
Prevalence of UIC  
<   20 μg/l 
 
<   50 μg/l 
 
< 100 μg/l 
 
≥ 100 μg/l  
 
≥ 300 μg/l 
 
≥ 500 μg/l 
 
% n % n % n 
1.7 
 d
 
25.7 
(19.2, 32.1) 
58.7 
(51.4, 65.9) 
41.3 
(34.1, 48.6) 
6.1 
(2.6, 9.7) 
1.7 
d 
(3) 
 
(46) 
 
(105) 
 
(74) 
 
(11) 
 
(3) 
 
2.5 
 d  
20.0 
(13.7, 26.3) 
46.9 
(39.1, 54.7) 
53.1 
(45.3, 60.9) 
4.4 
(1.2, 7.6) 
0.6 
d 
(4) 
 
(32) 
 
(75) 
 
(85) 
 
(7) 
 
(1) 
 
2.1 
(0.5, 3.6) 
e 
23.0 
(18.5, 27.5) 
53.1 
(47.8, 58.4) 
46.9 
(41.6, 52.2) 
5.3 
(2.9, 7.7) 
1.2 
d
 
(7) 
 
(78) 
 
(180) 
 
(159) 
 
(18) 
 
(4) 
 
a
 Abbreviation: UIC = urinary iodine concentration 
b 
95% CI, calculated with SPSS 16
 
c
 95% CI, calculation after (Campbell and Gardner, 1988). Calculating CI for the single age 
groups gave no reasonable results with this method (non-existing observations required). 
d
 Here the number of cases below/above the defined limit was too small for the used calculation 
for the 95% CI, see 
e
.  
e
 95% CI, calculation: p ± 1.96 * √ p(1-p)/n; p = proportion of cases below/above the defined 
limit, n = sample size (Altman, 1999), p. 230; (all such values in this section). 
 
The proportion of UIC < 100 μg/l and ≥ 100 μg/l was significantly different 
between the two age groups (chi-square, p < 0.05). A significantly higher 
percentage of 12-month-old infants (53%) had a UIC ≥ 100 μg/l compared to the 
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6-month-old infants (41%). All other proportions were not significantly different 
between the age groups. 
 
 
Figure 14: Distribution of urinary iodine concentrations (UIC) of the infants 
(n = 339, both age groups together) 
 
 
Figure 15: Box plots of urinary iodine concentrations (UIC) in infants by age group 
(6-months: n = 179; 12-months: n = 160) (MWU, p = 0.08) 
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4.4.3.1. Gender 
Table 31 shows median UIC (95% CI) in girls and boys. Comparing UIC 
between boys and girls in the total sample, there was no significant difference 
(MWU, p = 0.59). 6-month-old boys had the lowest median UIC.  
UIC between boys and girls was not significantly different within each age 
group, even if there was a strong tendency towards a significance in the 6-mo 
group (MWU, 6-mo: p = 0.053; 12-mo: p = 0.22).  
Comparing girls and boys between the age groups, 12-month-old boys had a 
significantly higher median UIC than 6-month-old boys (MWU, p < 0.05) and 
among girls, there was no significant difference in UIC (MWU, p = 0.73). 
 
Table 31: Urinary iodine concentration (UIC) [μg/l] of infants by gender 
UIC of infants 
Age group 
Total 
6-mo 12-mo 
 n [μg/l] n [μg/l] n [μg/l] 
Girls 91 
94.7
 a
 
(83.6, 114.6) 
 67 
103.7 
(71.2, 125.5) 
158 
99.8 
(86.7, 112.7) 
Boys 1 88 
68.2 
(56.2, 93.2) 
93 
104.3 
(84.8, 140.7) 
181 
90.0 
(71.0, 104.7) 
a  
Median (95% CI) (all such values) 
1
 Boys significantly different between age groups (p < 0.05) 
 
4.4.3.2. Weight and length 
No significant correlations were found between UIC and body weight or length 
of infants including the total sample (weight: rs = .11, p = 0.05; length: rs = .06, p 
= 0.25). The correlations were even weaker after controlling for gender and age 
in months (weight: rs = .04, p = 0.46; length: rs = .01, p = 0.85). 
Looking at age groups, no significant correlations were found for body 
weight/length in the 6-mo group (weight: rs = -.08, p = 0.30; length: rs = -.15, p = 
0.05) and no correlation was found with body length in the 12-mo group (rs = 
.09, p = 0.25). In contrast, there was a significant positive correlation between 
UIC and body weight in the 12-mo group (rs = .21, p < .01), which however, 
became non-significant after controlling for gender and exact age in months (r = 
.15, p = 0.06).  
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4.4.3.3. Nationality 
Table 32 shows median UICs (95% CI) of Swiss infants and infants with foreign 
nationality (85% vs. 15%, based on the nationality of the mother).  
 
Table 32: Urinary iodine concentration (UIC) [μg/l] of Swiss and foreign infants 
UIC of infants 
Age group 
Total 1 
6-mo 12-mo 1 
 n [μg/l] n [μg/l] n [μg/l] 
Swiss 158 
87.5 
a
 
(66.5, 99.8)
 131 
100.6 
(74.6, 114.8) 
289 
90.0 
(75.4, 102.4) 
Foreign nationality 21 
93.2 
(54.8, 162.5) 
29 
138.6 
(90.5, 196.2) 
50 
123.8 
(90.5, 145.4) 
a  
Median (95% CI) (all such values) 
1
 Swiss < foreign nationality: significantly different, p < 0.05 
 
Looking at the total sample, infants with foreign nationality were found to have a 
significantly higher median UIC than Swiss infants (MWU, p < 0.05). Figure 16 
shows the box plots of UIC of Swiss and foreign infants.  
 
 
Figure 16: Box plots of urinary iodine concentration (UIC) [µg/l] in Swiss (n = 289) and 
foreign infants (n = 50) (  Swiss < foreign: p < 0.05) 
 
Examining both age groups separately, foreign infants in the 6-mo group were 
found to have a slightly higher median UIC than Swiss infants, but the 
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difference in UIC was not significant (MWU, p = 0.39). In the 12-mo group, UICs 
of foreign infants were significantly higher compared to Swiss infants (MWU, p < 
0.05). 
12-month-old Swiss infants had a higher median UIC compared to 6-month-old 
Swiss infants, but the difference in UIC was not significant (MWU, p = 0.25). 
The same holds true for infants with foreign nationality (MWU, p = 0.23). 
 
4.4.3.4. Pediatric practice/region 
As the number of infants per pediatric practice (n = 2 to 62) and region (n = 4 to 
92) was variable, the data were not evaluated separately for each pediatric 
practice and region. Indeed, the study was not planned to be representative for 
single practices or geographic regions, but for the country as a whole.  
The median (range) UIC of infants in each practice can be found in Appendix 
16. There was no significant difference in UIC of infants between pediatric 
practices (K-W, p = 0.20). Median UICs of practices ranged from 67.4 to 184.3 
μg/l (all infants).  
 
Table 33 lists the median UICs of infants in the seven Swiss regions. Median 
UICs of regions ranged from 67.8 to 184.3 μg/l (total sample). 
Within each region, there was no significant difference in UIC between the two 
age groups (MWUs, all p > 0.05), except for Central Switzerland where UIC of 
12-month-old infants was significantly higher compared with 6-month-old infants 
(MWU, p < 0.05).  
There was a significant difference in UIC between the regions (total sample, K-
W, p < 0.05). Post-hoc tests (MWU with Bonferroni correction p < 0.005) 
showed that UIC in Ticino was significantly higher than UIC in Espace Mittelland 
and Eastern Switzerland (p < 0.005). The Lake Geneva region probably had too 
small a sample size (n = 4) to detect a significant difference to Ticino.  
Due to a very small sample size in some regions, a comparison between 
regions was not performed separately for the age groups. 
Looking at the box plots of the regions (total sample, Figure 17), Ticino tended 
to have the highest UICs. 
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Table 33: Urinary iodine concentration (UIC) [μg/l] of infants arranged by the seven 
Swiss regions 
UIC of infants 
Age group 
Total 2 
6-mo 12-mo 
Regions n [μg/l] n [μg/l] n [μg/l] 
Lake Geneva region 
(1) 
3 
61.6 
(47.3 – 91.1) 
a 1 
110.7 
 
4 
76.3  
(47.3 – 110.7) 
Espace Mittelland 
(2) 
24 
69.4 
(21.9 – 291.3) 
11 
64.0 
(36.7 – 205.8) 
35 67.8 ° 
(21.9 – 291.3) 
Northwestern 
Switzerland (3) 
27 
90.5 
(11.4 – 763.1) 
27 
140.2 
(18.5 – 296.4) 
54 
92.9 
(11.4 – 763.1) 
Zurich (4) 26 
97.0 
(17.4 – 452.1) 
20 
99.4 
(51.5 – 225.3) 
46 
98.5 
(17.4 – 452.1) 
Eastern Switzerland 
(5) 
42 
83.0 
(10.9 – 370.6) 
50 
82.3 
(6.4 – 306.6) 
92 82.5 * 
(6.4 – 370.6) 
Central Switzerland 
(6) 1 
49 
88.6 
(21.8 – 417.1) 
42 
133.8 
(15.8 – 372.6) 
91 
100.0 
(15.8 – 417.1) 
Ticino (7) 8 
152.9 
(51.9 – 405.1) 
9 
184.3 
(75.6 – 504.0) 
17 184.3 * ° 
(51.9 – 504.0) 
TOTAL 179 
88.4 
(10.9 – 763.1) 
160 
104.0 
(6.4 – 504.0) 
339 
93.2  
(6.4 – 763.1) 
a 
Median (range) (all such values) 
1
 6-mo vs. 12-mo p < 0.05 (MWU) 
2
 Significant difference between regions, K-W, p < 0.05; * ° p < 0.005 (MWU) 
 
 
Figure 17: Box plots of urinary iodine concentration (UIC) [µg/l] of all infants (n = 339) 
in each greater Swiss region (K-W, p < 0.05;  2 < 7 and 5 < 7: p < 0.005) 
Legend: Names of regions (numbers in brackets) and [n] per region can be found in Table 33 
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4.4.3.5. Urban – rural area of pediatric practice 
In the total sample the median UIC (95% CI) of samples collected from pediatric 
practices in urban areas (96.6 (88.1, 109.0) μg/l, n = 287) was higher compared 
to the median of samples from pediatric practices in rural areas (73.2 (57.3, 
105.1) μg/l, n = 52) (see also Table 19). Nevertheless, there was no significant 
difference in UIC (MWU, p = 0.06). There was also no significant difference 
when looking at the age groups separately (MWU, 6-mo: p = 0.08 (median UIC 
urban: 90.3 μg/l, rural: 71.0 μg/l), 12-mo: p = 0.28 (median UIC urban: 104.7 
μg/l, rural: 87.6 μg/l)). The proportion of breast-fed infants was about the same 
in urban and rural areas (39% and 36.5%). 
Pediatric practices in rural areas were located only in Espace Mittelland and 
Eastern Switzerland (see Table 19). Therefore, we analyzed these regions 
separately and found no significant difference between UIC of infants (both age 
groups together) from practices in urban and rural areas (MWU, Espace 
Mittelland: p = 0.46 (median UIC urban: 67.4 μg/l, rural: 71.0 μg/l) and Eastern 
Switzerland: p = 0.81 (median UIC urban: 82.6 μg/l, rural: 75.4 μg/l)). 
 
4.4.3.6. Month of study registration/sample collection 
Table 34 lists median UIC (range) by month of sample collection (= month of 
registration for study) and box plots of UIC (all infants) are shown in Figure 18. 
 
When including the total sample, there was no significant difference in UIC of 
infants between the months of sample collection (K-W, p = 0.42). The lowest 
median UIC was found in February ‟09 (62.2 μg/l, n = 24) and the highest in 
May ‟09 (180.4 μg/l, n = 3).  
In 6-month-old infants no significant difference in UIC was detected between the 
months of sample collection (K-W, p = 0.14). The lowest median UIC was found 
in February ‟09 (36.5 μg/l, n = 10) and the highest in Sept ‟08 (114.4 μg/l, n = 
34). 
In 12-month-old infants UIC also did not differ significantly between the months 
of sample collection (K-W, p = 0.69). The lowest median UIC was found in April 
‟09 (68.8 μg/l, n = 7) and the highest in May ‟09 (180.4 μg/l, n = 3). 
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Table 34: Urinary iodine concentration (UIC) of infants [μg/l] by month of study 
registration/sample collection 
UIC of infants 
Age group 
Total 
6-mo 12-mo 
Month n [μg/l] n [μg/l] n [μg/l] 
Aug „08 6 
72.5 
(11.4 – 216.3) 
a 
6 
76.5 
(20.2 – 224.4) 
12 
76.5 
(11.4 – 224.4) 
Sept „08 34 
114.4 
(10.9 – 763.1) 
25 
111.9 
(23.3 – 504.0) 
59 
112.0 
(10.9 – 763.1) 
Oct „08 34 
85.8 
(21.8 – 417.1) 
27 
102.4 
(28.8 – 365.5) 
61 
89.3 
(21.8 – 417.1) 
Nov „08 24 
73.9 
(21.8 – 329.9) 
30 
127.3 
(18.5 – 306.6) 
54 
105.5 
(18.5 – 329.9) 
Dec „08 31 
88.4 
(21.9 – 291.3) 
20 
97.8 
(6.4 – 300.4) 
51 
91.2 
(6.4 – 300.4) 
Jan „09 10 
70.0 
(35.9 – 171.7) 
14 
136.9 
(47.4 – 200.0) 
24 
113.6 
(35.9 – 200.0) 
Feb „09 10 
36.5 
(17.4 – 184.4) 
14 
78.1 
(36.7 – 225.3) 
24 
62.2 
(17.4 – 225.3) 
March „09 30 
99.9 
(40.8 – 550.5) 
14 
83.1 
(33.1 – 245.9) 
44 
96.9 
(33.1 – 550.5) 
April „09 0 -- 7 
68.8 
(30.8 – 265.2) 
7 
68.8 
(30.8 – 265.2) 
May „09 0 -- 3 
180.4 
(87.6 – 372.6) 
3 
180.4 
(87.6 – 372.6) 
a 
Median (range) (all such values) 
 
 
Figure 18: Box plots of urinary iodine concentration (UIC) [μg/l] of infants (n = 339) by 
month of study registration/sample collection (K-W, p = 0.42) 
Legend: Numbers in x-axis = months 8/2008 – 12/2008, 1/2009 – 5/2009; n per month 
see Table 34  
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4.4.3.7. Current infant feeding practices 
4.4.3.7.1. Breast-fed - not breast-fed 
Median UICs of breast-fed and not breast-fed infants are shown in Table 35. 
 
Table 35: Urinary iodine concentration (UIC) [μg/l] of breast-fed vs. not breast-fed 
infants  
UIC of infants 
Age group 
Total 1 
6-mo 1 12-mo 
 n [μg/l] n [μg/l] n [μg/l] 
Breast-fed 102 
70.7 
a
 
(56.6, 93.2)
 29 
105.4 
(78.7, 140.2) 
131 
83.8 
 (65.2, 99.8) 
Not breast-fed 77 
96.6 
(86.3, 125.5) 
131 
103.1 
(84.9, 128.8) 
208 
101.4 
(90.0, 120.6) 
a 
Median (95% CI) (all such values) 
1
 Significant difference between breast-fed vs. not breast-fed infants (p < 0.01) 
 
Figure 19 shows box plots of UIC of breast-fed and not breast-fed infants, 
subdivided by age group. 
 
 
Figure 19: Box plots of urinary iodine concentration (UIC) [μg/l] of breast-fed and not 
breast-fed infants, subdivided by age group (  6-mo: BF < not BF: p < 0.01) 
Legend: breast-fed (BF): 6-mo n = 102, 12-mo n = 29;  
 not breast-fed (not BF): 6-mo n = 77, 12-mo n = 131  
 
When including the total sample, median UIC in currently breast-fed infants was 
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17% lower compared with not breast-fed infants. The difference in UIC was 
significant (MWU, p < 0.01). This significant difference was also detected in the 
6-month-old infants (MWU, p < 0.01). In the 12-month-old infants, there was no 
difference in UIC between not breast-fed and breast-fed infants (MWU, p = 
0.99).  
Breast-fed infants in the 6-mo group had a 33% lower median UIC compared 
with breast-fed infants in the 12-mo group, but the difference in UIC was not 
significant (MWU, p = 0.087). UICs of not breast-fed infants in the 6-mo group 
also did not differ significantly from UICs of not breast-fed infants in the 12-mo 
group (MWU, p = 0.72).  
 
4.4.3.7.2. Exclusively/predominantly - partially breast-fed 
There was no significant difference in UIC between exclusively/predominantly 
breast-fed (n = 11, median UIC (range) = 68.7 (21.8 – 233.8) μg/l) and partially 
breast-fed infants (n = 120 (both age groups), median UIC (range) = 84.3 (6.4 – 
355.0) μg/l) (MWU, p = 0.99). However, the number of exclusively/ 
predominantly breast-fed infants was too small to make an accurate 
comparison. 
There was no significant correlation between UIC of breast-fed infants and the 
number of daily breast-feeds (data from registration form) (all BF infants: rs = -
.052, p = 0.56; exclusively/predominantly BF: rs = .48, p = 0.13; partially BF: rs = 
-.088, p = 0.34).  
 
4.4.3.7.3. Formula – no formula 
Median UICs of infants currently fed formula and infants not fed formula are 
given in Table 36. 
Infants who currently received formula had a higher median UIC than infants not 
receiving formula (total sample and both age groups). The difference in UIC 
was however, only significant when all infants were included in the comparison 
(MWU, p < 0.001, see also Figure 20) and when only the 6-month-old infants 
were included (MWU, p < 0.001). In the 12-month-old infants, the difference in 
UIC was not significant (MWU, p = 0.08). 
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Table 36: Urinary iodine concentration (UIC) [μg/l] of infants currently fed formula vs. 
infants not fed formula 
UIC of infants 
Age group 
Total 1 
6-mo 1 12-mo 
 n [μg/l] n [μg/l] n [μg/l] 
Formula 110 
102.5 
a
 
(90.0, 125.5)
 93 
111.9 
(91.2, 132.1) 
203 
105.4 
 (94.7, 121.5) 
No formula 69 
64.1 
(53.5, 85.6) 
67 
89.3 
(68.8, 126.1) 
136 
72.5 
(63.3, 88.6) 
a 
Median (95% CI) (all such values) 
1
 Significant difference between formula-fed vs. not formula-fed infants (p < 0.001) 
 
 
Figure 20: Box plots of urinary iodine concentration (UIC) in infants fed formula (n = 
203) and not fed formula (n = 136) (  formula > no formula: p < 0.001) 
 
There was no significant correlation between UIC of formula-fed infants and the 
number of daily FM feeds (data from registration form) (rs = .076, p = 0.30). 
 
4.4.3.7.4. Breast feeding - formula feeding 
The number of infants who did not yet receive complementary/family food 
(CF/FF) (= exclusively/predominantly breast-fed, formula-fed or breast- and 
formula-fed) was very small (see Table 25). Therefore, those infants were 
added to the respective groups of infants who already received CF/FF and the 
infants were grouped into four feeding groups for comparison based on their 
current consumption of BM/FM (1. BM with or without CF/FF, no FM; 2. FM with 
or without CF/FF, no BM; 3. BM and FM with or without CF/FF; 4. No BM and 
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no FM, but CF/FF). Table 37 shows the four groups and the median UICs of the 
infants by age group and for the total sample. 
 
Table 37: UIC [μg/l] of infants subdivided into four groups of different feeding practices 
UIC of infants 
Age group 
Total 1 
6-mo 2 12-mo 
 n [μg/l] n [μg/l] n [μg/l] 
BM 69 
64.1 * ° 
(53.5, 85.6) 
a 17 
95.9 
(65.2, 152.1) 
86 69.6 * ° 
 (55.0, 86.7) 
FM 77 96.6 *  
(86.3, 125.5) 
81 
112.8 
(88.1, 134.6) 
158 103.1 * 
(90.5, 125.5) 
BM & FM 33 114.6 ° 
(59.6, 165.8) 
12 
108.5 
(82.6, 183.3) 
45 112.0 ° 
(83.6, 140.2) 
No BM, no FM 0 --- 50 
82.5 
(61.4, 135.8) 
50 
82.5 
(61.4, 135.8) 
Abbreviations: UIC = Urinary iodine concentration; BM = breast milk; FM = formula milk 
a  
Median (95% CI) (all such values) 
1
 Significant difference between groups (K-W, p < 0.001), * p < 0.0001, ° p < 0.0083 
2
 Significant difference between groups (K-W, p < 0.005), * p < 0.001, ° p < 0.017 
 
When including the total sample, a comparison of the four feeding groups 
showed a significant difference in UIC (K-W, p < 0.001). The lowest median UIC 
was found in the BM group (69.6 μg/l), the highest in the BM & FM group (112.0 
μg/l). Post-hoc tests (MWU with Bonferroni correction p < 0.0083) showed that 
median UIC of the BM group was significantly lower compared with the FM 
group (p < 0.0001) and BM & FM group (p < 0.0083). The other groups were 
not significantly different from each other.  
All 6-month-old infants received either BM or FM. A comparison of UIC between 
the three groups showed that they were significantly different (K-W, p < 0.005). 
Post-hoc tests (MWU with Bonferroni correction p < 0.017) showed the same 
result as for the total sample. Median UIC of the BM group was significantly 
lower compared with the FM group (p < 0.001) and the BM & FM group (p < 
0.017). There was no significant difference in UIC between the BM & FM and 
FM group.  
A comparison between the feeding groups in 12-month-old infants showed no 
significant difference in UIC (K-W, p = 0.37). The lowest median was found in 
the group not receiving any BM or FM (82.5 μg/l), the highest was in the FM 
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group (112.8 μg/l).  
Figure 21 shows the box plots of UIC by feeding group in each age group. 
 
 
Figure 21: Box plots of urinary iodine concentration (UIC) in infants (6-mo and 12-mo) 
in different feeding groups (  6-mo: BM < FM: p < 0.001; BM < BM & FM: p < 0.017) 
Legend: BM = breast milk; FM = formula milk; n per box plot see Table 37 
 
Within each feeding group, UICs in 6-month-old infants did not significantly 
differ from 12-month-old infants (MWU, all p > 0.05). 
 
A significant positive correlation was found between UIC of infants only fed BM 
(with or without CF/FF, no FM) and the number of daily breast-feeds (data from 
individual registration form) (total sample: rs = .26, p < 0.05; 6-mo: rs = .41, p < 
0.01; 12-mo: rs = .49, p < 0.05). The number of daily FM feeds did not correlate 
with UIC of infants only fed FM (with or without CF/FF, no BM) (total sample: rs 
= .11, p = 0.19; 6-mo: rs = .21, p = 0.07; 12-mo: rs = .22, p = 0.05). UIC of 
infants fed BM and FM (with or without CF/FF) and the number of daily breast-
feeds (total sample: rs = -.27, p = 0.08) or daily FM meals (total sample: rs = -
.07, p = 0.70) also did not correlate.  
However, the number of daily feeds does not necessarily correlate with the 
Results 
 
 
 
University of Vienna  Nadja Wüst 
 
137 
amount of BM or FM that was drunk, and iodine content in BM/FM varies 
between infants. Moreover, mothers just had to indicate average numbers of 
daily feeds, which most probably does not allow any causality of the correlations 
between UIC and daily feeds. 
 
4.4.3.7.5. Complementary and family food 
All 12-month-old infants already received CF. In the 6-mo group, there was no 
significant difference in UIC between infants who already received CF (n = 158, 
median (range) = 85.9 (10.9 – 763.1) μg/l) and those who did not (n = 21, 
median (range) = 114.7 (21.8 – 355.0) μg/l) (MWU, p = 0.083). 
Very few 6-month-old infants already consumed FF. In contrast, nearly all 12-
month-old infants already ate foods from the family table. Therefore, a 
comparison in UIC between infants eating FF and infants not eating FF was not 
done as it would be equal to comparing the age groups (see 4.3.3).  
Types of complementary/family food (CF/FF): 
There was no significant difference in UIC between users and non-users of the 
following CF/FF types: milk-cereal porridge/bottle with FM, milk-cereal 
porridge/bottle with cow milk, diluted cow milk (w/o cereals), undiluted cow milk 
(w/o cereals) (in both age groups); fruit-(cereal)-meals (w/o milk) (6-mo group). 
All p > 0.05 (detailed data not shown).  
In the 6-mo group, non-consumers of vegetable-carbohydrate-(meat)-meals 
(w/o milk) (n = 35, median (range) = 135.1 (21.8 – 763.1) μg/l) had a 61.4% 
higher median UIC than consumers (n = 144, median (range) = 83.0 (10.9 – 
745.0) μg/l). The difference in UIC was significant (MWU, p < 0.001). About one 
third of the non-consumers was breast-fed (no FM, n = 13, median UIC = 68.7 
μg/l), one third was formula-fed (no BM, n = 11, median UIC = 263.9 μg/l) and 
another third was breast- and formula-fed (n = 11, median UIC = 176.9 μg/l). All 
12-month-old infants ate vegetable meals. 
In the 12-mo group, there was a significant difference in UIC between 
consumers (n = 150, median (range) = 102.5 (6.4 – 504.0) μg/l) and non-
consumers (n = 8, median (range) = 170.4 (69.1 – 271.5) μg/l) of fruit-(cereal)-
meals (w/o milk) (p < 0.05).  
No significant correlation was found between UIC and number of daily meals in 
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any type of CF/FF (total sample and both age groups, all p > 0.05). 
The questions about the consumption of CF/FF were rather general and we did 
not know from the registration form if the amounts and types of CF/FF given to 
the infants varied much from day-to-day. Therefore, we did not go deeper into 
this data. Furthermore, the average number of meals of CF/FF consumed per 
day lay between one and two and therefore the contribution of each of those 
foods to the total iodine intake is probably rather small compared with BM or 
FM.  
For more detailed analyses, data from the dietary questionnaires would be 
required. 
 
4.4.3.8. Use of salt for infants 
Home-made meals 
As the subgroups in each age group were rather small for comparisons (see 
4.3.3, Table 26) we only looked at the total number of infants.  
Just looking at infants who received salt in home-made meals (n = 159), there 
was no significant difference in UIC between infants who received iodized salt 
(n = 125 (6-mo: n = 14, 12-mo: n = 111), median UIC = 112.0 μg/l), who 
received non-iodized salt (n = 9, median UIC = 67.3 μg/l) and for whom it was 
unclear which kind of salt they received (n = 25, median UIC = 94.7 μg/l) (K-W, 
p = 0.57).  
There was however, a significant difference in UIC between infants who 
received salt (any kind) in home-made meals (n = 159 (6-mo: n = 22, 12-mo: n 
= 137), median UIC = 103.7 μg/l) and infants who did not receive salt in home-
made meals (n = 147 (6-mo: n = 127, 12-mo: n = 20), median UIC = 75.4 μg/l) 
(MWU, p < 0.01). Examining both age groups separately, no difference in UIC 
was detected (MWU, both p > 0.05) although infants who did not receive salt 
showed a lower median UIC in both age groups (6-mo: salt: 110.8 μg/l, no salt: 
75.4 μg/l; 12-mo: salt: 103.7 μg/l, no salt: 75.8 μg/l). Infants who did not receive 
CF/FF (n = 21, median UIC = 114.7 μg/l) or home-made meals (n = 8, median 
UIC = 159.3 μg/l) were excluded from the comparison. Data were missing in 
four cases. 
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Ready meals 
There was no significant difference in UIC between infants (total sample) who 
received salt in ready meals (n = 59 (6-mo: n = 24, 12-mo: n = 35), median = 
105.1 μg/l), who did not receive salt in ready meals (n = 167 (6-mo: n = 93, 12-
mo: n = 74), median = 88.6 μg/l) and for whom it was unclear if they received 
salt (n = 13, median = 120.6 μg/l) (K-W, p = 0.28). Infants not receiving CF/FF 
(n = 21) or ready meals (n = 65) were excluded from the comparison. 
 
General salt use 
All except four 12-month-old infants received salt. Therefore, no comparison 
was made. In 6-month-old infants, UIC in infants who received salt (n = 39, 
median UIC = 91.6 μg/l), who did not receive salt (n = 132, median UIC = 86.5 
μg/l) and for whom it was unclear if they received salt (n = 8, median UIC = 
104.4 μg/l) did not significantly differ (K-W, p = 0.64). 
 
4.4.3.9. Social demographics of mothers 
Professional activity of mothers 
Professional activity of the mother had no significant influence on UIC of the 
infants (both age groups together, K-W, p = 0.34; see Table 38), also not when 
looking at age groups separately (data not shown). 
 
Table 38: Professional activity of mother and UIC of infants (total sample) 
Professional activity UIC of infants
 
 n 
a
 [μg/l] 
Full time (90-100%) 10 
116.2 
 (58.0, 200.0) 
b
 
Part time (20-80%) 146 
98.5 
(84.9, 111.2) 
By the hour 45 
78.7 
(54.9, 113.5) 
Not working 120 
92.1 
(71.2, 116.2) 
UIC = Urinary iodine concentration;  
a
 Missing data of n = 18 infants; 
b 
Median (95% CI) (all such values) 
 
Classification of mothers’ occupation 
There was no significant difference in UIC of infants between different 
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occupational categories of the mothers (total sample, K-W p = 0.07, and age 
groups separately, both n.s., detailed data not shown; for categories see Table 
28). As nearly 50% of the participating mothers had an occupation belonging to 
the “8. Health, education & culture, scientists” category, we examined if UIC in 
the infants of those mothers differed from UIC in infants of mothers from other 
categories (total sample and both age groups). A comparison showed no 
significant difference (total sample (n = 315, missing data of 24 infants), MWU, 
p = 0.34). Table 39 shows the medians. 
 
Table 39: Classification of mothers‟ occupations and UIC of infants (total sample) 
Classification of occupations UIC of infants 
 n 
a
 [μg/l] 
Health, education & culture, scientists 
(category 8) 
146 
89.7 b 
 (70.9, 104.7)
 
Other occupational category 169 
96.6 
(84.8, 111.9) 
UIC = Urinary iodine concentration  
a
 Missing data of n = 24 infants;
 b 
Median (95% CI) (all such values) 
 
Educational background of mother 
There was no significant difference in UIC between the infants of mothers with 
different educational background (all infants together (n = 315, missing data of 
24 infants), K-W, p = 0.24, and age groups separately, both p > 0.05). Table 40 
shows the medians. 
 
Table 40: Educational background of mother and UIC of infants (total sample) 
Educational background UIC of infants
 
 n 
a 
[μg/l] 
Compulsory school/secondary 
education level 
166 
97.5 b 
 (85.6, 114.4) 
Higher vocational education 77 
93.4 
(62.1, 111.6) 
University level 72 
85.7 
(62.9, 105.4) 
UIC = Urinary iodine concentration 
a
 Missing data of n = 24 infants; 
b  
Median (95% CI) (all such values) 
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4.4.4. Mothers - Overview 
An overview of the measured UICs of the mothers is given in Table 41.  
The UIC values of mothers were not normally distributed, but positively skewed 
(mean ± SD = 93.3 ± 60.2 μg/l; median = 81.1 μg/l). Figure 22 shows the 
distribution of UICs.  
 
Table 41: Overview of urinary iodine concentrations [μg/l] of mothers (total sample) 
 UIC 
a of mothers  
n 343 
Median [μg/l] 
81.1 
(74.3, 92.7) 
b
 
Minimum [μg/l] 6.4 
Maximum [μg/l] 403.0 
Percentiles [μg/l] 
2.5th 
25th 
50th 
75th 
97.5th 
13.0 (9.7, 18.8) c  
46.8 
81.1 
127.9 
237.0 (213.3, 310.1) c 
Prevalence of UIC  
<   20 μg/l 
 
<   50 μg/l 
 
< 100 μg/l 
 
≥ 100 μg/l  
 
≥ 300 μg/l 
 
% n 
5.8 
(3.4, 8.3) 
d 
26.5 
(21.9, 31.2) 
d 
58.0 
(52.8, 63.2) 
d 
42.0 
(36.8, 47.2) 
d 
1.2 
e
 
(20) 
 
(91) 
 
(199) 
 
(144) 
 
(4) 
 
a
 Abbreviation: UIC = Urinary iodine concentration 
b
 95% CI, calculated with SPSS 16 
c 
95% CI, calculation after (Campbell and Gardner, 1988) 
d 
95% CI, calculation: p ± 1.96 * √ p(1-p)/n; p = proportion of cases below/above the defined 
limit, n = sample size (Altman, 1999), p. 230. 
e 
Here the number of cases below/above the defined limit was too small for the used calculation 
for the 95% CI, see 
d
.  
 
Median (95% CI) UIC of mothers (n = 343) was 81.1 (74.3, 92.7) μg/l. UIC 
between mothers of both age groups (median (95% CI) 6-mo = 78.5 (68.4, 92.7) 
μg/l; 12-mo = 86.6 (74.3, 102.4) μg/l) showed no significant difference (MWU, p 
= 0.42). Therefore, data for all mothers together are given in Table 41. 
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The UICs ranged from 6.4 to 403.0 μg/l. The interquartile range was 81.0 μg/l 
(from 46.8 to 127.9 μg/l). 95% of all UICs lay between 13.0 and 237.0 μg/l.  
 
 
Figure 22: Distribution of urinary iodine concentrations (UIC) in mothers (n = 343) 
 
4.4.4.1. Lactation 
Table 42 gives an overview of UIC of non-lactating (n = 212) and lactating (n = 
131) mothers.  
The median UIC of non-lactating mothers was 34.3% higher than the median 
UIC of lactating mothers. The difference in UIC was significant (MWU, p < 0.01). 
The box plots are shown in Figure 23. 
The median UIC of non-lactating mothers (95.5 μg/l) was below 100 μg/l, which 
is the WHO cut-off for iodine sufficiency in SAC and adults (World Health 
Organization et al., 2007). 50.9% of the non-lactating mothers had a UIC below 
100 μg/l and 23.1% < 50 μg/l. According to WHO references, this would just 
indicate mild iodine deficiency (World Health Organization et al., 2007).   
In lactating mothers the median UIC (71.1 μg/l) was clearly below 100 μg/l. 
69.5% had a UIC < 100 μg/l, indicating mild ID (World Health Organization et 
al., 2007). Nearly one third of the lactating mothers had a UIC < 50 μg/l. 
Only four mothers in total had a UIC ≥ 300 μg/l (the cut-off for excessive iodine 
intake (World Health Organization et al., 2007)).  
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Table 42: UIC [μg/l] of non-lactating and lactating mothers 
 UIC of mothers Non-lactating Lactating 
n 212 131 
Median [μg/l] 1 
95.5 
(80.7, 106.1)
 a 
71.1 
(60.4, 79.9) 
a 
Minimum [μg/l] 9.7 6.4 
Maximum [μg/l] 403.0 305.4 
Percentiles [μg/l] 
2.5th 
25th 
50th 
75th 
97.5th 
13.5 
51.5 
95.5 
137.2 
267.1 
11.8 
41.4 
71.1 
110.5 
193.2 
Prevalence of UIC  
<   20 μg/l 
 
<   50 μg/l 
 
< 100 μg/l 
 
≥ 100 μg/l  
 
≥ 300 μg/l 
 
% n % n 
4.2 
 
(1.5, 7.0) 
b
 
23.1 
(17.4, 28.8) 
50.9 
(44.2, 57.7) 
49.1 
(42.3, 55.8) 
1.4 
c
 
(9) 
 
(49) 
 
(108) 
 
(104) 
 
(3) 
 
8.4 
 
(3.6, 13.1) 
b
 
32.1 
(24.1, 40.1) 
69.5
 
(61.6, 77.4) 
30.5 
(22.6, 38.4) 
0.8 
c
 
(11) 
 
(42) 
 
(91) 
 
(40) 
 
(1) 
 
Abbreviation: UIC = Urinary iodine concentration 
a  
Median (95% CI) 
b
 95% CI, calculation: p ± 1.96 * √ p(1-p)/n; p = proportion of cases below/above the defined 
limit, n = sample size (Altman, 1999), p. 230; (all such values in this section). 
c
 Here the number of cases below/above the defined limit was too small for the used calculation 
for the 95% CI, see 
b
.  
1
 Significant difference non-lactating vs. lactating (MWU, p < 0.01) 
 
The proportion of UIC < 100 μg/l and ≥ 100 μg/l was significantly different 
between non-lactating and lactating mothers (chi-square, p < 0.001) indicating 
that a significantly higher percentage of non-lactating mothers (49.1%) had a 
UIC ≥ 100 μg/l compared to lactating mothers (30.5%). Figure 24 shows these 
proportions. All other proportions were not significantly different from each 
other. 
 
The median UIC in lactating mothers of 6-month-old infants (n = 102, median 
(95% CI) = 66.4 (57.8, 79.1) μg/l) was lower, but not significantly different from 
the median UIC in lactating mothers of 12-month-old infants (n = 29, median 
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(95% CI) = 79.9 (65.9, 117.3) μg/l) (MWU, p = 0.30). In non-lactating mothers, 
UIC was also not significantly different between mothers of both age groups (6-
mo group: n = 78, median (95% CI) = 101.0 (80.7, 116.7) μg/l; 12-mo group: n = 
134, median (95% CI) = 91.9 (74.7, 107.1) μg/l) (MWU, p = 0.23).  
 
 
Figure 23: Box plots of urinary iodine concentration (UIC) [µg/l] of non-lactating (n = 
212) and lactating mothers (n = 131) (  MWU, p < 0.01) 
 
 
Figure 24: Proportion of urinary iodine concentrations (UIC) below/above 100 μg/l for 
non-lactating (n = 212) and lactating mothers (n = 131) (significant difference  in 
proportions, p < 0.001) 
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There was no significant correlation between UIC of lactating mothers and 
number of breastfeeds per day (rs = -.098, p = 0.26; data about breast-feeds 
from individual registration form). 
There was no significant difference in UIC comparing mothers who indicated a 
daily number of breastfeeds between 1 and 5 (n = 99; median (95% CI) = 72.7 
(65.9, 82.2) µg/l) with mothers who indicated between 6 and 10 breast-feeds 
per day (n = 32; median (95% CI) = 53.4 (40.6, 100.2) µg/l) (MWU, p = 0.20). 
However, there was a tendency for lower UICs in the mothers with the higher 
number of breastfeeds per day.  
Looking at UIC of exclusively/predominantly breastfeeding mothers (n = 11; 
median (95% CI) = 47.3 (16.7, 123.2) µg/l) and partially breastfeeding mothers 
(n = 120; median (95% CI) = 71.8 (64.0, 81.1) µg/l), no significant difference in 
UIC was detected either (MWU, p = 0.17). However, there was also a tendency 
for lower UICs in exclusively/predominantly breastfeeding mothers. Box plots 
are shown in Figure 25. 
 
 
Figure 25: Box plots of urinary iodine concentration (UIC) [µg/l] of 
exclusively/predominantly (n = 11) and partially breastfeeding mothers (n = 120) 
(MWU, p = 0.17) 
 
4.4.4.2. BMI 
There was a significant positive relationship between UIC [μg/l] and BMI [kg/m2] 
of mothers (rs = .15, p < 0.01).  
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Figure 26 shows the scatter plot of the correlation. 
 
Figure 26: Scatter plot of BMI and UIC of mothers (n = 336, missing data on BMI n = 7) 
(rs = .15, correlation p < 0.01)  
 
4.4.4.3. Nationality 
There was no significant difference between UIC of Swiss and foreign mothers 
(MWU, p = 0.29) (for medians see Table 43).  
40% of the Swiss mothers were lactating compared to 28% of the foreign 
mothers. Looking at lactating and non-lactating mothers separately, no 
significant differences were found comparing UIC of Swiss and foreign mothers 
in both groups (Lactating mothers: Swiss vs. foreign p = 0.82; Non-lactating 
mothers: Swiss vs. foreign p = 0.55; for medians see Table 43). 
 
Table 43: Urinary iodine concentration [μg/l] of Swiss and foreign mothers 
UIC of mothers Lactating Non-lactating Total
 
 n [μg/l] n [μg/l] n [μg/l] 
Swiss 1 116 
69.3 
(58.5, 80.1)
 a
 
 174 
97.5 
(75.4, 108.7) 
290 
79.4 
(69.5, 94.8)
 
Foreign nationality 15 
77.3 
(41.3, 102.7) 
38 
94.1 
(77.6, 111.9) 
53 
88.3 
(74.3, 92.7)
 
Abbreviation: UIC = urinary iodine concentration 
 
a  
Median (95% CI), all such values 
1
 Significant difference lactating vs. non-lactating (p < 0.05) 
 
In Swiss mothers, non-lactating women had a 41% higher median UIC 
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compared to lactating women. The difference in UIC was significant (MWU, p < 
0.05, see Table 43). In foreign mothers, there was also a trend of higher UICs in 
non-lactating mothers compared to lactating mothers, but the difference in UIC 
was not significant (MWU, p = 0.08). 
 
4.4.4.4. Pediatric practice/region 
The median (range) UIC of mothers in each pediatric practice is given in 
Appendix 17. There was no significant difference in UIC of mothers between 
pediatric practices (K-W, p = 0.12). Median UICs of practices ranged from 50.6 
to 146.2 μg/l. 
 
Table 44 lists the median (range) UICs [μg/l] of mothers in the seven Swiss 
regions. A comparison between the regions did not show a significant difference 
in UIC of mothers (K-W, p = 0.27). Box plots of UIC [µg/l] of mothers in each 
greater Swiss region are shown in Figure 27. Lake Geneva region and Ticino 
had a tendency for lower respectively higher UICs than the other regions, but 
their sample sizes were very small (n = 4 respectively 18) for comparisons. 
 
Table 44: Urinary iodine concentration [μg/l] of mothers in the seven Swiss regions 
 UIC of mothers 
Regions n [μg/l] 
Lake Geneva region (1) a 4 
50.6 
(16.7 – 143.7) 
b 
Espace Mittelland (2) 35 
94.8 
(16.6 – 310.1) 
Northwestern Switzerland (3) 58 
83.3 
(6.4 – 403.0) 
Zurich (4) 46 
88.2 
(20.5 – 232.5) 
Eastern Switzerland (5) 92 
71.7 
(9.1 – 312.1) 
Central Switzerland (6) 90 
80.9 
(11.0 – 213.3) 
Ticino (7) 18 
104.8 
(64.3 – 142.7) 
TOTAL 343 
81.1 
(6.4 – 403.0) 
Abbreviation: UIC = urinary iodine concentration 
a
 Numbers in brackets correspond to the numbers in the box plot figure 
b 
Median (range) (all such values) 
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Figure 27: Box plots of urinary iodine concentration (UIC) [µg/l] of mothers in each 
greater Swiss region (K-W, p = 0.27) 
Legend: The names of the regions (numbers in brackets) and [n] per region can be 
found in Table 44  
 
4.4.4.5. Urban – rural area of pediatric practice 
There was no difference in maternal UIC between samples collected from 
pediatric practices in urban and rural areas (MWU, p = 0.94; median UIC urban 
areas = 81.1 μg/l (n = 291); median UIC rural areas = 85.8 μg/l (n = 52)).  
UIC of mothers in urban areas also did not differ significantly from rural areas, 
when non-lactating (urban: n = 179, median UIC = 95.0 μg/l; rural: n = 33, 
median UIC = 100.3 μg/l) and lactating mothers (urban: n = 112, median UIC = 
71.8 μg/l; rural: n = 19, median UIC = 62.6 μg/l) were analyzed separately 
(MWU, p = 0.63 respectively p = 0.66).  
Pediatric practices in rural areas were located only in Espace Mittelland and 
Eastern Switzerland (see Table 19). Therefore, we analyzed these regions 
separately. UIC of mothers from practices in urban areas was not significantly 
different from practices in rural areas in both regions (MWU, Espace Mittelland: 
p = 0.27 and Eastern Switzerland: p = 0.96). 
 
4.4.4.6. Month of study registration/sample collection 
Table 45 lists median (range) UIC of mothers by month of sample collection (= 
month of registration for study) and Figure 28 shows the box plots.  
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Table 45: UIC of mothers [μg/l] by month of registration/sample collection (n = 343) 
 UIC of mothers 
Month n 
 
[μg/l] 
Aug „08 
12
 a
 
(9 / 3)
 
 
69.0 
(32.6 – 305.4) 
b 
Sept „08 
60 
(38 / 22) 
75.3 
(10.1 – 312.1) 
Oct „08 
61 
(37 / 24) 
99.5 
(11.1 – 289.5) 
Nov „08 
55 
(34 / 21) 
77.3 
(9.7 – 310.1) 
Dec „08 
51 
(26 / 25) 
86.1 
(6.4 – 244.4) 
Jan „09 
25 
(16 / 9) 
108.7 
(16.6 – 232.5) 
Feb „09 
25 
(17 / 8) 
86.9 
(18.6 – 230.7) 
March „09 
44 
(25 / 19) 
61.3 
(12.2 – 403.0) 
April „09 7 
c
 
64.1 
(20.2 – 155.2) 
May „09 3 
c
 
149.4 
(71.9 – 191.4) 
Abbreviation: UIC = urinary iodine concentration 
a
 All mothers (non-lactating/lactating) (all such values) 
b 
Median (range) (all such values); 
c No lactating mothers in this month 
 
 
Figure 28: Box plots of urinary iodine concentration (UIC) [μg/l] of mothers (n = 343) by 
month of study registration/sample collection (K-W, p = 0.3) 
Legend: Numbers in x-axis = months 8/2008 – 12/2008, 1/2009 – 5/2009; n per month see 
 Table 45 
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No significant difference in UIC of mothers was detected between the months of 
sample collection (K-W, p = 0.31). The lowest median UIC was found in March 
‟09 (61.3 μg/l, n = 44) and the highest in May ‟09 (149.4 μg/l, n = 3) (Table 45). 
 
4.4.4.7. Supplements 
No significant difference was found in UIC comparing mothers who took an 
iodine-containing supplement, those who did not take any iodine-containing 
supplement (incl. mothers not taking any supplements at all) and those who 
took a supplement where it was unclear if it contained iodine (K-W, p = 0.81). 
Table 46 shows the medians.  
However, the number of mothers taking an iodine-containing supplement was 
very small for a comparison (n = 13, of which 5 lactating and 8 non-lactating). 
 
Table 46: Use of supplement and UIC [μg/l] of mothers 
Supplements UIC of mothers 
 n 
a
 [μg/l] 
Taking an iodine-containing 
supplement 
13
 b
 
(8 / 5)  
66.8 
(29.0 – 403.0) 
c 
Unclear if supplement contained 
iodine 
15 
(9 / 6) 
78.2 
(24.7 – 173.2) 
Not taking any iodine-containing 
supplement/no supplement 
312 
(193 / 
119) 
81.6 
(6.4 – 312.1) 
Abbreviation: UIC = urinary iodine concentration  
a
 Missing data of 3 mothers 
b
 All mothers (non-lactating/lactating) (all such values) 
c 
Median (range) (all such values) 
 
4.4.4.8. Iodized salt 
There was no significant difference in UIC between mothers using iodized salt, 
not using iodized salt and mothers who indicated not knowing if they used 
iodized salt (K-W, p = 0.35). However, median UIC of mothers answering 
“unknown” was about 40 – 50% higher compared to the other two groups. 
Nevertheless, interquartile ranges (IQR) of all three groups were very close to 
each other and the number of mothers with answers “no” or “unknown” was 
rather small for comparison. Table 47 gives medians and IQRs.  
83% of the non-lactating mothers (n = 177) and 90% of the lactating mothers (n 
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= 118) answered “yes”. Numbers of mothers answering “no” or “unknown” were 
equally distributed in non-lactating and lactating mothers (see Table 47). 
 
Table 47: Use of iodized salt and UIC of mothers [μg/l] 
Use of iodized salt UIC of mothers 
 n 
a
 [μg/l] IQR 
Yes 295 
b 
(177 / 118) 
 
80.7 
 (6.4 – 403.0) 
c 46.8 – 126.7 
No 20 
(14 / 6) 
75.7 
(10.0 – 289.5) 
39.1 – 131.8 
Unknown 25 
(19 / 6) 
113.8 
(19.3 – 230.7) 
49.9 – 144.1 
Abbreviations: UIC = urinary iodine concentration; IQR = interquartile range 
a
 Missing data of 3 mothers 
b
 All mothers (non-lactating/lactating) (all such values) 
c 
Median (range) (all such values) 
 
4.4.4.9. Social demographics 
Smoking 
There was no difference in UIC between smokers and non-smokers (MWU, p = 
0.69). Medians are shown in Table 48. 
 
Table 48: Smoking and UIC [μg/l] of mothers 
Smoking UIC of mothers 
 n 
a
 [μg/l] 
Yes 
30 b 
(25 / 5)
 
81.0 
 (28.4 – 224.6) 
c 
No 
293 
(171 / 122) 
81.1 
(6.4 – 403.0) 
Abbreviation: UIC = urinary iodine concentration  
a
 Missing data of 20 mothers (of which 4 lactating)
 
b
 all mothers (non-lactating/lactating) (all such values); 
c 
Median (range) (all such values) 
 
Professional activity 
No significant difference in UIC was detected comparing professional activity of 
mothers (full time, part time, by the hour, not working) (K-W, p = 0.46).  
As we saw no reason why professional activity should influence the mothers‟ 
UIC, we did not examine this association in more detail.  
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Classification of occupation 
There was no significant difference in UIC between different occupational 
categories of the mothers (K-W, p = 0.23, detailed data not shown).  
Almost 50% of participating mothers had an occupation belonging to the “8. 
Health, education & culture, scientists” category. Therefore, we examined if UIC 
of those mothers was different from mothers belonging to the other categories 
(all together, see Table 49). Comparison showed a significantly lower median 
UIC in mothers belonging to the occupation category “Health, education & 
culture, scientists” (MWU, p < 0.05). The percentage of lactating mothers 
compared to non-lactating mothers was 47% in the category 8 and only 34% in 
the other occupational categories. Analyzing lactating and non-lactating 
mothers separately, there was no significant difference in UIC between category 
8 and other categories in non-lactating mothers (p = 0.45, median cat. 8 = 88.1 
μg/l; median other cat.: 101.2 μg/l), but there was a significance in lactating 
mothers (p = 0.0496, median cat. 8 = 65.1 μg/l; median other cat. = 77.3 μg/l) 
(for numbers see Table 49). 
 
Table 49: Classification of mothers‟ occupations and UIC of mothers [μg/l] 
Classification of occupations UIC of mothers 
1 
 n 
a
 [μg/l] 
Health, education & culture, scientists 
(category 8) 
148
 b
 
(79 / 69) 
 
74.3 
 (64.1, 85.3) 
c 
Other occupational category 
170 
(113 / 57)  
94.7 
(77.4, 105.8) 
Abbreviation: UIC = urinary iodine concentration
 
a
 Missing data of 25 mothers (of which 5 lactating)
 
b
 All mothers (non-lactating/lactating) (all such values) 
c 
Median (95% CI) (all such values) 
1 
Significant difference between categories (MWU, p < 0.05) 
 
Educational background of mothers 
There was no significant difference in UIC between mothers with different 
educational background (K-W, all mothers: p = 0.092; non-lactating: p = 0.47; 
lactating: p = 0.57). Table 50 shows the medians (all mothers). 
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Table 50: Educational background of mothers and UIC of mothers [μg/l] 
Educational background UIC of mothers
 
 n 
a 
[μg/l] 
Compulsory school/secondary 
education level 
166 b 
(111 / 55) 
 
88.4 
 (75.7, 106.1) 
c
 
Higher vocational education 
79 
(48 / 31) 
75.9 
(64.4, 100.3) 
University level 
73 
(33 / 40) 
76.0 
(59.0, 92.5) 
Abbreviation: UIC = urinary iodine concentration
  
a
 Missing data of 25 mothers (of which 5 lactating)
 
b
 all mothers (non-lactating/lactating) (all such values) 
c 
Median (95% CI) (all such values) 
 
4.4.4.10. UIC of breast-fed infants and UIC of mothers 
There was no correlation between the UIC of breast-fed infants (n = 131) and 
the UIC of their mothers (rs = .024, p = 0.78). 
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4.4.5. Quality control of Sandell-Kolthoff method 
4.4.5.1. Measurement repeats 
Eight percent (infants n = 19, mothers n = 34) of the samples had to be 
measured twice because the difference of the duplicate was greater than the 
allowed difference (see methods). Of these, six had to be measured a third time 
and one a fourth time (always in duplicate).  
As control, another eight percent of the samples (infants n = 18, mothers n = 
38) were measured twice even if the first measurement was acceptable (both 
measurements in duplicate). In this case, the average UIC of both 
measurements was taken for data analysis. 
 
4.4.5.2. Internal quality control 
The intra- and inter-assay precision tests of the method showed good results. 
The results are given in Table 51, which also shows the results of the validation 
of the X and Z controls with ICP-MS. The ICP-MS validation showed good 
agreement with the Sandell-Kolthoff values. 
 
Table 51: Intra-/inter-assay precision of modified S-K method and ICP-MS validation 
 
Intra-assay 
precision 
S-K 
(n = 12) a 
Inter-assay precision S-K 
ICP-MS validation 
(intra-assay precision) 
X – 
reference b 
(n = 37) 
Z – 
reference c 
(n = 37) 
X – 
reference 
(n = 3) 
Z – 
reference 
(n = 3) 
Mean [μg/l] 104.9 ± 3.3 d 33.1 ± 2.1 214.9 ± 6.6 31.2 ± 0.8 211.4 ± 1.5 
CV [%] 3.2 6.4 3.1 2.7 0.7 
Abbreviations: S-K = Sandell-Kolthoff method; ICP-MS = inductively coupled plasma mass 
spectrometry; CV = coefficient of variation 
a 
Spot urine sample of NW 
b/c
 Laboratory reference values: X = 34.1±3.34 μg/l (CV% 9.80); Z = 218±7.05 μg/l (CV% 3.24) 
d 
mean ± SD (all such values) 
 
Two plates with urine samples of mothers had to be excluded because in one 
case the X-reference was above the allowed limit and in the other case the 
standard curve was below R = 0.99. All of these samples were measured again. 
 
4.4.5.3. External quality control 
The four EQUIP urine control specimens were measured in three different runs 
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in duplicate on three different days. All measured means were within the 
acceptable range (defined by EQUIP) with a slight drift towards the lower end of 
the range with increasing iodine concentration. This drift could have been due to 
several reasons and should be considered in future experiments. As all EQUIP 
results were in the acceptable range, the results of the urinary iodine analysis 
can be considered as accepted. Table 52 lists the EQUIP results and Figure 29 
shows the regression of the measured UICs for EQUIP at ETH and the CDC 
target values. 
 
Table 52: Results EQUIP round 21 
EQUIP 
round 21 
Urine specimen 
060489 060439 060404 060414 
UIC, ETH [μg/l] 17.7 ± 2.0 
a 
68.1 ± 1.1 122.7 ± 1.7 406.0 ± 1.8 
CV,  ETH [%] 10.6 2.5 1.8 1.7 
Mean  
all labs 
b
 [μg/l] 
18.8 ± 6.5 68.7 ± 11.5 134.1± 22.5 428.7 ± 48.9 
CDC target 
value [μg/l] 
19.9 
(13.9-25.9) 
c 
73.4  
(55.0-91.7) 
136.3  
(109.0-163.6) 
438.5  
(372.7-504.3) 
% Error  
(measured vs. 
CDC target) 
-11.1 -7.2 -10.0 -7.4 
Abbreviations: ETH = Federal Institute of Technology, Zurich; UIC = urinary iodine concentration;  
CV = coefficient of variation (%); CDC = Center for disease control 
a
 Mean ± SD (all such values) 
b
 All labs which participated at the current EQUIP round 
c
 CDC target value (acceptable range) 
 
 
Figure 29: Regression of urinary iodine concentration ETH (Lab#E-017) and CDC 
target values [μg/l] 
Legend:  
Solid line = line of identity 
Dashed line = linear regression of ETH values 
Error bars = acceptable range 
Black circles = measured values at ETH (individual 
points) 
Center of large circle = mean of ETH data 
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4.5. Breast milk iodine concentration 
4.5.1. Sample collection 
The BM samples included in this thesis were collected between mid August 
2008 and end of March 2009 (date of study registration). The numbers of 
included samples per month were (BM total n = 119): Aug ‟08 n = 3, Sept ‟08 n 
= 18, Oct ‟08 n = 23, Nov ‟08 n = 19, Dec ‟08 n = 23, Jan ‟09 n = 9, Feb ‟09 n = 
6, Mar ‟09 n = 18.  
All BM samples were collected at home, by which collection technique is not 
known. 
Some of the BM samples showed coagulations when they arrived at ETH, 
therefore those were treated in a special way before storage and analysis (see 
respective chapters). 
 
4.5.2. Overview of breast milk iodine concentration 
An overview of the measured breast milk iodine concentrations (BMIC) in total 
and by age group of infants is given in Table 53.  
The overall median BMIC was 51.2 μg/kg (n = 119). As breast milk was 
weighed and pipetted for the measurement, BMIC was available as μg/kg and 
μg/l (see 1 and 2 in Table 53). Weighing the samples on the analytical scale 
was more precise than pipetting; therefore, BMIC in μg/kg was used for 
comparisons. BMIC [μg/kg] multiplied with the specific density (1.031 kg/l) of 
breast milk (Neville and Jensen, 1995) is also a possible way of transforming 
BMIC to the unit μg/l (see 3 in Table 53). As the specific gravity of BM is close 
to the one of water (0.998 kg/l), all three medians were very close to each other. 
Figure 30 shows the distribution of the BMICs [µg/kg] (n = 119). The BMICs 
were not normally distributed (K-S test), but skewed to the right (mean ± SD = 
56.6 ± 28.7 μg/kg; median = 51.2 μg/kg). 
The median BMIC of mothers of 6-month-old infants (53.3 µg/kg) was 26% 
higher than that of mothers of 12-month-old infants (42.3 µg/kg). Nevertheless, 
there was no significant difference in BMIC between the two age groups (MWU, 
p = 0.29, see also Figure 31). There was also no significant correlation between 
BMIC and age of infant [months] (rs = -.086, p = 0.35). However, the sample 
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size of BM in the 12-mo group was very small (n = 24) compared with the 6-mo 
group (n = 95). Therefore, further analysis of BMIC was done for both age 
groups together. 
Even though the sample size of BMIC was much smaller (n = 119) compared 
with maternal UIC (n = 343), the BMIC range was much narrower (10.7 – 147.7 
µg/kg). 95% of all BMICs lay between 18.0 and 128.2 µg/kg. 
The major part of the samples (89.1%) had an iodine concentration < 100 µg/kg 
and nearly half of the samples (47.9%) had a concentration < 50 µg/kg. 
 
Table 53: Overview of breast milk iodine concentrations  
BMIC a 
Age group of infants 
Total 
6-mo 12-mo 
n 95 24 119 
1) Median [μg/kg] 
53.3  
(45.1, 59.8)
 b
 
42.3 
(35.6, 62.2) 
b 
51.2 
(44.3, 58.9) 
b 
Minimum [μg/kg] 10.7 19.6 10.7 
Maximum [μg/kg] 147.7 127.1 147.7 
Percentiles [μg/kg] 
2.5th 
25th 
50th 
75th 
97.5th 
16.5 
38.2 
53.3 
68.9 
138.3 
19.6 
33.0 
42.3 
62.2 
127.1 
18.0 
37.2 
51.2 
68.4 
128.2 
Prevalence of BMIC 
<   20 μg/l 
<   50 μg/l 
< 100 μg/l 
≥ 100 μg/l  
% (n) % (n) % (n) 
5.3 
46.3 
89.5 
10.5 
(5) 
(44) 
(85) 
(10) 
4.2 
54.2 
87.5 
12.5 
(1) 
(13) 
(21) 
(3) 
5.0 
47.9 
89.1 
10.9 
(6) 
(57) 
(106) 
(13) 
2) Median BMIC [μg/l] 56.2 44.0 53.9 
3) Median (BMIC [μg/kg] * 
specific gravity) [μg/l] 
55.0 43.6 52.8 
a
 Abbreviation: BMIC = Breast milk iodine concentration 
b
 95% CI, calculated with SPSS 16 
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Figure 30: Distribution of breast milk iodine concentrations (n = 119) 
 
 
Figure 31: Box plots of breast milk iodine concentration (BMIC) [µg/kg] by infant age 
group (6-mo: n = 95, 12-mo: n = 24; MWU, p = 0.3) 
 
4.5.2.1. Body weight & BMI 
No significant correlations were found between BMIC and body weight of 
mothers (rs = -.031, p = 0.75) and between BMIC and BMI of mothers (rs = -
.085, p = 0.36). 
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4.5.2.2. Nationality 
Only 10% (n = 12) of the BM samples came from mothers with foreign 
nationality and 90% (n = 107) from Swiss mothers. No significant difference was 
detected comparing BMIC of Swiss mothers (n = 107, median (range) = 53.3 
(10.7 – 147.7) µg/kg) to that of foreign mothers (n = 12, median (range) = 41.2 
(19.6 – 112.3) µg/kg) (MWU, p = 0.72). The number of foreign mothers was 
very small for a comparison. 
 
4.5.2.3. Pediatric practice/region 
The median (range) BMIC in each pediatric practice can be found in Appendix 
18. There was no significant difference in BMIC between pediatric practices (K-
W, p = 0.60). Median BMICs of practices ranged from 31.3 to 64.6 μg/kg. 
 
Table 54: BMIC [μg/kg] arranged by the seven Swiss regions 
  BMIC 
Regions n [μg/kg] 
Lake Geneva region (1) a 2 
58.8 
(57.8 – 59.8) 
b 
Espace Mittelland (2) 16 
50.5 
(18.5 – 112.3) 
Northwestern Switzerland (3) 17 
55.3 
(18.6 – 147.7) 
Zurich (4) 12 
44.1 
(10.7 – 74.3) 
Eastern Switzerland (5) 32 
52.3 
 (15.5 – 128.2) 
Central Switzerland (6) 35 
49.5 
(21.2 – 123.5) 
Ticino (7) 5 
64.6 
(24.9 – 145.1) 
TOTAL 119 
51.2 
(10.7 – 147.7) 
Abbreviation: BMIC = breast milk iodine concentration 
a
 Numbers in brackets correspond to the numbers in the box plot figure 
b 
Median (range) (all such values) 
 
No significant difference was detected comparing BMIC between the seven 
Swiss regions (K-W, p = 0.45, medians shown in Table 54), also not if the 
regions 1 and 7 were excluded from the comparison due to their very small 
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sample size (n = 2 resp. 5) (K-W, p = 0.38). The median BMICs of the regions 
ranged from 44.1 µg/kg (Zurich) to 64.6 µg/kg (Ticino). The median BMICs in 
the seven regions are given in Table 54 and box plots are shown in Figure 32. 
 
 
Figure 32: Box plots of breast milk iodine concentration (BMIC) [µg/kg] by the greater 
Swiss regions (K-W, p = 0.45) 
Legend: The names of the regions and n per region are given in Table 54, see 
numbers in brackets 
 
4.5.2.4. Urban – rural area of pediatric practice 
The median BMIC from samples collected in urban areas was 34% higher 
compared to the median BMIC from samples collected in rural areas (urban 
areas: median (95% CI) BMIC = 55.9 (45.1, 60.0) μg/kg, n = 100; rural areas: 
median BMIC = 41.8 (29.6, 56.8) μg/kg, n = 19). The difference in BMIC was 
significant (MWU, p < 0.05).  
Pediatric practices in rural areas were located only in Espace Mittelland and 
Eastern Switzerland (see Table 19). If only these regions were examined, there 
was no significant difference in BMIC between mothers from practices in urban 
and rural areas in both regions (MWU, Espace Mittelland: p = 0.27 (urban: 
median BMIC = 56.7 μg/kg, n = 7; rural: median BMIC = 44.1 μg/kg, n = 9); 
Eastern Switzerland: p = 0.14 (urban: median BMIC = 57.7 μg/kg, n = 22; rural: 
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median BMIC = 37.1 μg/kg, n = 10)). 
 
4.5.2.5. Month of study registration/sample collection 
Table 55 lists the median (range) BMICs by month of sample collection (= 
month of registration for study) and Figure 33 shows the box plots. 
BMIC did not differ significantly between different months of sample collection 
(K-W, p = 0.76). The lowest median BMIC was measured in November ‟08 (44.1 
μg/kg, n = 19) and the highest in August ‟08 (63.1 μg/kg, n = 3). 
 
Table 55: BMIC [μg/kg] by month of study registration/sample collection (n = 119) 
  BMIC 
Month n
 
[μg/kg] 
Aug „08 3 
63.1 
(55.3 – 68.8) 
a 
Sept „08 18 
47.8 
(15.5 – 127.1) 
Oct „08 23 
56.8 
(10.7 – 108.3) 
Nov „08 19 
44.1 
(21.8 – 81.4) 
Dec „08 23 
49.5 
(18.6 – 128.2) 
Jan „09 9 
56.8 
(19.6 – 147.7) 
Feb „09 6 
60.7 
(18.5 – 145.1) 
March „09 18 
56.2 
(18.0 – 123.5) 
April „09 0 -- 
May „09 0 -- 
Abbreviation: BMIC = breast milk iodine concentration  
a
 Median (range) (all such values) 
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Figure 33: Box plots of breast milk iodine concentration (BMIC) [μg/kg] (n = 119) by 
month of study registration/sample collection (K-W, p = 0.8) 
Legend: Numbers in x-axis = months 8/2008 – 12/2008, 1/2009 – 3/2009; n per month 
 are given in Table 55 
 
4.5.2.6. Breast feeding practice 
There was no difference in BMIC between mothers who breast-fed 
exclusively/predominantly and mothers who breast-fed partially (MWU, p = 
0.17). Table 56 shows the medians. However, the number of mothers who 
breast-fed exclusively/predominantly was very small for comparison (n = 11). 
 
Table 56: BMIC [μg/kg] by breast feeding practice 
Breast feeding  BMIC [μg/kg] 
 n Median  Min Max 
Exclusive/predominant 11 
51.2 
 (41.7, 72.2) 
a 37.3 115.9 
Partial 108 
52.1 
(43.7, 58.9) 
10.7 147.7 
Abbreviation: BMIC = breast milk iodine concentration 
a 
Median (95% CI) (all such values) 
 
A significant positive correlation was observed between BMIC and number of 
daily breast-feeds (data from individual registration form) (rs = .24, p < 0.01). A 
scatter plot of the correlation is shown in Figure 34. 
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Figure 34: Scatter plot of breast milk iodine concentration [μg/kg] and number of daily 
breast-feeds (n = 119) (p < 0.01) 
 
4.5.2.7. Supplements  
Only 3% (n = 4) of mothers who provided a breast milk sample were taking an 
iodine-containing supplement. This percentage was very small for a 
comparison. The median BMIC of mothers taking an iodine-containing 
supplement was about 48% higher compared to the median BMIC of mothers 
not taking an iodine-containing supplement, but the range was very wide (27.0 - 
145.1 μg/kg). Table 57 gives the medians and Figure 35 shows the box plots.  
 
Table 57: Use of supplements by lactating mothers and their BMIC [μg/kg] 
Supplements  BMIC 
 n 
a
 [μg/kg] 
Taking an iodine-containing 
supplement 
4 
75.0 
(27.0, 145.1) 
b 
Unclear if supplement contains 
iodine 
5 
51.2 
(10.7, 147.7) 
Not taking any iodine-containing 
supplement/no supplement 
109 
50.8 
(43.7, 57.9) 
Abbreviation: BMIC = breast milk iodine concentration  
a 
Missing data of one mother 
b 
Median (95% CI) (all such values) 
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Figure 35: Box plots of maternal supplement intake and breast milk iodine 
concentration (BMIC) [μg/kg]: iodine-containing (n = 4), unclear if iodine-containing     
(n = 5), not iodine-containing/no supplement intake (n = 109) (K-W, p = 0.4) 
 
No significant difference was found in BMIC comparing lactating mothers who 
took an iodine-containing supplement, those who did not take any iodine-
containing supplement (incl. mothers not taking a supplement at all) and those 
who took a supplement where it was unclear if it contained iodine (K-W, p = 
0.44; medians are given in Table 57). 
 
4.5.2.8. Iodized salt 
Ninety-one percent of mothers who provided a BM sample indicated using 
iodized salt at home. The number of mothers answering “no” or “unknown” was 
therefore very small for comparison of UIC (see Table 58). 
Table 58 shows the median BMICs of the different groups of salt users. The 
median BMIC of mothers who did not use iodized salt was 28.5% lower 
compared to mothers who used iodized salt (MWU, p = 0.28). The median 
BMIC of mothers who did not know if they used iodized salt or not was in 
between the other groups. However, there was no significant difference in BMIC 
among the three groups (K-W, p = 0.56).  
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Table 58: Use of iodized salt and BMIC [μg/kg] 
Use of iodized salt  BMIC 
 n 
a 
[μg/kg] 
Yes 107 
53.3 
 (10.7 – 147.7) 
b 
No 6 
38.1 
(25.9 – 80.5) 
Unknown 5 
44.1 
(21.8 – 115.9) 
Abbreviation: BMIC = breast milk iodine concentration 
a 
Missing data of one mother 
b 
Median (range) (all such values) 
 
4.5.2.9. Social demographics 
Smoking 
The median BMIC of smoking mothers was 50% lower compared to non-
smokers. Table 59 shows the medians. However, as just four mothers indicated 
that they smoked this number was very small for comparison. The BMIC values 
were 10.7, 18.5, 37.2, 115.9 μg/kg. There was no significant difference in BMIC 
between smokers and non-smokers (MWU, p = 0.18). 
 
Table 59: Smoking and BMIC [μg/kg] of mothers 
Smoking  BMIC 
 n 
a
 [μg/kg] 
Yes 4 
27.8  
 (10.7 – 115.9)
 b 
No 110 
54.3 
(15.5 – 147.7) 
Abbreviation: BMIC = breast milk iodine concentration 
a
 Missing data of 5 mothers 
b 
Median (range) (all such values) 
 
Professional activity 
No significant difference in BMIC was found when comparing professional 
activity of mothers (full time, part time, by the hour, not working) (K-W, p = 
0.094). As we saw no reason why professional activity should influence the 
mother‟s BMIC, we did not look at this in more detail.  
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Classification of occupation 
There was no significant difference in BMIC between different occupational 
categories of the mothers (K-W, p = 0.43, detailed data not shown). Fifty-five 
percent (n = 63) of BM samples were provided from mothers with an occupation 
belonging to the category “8. Health, education & culture, scientists”. Therefore, 
we examined if median BMIC of those mothers was different compared with 
mothers from other categories. Comparison showed no significant difference in 
BMIC between mothers belonging to the occupation category “Health, 
education & culture, scientists” and the other categories (MWU, p = 0.34). 
Medians are given in Table 60.  
 
Table 60: Classification of mothers‟ occupations and BMIC [μg/kg] 
Classification of occupations  BMIC 
 n 
a
 [μg/kg] 
Health, education & culture, scientists 
(category 8) 
63  
51.2  
 (43.2, 57.9)
 b 
Other occupational category 51 
56.7 
(42.5, 62.2) 
Abbreviation: BMIC = breast milk iodine concentration 
a
 Missing data of 5 mothers; 
b 
Median (95% CI) (all such values) 
 
Educational background 
BMIC did not differ significantly between mothers with different educational 
background (K-W, p = 0.47). Table 61 shows the medians. Even though the 
median BMIC of mothers with a compulsory school/secondary educational level 
was around 20% lower compared to the two higher education levels, IQR was 
rather similar in all groups (see Table 61). 
 
Table 61: Educational background of mother and BMIC [μg/kg] 
Educational background  BMIC
 
 n 
a 
[μg/kg] IQR 
Compulsory school/secondary 
education level 
50 
44.7  
 (40.2, 60.0)
 b
 
35.7 – 64.7 
Higher vocational education 26 
59.2 
(40.0, 74.3) 
34.7 – 79.9 
University level 38 
54.3 
(44.1, 61.2) 
38.8 – 66.1 
Abbreviations: BMIC = breast milk iodine concentration; IQR = interquartile range 
a
 Missing data of 5 mothers; 
b 
Median (95% CI) (all such values) 
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4.5.2.10. Maternal UIC and BMIC 
No correlation was detected between maternal UIC and BMIC (rs = -.062, p = 
0.50 (n = 119); exclusive/predom. BF: rs = .036, p = 0.92 (n = 11); partial BF: rs 
= -.058, p = 0.55 (n = 108)). 
 
4.5.2.11. UIC of breast-fed infants and BMIC 
A significant positive correlation was found between UIC of breast-fed infants 
and BMIC (rs = .22, p < 0.05, n = 119). The correlation was even stronger when 
log transforming UIC of infants and BMIC (rs = .25, p < 0.01). 
This significant correlation also existed if only partially breast-fed infants were 
examined (rs = .21, p < 0.05, n = 108). For exclusively/predominantly breast-fed 
infants (n = 11) a positive correlation was observed as well, but it was not 
significant (rs = .27, p = 0.42). Figure 36 shows the correlations. 
Examining both infant age groups separately, the correlation was significant for 
the 6-month-old infants (rs = .23, p < 0.05, n = 95), but not for the 12-month-old 
infants (rs = .39, p = 0.062, n = 24). 
 
 
Figure 36: Scatter plot of breast milk iodine concentration (BMIC) [μg/kg] and urinary 
iodine concentration (UIC) of infants [μg/l] (total n = 119, excl./predom. BF n = 11, 
partial BF n = 108) (BF = breast feeding) 
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4.5.3. Limit of detection & limit of quantification of ICP-MS 
The average ± SD of spike ratios ((127I/129I)Spike) was 0.1518 ± 0.0044 (n = 54, 
measured in spike ratio solutions). Based on this value the RLOD was > 0.1651 
and the RLOQ was > 0.1960. The usual sample weight per 12ml-tube was about 
0.31 g. Therefore, the LOD for iodine with ICP-MS was ~ 1.5 μg/kg and the 
LOQ was ~ 4.9 μg/kg. All BM samples had a higher iodine concentration than 
the LOQ (minimal BMIC was 10.7 μg/kg). 
 
4.5.4. Quality control of ICP-MS 
4.5.4.1. Blank 
At m/z 127 no elevated blank levels were measured. The signal intensities 
corresponded to the basic instrumental noise. Blank variations introduced by 
memory effects (e.g. due to contamination) were not observed.  
At m/z 129 the blank intensities were higher by at least a factor of 4.5. This was 
accredited to the interference by 129Xe which was however expected. Xenon is 
found as a trace contaminant in the plasma gas argon (Haldimann et al., 2000). 
It has, however, no influence on the iodine measurement as the interference is 
the same in blank, samples and spike ratio solution. 
The measured blank levels were as expected. Therefore, they showed that the 
materials and chemicals used for the analysis were not contaminated with 
iodine. 
 
4.5.4.2. Whole milk reference 
The measured iodine concentrations [mg/kg] of the whole milk reference 
samples are shown in Figure 37. The mean ± SD of all measured reference 
samples (n = 18) in seven runs was 2.37 ± 0.15 mg/kg powder (= 237 ± 15 
μg/100 g). The values ranged from 1.98 to 2.53 mg/kg. The measured mean 
was close to the certified mean (2.3 mg/kg) and all measured values were 
within the certified 95% CI of the mean (1.9, 2.7 mg/kg).  
The CV% between the seven runs was 6.3% and the mean intra-run CV% was 
2.9%. The measured whole milk reference samples showed that the BMIC 
measurements were reliable. 
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Figure 37: Iodine concentration of whole milk reference samples [mg/kg] measured 
with ICP-MS 
 
4.5.5. Test of iodine stability in cow milk 
There was no significant difference in the mean iodine concentration of cow milk 
(n = 3) which was measured on the day of purchase (mean ± SD: 86.133 ± 
1.893 μg/kg) and again after seven days storage at ambient temperature having 
coagulations (mean ± SD: 83.733 ± 0.850 μg/kg) (p = 0.173, paired samples t-
test; performed at FOPH using SYSTAT 12). 
Based on this, we concluded that probably no iodine loss in breast milk 
occurred in the time between sample collection and freezing, even if some 
samples stayed at ambient temperature for a few days and had coagulations. 
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4.6. Iodine in formula and infant food 
4.6.1. Formula 
The labeled iodine contents of formula products are compared with the 
measured iodine concentrations in Table 62, which shows the difference 
between the values for each analyzed product. The twelve analyzed products 
were a convenient selection of products that were frequently indicated in the 
dietary questionnaires including at least one product of each available brand in 
Switzerland. The products were purchased in February 2009. Ten products 
were bought in pharmacies and two in retail stores. 
Four products had labeled iodine concentrations lower than required by the new 
Swiss regulation, which was however not yet mandatory by the time of product 
purchase (all products with iodine concentration < 10 μg/100 kcal; regulation 
changed in March 2008, implementation in March 2010 (EDI, 2005b), see also 
chapter 2.3.3.3). The other products were consistent with the new regulations. 
None of the measured iodine contents was below the required iodine content of 
the still valid previous Swiss regulation (minimum iodine content of 5 μg/100 
kcal, see also chapter 2.3.3.3). None of the products exceeded the allowed 
iodine content of 50 μg/100 kcal (EDI, 2005b).  
The mean ± SD abs. difference [%] between labeled and measured values was 
13.1 ± 7.7%. The range of abs. difference was 3.4% to 29.3 %. In absolute, the 
measured iodine concentrations differed between 0.2 and 2.6 μg/100 ml from 
the labeled values. Seven of the analyzed formula products had a slightly lower 
iodine concentration (- 7.2 to - 17.0%; - 0.2 to - 1.9 μg/100 ml) than labeled and 
five, a slightly higher one (5.6 to 29.3%; 0.6 to 2.6 μg/100 ml) (Table 62). 
  
In the products Holle 2, Milumil 2 and Aptamil HA 2 the iodine concentration 
was also measured in the instant product (without reconstitution of one portion). 
The results corresponded well to the iodine contents measured in the 
reconstituted products:  
- Holle 2: instant: 58.2 μg /100 g powder, reconst.: 62.8 μg/100 g powder  
- Milumil 2: instant: 76.1 μg/100 g powder, reconst.: 78.9 μg/100 g powder 
- Aptamil HA 2: instant: 79.5 μg/100 g powder, reconst.: 75.3 μg/100 g powder.  
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Table 62: Comparison of labeled and measured (ICP-MS) iodine concentrations in 
different brands of formula 
 Iodine concentration 1 
Brand/ 
Product specification 
Labeled 2 
[μg/100 kcal] 
Labeled 3 
[μg/100 ml] 
Measured 4 
[μg/100 ml] 
Difference 
[%] 5 
Infant formulae 6   
Bimbosan a  7.1 4.8 4.6 -3.4 
Bimbosan Bio a 7.7 5.2    4.4 4a -17.0 
Follow-on formulae 6   
Adapta 2 b 14.5 10 9.1 -9.2 
Coop Naturplan Bio 
Galactina 2 c 
14.7 10 12.6 23.4 
HiPP Folgemilch 2 d 14.3 11 11.6 5.6 
Holle Bio 2 e 9.3 7      9.4 4b 29.3 
Milupa Aptamil 2 f 17.6 12 13.2 9.2 
Milupa Aptamil HA 2 f 19.1 13    11.1 4a -15.5 
Milupa Milumil 2 f 19.1 13    11.5 4b -12.1 
Nestlé Beba 2 g 23.9 16 14.8 -7.9 
Nestlé Beba HA 2 g 14.9 10 9.3 -7.2 
Soy-based formula  
Bimbosan Bisoja a 9.8 6.5 7.8 17.8 
1
 Refers to product as prepared ready-to-drink 
2
 Calculated based on energy and iodine content per 100 ml ready-to-drink product 
3
 Values as they were indicated on the product packages or medical product documentation 
4
 Measured in reconstituted products; 
4a + 4b 
Measured twice as a control, mean of both 
measurements given; 
4a
 new package, 
4b
 same package, but second bag 
5
 Based on μg/100 ml; Difference % = (x1 – x2)/((x1 + x2)/2)*100; (x1 = measured iodine 
concentration, calculated with the exact value, not with the rounded one that is indicated in the 
table; x2 = labeled iodine content) 
6
 Cow milk-based, HA = partially hydrolyzed milk proteins 
a – g
 Products of 
a 
Bimbosan Ltd. (Welschenrohr, Switzerland); 
b 
Adapta (Lenzburg, Switzerland); 
c 
Coop (Basel, Switzerland); 
d 
HiPP GmbH (Sachseln, Switzerland); 
e 
Holle baby food GmbH 
(Riehen, Switzerland); 
f 
MILUPA SA (Domdidier, Switzerland); 
g 
Nestlé Suisse S.A. (Vevey, 
Switzerland). 
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4.6.2. Infant cereals 
The iodine content was not labeled on many infant cereal products as many of 
them were not fortified with iodine. Still, the products often contained cow milk 
and therefore were thought to have a relevant amount of iodine. The ten 
analyzed products were a convenient selection of products that were often 
indicated in the dietary questionnaires (purchased in February and April 2009). 
On five of the products the iodine content was not labeled. Iodine was 
measured in the dry and reconstituted products. Table 63 compares the labeled 
and measured iodine contents of the five labeled products. The results of the 
measurements in the reconstituted products are shown as this reflects the form 
of product intake.  
None of the products exceeded the maximum allowed iodine content of 35 
μg/100 kcal (EDI, 2005b) (Table 63). 
For the four instant products, the mean ± SD abs. difference [%] between 
labeled and measured values was 4.6 ± 2.8%. The range of abs. difference was 
1.6% to 7.2%. Two products had a slightly higher and two a slightly lower iodine 
concentration than labeled (Table 63). The three instant milk-cereal products 
were fortified with iodine and contained skimmed milk and whey powder 
(partially demineralized). The “Galactina Ceralino Milchzusatz” was fortified with 
iodine but did not contain any milk.  
For the ready-to-eat HiPP “Gute-Nacht Brei” the difference between labeled and 
measured value was 46% (Table 63). The product was not fortified with iodine 
but contained cow milk. 
 
In two products the iodine concentrations measured in the reconstituted instant 
products were very similar to the iodine concentrations measured directly in the 
instant products (without reconstitution of one portion): Milupa “Miluvid plus”: 
reconstituted: 74.3 μg/100g powder, instant: 73.6 μg/100g powder; Nestlé Baby 
Cereals “Vollkorn mit Früchten“: reconstituted: 36.6 μg/100g powder, instant: 
32.6 μg/100g powder. In the Nestlé Baby menu "Milchgriess” the measured 
iodine concentrations differed considerably. In the first measurement the iodine 
concentration was approximately twice as high for the reconstituted product as 
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for the instant product (46.2 vs. 19.9 μg/portion). The measured iodine 
concentration in the reconstituted product corresponded very well to the labeled 
concentration (45 μg/portion). Therefore, the low iodine content measured in the 
instant product was suspected to be an error in sample preparation or 
measurement. To check this, the measurement of the instant powder was 
repeated (using the second bag in the package). In the second measurement 
the iodine concentration of the instant powder (20.9 μg/portion) was still very 
different from the labeling (45 μg/portion), but very similar to the first 
measurement (19.9 μg/portion).  
 
Table 63: Comparison of labeled and measured (ICP-MS) iodine concentrations of 
iodine-labeled infant cereals 
 Iodine concentration 1 
Brand/ 
Product specification 
Labeled 2 
[μg/100 kcal] 
Labeled 
[μg/portion] 3 
Measured 
[μg/portion] 3 
Difference 
[%] 4 
Instant milk-cereals,  
preparation with water 
Milupa “Miluvid plus” a 19.1 36 33.5 -7.2 
Nestlé Baby Cereals 
“Vollkorn mit Früchten“ b 
8.5 18 18.3 1.6 
Nestlé Baby menu 
“Milchgriess” b 
21.4 45 46.2    2.7 
Instant cereals,  
preparation with milk & water 
Galactina  
“Ceralino Milchzusatz 
Getreide&Ovomaltine” c 
10.7 40 5 37.4 5 -6.7 
Ready-to-eat milk-cereal  
HiPP Gute-Nacht Brei 
“Griessbrei Früchte“ (jar) d 
4.6 7.6 4.8 -46.0 
1
 Refers to product as prepared ready-to-eat 
2
 Calculated based on energy and iodine content per 100 g dry product, except for “HiPP”: 
based on ready-to-eat product 
3 
Standard portion as indicated on the package, varying from 175 to 200g. 
4
 Based on μg/portion; Difference % = (x1 – x2)/((x1 + x2)/2)*100; (x1 = measured iodine 
concentration, calculated with the exact value, not with the rounded one that is indicated in the 
table; x2 = labeled iodine content) 
5
 Here μg/100g instant powder, as the iodine content per portion (on the package) was indicated 
for the preparation with milk and water. We used just water. 
a – d 
Products of 
a 
MILUPA SA (Domdidier, Switzerland); 
b
 Nestlé Suisse S.A. (Vevey, 
Switzerland); 
c 
Adapta (Lenzburg, Switzerland); 
d 
HiPP GmbH (Sachseln, Switzerland). 
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In the five non-iodine-labeled products the following iodine contents were 
measured: 
- Bimbosan  “Bio-Hirsana” and “Bio-Prontosan” (Bimbosan Ltd., Welschenrohr, 
Switzerland): These two products mainly consisted of cereals (Bio-Hirsana: 
99.99% millet flour; Bio-Prontosan: 80% flour from barley, millet, rice, wheat and 
rye). They were not fortified with iodine and did not contain any cow milk. The 
purpose of the measurement was to check if pure cereals were a source of 
iodine. The measured iodine concentrations were between the iodine detection 
and quantification limit (LOD ~ 1.5 μg/kg, LOQ ~ 4.9 μg/kg, see 4.5.3; Bio-
Hirsana: 1.9 μg/kg; Bio-Prontosan: 4.3 μg/kg), therefore, it could be concluded 
that these products contained virtually no iodine. 
- Milupa “Brei mit Früchten” (MILUPA SA, Domdidier, Switzerland): This product 
was not fortified with iodine but it contained skimmed milk and whey powder 
(demineralized). The measured iodine content in the reconstituted product was 
14.3 μg per standard portion (120 ml of water and 40 g of powder). The same 
amount was measured in the powder.  
- Holle Bio “Dinkel-Milchbrei” and “Hirse-Milchbrei” (Holle baby food GmbH, 
Riehen, Switzerland): These products were not fortified with iodine but they 
contained skimmed milk and whey powder (partially demineralized). The 
measured iodine content in the reconstituted product was 10 μg respectively 7.1 
μg per standard portion (130 ml water and 40g powder). In the powder 9.3 μg 
respectively 6.7 μg per standard portion were measured. 
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4.6.3. Quality control of ICP-MS  
4.6.3.1. Infant formula reference 
The measured iodine concentrations [mg/kg] of the infant formula reference 
samples are shown in Figure 38.  
The mean ± SD iodine concentration of the measured samples (n = 14) in four 
runs was 1.02 ± 0.10 mg/kg powder (= 102 ± 10 μg/100 g). The values ranged 
from 0.85 to 1.20 mg/kg. The measured mean was close to the certified mean 
(1.11 mg/kg) and 10 out of 14 iodine values were within the certified 95% CI (= 
0.94, 1.28 mg/kg). Three values were slightly below the lower boundary of the 
certified 95% CI (values: 0.91, 0.91, 0.93 mg/kg). Only one value was clearly 
below the 95% CI (value: 0.85 mg/kg). This was suspected to be due to an error 
in preparation or measurement. All intra-run means were within the certified 
95% CI (means: 0.99 mg/kg (sample no. 1-4), 1.04 mg/kg (no. 5-7), 1.07 mg/kg 
(no. 8-11) and 0.97 mg/kg (no. 12-14)). The CV% between the four runs was 
4.2% and the mean intra run CV% was 9.7%. 
 
 
 
Figure 38: Infant formula reference samples measured with ICP-MS 
 
 
No. of measured sample 
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4.7. Dietary assessment of infants 
The data entry and evaluation of the dietary questionnaires were not part of this 
thesis and will be reported elsewhere. 
 
4.7.1. Questionnaire response rate 
Table 64 shows the response rate of the first and second dietary questionnaire. 
Overall, the response rate was > 89% in both age groups and for both the first 
and second questionnaire. A slightly higher percentage of first questionnaires 
was returned compared to the second. 
 
Table 64: Response rate of dietary questionnaires (%) 
Dietary questionnaires 
Age group 
Total 
6-mo 12-mo 
Included infants [n] 179 160 339 
1st questionnaire % (n) 97.8%  
(175) 
92.5% 
(148) 
95.3% 
(323) 
2nd questionnaire % (n) 91.1% 
(163) 
89.4% 
(143) 
90.3% 
(306) 
 
4.7.2. Infant food database 
Within this diploma thesis, 148 products were entered into the infant food 
database. An overview of the number of products per food category and their 
iodine content can be found in Table 65 (for an explanation of the categories 
see also chapter 3.7.4.4). 
All formula products were fortified with iodine as required by law (EDI, 2005b). 
The mean ± SD iodine content of the instant formula products (n = 39) per 100 
ml reconstituted product was 11.8 ± 3.5 µg/100 ml and ranged from 4.0 to 18.2 
µg/100 ml. 
Only 28% of the complementary food products were fortified with iodine. The 
highest percentage (67%) of fortified products was observed in the instant milk-
cereal mixtures. In contrast, of the ready-to-eat cereal-milk products, only 1% 
was fortified with iodine. Milk-free instant cereal products were fortified in 29% 
of cases. 50% of the baby menus contained iodized salt (see Table 65).  
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Table 65: Iodine content of formula/infant food in infant food database sorted by food 
category 
Food category n 
Brands 
[n] 
Energy 
[kJ/100g] 
Iodine [µg/100g]
 b
 Lab./ 
calc./ 
meas.
c 
Mean ± SD Mean ± SD Min Max 
Infant/follow-on 
formula, junior-milk 
(inst.) a 
       
- fortified with iodine 39 8 2022 ± 73 81 ± 25 30 140 l 
Junior-milk (ready.) a        
- fortified with iodine 2 2 288 ± 11 16 11 21 l 
Instant milk-cereal 
mixtures 
       
- fortified with iodine 14 5 1768 ± 50 76 ± 21 40 120 l 
- not fortified with iodine 6 4 1731 ± 93 25 ± 7 17 36 c/me 
Milk-free cereal 
based products or 
cereal mixtures 
(inst.) 
       
- fortified with iodine 8 3 1635 ± 73 52 ± 28 11 100 l 
- not fortified with iodine 20 7 1580 ± 83 2 ± 1 2 4 c 
Cereal-milk-
(fruit/vegetable) 
porridge/drink meal, 
baby yoghurts/ 
desserts (ready.) 
       
- fortified with iodine 1 1 401 20 -- -- l 
- not fortified with iodine 10 4 366 ± 73 5 ± 1 4 7 c/lf 
Vegetable/fruit 
purees (ready.) 
       
- not fortified with iodine 22 6 244 ± 70 1 ± 0 1 2 c/lf 
Baby menus 
(ready.) 
       
- fortified with iodine 7 d 1 305 ± 46 8 ± 4 5 16 l/cg 
- not fortified with iodine 7 4 286 ± 42 2 ± 2 1 6 c 
Biscuits/rusks/bars        
- not fortified with iodine 11 8 1726 ± 123 5 ± 2 2 8 c 
Baby pasta (dry)        
- not fortified with iodine 1 1 1459 1 -- -- c 
a
 Product in: inst. = instant condition; ready. = ready-to-eat condition 
b
 100g is related to the product as it is in the package either instant/dry or ready-to-eat 
c
 l = iodine labeled on package; c = iodine calculated by EBISpro (see also chapter 3.7.4.2); m = 
iodine measured (ICP-MS) 
d
 Fortified via iodized salt 
e
 Three products; 
f
 Two products; 
g
 One product 
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None of the vegetable/fruit-purees, biscuits/rusks/bars and pasta products was 
fortified with iodine or contained iodized salt. Therefore, all these food items had 
a low iodine content. 
Mean iodine content of fortified products was clearly higher than iodine content 
of non-fortified products in all food categories [µg/100g] (see Table 65). 
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5. DISCUSSION 
5.1. Overview 
The present study was designed to obtain data on UIC of 6- and 12-month-old 
Swiss infants in a nationally representative sample and to establish a reference 
range for UIC in infants. An iodine-sufficient population is an obvious 
precondition to be able to establish a reference range. Switzerland has a long 
existing salt iodization program which is regularly monitored. The national 
surveys which monitored the iodine status of SAC, pregnant women (UIC) and 
newborns (TSH) in 1999 and 2004 showed iodine sufficiency (Hess et al., 2001; 
Zimmermann et al., 2005). In addition, a recent study of Swiss newborns (UIC 
and TSH) concluded that they were iodine-sufficient (Dorey and Zimmermann, 
2008). Therefore, infants in Switzerland were assumed to be iodine-sufficient. 
To confirm this assumption, the present study measured UIC and BMIC in the 
infants‟ mothers. Furthermore, the labeling of iodine content on infant food was 
checked and dietary iodine intake of infants was examined by a dietary 
questionnaire. 
The interim analysis of UICs and BMICs in the present diploma thesis showed 
lower medians of UIC (81.1 µg/l) and BMIC (51.2 µg/kg) in mothers than 
expected. This finding was in agreement with two other recent regional studies 
in Switzerland on UIC in non-pregnant, non-lactating women who also showed 
low median UICs (1) median UIC = 81.0 µg/l (n = 144) (M Kammermann, ETH 
Zurich, 2009, personal communication) and (2) median UIC = 79.1 µg/l (range: 
0-1193) (n = 567, young Swiss women 18-42 years old) (M Andersson, ETH 
Zurich, 2007, personal communication). Median UICs were below the 
recommended cut-off of 100 µg/l (World Health Organization et al., 2007) for 
women in the mentioned studies. Furthermore, in the new 2009 Swiss iodine 
monitoring study, pregnant women had a marginally sufficient iodine status 
(interim analysis of 318 women, median UIC = 151 µg/l; A Piacenza, ETH 
Zurich, 2009, personal communication). School age children showed a sufficient 
iodine status in the new monitoring study (n = 916, median UIC = 120 µg/l; I 
Henschen, ETH Zurich, 2009, personal communication). They had, however, a 
lower median UIC compared to the survey in 2004 (median UIC = 141 µg/l) 
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(Zimmermann et al., 2005). Thus, the above data indicate that the precondition 
of iodine-sufficiency in Swiss infants might not be met for the use of the final 
study data to establish a reference range. 
The present study was the first national study on iodine status in infants and 
women of childbearing age in Switzerland. Within the framework of the diploma 
thesis, the study set-up, execution and data analysis of the first part of samples 
was performed and the iodine status of infants and mothers was evaluated and 
discussed. The focus of the discussion is on the iodine status of infants; 
mothers were mainly taken as comparison. 
 
5.2. Selection of pediatric practices 
The WHO recommends cross-sectional surveys with “probability proportion to 
size” cluster sampling for monitoring iodine status of a country using 30 clusters 
(World Health Organization et al., 2007). For practical reasons we decided to 
perform a cross-sectional survey with 20 clusters in the study. The clusters 
were selected proportionately to the percentage of annual live births in the 
seven “greater Swiss regions”. Within the regions convenient sampling of the 
clusters was performed. This was justified as iodine intake has been reported 
as uniform across the country (Hess et al., 2001; Zimmermann et al., 2005). 
The study was not planned to be representative for each region or cluster, but 
for the whole country. 
Pediatric practices were regarded as the best place to reach the population 
group of 6- and 12-month-old infants as they attend pediatric practices in 
healthy condition for the 6-month and 12-month routine check-up/vaccination 
appointment. The pediatrician knows about the medical history of the infants 
and is able to confirm their health and absence of thyroid disorders. Routine 
check-ups/vaccinations for infants are, to our knowledge, not offered by 
hospitals in Switzerland. 
We had a rather high positive response rate for study participation in the 
German speaking part of Switzerland, but a very low one for the French (Lake 
Geneva Region) and Italian speaking parts (Ticino). The reason for this is 
unclear, but the same difficulties occurred in the SAC and pregnant women 
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monitoring study of 2009 (I Henschen and A Piacenza, 2009, personal 
communication). The recruitment of pediatric practices was postponed for the 
French speaking part. The pediatric practice that agreed to participate sent only 
five samples. Therefore, in the present interim analysis the French speaking 
part of Switzerland was mainly not included (Lake Geneva Region). The 
participating pediatric practice in the Ticino region only returned a small number 
of samples (n = 17). Thus, this interim analysis of the study cannot be regarded 
as nationally representative. 
 
5.3. Recruitment and sample collection 
For this interim analysis a total of 379 mother-infant pairs were recruited during 
a time period of 10 months. After exclusions, 339 infants (53% 6-mo, 47% 12-
mo) and 343 mothers were included for the analysis. This number is much 
lower than the estimated required sample size of 600 per age group. Therefore, 
it was not possible to discuss the data in terms of setting reference values. 
However, the results provide a first evaluation of the iodine status of infants and 
mothers in Switzerland.  
The WHO recommends determining UIC in 30 urine specimens from a defined 
sampling group to compensate for varying degrees of hydration in subjects 
(World Health Organization et al., 2007). Therefore, we aimed to collect 30 
urine samples per age group at each pediatric practice. At the time point of data 
evaluation only two pediatric practices had accomplished this target. The other 
practices had enrolled between 0 and 19 mother-infant pairs per age group. 
Therefore, it was not possible examine single pediatric practices. In terms of 
regions, all except Ticino and Lake Geneva region had collected more than 30 
urine samples.  
Usually, after analyzing more than 100 urine samples of a population group, the 
median UIC does not substantially change (personal communication, M 
Zimmermann). More than 100 samples per age group were available for the 
present evaluation (see above). 
The recruitment of study subjects took more time than expected. Several 
reasons for this observation were communicated to us by the pediatric 
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practices, of which the most important were: not always enough time to recruit 
infants due to workload and language problems with non-German speaking 
parents. 10% of infants had to be pre-excluded due to not term birth, which is a 
rather high percentage but which was also confirmed by the Swiss Federal 
Statistical Office (Bundesamt für Statistik, 2007). Probably the most important 
reason for the rather slow sampling was the low weekly visiting frequency of 
infants for routine check-ups/vaccinations at the pediatric practices even though 
we aimed to select the practices with the highest weekly visiting frequencies. 
There are about 700 pediatric practices in Switzerland (personal 
communication, FFP) and the annual birth number is about 75‟000 (Swiss 
Federal Statistical Office, 2008b), of which 10% preterm infants need to be 
excluded. Based on these numbers and estimating that the pediatric practices 
are open 48 weeks a year, this would result in about two infants per age group 
visiting a practice for routine check-up per week. Considering that each infant 
can only participate in the study once, the number of eligible infants is further 
reduced. This finally results in a rather small weekly number of infants and 
additionally including the fact that not every eligible infant is enrolled due to the 
above-mentioned reasons, it seems clear that a large time span for sample 
collection is required. 
Urine collection in infants is more complicated than in children or adults and this 
is also regarded as a main problem for using UIC in iodine status assessment of 
infants (WHO Secretariat on behalf of the participants to the Consultation et al., 
2007). The “pad collection” method was already tested in the Swiss newborn 
study (Dorey and Zimmermann, 2008). In the present study the method was 
generally well accepted by pediatricians with the exception of one practice in 
the Ticino region which insisted on using urine bags for collection. The pad 
method was also considered as a good method for sample collection by the 
parents, by whom most of the samples were collected. No problems with the 
method were reported to the study team at ETH. Most of the samples arrived at 
ETH within a short time (median three days) and all infants provided a sufficient 
amount of urine for analysis. Furthermore, our iodine recovery tests with the 
pads showed accurate results and, as a comparison, Crofton et al. recently 
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showed reliable quantitative results in routine biochemistry tests with urine 
extracted from pads of the same brand as used for the present study (Crofton et 
al., 2008). The “pad collection” method can be thus recommended for urine 
collection in infants in further studies on UIC. 
Another important point was to avoid sample contamination (directly or 
indirectly) with iodine-containing disinfectants or contrast media. Therefore, 
pediatricians and their assistants were specifically made aware of this problem 
and the samples suspected of contamination (due to extremely high iodine 
concentration, see results) were excluded from the study. Iodine-containing 
disinfectants are not to be applied to infants under 6 months of age and only 
with medical prescription in the following years (till 6 years of age) (information 
retrieved from http://www.kompendium.ch/, accessed July 2008). The two 
pediatric practices which had already finished sampling confirmed in the final 
questionnaire not having used any iodine containing disinfectants where the 
samples were collected or the urine was extracted. 
 
5.4. Subject characteristics 
In order to provide data for reference values it was important to include healthy 
and normally growing and developing infants in the study.  
All included infants had a term birth, were healthy, did not have any thyroid 
disorders and had not had any treatment with iodine-containing contrast media 
or disinfectants (confirmed by the pediatricians). The included infants had a 
mother who had neither a recent thyroid disorder nor was treated with contrast-
media or iodine-containing drugs during pregnancy or lactation as this could 
have had negative impacts on the health or iodine status of the infants. 
The infants included in the present analysis were growing normally when 
compared with the WHO reference population with mean z-score values close 
to zero (World Health Organization, 2008) (see also result section). 
The data should represent the population living in Switzerland. Therefore, all 
included mothers had already lived in Switzerland for at least one year before 
the infant‟s birth and all mother-infants pairs had lived in Switzerland since the 
infant was born. 
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The other subject characteristics are discussed together with the urine and 
breast milk analysis data. 
 
The two pediatric practices which had already finished the study reported in the 
final questionnaire that they had the impression that the mothers/parents did not 
have much knowledge about the importance of iodine for their infants‟ healthy 
development. 
 
5.5. Iodine status in infants and mothers  
5.5.1. Comparison with cut-offs and recommendations 
Infants are particularly sensitive to ID because the iodine content of their 
thyroids is still low, but they have a fast intrathyroidal iodine turnover (Brown et 
al., 2005). Furthermore, ID has the worst consequences in the fetal period and 
infancy (Zimmermann, 2009). 
The currently available cut-off for median UIC which indicates iodine-sufficiency 
in infants and adults is ≥ 100 µg/l (World Health Organization et al., 2007). In 
2007, a technical consultation of the WHO recommended revising this cut-off for 
infants (WHO Secretariat on behalf of the participants to the Consultation et al., 
2007). The present study was planned to contribute to the revision. The data 
included in the diploma thesis are an interim analysis of the study and provide a 
first insight on the direction of the final study results. Looking at infants and 
mothers, both groups were found to have a median UIC below the cut-off (93.2 
µg/l infants, 81.1 µg/l mothers) which would indicate iodine deficiency. Using the 
classification for SAC and adults, the medians indicate mild ID because they are 
between 50 and 99 µg/l (World Health Organization et al., 2007). Examining 
both age groups separately, the median UIC of 12-month-old infants (104.0 
µg/l) was just above 100 µg/l. The 95%CI of the median, however, was 88.1, 
125.5 µg/l which indicated that also for the 12-month-old infants the measured 
median above 100 µg/l was not assured. 6-month-old infants were clearly below 
100 µg/l with a median UIC of 88.4 µg/l. The 95%CI (67.8, 99.8 µg/l) did not 
even reach the cut-off. Even if the 12-month-old infants showed a tendency 
towards a higher median UIC, UIC was not significantly different between the 
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two age groups. This was further supported by the fact that age (in months) did 
not correlate with UIC, indicating that there was no overall tendency for an 
increasing UIC with age. Pouessel et al. who also examined infants in the first 
year of life also did not find any relation between age and UIC in infants; 
however they examined hospitalized infants (Pouessel et al., 2008). 
Nevertheless, in our study, the proportion of 12-month-old infants with UICs ≥ 
100 µg/l was significantly greater than in 6-month-old infants (see results).  
The UICs of the infants in the present study were compared with the UICs of the 
Swiss newborn study which was carried out between 2005 and 2007 at ETH (n 
= 634 newborns, which provided 1224 spot urine samples) (Dorey and 
Zimmermann, 2008). The newborns had a median UIC of 77 µg/l. The authors 
of the newborn study suggested that this median indicated a sufficient iodine 
intake which was supported by the fact that the newborns had low TSH values 
(Dorey and Zimmermann, 2008). It is possible however, that the iodine status in 
newborns is not comparable with that of older infants due to the recent 
metabolic changes in newborns from birth.  
 
 
Figure 39: Bar diagrams showing median UIC [µg/l] of newborns (n = 1224) (Dorey and 
Zimmermann, 2008), 6- (n = 179) and 12- (n = 160) month-old infants (significant 
difference between , p < 0.0001) (UIC = urinary iodine concentration) 
 
Comparison of newborns and 6- and 12-month-old infants showed a significant 
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difference in UIC between the three groups (K-W, p < 0.0001). Post-hoc tests 
revealed that only the 12-month-old infants had a significantly higher median 
UIC than the newborns (MWU, p < 0.0001). UIC of the 6-month-old infants did 
not differ significantly from the newborns (MWU, p = 0.15). Looking at the three 
age groups together, a constant increase in median UIC could be observed 
during the first year of life. This is shown in Figure 39. However, all samples of 
the present study must be first analyzed before drawing firm conclusions about 
such an increase. 
Reasons for the increase could be, for example, changes in metabolism or in 
feeding practice of infants during the first year of life. While 92% of the 
newborns were exclusively breast-fed (Dorey and Zimmermann, 2008), the 
breast-feeding rate decreased to 57% (6% exclusively/predominantly, 51% 
partially) in 6-month-old infants and to 18% in 12-month-old infants in the 
present study. Exclusive breast-feeding is recommended during the first six 
months of life by WHO (Butte et al., 2002). In Switzerland, the recommendation 
is exclusive breast-feeding or exclusive feeding with infant formula in the first 4 
to 6 months of life (Ernährungskommission der Schweizerischen Gesellschaft 
für Pädiatrie, 2008). After this period, complementary foods should be 
sequentially introduced while feeding with BM or FM is continued 
(Ernährungskommission der Schweizerischen Gesellschaft für Pädiatrie, 2008; 
World Health Organization, 2001). By the end of the first year, infants then start 
to eat family foods as well. Almost all infants in our study (88%) already 
received complementary foods by the age of 6 months. At 12 months most of 
the infants had already started to eat family foods. This indicates a constant 
change in iodine sources from foods. However, in literature the major iodine 
source for infants (at 6 and 12 months) is clearly milk (breast milk, formula, cow 
milk) contributing to about 70 - 90% of the daily iodine intake (Mills and Tyler, 
1992; Murray et al., 2008; Thomson et al., 2008). Therefore, the determining 
factor for the iodine status of infants who are mainly breast-fed is breast milk. 
The iodine content of breast milk in turn is dependent on maternal iodine intake 
as reviewed by Semba and Delange (2001). BMIC was shown to be lower in 
goitrous areas compared to areas with efficient iodization of salt (Azizi and 
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Smyth, 2009). However, a recent US study found no correlation between BMIC 
and iodine intake, which was assessed by 24-h-dietary-recall. They used, 
however, only a sample size of 29 for the comparison (Hannan et al., 2009). 
The BMIC which was measured in 119 samples in the present study was 51.2 
µg/kg (µg/kg is practically the same as µg/l for BM as the specific gravity of BM 
is nearly identical to water). No reference value exists for BMIC by WHO or 
other institutions as there is no agreement on the optimal iodine concentration 
of BM (Zimmermann, 2009). Semba and Delange recommended that the 
proportion of women with a BMIC ≥ 100 µg/l could be an indicator for the iodine 
status of a population (Semba and Delange, 2001). In our sample, only 10.9% 
of lactating women had a BMIC over 100 µg/kg, which is a rather low 
percentage. Bazrafshan et al. recently used a cut-off of ≥ 50 µg/l to indicate 
iodine sufficiency (Bazrafshan et al., 2005). The median BMIC of women in our 
study was slightly above this cut-off which would just indicate iodine sufficiency. 
Nevertheless, the iodine concentration was below 50 µg/kg in 48% of the BM 
samples. Zimmermann reported in a review that the mean or median BMIC 
found in iodine-sufficient countries ranged from 50 to 270 µg/l (Zimmermann, 
2007b). Therefore, our measured median BMIC in women in Switzerland would 
be at the lower end. Azizi and Smyth suggested, on the contrary, that BMIC 
should be between 100 – 150 µg/l in iodine-sufficient countries and they 
proposed that values > 75 µg/l might be considered as an index of sufficient 
iodine nutrition (Azizi and Smyth, 2009). Compared with this, the median BMIC 
of Swiss women would clearly be categorized as too low. 
Eleven infants of the present study relied solely on BM as their nutrient source. 
The median UIC of breast-fed infants (38.6% of all infants) was significantly 
lower than the median UIC of infants receiving no BM at all (83.8 µg/l vs. 101.4 
µg/l). Examining both age groups separately, only the 6-month-old breast-fed 
infants had a significantly lower median UIC (70.7 µg/l) than the non-breast-fed. 
In the 12-month-old infants, no significant difference in UIC was observed 
between breast-fed and non-breast-fed infants. Subdividing the data by the 
consumption of different milk types (BM; FM; BM & FM; no BM & no FM), 6-
month-old breast-fed infants who did not receive FM had the lowest median UIC 
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(64.1 µg/l) compared to all other feeding categories in both age groups. The 
median of these infants was significantly lower than the medians of 6-month-old 
infants who received FM or BM & FM, but not than the median UIC of 12-
month-old infants in the same category (BM). This finding suggests that infants 
who are mainly breast-fed have a lower iodine supply than infants who receive 
FM or a relevant amount of complementary/family food as is normally the case 
at 12 months of age.  
The mean ± SD of daily breast milk intake of 6-month-old exclusively and 
partially breast-fed infants was estimated to be 854 ± 118 ml and 612 ± 180 ml, 
respectively, as reported by Butte et al. (Butte et al., 2002). Based on this 
estimation and the assumption that 95% of BM iodine is absorbed 
(Zimmermann, 2009), 6-month-old exclusively or predominantly breast-fed 
infants would have a daily iodine intake of about 43 ± 6 µg. In partially breast-
fed infants, an estimated daily quantity of 31 ± 9 µg of iodine originates from BM 
(both calculations made with the median BMIC of 53.3 μg/kg, measured in BM 
of mothers with 6-month-old infants). If the complementary food the infants 
receive additionally to the BM is low in iodine (like vegetable or fruit puree 
(Haldimann et al., 2005)), the quantity of iodine from BM might reflect the total 
iodine intake quite well. To accurately estimate the total iodine intake of infants 
who also receive other milk/foods than BM, it would be necessary to evaluate 
the dietary questionnaires. 
 
As reported in the background section, UIC is a good indicator for recent iodine 
intake in adults as > 90% of dietary iodine is excreted in urine (Nath et al., 1992; 
Zimmermann, 2008b). This percentage might be different in infants as they also 
need iodine to build up iodine stores in the thyroid (van den Hove et al., 1999) 
and as their body grows and develops. However, the daily iodine retention for 
stores might be rather small as the thyroid weighs about 1 g at birth with an 
iodine store of 0.3 mg and increases to 15-20 g in adolescence with an iodine 
store of about 16 mg (annual increase of thyroid: about 1 g) (Brown, 2009; 
Brown et al., 2005). Therefore, the daily increase of the store could be 
estimated to be about 3 µg, which is a negligible amount. Infants also have a 
higher thyroid hormone turnover rate than adults (Brown, 2009), which could 
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also be responsible for a different urinary iodine excretion pattern. In the 
balance study of Delange et al. only about 57% of absorbed iodine was 
excreted through urine in one month old infants (iodine intake 20 µg/kg/day, 
body weight at one month of age about 4.5 kg) and 37% was kept in the body 
(Delange et al., 1988). Iodine metabolism is probably different in such young 
infants. If the infants would constantly retain such a high percentage of iodine in 
their body, body iodine content would increase by about 30 µg per day. Another 
study of Delange et al. in which 6 – 36-month-old infants were supplemented 
with 90 µg iodine per day showed indeed a urinary iodine excretion of about 
90% after several weeks (Delange et al., 2001).  
It was not clear from this data or studies how much the iodine excretion rate 
actually is in infants and further research is required. Therefore, the adults‟ 
excretion rate was relied on for the UIC based estimation of the iodine intake 
(Institute of Medicine et al., 2001). The average body weight for a 6-month-old 
infant is about 7.8 kg (mean BW of 6-mo study infants: 7.7 kg) and for a 12-
month-old infant, 9.5 kg (mean BW of 12-mo study infants: 9.7 kg) (Butte, 
2005). A daily urine volume of about 0.055 l/kg/day was estimated for infants 
(data from (Zimmermann, 2007b)). The iodine bioavailability was estimated to 
be 92% (Institute of Medicine et al., 2001). This resulted in the following 
estimation: daily iodine intake of infants = UIC [µg/l] : 0.92 * 0.055 l/kg/day * BW 
[kg].  
Based on the measured median UIC, the iodine intake for 6-month-old infants 
was: 88.4 µg/l : 0.92 * 0.055 l/kg/day * 7.7 kg = 40.5 µg iodine per day. For 12-
month-old infants the estimation was: 104.0 µg/l : 0.92 * 0.055 l/kg/day * 9.7 kg 
= 60.3 µg iodine per day. Taking both age groups of the present study together, 
the measured median UIC would suggest an average iodine intake between 
around 40 and 60 µg per day. 
The iodine intake of 6-month-old breast-fed infants (no FM) estimated with the 
above formula would be 29.9 µg iodine per day (median UIC = 64.1 µg/l). This 
intake level is lower than when calculated with the BMIC for 
exclusively/predominantly BF infants, but it is very similar to the estimated 
quantity for partially BF infants (see above). Most of the breast-fed 6-month-old 
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infants (no FM) were partially BF (84%) and most of them (76%) did not receive 
additional CF with a potentially high iodine content (= milk-cereal porridge with 
cow milk/FM or cow milk). It is, however, difficult to draw conclusions about 
iodine intake from the calculations because they are just rough estimations. BM 
and CF intake and urine volume can vary and the true percentage of iodine 
excretion/retention is unclear. We observed however, a weak but significant 
correlation between UIC of breast-fed infants and BMIC.  
For 6-month-old formula-fed infants (FM or FM & BM) the average daily iodine 
intake was estimated to be 47.2 µg (median UIC = 102.5 µg/l). In the 12-month-
old infants, breast-fed infants (no FM; median UIC = 95.9 µg/l), formula-fed 
infants (FM or FM & BM; median UIC = 102.5 µg/l) and infants who did not 
receive any BM or FM (median UIC = 82.5 µg/l) had estimated daily iodine 
intakes of 55.6 µg, 64.9 µg and 47.8 µg, respectively.  
 
Even if it seems clear that adequate iodine supply is essential for optimal child 
development (see background section), there are only a few studies on iodine in 
infants. The recommendations for iodine intake in infants are not based on well-
controlled studies. The multiplicity of recommendations indicates a lack of data 
(see Table 2: Recommendations for iodine intake: Infants). Our estimated 
average iodine intake of 40 – 60 µg per day for 6- to 12-month-old infants was 
comparable with several of the recommendations such as: the D-A-CH 
recommendation for Switzerland (< 12 mo: 50 µg/day; ≥ 12 mo: 90 µg/day) (D-
A-CH, 2008), the recommendation of the SCF of the European Commission 
(population reference intake 50-70 µg/day) (SCF (Scientific Committee for 
Food), 1993), the COMA (United Kingdom) reference nutrient intake (60 µg/day) 
(Thomson, 2002), the Nordic Nutrition Recommendations (50-70 µg/day) 
(Becker et al., 2004) and the AFSSA (France) recommendation (50 µg/day) (EU 
Scientific Committee on Food, 2003). The estimated iodine intake of 6-month-
old infants (40 µg/day) in Switzerland would still be below the recommendations 
and that of 6-month-old breast-fed infants who do not receive FM (~ 30 µg/day) 
would even be clearly below the recommendations. 12-month-old infants (60 
µg/day) would meet the above recommendations, which would suggest on 
average an adequate iodine supply for this age group. Except according to the 
Discussion 
 
 
 
University of Vienna  Nadja Wüst 
 
191 
Swiss D-A-CH recommendation (D-A-CH, 2008), the 12-month-old infants 
would be just on the borderline between adequate and inadequate intake. The 
above recommendations were based either on estimated intakes from BM or 
extrapolations from adult values and for some, no explanation was found (see 
also background section, chapter 2.2.2). 
The recommendation of the Spanish Dietetic and Food Science Association (35 
µg/day) (EU Scientific Committee on Food, 2003) was even lower than our 
estimated average intake. 
On the other hand, intake recommendations from UNICEF, ICCIDD, WHO (90 
µg/day) (World Health Organization et al., 2007), D-A-CH Germany/Austria (< 
12 mo: 80 µg/day; ≥ 12 mo: 100 µg/day) and Switzerland (≥ 12 mo: 90 µg/day) 
(D-A-CH, 2008), the US Institute of Medicine (130 µg/day) (Institute of Medicine 
et al., 2001) and CSH (Belgium) (90 µg/day) (EU Scientific Committee on Food, 
2003) are higher than our estimation. They would thus indicate insufficient 
iodine intake. These intake recommendations should result in UIC levels 
between 150-220 µg/l (Delange, 2004; FAO and WHO, 2004), which is much 
higher compared to the median UICs measured in the present study. The new 
UNICEF, ICCIDD, WHO recommendation was revised in 2001 from the earlier 
recommendation (WHO et al., 1996) and the earlier RDAs (FAO and WHO, 
2004). In fact, those earlier RDAs (50 µg/day), which were based on relative 
energy requirements of adults, were in the middle of our estimates 
(Subcommittee on the tenth edition of the RDAs et al., 1989). The revised 
recommendation of 90 µg/day was, on one hand, based on calculations from 
breast milk intake (90 µg/day is the mean of an estimated iodine intake from BM 
in Europe (60 µg/day) and the USA (120 µg/day)) and on the other hand, on 
Delange‟s balance study (FAO and WHO, 2004). If only the iodine intake from 
BM in Europe (60 µg/day) had been considered, this would have resulted in a 
similar recommendation compared to our estimation. The recommendation of 
the US Institute of Medicine, which is the highest of all recommendations, used 
BMICs of US women for the estimation and Delange‟s balance study (Institute 
of Medicine et al., 2001). Usually, higher iodine intakes and BM excretions were 
reported for the USA, compared to Europe. The reason for this observation is 
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the high iodine content in bread and cow milk in the USA, which mainly 
originates from iodophor disinfectants in the dairy industry and from iodate 
bread conditioners (Haldimann et al., 2005; Murray et al., 2008; Pearce, 2007; 
Pearce et al., 2004). 
 
As mentioned before, two recent regional surveys on UIC in Swiss women of 
childbearing age showed medians below the WHO cut-off of 100 µg/l (World 
Health Organization et al., 2007). Therefore, we decided to analyze UIC of 
mothers as well, to check if they have a sufficient iodine status. Their median 
UIC was similar to the other studies below 100 µg/l. This was surprising as the 
last Swiss iodine monitoring study in 2004 showed an adequate iodine status in 
SAC and pregnant women (UIC) (Zimmermann et al., 2005). However, the UIC 
levels of the new 2009 monitoring study in SAC and pregnant women indicated 
lower levels than in 2004 with pregnant women (interim analysis) close to the 
cut-off of ID. SAC still had an adequate UIC (I Henschen, A Piacenza, 2009, 
personal communication). Based on this, the question was raised if mothers in 
Switzerland do have an adequate iodine intake or not. In the interim analysis of 
the present study, significantly lower UI values were measured in lactating 
mothers (median UIC = 71.1 µg/l) compared to non-lactating mothers (median 
UIC = 95.5 µg/l). This seems to support our concerns. 
Similar to the present findings, other studies also found a higher UIC in SAC in 
comparison to women of childbearing age. In a Swiss longitudinal study (2 yr), 
Als et al. found a median UIC of 96 µg/l in women (n = 5, 30-46 yr) compared to 
130 µg/l in SAC (n = 7, 6-10 yr) and 144 µg/l in pre-school children (n = 6, 3-5 
yr). Men had the same median as SAC. The daily milk consumption was also 
assessed. The higher milk consumption of children (0.7-0.8 l/day) compared to 
adults was regarded as a reason for the lower UIC in women (0.3 l/day) (Als et 
al., 2003). In the NHANES I and III and 2003-2004 surveys, UIC was also 
higher in SAC than in adults (Caldwell et al., 2008; Hollowell et al., 1998). The 
reason for this could be not explained based on dietary iodine sources (Pearce 
et al., 2004). 
A study in La Reunion found lower UICs in women of childbearing age (median 
UIC = 42 µg/l) compared to infants (median UIC = 120 μg/l) and SAC (median 
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UIC = 78 μg/l). In this study, infants had the highest UI values and the values 
decreased with age and with decrease in milk consumption. Goiter rate on the 
other hand increased with age (0% infants, 12% SAC, 38% women) (Jaffiol et 
al., 1997). In China, a similar picture was found in a recent multi-community 
study (Yan et al., 2005). Infants had the highest median UIC followed by SAC, 
women of childbearing age, lactating women and pregnant women, who had the 
lowest median UIC. However, all medians were above 150 µg/l. It has to be 
mentioned that salt iodization is mandatory in China (35 ppm) (Yan et al., 2005). 
Based on those study results, it seems common that women of childbearing age 
have lower UI values than SAC and infants. In contrast, the finding that infants 
have higher UICs than SAC was not encountered in the present Swiss study. 
There are, however, only a few studies available and further investigations are 
needed to decide why women have lower UICs than SAC (e.g. due to different 
food intake patterns or metabolic reasons) and whether they are at risk of ID. 
The iodine intake estimations from the US FDA Total Diet study would support 
the theory of different food intake patterns. In this study, SAC had a much 
higher estimated iodine intake which was mainly driven by the contribution of 
cow milk (70% of iodine intake versus only 49% in women) (Murray et al., 
2008). As already mentioned, milk together with bread is the most important 
dietary iodine source also in Switzerland (use of iodized kitchen salt not 
included) (Haldimann et al., 2005). 
Gowachirapant et al. explained their recent findings on higher UICs in SAC 
compared to pregnant women. They reported that SAC had a similar iodine 
intake compared to pregnant women, but that the daily urine volume of SAC is 
smaller compared to adults (Gowachirapant et al., 2009). The daily urine 
volume of a 26-kg child is about 600 ml based on a urine excretion of 0.9 
ml/kg/h (Joint FAO/WHO/UNU Expert Consultation, 2004; Mattsson and 
Lindstrom, 1995) and the approximate daily urine volume in adults is 1.5 l 
(Larsson and Victor, 1988). This is the reason for a higher dilution of iodine in 
women‟s urine and therefore for their lower UI concentrations (Gowachirapant 
et al., 2009). 
More studies are clearly required to ensure that women of reproductive age are 
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iodine-sufficient as ID in this population group can have detrimental effects 
during pregnancy and lactation. 
 
For years, people have been encouraged to consume less salt due to health 
reasons and the WHO recommends a population average for salt intake of < 5 
g/day (WHO, 2007). The Swiss Federal Office of Public Health reported in their 
“salt strategy” paper that between 2008 – 2012, a reduction of salt intake to < 8 
g/day/person (this corresponds to a reduction of 16%) is aimed at and that the 
long-term goal is to achieve the WHO recommendation (EDI et al., 2009). This 
will consequently also lead to a reduced iodine intake, if the salt iodization level 
is not increased. The WHO and the Swiss FOPH both stated that this fact 
needs to be considered and appropriate measures must be taken (e.g. 
elevation of salt iodization level or different vehicle for iodine) (EDI et al., 2009; 
WHO, 2007).  
A recent study in Switzerland estimated that about 35% (~ 2.8 g) of women‟s 
salt intake comes from discretionary salt consumption (Beer-Borst et al., 2009). 
Most of the women in our study used iodized salt at home (86%). However, the 
major part of salt intake comes from industrial food products (17% from bread, 
10% from cheese, 7% from meat(-products), 9% from soups, 5% from ready-to-
eat products) (Beer-Borst et al., 2009). Haldimann et al. stated that about 70% 
of salt used for the Swiss industrial food production is iodized (Haldimann et al., 
2005). Bürgi, however, reported that export-orientated food producers in 
Switzerland are reluctant to use iodized salt as this could be disadvantageous 
for their markets. Furthermore, he pointed out that an increasing number of 
imported processed foods are not produced with iodized salt (Bürgi, 2005). This 
is supported by the salt producer “Swiss Salt Works on the Rhine”, which 
confirms that decreasing amounts of iodized table salt (in bags) have been sold 
since 2006 (from about 1050 t in January 2006 to about 630 t in September 
2009). In contrast, the sales of non-iodized salt has increased (about 250 t in 
January 2006 to about 590 t in September 2009) (personal communication by S 
Trachsel, Swiss Salt Works on the Rhine AG, Pratteln, September 2009). A 
personal communication (C Daeniker Roth, Migros-Genossenschafts-Bund, 
Zürich, February 2009) of the large Swiss retailer “Migros” affirmed that many 
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Swiss food producers have halted the use of iodized salt due to export reasons. 
France e.g. does not allow the import of food products with iodized salt 
(personal communication). FROMARTE (a Swiss association of cheese 
producers) have also restricted the use of iodized salt for cheese production 
due to export reasons (personal communication by C Daeniker Roth, Migros-
Genossenschafts-Bund, Zürich, February 2009). This development could be a 
reason for the encountered decrease in UIC in the latest Swiss iodine 
monitoring study (2009) and should be carefully observed. The use of iodized 
salt at home did not change between the monitoring studies in 1999 and 2005 
(82 - 86%) (Zimmermann et al., 2005) and the percentage use in the present 
study (87%). 
An elevation of salt iodization will probably be necessary in the future in order to 
ensure a sufficient iodine supply for the Swiss population if the use of iodized 
salt by industries continues to decrease and the goal of a reduced salt intake of 
the population is achieved.  
 
5.5.2. Comparison of infants’ UIC and BMIC with previous 
studies 
An overview of studies on UIC in infants that were carried out between 1989 
and 2009 can be found in Appendix 3. Studies in newborns were not included 
as their iodine metabolism is probably not directly comparable with older infants. 
An overview of studies on BMIC within the last 10 years is given in Appendix 4. 
 
5.5.2.1. Urinary iodine concentration in infants 
In Switzerland, only one regional study on UIC examined 0 – 5-year-old children 
and women (Als et al., 2000b). The median UIC of 104 µg/l for 0-5 year old 
children was slightly higher than our overall median of 93.2 µg/l. However, most 
of the 31 children of Als et al.‟s study were probably older than the infants in the 
present study. Exactly the same median UIC was found when looking only at 
the 12-month-old infants of our study. Women of reproductive age also had a 
very similar median UIC (90 µg/l) (Als et al., 2000b) compared to the mothers in 
the present study and the other two recent studies. This indicates that women in 
Switzerland have had a median UIC below 100 µg/l for several years now. The 
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study of Als et al., however, was carried out before the elevation of salt 
iodization from 15 to 20 ppm in 1998. Als et al. concluded that the iodine status 
measured in their study was not satisfactory (Als et al., 2000b).  
 
Looking at worldwide studies on UIC, studies carried out in four countries found 
lower UIC values than we did: Germany (Manz et al., 1993), Italy (Rapa et al., 
1999), Malaysia (Foo et al., 1996) and New Zealand (Skeaff et al., 2005). The 
medians in these studies ranged from 11 µg/l to 69 µg/l. All countries except 
Germany were currently classified by WHO as having an insufficient iodine 
intake (WHO Nutrition, 2008a; WHO Nutrition, 2008b). Thirteen studies found a 
mean or median UIC which was higher than our median UIC, ranging from 120 
µg/l (Reunion Island) to 328 µg/l (France) (for references see Appendix 3). Six 
of those studies were carried out in countries that were classified as having a 
more than adequate or excessive iodine intake (Armenia, Mexico, Venezuela, 
Indonesia and China (2 studies)) (WHO Nutrition, 2008a). Two studies were 
performed in countries with an adequate iodine intake (Austria and India) (WHO 
Nutrition, 2008a). Three studies were carried out in France (Pouessel et al., 
2003; Pouessel et al., 2008; Valeix et al., 1994) and in all study sites, very high 
median UICs for infants were measured even though France is classified as ID 
by WHO (WHO Nutrition, 2008a). Two other studies, one in Turkey (mean UIC 
= 130 µg/l) (Yilmaz et al., 2003) and one in Reunion Island (median UIC = 120 
µg/l) (Jaffiol et al., 1997) measured higher UIC values compared to the present 
Swiss study, but the countries were classified as ID by WHO (WHO Nutrition, 
2008a). 
Only five studies found UIC medians close to the median UIC of our study. One 
was a local study in Belgium with 6-month- to 3-year-old children (n = 111). 
Their median UIC was 101 µg/l, which was classified by Delange et al. as ID 
(Delange et al., 2001). Belgium is also classified by WHO as having insufficient 
iodine intake (WHO Nutrition, 2008a).  
A large national study in the Czech Republic measured a median UIC of 104 
µg/l in 0- to 1-year-old infants and 114 µg/l in 1-5-year-old children. 
Measurements in SAC of the same study were 113 µg/l and for adults 98 µg/l 
(Bilek et al., 2005). Another large national study in Germany found higher 
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median UIC values for boys (113-133 µg/l) compared to our overall median, but 
identified the same or lower medians for girls  (82-100 µg/l) between 0 and 2 
years of age. The overall median UIC for children from 0-17 years was 117 µg/l 
(Thamm et al., 2007). The Czech Republic and Germany are classified as 
having an adequate iodine intake (WHO Nutrition, 2008a). Those two studies 
were probably the best comparable ones to our study as both were national and 
carried out in an iodine-sufficient European country.  
One other local study was carried out in Nigeria, which is also classified as an 
iodine-sufficient country. A mean UIC of 99 µg/l (n = 68) was found there in 9- to 
18-month-old infants. Mothers in this study had a mean UIC of 145 µg/l (Akanji 
et al., 1996). Nutrition habits in Africa are probably rather different from Europe 
and therefore this study is not ideal for comparison, especially as the study was 
carried out in a low socio-economic group (goiter-non-endemic area). This 
explanation might also be used for the study in Sudan, which was carried out in 
a goitrous area where no iodized salt was used. Still, a median UIC of 100 µg/l 
was measured in the study in  1 – 6-year-old children (n = 191) (Elnour et al., 
2000). However, all of those infants were probably older than the infants in the 
present study. 
 
In summary, it was difficult to draw conclusions about the iodine status in Swiss 
infants based on the reported earlier studies on UIC in infants because they 
usually did not include the same age range, were carried out in countries with 
different WHO iodine classification or in other cultures, were just regional/local 
or used different study settings. It was striking that median UIC in infants varied 
greatly by countries and sometimes was not consistent with the overall WHO 
country classification (e.g. France). However, the two only European national 
studies (Germany and Czech Republic) and the only earlier regional Swiss 
study were probably most comparable to the present study and reported UIC 
values which were slightly higher, but close to the median UIC of infants in the 
present Swiss study. Nevertheless, those studies found median UICs above the 
WHO cut-off of 100 µg/l (except for two sub-groups of girls in the German study, 
see above) (Als et al., 2000b; Bilek et al., 2005; Thamm et al., 2007), in contrast 
to our median in the total sample. This could indicate that Swiss infants are on 
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the borderline between adequate and inadequate iodine nutrition, especially the 
younger ones. 
 
5.5.2.2. Breast milk iodine concentration 
Even though infants rely on an adequate BMIC especially during exclusive or 
predominant breast-feeding and despite the importance of iodine for normal 
growth and brain development in infants, only a few studies have examined 
BMIC (Azizi and Smyth, 2009). No studies carried out between 1998 and 2009 
(summarized in Appendix 4) were performed on a national level.  
 
Four small studies on BMIC were carried out in Switzerland before the present 
study. Three of them examined colostral or transitory milk and observed a BMIC 
range between 78 and 98 µg/l (mean/median) (Facheinheit Lebensmittel und 
Gebrauchsgegenstände des Bundesamtes für Gesundheit, 2000; Hoang 
Truong et al., 1997). Semba and Delange reported in a review that the highest 
BMIC is found in colostrum and that the concentration then decreases and 
remains steady in mature milk (> 12th day post-partum) (Semba and Delange, 
2001). The BMICs measured in colostral/transitory milk samples in the earlier 
Swiss studies were therefore probably higher than we could expect for the 
mature BM we analyzed in the present study. The fourth Swiss study measured 
BMIC in mature BM samples (n = 52) and found a median BMIC of 68 µg/l 
(Facheinheit Lebensmittel und Gebrauchsgegenstände des Bundesamtes für 
Gesundheit, 2000). This value was still about 30% higher compared to the value 
measured in the present study. 
 
Comparing the median BMIC of the present Swiss study (51.2 µg/kg) with 
international studies, nine of the sixteen reported studies measured a higher 
mean or median BMIC than ours (listed in Appendix 4). All except one 
(Belgium) of those studies were carried out in countries that were classified by 
WHO as having an adequate or more than adequate iodine intake (Germany, 
Spain, USA, Iran, Australia and China) (WHO Nutrition, 2008a). 
Only two studies observed a BMIC that was lower than ours. A study in New 
Zealand, which is classified as an ID country, found a mean BMIC of only 22 
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µg/l (n = 39) in mature BM. The study also measured UIC in 6- to 24-month-old 
infants and their UIC was also lower compared to our results (Skeaff et al., 
2005). The other was a US study which reported a median BM iodide 
concentration of 33.5 µg/l. As they only measured iodide, the iodine content 
might actually have been higher (Kirk et al., 2005). 
In a study in Belgium (classified as an ID country by WHO), a median BMIC of 
78 µg/l was measured in transitory milk (Ciardelli et al., 2002). Laurberg et al. 
found a (geometric) mean BMIC of 53.8 µg/l in transitory milk of Danish women 
(n = 90). Denmark is also classified as ID by WHO and the study was carried 
out before the introduction of iodized salt into the market. (Geometric) mean 
UIC in those women was only 40.8 µg/l and 50.4 µg/l in infants (Laurberg et al., 
2004). A recent German study measured a median BMIC of 52 µg/l in 
colostral/transitory milk. Women were supplemented with iodine (150 µg K /day) 
during pregnancy. No data on sample size was given (Gärtner and Arbeitskreis 
Jodmangel, 2009). Another quite recent German study observed, however, a 
median BMIC of 156 µg/l in colostral/transitory milk (Bader et al., 2005) and a 
small Spanish study (a country classified as iodine-sufficient) reported a mean 
BMIC of 144 ± 93 µg/l (Fernandez-Sanchez et al., 2007). These recent 
European studies leave it unclear whether our measured median BMIC shows 
iodine-sufficiency or deficiency in women and thus in infants in Switzerland, but 
rather point to an inadequate iodine supply.  
In non-European countries, median/mean BMICs in the review of studies in 
Appendix 4 ranged from 43 µg/l (USA) to 163 µg/l (China) in countries with 
adequate or more than adequate iodine intake. Three recent US studies 
measured a mean/median BMIC between 43 - 55.2 µg/l (Dasgupta et al., 2008; 
Hannan et al., 2009; Kirk et al., 2007), which was close to our median BMIC. On 
the other hand, a US study in Boston women observed a median BMIC of 155 
µg/l (Pearce et al., 2007). Studies performed in Iran, Australia and China found 
higher median BMICs than we did, ranging from 84 µg/l (Australia) to 163 µg/l 
(China).  
Taking into account earlier reviews, a median BMIC of 50 µg/l has been 
reported from iodine-sufficient and from deficient countries (Dorea, 2002; 
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Semba and Delange, 2001; Zimmermann, 2007b). 
 
To draw conclusions on BMIC from all those studies is rather difficult as most of 
them included small sample sizes or were regional and used different methods 
to determine iodine in BM. It is, however, uncertain, based on the earlier 
studies, whether the measured BMICs in the present Swiss study indicate 
iodine-sufficiency, as the median concentration is at the lower end of observed 
concentrations in other studies of iodine-sufficient countries and as it is lower 
than in the earlier Swiss studies. 
 
 
In the next subchapters, possible factors that might have an influence on UIC 
and BMIC of infants and mothers are discussed and compared with results of 
earlier studies. It has to be mentioned however, that the number of subjects was 
often below thirty in the compared sub-groups of the present interim analysis 
(see results). Due to the small sample sizes, it is possible that some 
comparisons in the final study evaluation will lead to different results.  
 
5.5.3. Gender 
We did not detect significant gender differences in UIC between infants. Even 
though there was a strong tendency towards a difference in 6-month-old infants. 
6-month-old boys had the lowest median UIC (68.2 µg/l) and compared to 12-
month-old boys it was even significantly lower. The reason for this is unclear. 
There was equal breast-feeding prevalence in 6-month-old boys and girls (50% 
each). 
Gender differences in infants of our studied age groups were also not shown in 
several other studies (Pouessel et al., 2003; Pouessel et al., 2008; Skeaff et al., 
2005). In the Swiss newborn study no gender differences were observed either 
(Dorey and Zimmermann, 2008). 
Gender differences however, have been shown in older population groups.  
A study in Sudan with 1- to 6-year-old children showed a significantly higher 
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median UIC in boys compared to girls (Elnour et al., 2000). Those infants were 
generally older than the infants in our study were and suffered from various 
deficiencies. Therefore, those are not ideal for comparison. 
Thamm et al. examined UIC in German children between 0 and 17 years of age 
(n = 17‟641). Girls showed slightly lower median UICs at all ages with values 
below 100 µg/l at one and two years. The publication did, however, not indicate 
any significances regarding UIC between genders (Thamm et al., 2007).  At the 
age of one year, in contrast, girls and boys of our study group showed nearly 
the same median UIC (girls = 103.7 µg/l; boys = 104.3 µg/l). 
In a small regional Swiss study on UI excretion (total n = 412; subjects between 
0 to > 65 yr) women showed significantly lower UI values compared to men (Als 
et al., 2000b). Women of child-bearing age (13-35 yr) had the lowest values 
with a median UIC of 90 µg/l. Men in the same age group had a median UIC of 
around 150 µg/l. The researchers wondered whether the reason for this could 
lie in: 1) different iodine intakes in analogy to different proteo-caloric intakes 
between genders, 2) a qualitatively different diet of women, 3) smaller urine 
volumes in young men due to their higher perspiration (because of higher 
physical activity) (Als et al., 2000b). 
 
5.5.4. Weight/length/BMI 
In our study infants, there were no significant correlations between body weight 
or length and UIC. 
In two French studies, no relation between nutritional status and UIC in infants 
was found either (Pouessel et al., 2003; Pouessel et al., 2008).  
In the regional Swiss study of Als et al., UIC did not correlate with weight or BMI 
in the examined age groups (0 to > 65 yr) (Als et al., 2000b). In our study, 
however, we found a weak but significant correlation between UIC of mothers 
and their BMI. This resulted perhaps from a higher energy and nutrient intake of 
mothers who had a higher BMI. 
No correlations were found between weight and BMIC as well as BMI and 
BMIC. 
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5.5.5. Nationality 
Most of the mother-infant pairs participating in the study were Swiss (85%; 
nationality of the mother). The percentage of Swiss versus foreign nationalities 
in the present study was close to the overall distribution in Switzerland (21.7% 
foreign nationalities (Bundesamt für Statistik, 2008a)).  
Looking at the total sample and then only at the 12-mo group, foreign infants 
had a 37% higher median UIC compared to Swiss infants (significant). In 6-
month-old infants, foreign infants also had a higher median UIC than Swiss 
infants, but the difference was not significant. Reasons for the higher UI values 
in foreign infants could be different feeding practices or food choices.  
According to the indications that mothers gave about feeding practices on the 
individual registration forms, Swiss and foreign infants were fed rather similarly 
concerning milk types (chi-square, p = 0.31):  
Swiss:  BM: 26.0%, FM: 46.4%, BM & FM: 14.2%, no BM and no FM: 13.5%;  
Foreign: BM: 22.0%, FM: 48.0%, BM & FM:   8.0%, no BM and no FM: 22.0%. 
The percentage of breast-fed Swiss infants (40%) was 10% higher compared to 
foreign infants (30%), but the association was not significant (chi-square, p = 
0.17). All foreign infants received CF/FF compared to 93% of the Swiss infants. 
A higher percentage of foreign infants was fed milk-cereals with FM (39%) or 
cow milk (25%) compared to Swiss infants (30% and 13%, respectively; chi-
square, p = 0.21 and p < 0.05). Diluted/undiluted cow milk was fed to 
approximately the same percentage of infants in both groups (Swiss: 22%, 
foreign: 25%; chi-square, p = 0.30). A higher percentage of foreign infants 
received vegetable-carbohydrate (98%) and fruit meals (84%) as well as meals 
from the family table (58%) compared with Swiss infants (88%, 69% and 46%, 
respectively; chi-square, p < 0.05, p < 0.05 and p = 0.27). Moreover, the 
percentage of infants who already received salt was higher in foreigners (70%) 
compared with Swiss (54%) (chi-square, p = 0.09). There was no significant 
difference in the percentage use of iodized salt in Swiss and foreign households 
(87% and 82%, respectively; chi-square, p = 0.13). 
Therefore, some differences in feeding practices between Swiss and foreign 
infants living in Switzerland seem to exist, which might have an influence on 
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UIC. The evaluation of the dietary questionnaires could provide more 
information about this topic. 
 
Two French studies also observed significant differences between UIC of 
infants from different ethnic/geographic origins, but no explanation for this was 
given by the authors (Pouessel et al., 2003; Valeix et al., 1994). 
 
UICs and BMICs did not significantly differ between Swiss and foreign mothers.  
 
5.5.6. Pediatric practice/region 
No significant differences between pediatric practices were found for all three 
parameters. We did not expect differences and the study was not designed to 
compare single pediatric practices with each other. 
 
There was a significant difference in UIC of infants between the seven Swiss 
greater regions, but not in UIC or BMIC of mothers. In the previous monitoring 
studies in Switzerland, no significant differences were observed between 
regions (Hess et al., 2001; Zimmermann et al., 2005). We also did not expect a 
difference. However in infants, the median UIC in the Ticino region was 
significantly higher compared to two other regions. The median UIC in infants in 
Ticino was 184.3 µg/l (n = 17). The medians of all other regions varied between 
67.8 and 100.0 µg/l. Ticino represents the Italian speaking part of Switzerland. 
The mothers there might also buy infant foods from Italy. Perhaps the iodine 
content of Italian infant food products differs from Swiss products. However, this 
could be clarified with the questionnaires.   
Interestingly, the median UIC and BMIC of mothers were also highest in the 
Ticino region (not significant). Such a tendency (not significant) for higher 
median UIC in Ticino was already seen in SAC in the 2004 iodine monitoring 
study (Zimmermann, 2005) and in the new 2009 monitoring study (personal 
communication, I Henschen, ETH Zurich, 2009). The investigators of these 
studies suspected that soil or water in Ticino might have a different iodine 
concentration compared to the German part of Switzerland, which could lead to 
different iodine excretion. This presumption needs to be further explored. 
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5.5.7. Urban - rural area of pediatric practice 
Only 15% (n = 52) of infants were recruited from pediatric practices in rural 
areas (in total four practices). In Switzerland, 26% of the population lived in rural 
areas in 2008 (Bundesamt für Statistik, 2008b). Consequently, subjects from 
urban areas were probably overrepresented in the present study. However, 
some of the subjects who had their pediatrician in an urban area, maybe 
actually lived in rural areas. We suspected that people living in rural areas might 
have different dietary habits compared to people from urban areas and thus, 
they might have different iodine intakes. Proportions of breast-feeding mothers 
were quite similar between urban and rural areas (39% and 36.5%; chi-square, 
p = 0.74). The percentage of formula-fed infants was higher in urban areas than 
in rural areas, but the difference was not significant (61% and 52%; chi-square, 
p = 0.20). Furthermore, the feeding practices of different types of CF, family 
food and salt use did not differ significantly on a percentage basis between 
urban and rural areas (data not shown; chi-square, all p > 0.05).  
We did not detect significant differences in UIC of infants and mothers between 
urban and rural areas, even though the median UIC of infants from urban areas 
(97 µg/l) was 33% higher than the median UIC in infants from rural areas (73 
µg/l). However, median BMIC in urban areas (56 µg/kg) was significantly higher 
than in rural areas (42 µg/kg). Nevertheless, there was no significant difference 
in UIC between lactating mothers from urban (median UIC = 72 µg/l) and rural 
areas (median UIC = 63 µg/l). 
 
In the regional Swiss study of Als et al. (2000) no significant difference in UIC 
between suburban and rural areas was found in all the examined age groups (0 
- > 65 yr).  
In a study in Sudan in 1 – 6-year-old children, no significant difference in UIC 
was found between urban and rural areas either (Elnour et al., 2000). 
An Armenian study found that UIC of infants in rural areas was lower compared 
to urban areas, even though the percentage use of iodized salt was higher in 
rural areas. No explanation was given for this finding (Rossi and Branca, 2003). 
Rapa et al. (1999) also detected a significantly higher median UIC in SAC of 
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urban areas compared to SAC of rural areas in Italy. UIC of newborns had a 
positive correlation with UIC of SAC. Therefore, the authors concluded that UIC 
of people living in the same environment showed similar trends (Rapa et al., 
1999). 
 
5.5.8. Month of study registration/sample collection 
Seasonal variations in UIC were observed in previous studies. Lower UI values 
were found in summer compared to winter in a national Czech study (Bilek et 
al., 2005) as well as in an earlier Swiss study (Als et al., 2003). In the Swiss 
study only children and not adults had lower UI values in summer (Als et al., 
2003). The investigators of both studies attributed the variations in UIC to 
seasonal variations of iodine concentration in cow milk and dietary habits (see 
also background section 2.3.1) (Als et al., 2003; Bilek et al., 2005). In the Swiss 
study, milk was a more important iodine source for children than for adults for 
what reason probably the variations were only observed in children (Als et al., 
2003).  
In the interim analysis of the present study, UI and BM samples that were 
collected between August 2008 and May 2009 were included. However, no 
significant differences and no patterns were observed in UIC of infants and 
mothers or BMIC between different months of sample collection. 
 
5.5.9. Supplement use 
A low percentage of mothers from the present study was taking an iodine-
containing supplement, five lactating mothers and eight non-lactating mothers. 
Perhaps due to this low percentage, we did not observe significantly higher 
UICs or BMICs in mothers taking an iodine-containing supplement. 
 
In their recent study, Laurberg et al. detected that the intake of iodine 
supplements was positively associated with UIC of mothers and infants and with 
BMIC (Laurberg et al., 2004). 
 
Iodine supplementation during pregnancy and lactation is not recommended by 
Swiss Nutrition Society (SGE) (Schweizerische Gesellschaft für Ernährung 
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SGE, 2008), the Swiss Gynecologist Society (SGGG) (oral communication, May 
2009) or the Swiss Federal Office of Public Health (Camenzind-Frey and 
Hesse-Lamm, 2008).  
The widest used multivitamin/mineral supplement of Swiss pregnant and 
lactating women is Elevit (Bayer (Schweiz) AG, Zürich) which does not contain 
iodine. 
 
According to WHO recommendations, Switzerland is not a country that needs 
iodine supplementation for lactating women because it is classified as iodine-
sufficient by WHO (WHO Nutrition, 2008a; WHO Secretariat on behalf of the 
participants to the Consultation et al., 2007). This classification is however, 
based on the iodine monitoring studies in 1999/2004 (Hess et al., 2001; 
Zimmermann et al., 2005). Taking into account the present study and the 
pregnant women in the latest Swiss monitoring study (2009), Switzerland would 
already rather belong to the category of countries for which WHO suggests 
iodine supplementation for women of reproductive age, pregnant and lactating 
women (WHO Secretariat on behalf of the participants to the Consultation et al., 
2007). 
 
Bazrafshan et al. recently measured a median BMIC of 93.5 μg/l in 100 Iranian 
mothers, who showed a high median UIC of 259 μg/l. However, the authors 
concluded that some breast-fed infants were at risk of ID as 19% of BMICs 
were below their applied cut-off of 50 μg/l. They proposed iodine supplements 
for lactating mothers (Bazrafshan et al., 2005). Also, other studies which 
measured even higher BMICs than we did in the present study, suggested 
supplementation of lactating mothers in order to ensure a sufficient iodine intake 
in infants (Ciardelli et al., 2002; Pearce et al., 2007; Yan et al., 2005). The 
American Thyroid Association recommends supplementation with 150 µg 
iodine/day for pregnant and lactating women in the USA and Canada (Becker et 
al., 2006). Iodine supplementation with iodine tablets (100 - 150 μg iodine/day) 
is also recommended by the German “Arbeitskreis Jodmangel” for pregnant and 
lactating women in Germany (Arbeitskreis Jodmangel, 2006). 
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Therefore, iodine supplementation of lactating mothers would also probably be 
a good means for Switzerland, especially as the median UIC of mothers was 
below the WHO cut-off and as lactating mothers showed significantly lower 
UICs compared to non-lactating mothers. Furthermore, BMICs measured in the 
present study were low and breast-fed infants had a significantly lower median 
UIC than non-breast-fed infants. In addition, the overall median UIC of infants 
was also below the current WHO cut-off. By iodine supplementation of lactating 
mothers, breast-fed infants would consequently also receive more iodine 
through BM (WHO Secretariat on behalf of the participants to the Consultation 
et al., 2007). 
 
5.5.10. Iodized salt 
Only 6% of the mothers acknowledged not using iodized salt at home and 7% 
did not know what kind of salt they used. The high percentage of iodized salt 
users in the present study is in accordance with earlier monitoring studies 
(Dorey and Zimmermann, 2008; Zimmermann et al., 2005). This is 
consequently not suggested to be the reason for the decreasing tendency of UI 
values in Switzerland.  
No significant differences were detected in UIC or BMIC between mothers using 
iodized salt and non-iodized salt. We had, however, very small numbers in the 
subgroups of non-iodized salt for comparison. 
  
Also, no significant difference in BMIC was found between users and non-users 
of iodized salt in the Boston study of Pearce et al. (Pearce et al., 2007). 
 
Even if salt should be avoided during the first year of life (Swiss pediatric 
society, 2002), 12% and 86% of mothers reported using salt in home-made 
meals for their 6-month-old and 12-month-old infants. The percentage of 
mothers who indicated using iodized salt was only 64% in the 6-mo group and 
81% in the 12-mo group. No significant differences were found between the 
infants who received iodized salt, non-iodized salt or for whom the kind of salt 
was unknown. Nevertheless, the median UIC was higher in infants who 
received iodized salt compared to the other infants. In addition, infants who 
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already received salt in home-made meals had higher UICs compared to infants 
who did not yet receive any salt (only significant when examining both age 
groups together). The reason for this is unclear. As most infants probably 
received very small amounts of salt, other iodine sources presumably 
overlapped the influence of (iodized) salt on iodine excretion. No clear 
differences in feeding patterns could be detected between the different groups 
of salt users based on the data from the individual registration forms. 
 
In a New Zealand study with infants and toddlers, there was no significant 
difference in mean UIC between children whose caregivers used iodized salt 
and those whose caregivers did not (Skeaff et al., 2005). 
 
5.5.11. Social demographics 
Smoking 
Smoking is suspected to have a negative influence on BMIC as thiocyanate 
from smoke inhibits iodine uptake by the mammary gland (Laurberg et al., 
2004). Nine percent (n = 30) of the mothers who filled in the sociodemographic 
questions in the dietary questionnaire indicated that they are smokers. Five of 
those were lactating. Median UIC was the same between smokers and non-
smokers. Median BMIC of smoking mothers (27.8 μg/kg) was 50% lower 
compared to non-smokers (54.3 μg/kg). However, as just four smoking mothers 
provided a breast milk sample, this number was probably too small to detect a 
significant difference.  
 
Pearce et al. found no significant difference in UIC between lactating women 
who smoked and who did not smoke (Pearce et al., 2007). The same finding 
was also observed by Laurberg et al., but they found that smoking mothers (n = 
50) had significantly lower BMICs (geometric mean = 26 µg/l) compared to non-
smoking mothers (n = 90; BMIC = 54 µg/l). In addition, the neonates of smoking 
women had significantly lower UI values (geometric mean = 33 µg/l) compared 
to the neonates from non-smoking women (geometric mean = 50 µg/l) 
(Laurberg et al., 2004). Pearce et al. also found a highly significant lower mean 
BMIC in smokers (62 µg/l) compared to non-smokers (221 µg/l) (p = 0.0005) 
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(Pearce et al., 2007). 
 
This topic remains interesting and for the final data evaluation, more data about 
BMIC of smoking mothers will be available. However, it is strictly recommended 
not to smoke during lactation in order to protect the infants from the risk of 
developing ID and of course from the overall detrimental effects of smoking. 
 
Occupational/educational background of mother 
Nearly 50% of the mothers who participated in the study had an occupation in 
the category “health, education & culture, scientists”. The connection with their 
occupation to health questions and consequently a high interest in nutrition, 
could be a reason for this incidence. We assumed that these mothers might 
have a better knowledge about iodine nutrition. Therefore, we compared this 
occupational category with the others. We discovered however, that mothers 
with a “health, education & culture, scientists” occupation had a lower median 
UIC (74.3 µg/l) compared to others (94.7 µg/l) (difference significant). This could 
be interpreted by the fact that 47% of mothers with a “health, education & 
culture, scientists” occupation were lactating and only 34% were lactating in the 
other categories (chi-square, p < 0.05). They might also have a healthier 
lifestyle using less salt or ready meals with salt and this might have resulted in a 
lower iodine intake. BMICs were however, not significantly different between 
those categories. There was also no significant difference in UIC between the 
infants. 
 
It is often the case that a high percentage of people with higher educational 
levels participate in scientific studies. According to the Swiss Federal Statistical 
office (BFS), 16.8% of women have a lower than secondary level education (no 
post-compulsory education), 57.6% have a secondary level education, 6.7% 
have a higher vocational education and 18.9% a university level education 
(Bundesamt für Statistik, 2009b). Compared to this data, the mothers of the 
present study had a higher education level than the population average (52% 
compulsory school/secondary level, 25% higher vocational education, 23% 
university level). 
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However, we did not detect significant differences in UIC of infants and in UIC 
and BMIC of mothers between the different education levels. 
 
Other studies have also found no differences in UIC between infants of 
mothers/parents with different education levels or occupation categories 
(Pouessel et al., 2003; Pouessel et al., 2008; Valeix et al., 1994). 
A recent Iranian study observed no association between educational level or 
occupational status and iodine status in mothers (based on UIC and BMIC of 
lactating mothers, n = 100) (Bazrafshan et al., 2005). 
 
5.5.12. Correlations of UIC and BMIC between infants and 
mothers 
There was no correlation detected between UIC of breast-fed infants and UIC of 
their mothers and no significant association was observed between maternal 
UIC and BMIC. However, UIC of breast-fed infants was significantly positively 
related to BMIC in the present study.  
 
A recent Indian study also observed no significant relationship between UIC of 
exclusively breast-fed infants and UIC of their mothers (Gupta et al., 2006). In 
contrast, Akanji et al. found a significant positive correlation between UIC of 
(almost) exclusively breast-fed infants (9-18 months old) and UIC of mothers (n 
= 68 each, r = 0.47). Mothers in the study had a 46% higher mean UIC 
compared to their infants (mean mothers: 145 µg/l, infants: 99 µg/l) (Akanji et 
al., 1996). 
As in the present study, BMIC and UIC of lactating women were not significantly 
correlated in a Boston (mature milk, n = 57) (Pearce et al., 2007) and Australian 
study (transitory milk, n = 49) (Chan et al., 2003). In contrast, in two recent 
Iranian studies, including 100 and 142 lactating iodine-sufficient mothers, a 
moderate but significant relationship between BMIC and UIC of mothers was 
shown (mature milk) (Azizi and Smyth, 2009; Bazrafshan et al., 2005). 
Similarly to the present Swiss study, there was also a significant positive 
correlation found between UIC of infants and BMIC in a recent Chinese study (> 
90% of households in the studied area used iodized salt since 2000) (Wang et 
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al., 2009). 
Ordookhani et al. recently examined Iranian neonates and their mothers (n = 
42) and detected significant positive correlations between maternal and 
neonatal UIC, neonatal UIC and BMIC and maternal UIC and BMIC 
(Ordookhani et al., 2007). 
 
The varying findings of the earlier studies in comparison with the present study 
indicate that there are no clear relationships between UIC and BMIC in infants 
and mothers. 
 
5.6. Influence of infant feeding practices on urinary iodine 
concentration 
The influence of infant feeding on UIC was examined based on the data about 
feeding practices on the individual registration forms.  
 
It was not possible to compare general infant feeding patterns of the present 
study with the previous study on infant feeding in Switzerland of Dratva et al. 
and Merten et al. (see background) as they indicated feeding prevalence of milk 
and CF for other age subgroups than ours and as the prevalence changed 
quickly from one to the next age subgroup (Dratva et al., 2006; Merten et al., 
2005). 
 
Milk is the most important iodine source for infants (Mills and Tyler, 1992; 
Murray et al., 2008) and its intake was assumed to be more stable from day to 
day compared to complementary/family foods. Therefore, we subdivided the 
infants according to the pattern of BM and FM intake for the analysis. UIC 
differences according to the milk feeding practice were already discussed above 
(see chapter 5.5.1). 
 
Similar findings concerning the difference in UIC according to milk feeding 
pattern were also found in two earlier studies. In the New Zealand study 
(including 6 - 24 month old children, n = 230) formula-fed children had a 
significantly higher (geometric) mean UIC (105 µg/l) compared to breast-fed 
children (40 µg/l), formula- and breast-fed children (56 µg/l) and children who 
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did not receive BM or FM at all (56 µg/l) (Skeaff et al., 2005). FM was the only 
feeding mode that was significantly different from the others. BMIC in the New 
Zealand study was very low with a mean of 22 µg/l. The reported mean iodine 
concentration of FM in New Zealand was 95 µg/l (range 30 - 270 µg/l) (Skeaff et 
al., 2005). Manz et al. also observed that breast-fed infants had significantly 
lower UICs compared to infants fed with FM (age: 3 – 5 mo, total n = 78) (Manz 
et al., 1993). 
 
Pouessel et al. found in France (n = 160, children 10 days - 6 years old) that the 
only significant risk factor for UIC below 100 µg/l was the consumption of FM 
(median UIC = 165 µg/l; 29% < 100 µg/l) compared to the consumption of BM 
(exclusive), cow milk or no milk at all at the time of study (breast milk 
consumers (exclusive): median UIC = 206 µg/l; cow milk consumers: median 
UIC = 220 µg/l; together 19% < 100 µg/l) (Pouessel et al., 2003). This finding 
about FM is in contrast to the results of the present study. A reason for this 
could be that their study population included a wider age range (34% 0-6 mo, 
36% 6 – 24 mo, 30% > 24 mo) (Pouessel et al., 2003). Older children have a 
different eating pattern compared to younger children, e.g. the older ones 
probably consume more iodized salt. The investigators found however, no 
significant difference in UIC between age groups. Pouessel et al. did not 
measure BMIC or iodine content of FM/cow milk which are probably different in 
France compared with Switzerland (Pouessel et al., 2003). The much higher 
median UIC of exclusively breast-fed infants in this French study compared to 
the present Swiss study points out that BMICs are also much higher in France 
compared with Switzerland. 
 
It seems clear that the median UIC in (exclusively/predominantly) breast-fed 
infants is only lower than in formula-fed infants when the iodine concentration in 
BM is lower than in FM. In the new Swiss regulation, which should be 
implemented by March 2010, the allowed iodine concentration in FM is between 
6.5 µg/100ml and 32.5 µg/100ml (EDI, 2005b). This is higher compared to the 
measured BMIC of 5.1 µg/100ml in the present study. The mean ± SD iodine 
content of formula products in our infant food database was 11.8 ± 3.5 µg/100 
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ml and ranged from 4.0 to 18.2 µg/100 ml. This mean is about twice as high as 
the measured median BMIC. This supports our finding that infants receiving FM 
have a higher median UIC than breast-fed infants (no FM).  
The reported average iodine content of cow milk (whole milk, pasteurized) in 
Switzerland is 7.6 µg/100 g (SwissFIR, 2008) which is in-between BM and FM.  
In Switzerland, fortification with iodine is only mandatory for FM and not for 
complementary foods such as cereals or purees (EDI, 2005b). 
At 6 months of age, complementary foods are usually recently introduced and 
rather small quantities are eaten in addition to BM/FM. Therefore, they might 
not have any substantial influence on the total iodine intake and nearly all iodine 
comes from BM/FM. Most of the 6-month-old infants in the present study 
received vegetable or fruit purees, which were probably often home-made and 
therefore not fortified with iodine. Only 8% of the mothers reported using iodized 
salt for their infants‟ meals. Interestingly, 6-month-old non-consumers of 
vegetable-carbohydrate(-meat) meals had significantly higher UICs than 
consumers. The reason for this is unclear. The distribution of the non-
consumers to the milk-feeding categories (BM, FM and BM & FM) was about 
equal. 
At 12 months of age, CF/FF such as milk-cereal-porridges, cow milk and other 
dairy products along with bread, maybe fish, eggs and iodized salt usually 
contribute to a higher percentage of the total iodine intake than in younger 
infants. This might be a reason why no significant difference in UIC of 12-
month-old infants was detected between the four feeding groups which were 
only based on BM/FM feeding practice. Nevertheless, 12-month-old infants who 
received FM or BM & FM had higher median UICs than infants who only 
received BM or neither BM nor FM, which indicates that FM still had a high 
influence on iodine intake compared with CF/FF. It was not possible to further 
subdivide the infants according to their CF consumption as this would have 
resulted in too small sample sizes per group. As mentioned before, milk (BM, 
FM, cow milk) and dairy products have been shown to have the highest 
contribution to the daily iodine intake in infants (Mills and Tyler, 1992; Murray et 
al., 2008) and therefore, the amount of iodine in these foods will anyway mainly 
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influence the iodine status in both age groups. 
 
An evaluation of the dietary questionnaires could show whether infants who 
mainly receive non-iodine-fortified home-made meals have a significantly lower 
iodine supply compared to infants who are fed with fortified industrial foods. 
This was supposed by some German and Swiss authors (Alexy et al., 2009; 
Dähler et al., 2007; Kersting, 2001) (see also chapter 2.3.3.3). All FM products 
that were added to the infant food database so far were fortified with iodine as 
required by law (EDI, 2005b). Only 28% of commercial complementary foods 
were fortified with iodine. Most of the fortified CF products were instant milk-
cereals (47%). The assumption of the above mentioned German and Swiss 
authors is already partially supported by the presently available study results 
looking at the consumption of FM. Formula-fed infants had a higher median UIC 
than non-formula-fed infants. However, the difference in UIC was only 
significant in 6-month-old infants and not in 12-month-olds.  
 
5.7. Iodine measurements in infant food 
5.7.1. Formula 
In 1999, the Swiss FOPH measured iodine content in formulae at the same 
laboratory as we did. They found high variations between labeling and 
measurement results and four products even did not fulfill the legal 
requirements of iodine (Facheinheit Lebensmittel und Gebrauchsgegenstände 
des Bundesamtes für Gesundheit, 2000). 
None of our measured iodine concentrations in formula products differed much 
from the labeled concentration (mean abs. difference 13%). None of the 
products had a concentration below the legally required 5 µg/100kcal. 
According to the new regulation (effective from March 2010), the measured 
iodine content of two products (Bimbosan and Bimbosan Bio) would have been 
below the required minimum content (10 µg/100kcal). No product exceeded the 
allowed 50 µg/100kcal (EDI, 2005b). Our results indicate that the producers 
label their products correctly in terms of iodine content.  
The measured differences could have occurred due to natural variations of 
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iodine in the product. On some packages there is an indication concerning 
natural variations of the product (Bimbosan products). The main part of iodine in 
the products comes from fortification. An additional amount of iodine may 
originate from the cow milk, which shows seasonally varying iodine 
concentrations depending on the amount of iodine in the fodder. Winter milk has 
higher iodine concentrations compared to summer milk (Haldimann et al., 
2005). The kinds of milk used were: skimmed milk (Milumil 2), skimmed milk 
and partially demineralized whey powder (Galactina 2, HiPP 2, Holle 2, and 
Beba 2), partially demineralized whey powder (Beba HA 2), skimmed milk and 
demineralized whey powder (Bimbosan (Bio), Adapta 2, Aptamil 2). The 
variations could also have partly occurred during preparation of the FM samples 
or the ICP-MS measurement. 
 
Pearce et al. measured iodine content in US formula milk and found much 
higher iodine contents than the labeled ones in many of the products 
(sometimes 7x higher) (Pearce et al., 2004). No explanation for this finding was 
given. In another more recent study, Pearce et al. again measured iodine 
concentrations in US formula milk products that were significantly higher 
compared to the labeled values (Pearce et al., 2007). 
 
5.7.2. Infant cereals 
The comparison of labeled and measured iodine contents of reconstituted infant 
cereals showed only small differences, indicating that the labeling was correct. 
For the ready-to-eat HiPP product the measured iodine content was only about 
half of the labeled content. A reason for the large difference could be that this 
product was not iodized, but contained 50% whole milk. Therefore, the actual 
iodine content could differ from the labeled one due to natural variances 
(Haldimann et al., 2005). 
For one Nestlé product (“Baby Menu Milchgriess”), the measurement in the 
instant powder showed a large difference compared to the measurement in the 
reconstituted product. The quantity of iodine per portion measured in the instant 
powder was about 50% lower (see also results). The reason for this needs to be 
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further investigated. However, it could be that the particles in this product are 
too roughly textured and are not digested well enough with TMAH in the dry 
product and therefore interfere with the measurement. This problem was also 
recognized by Fecher et al. who showed that iodine associated with larger 
sample particles (> 300 μm) was not extracted with TMAH and therefore not all 
iodine was determined with ICP-MS (Fecher et al., 1998). Visually, the products 
did not show much difference between each other. All infant cereals were rather 
smooth, homogeneous powders. Nevertheless, they were less smooth than the 
formula products.  
 
5.7.3. Infant formula reference 
The measurement of the infant formula reference samples showed that our FM 
and infant food measurements were reliable as the products have very similar 
matrices to the reference.  
If the infant formula reference would have been measured in the reconstituted 
form instead of in the powder form, the measured concentrations might have 
been even closer to the certified mean. The powder did not dissolve well in the 
tubes (therefore ultrasound bath treatment was applied) and the solutions 
showed some small residues on the tube wall after the TMAH digestion of which 
probably not all iodine went into solution. This needs further investigation. 
 
In accordance with the present measurements, Fecher et al. showed in a round-
robin test with 15 laboratories that the determination of iodine in an infant milk 
porridge and a soy diet (artificially enriched with iodide, both from Milupa, 
Germany) was accurate and precise with the TMAH-extraction ICP-MS method 
(procedure very similar to ours) in dry and reconstituted samples (Fecher et al., 
1998).  
 
5.8. Limitations of the study 
Several limitations should be pointed out in the current study. 
The selection of pediatric practices and study subjects was not random, which 
could have had an influence on the results. The pediatricians were asked to try 
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to enroll every eligible mother-infant pair, if feasible. It is however possible that 
some pediatricians chose mothers from whom they expected good cooperation 
e.g. when they had a high workload in the practice. The pediatricians had to 
keep just a list of the subjects who agreed to participate in the study and not of 
all eligible subjects who visited the pediatric practice during the study period. It 
is possible that in general, more mothers who were interested in nutrition and 
who had time to be engaged in the study participated. This is an often 
experienced problem with scientific studies. However, mothers of young 
children are probably more interested in health and nutrition (especially of their 
infant) compared with other population groups. 
Most of the mothers collected the samples at home. This may have led to less 
standardization of the study even if we provided clear instructions for the 
sample collection at home in order to standardize as far as possible. 
Pediatricians were also instructed to ask mothers to do the sample collection 
ideally on the same day as the practice visit or as soon as possible. Most, but 
not all mothers, followed this instruction. The best standardization would have 
been to have a large enough well-instructed study team from ETH instructing 
parents about sample collection and questionnaires, filling in forms and directly 
doing the sampling. This was not possible due to limited human, financial and 
time resources. Therefore, the best solution was seen in a cooperation with the 
pediatricians who were instructed as well as possible. 
The study information was provided in the three national languages (depending 
on the language of the region). We did not have the resources to translate the 
information into more languages. Therefore, mothers living in Switzerland for 
more than one year before and after the infant‟s birth, but who were not able to 
speak German, French or Italian, might have been under-represented in the 
study. 
 
A small sample size in some group comparisons was a limitation of this interim 
analysis of the study. 
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6. CONCLUSION 
For many years, Switzerland has successfully eliminated the adverse health 
consequences of ID by iodization of salt. Therefore, Switzerland has been 
classified as a country with adequate iodine intake by WHO (de Benoist et al., 
2008). The need for a reliable reference range for UIC in infants based on new 
studies was recently addressed by the WHO (WHO Secretariat on behalf of the 
participants to the Consultation et al., 2007). UIC of newborns was already 
measured in a previous national study in Switzerland (Dorey and Zimmermann, 
2008). The first aim of the present study was to collect nationally representative 
data on UIC in 6- and 12-month-old infants to obtain the entire range of UIC of 
infants in the first year of life. This data was then planned as basis to set a UIC 
reference range with the precondition that infants in Switzerland are iodine-
sufficient. This should be confirmed by determination of UIC and BMIC in the 
infants‟ mothers and by assessment of the infants‟ dietary iodine intake with 
dietary questionnaires. The estimated required sample size for setting the 
reference range was 600 infants per age group. During the diploma thesis, the 
study was set up (including development of the self-administered dietary 
questionnaire) and it was executed in the first months of sampling. In an interim 
study analysis, the iodine excretion of infants and mothers was examined and 
their iodine status was evaluated based on the first urine samples of infants (n = 
339) and mothers (n = 343), breast milk samples (n = 119), formula and infant 
food samples (n = 22) and the obtained data on the individual registration forms 
(including current infant feeding practices). 
In the interim analysis, lower UI values of infants and their mothers than 
expected were found. The overall medians of infants and mothers were below 
the currently available cut-off of 100 µg/l as defined by WHO (World Health 
Organization et al., 2007) and the median of infants was even far below the 
range proposed by Delange of 180 – 225 µg/l (Delange, 2007). 6- and 12-
month-old infants did not differ significantly in UIC although the median UIC of 
12-month-old infants, which was just above the WHO cut-off, was higher than 
the median of 6-month-old ones. Furthermore, the 2009 Swiss iodine monitoring 
study in SAC and pregnant women showed lower UI values than in the 
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monitoring study five years ago (Zimmermann et al., 2005) with pregnant 
women on the border of mild ID (personal communication, I Henschen and A 
Piacenza, ETH Zurich, 2009). As with mothers in the present study, women of 
childbearing age in two other recent local studies in Switzerland showed median 
UICs below 100 µg/l (personal communication, M Andersson and M 
Kammermann, ETH Zurich, 2009). It could not be concluded from currently 
available data whether women in Switzerland are mildly iodine-deficient or their 
median UIC is naturally lower than in SAC who were the basis for the WHO cut-
off. About 50% of the mothers in the present study had an occupation in the 
health/education/science sector and their median UIC was significantly lower 
compared to the other mothers. 
Median BMIC was lower than in earlier regional studies carried out in 
Switzerland. It was just above 50 µg/kg which was used as cut-off for ID by 
Bazrafshan et al. (Bazrafshan et al., 2005) and about 50% below the cut-off of 
100 µg/l which was proposed by Semba and Delange (Semba and Delange, 
2001). Median BMIC was about 50% lower than the mean iodine content of FM 
products consumed by the study infants. 
Breast-fed infants and lactating mothers were found to have significantly lower 
UICs compared to non-breast-fed infants respectively non-lactating mothers. 
These subgroups could therefore have an insufficient supply of iodine along 
with the rather low median BMIC. UIC of breast-fed infants correlated 
significantly positively with BMIC. 6-month-old infants who received only breast 
milk (as milk source) were at greatest risk of having a low UIC (based on 
median UIC) probably because of the low BMIC. The estimated average daily 
iodine intake of these infants (based on BMIC and UIC) was below all available 
recommendations for iodine intake.  
Including all infants, the estimated average daily iodine intake was close to most 
of the European intake recommendations, but it was much lower than the 
recommendations of the WHO (World Health Organization et al., 2007) and the 
US institute of medicine (Institute of Medicine et al., 2001).  
A conclusion about the infants‟ iodine status based on a comparison to earlier 
studies was difficult due to the varying study settings and as the measured UICs 
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and BMICs varied considerably between the studies. The medians of the 
present study were among the lower measured medians. The median UIC of 
infants (total sample) was, however, close to the measured median UICs in the 
two only national studies in iodine-sufficient European countries (Bilek et al., 
2005; Thamm et al., 2007). Nevertheless, those two studies found median UICs 
slightly above 100 µg/l. 
Infants with foreign nationality, living in Ticino region, receiving FM, no BM or 
receiving salt in home-made meals showed significantly higher median UICs 
compared to their respective counterparts (total sample). No significant 
differences in UIC of infants were detected among groups in comparison of 
genders, anthropometry, pediatric practices, urban/rural areas (sig. difference in 
BMIC), months of sample collection, consumption of CF/iodized salt and social 
demographics of mothers (total sample). 
Based on the interim study results and the comparisons to earlier studies and 
recommendations, it is questionable whether infants in Switzerland, especially 
breast-fed infants, generally are iodine-sufficient or not and if the final study 
data will be applicable to define a UIC reference range for infants. To be able to 
make a clearer statement on this it remains to wait for all UIC and BMIC data 
and for the evaluation of the dietary questionnaires, which could help to draw 
conclusions also from the point of view of iodine intake from different foods. As 
there is not much data available on the percentage of iodine excretion in urine 
in infants and as it is unclear what the actual daily needs for iodine in infants are 
and how much of daily-ingested iodine is required for build-up of iodine stores 
and for growth, a well-controlled iodine balance study with infants could be 
helpful to broaden this knowledge. Such a study is, however, rather difficult to 
carry out.  
To our knowledge, no visible signs of ID are recognizable in Switzerland and 
data on TSH from newborn screenings give no hint of a possible inadequate 
supply of iodine during fetal period (Dorey and Zimmermann, 2008; 
Zimmermann et al., 2005). Furthermore, anthropometric measurements (weight, 
length) in the present study showed normal growth of the infants. Further 
research would be necessary to investigate if any mild, unapparent 
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developmental impairment in infants occurs in Switzerland due to a possible 
mild ID, e.g. by performing development tests (Velasco et al., 2009). 
Despite a high percentage use of iodized salt in Swiss homes (~ 90%), attention 
should be paid to the indicated trend of decreasing use of iodized salt by the 
food industries in Switzerland and importing countries as well as to the “salt 
strategy” of the Swiss Federal Office of Public Health to reduce salt intake in 
Switzerland (EDI et al., 2009). An elevation of the salt iodization level might be 
necessary in the future. 
 
A second aim of the study was to assess the infants‟ dietary intake to evaluate if 
infants who are mainly fed with home-made meals have a lower iodine intake 
compared to infants mainly fed with commercial infant products. This question 
can only be clearly answered after evaluating the dietary questionnaires. 
However, the higher median UICs of infants who were formula-fed compared to 
breast-fed infants indicates that this could be the case (significant difference in 
the total sample and in 6-month-old infants), especially as BMIC was found to 
be low. In Switzerland, it is only mandatory to fortify FM with iodine at a 
minimum level and not commercial complementary foods (EDI, 2005b). Within 
the diploma thesis, commercial formula and infant food products were tested for 
their iodine labeling and it was found that the products were labeled correctly. 
However, only a low percentage of the CF products consumed by the study 
infants was fortified with iodine (28%). This could pose a risk for breast-fed 
infants in Switzerland (who do not receive FM) if they are fed only home-made 
CF without iodized salt or non-fortified commercial CF, especially during the 
weaning period in the second half of the first year when salt and cow milk 
(particularly undiluted) are not yet recommended (Dähler et al., 2007; Swiss 
pediatric society, 2002). By 12 months of age and afterwards, most infants start 
to receive small amounts of salt and many consume cow milk, dairy products 
and bread which are important iodine sources (Dratva et al., 2006; Haldimann 
et al., 2005) and therefore they do not rely solely on the iodine content of BM 
anymore. However, 12-month-old breast-fed infants in the present study still 
had a lower median UIC than formula-fed ones (n.s.) and when 12-month-old 
infants did not receive BM or FM at all, they even showed the lowest median 
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UIC compared to the others (n.s.), which indicates that they did not receive 
many foods with a comparably high iodine content to FM. 
A possibility to reduce the risk for ID in infants might be to also mandate the 
fortification of commercial CF with iodine in Switzerland. The fortification of CF 
was also recommended by Dunn (Dunn, 2003) and the WHO (WHO Secretariat 
on behalf of the participants to the Consultation et al., 2007). This measure 
would however still not reach breast-fed infants who exclusively receive home-
made CF. 
 
To ensure that women of childbearing age, lactating and pregnant women and 
consequently infants have an adequate iodine intake, it is necessary to make 
them aware of the importance of iodine for themselves and their infants and to 
inform them about major dietary iodine sources (see background) e.g. by 
gynecologists, pediatricians or public counseling centers for mothers using 
information material that could be provided by the FOPH. Furthermore, it might 
be recommendable to advise pregnant and lactating women to take an iodine-
containing supplement, which is not yet common in Switzerland (< 1% of 
lactating mothers in the present study) (Zimmermann and Delange, 2004; 
Zimmermann et al., 2005), to provide them and thus their fetuses and infants 
(through breast milk) with an adequate daily iodine supply. An iodine 
supplementation has even been proposed by researchers who have found 
higher UICs and BMICs than we did in the present study (Bazrafshan et al., 
2005; Becker et al., 2006; Ciardelli et al., 2002; Pearce et al., 2007; Yan et al., 
2005) . It would also be advisable to include infants and women of childbearing 
age in regular iodine monitoring, especially as ID can have severe health 
consequences for fetuses and infants (see background). More studies on UIC in 
infants of the same age groups and on UIC and BMIC in women are necessary 
from iodine-sufficient countries to be able to set reference ranges and to allow a 
reliable monitoring of the iodine status in the vulnerable population groups. 
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7. SUMMARY 
Iodine is crucial for optimal mental and physical development of infants. 
Insufficient iodine intake leads to so called iodine deficiency (ID) disorders and 
may cause irreversible damage in infants. As > 90% of ingested iodine is finally 
excreted in urine, median urinary iodine concentration (UIC) is the 
recommended indicator for assessing a population‟s iodine status. However, the 
median UIC indicating iodine sufficiency (IS) in infants (< 2 yr) was questioned 
by the WHO in 2007. More studies are required from IS countries to establish a 
reliable reference range for monitoring UIC in infants. In Switzerland iodine 
nutrition was classified as optimal by the WHO.  
Therefore, the aim of the present study was to assess UIC in healthy 6- and 12-
month-old infants and their mothers in Switzerland in a nationally representative 
cross-sectional sample enrolled at pediatric practices. Another aim was to 
examine the infants‟ dietary iodine intake and the influence of different feeding 
practices on the UIC of infants. To achieve these aims, iodine concentration 
was measured in: spot urine samples of infants and their mothers (modified 
Sandell-Kolthoff method), breast milk (BMIC) and formula/infant food (both ICP-
MS). Iodine intake of infants was recorded retrospectively by a 24h-dietary 
questionnaire (DQ) (self-administered by mothers). This diploma thesis 
presents the study set-up and execution, the interim analysis of urine samples 
from 339 infants and 343 mothers, 119 breast milk and 22 formula/infant food 
samples and their examination in different aspects (such as gender, 
anthropometry, nationality, region, season, dietary habits, social demographics) 
as well as the development of the DQ and an infant food database.  
Median UIC was 93 μg/l in infants (88 μg/l at 6 months, 104 μg/l at 12 months) 
and 81 μg/l in mothers (71 μg/l in lactating, 96 μg/l in non-lactating mothers). 
Median BMIC was 51 μg/kg. Formula/infant food iodine content was found to be 
accurately labeled. Breast-fed (BF) infants/lactating mothers had significantly 
lower UICs compared to the other infants/mothers. Significantly higher UICs 
were found in infants receiving formula or salt (in home-made meals) and in 
infants with foreign nationality or from Ticino. UIC of BF infants was positively 
related to BMIC (sig.).  
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The overall interim study results were lower than proposed values from 
literature for an IS country. According to the current WHO cut-off of ≥ 100 μg/l 
the median UICs would indicate mild ID. This was the first Swiss national study 
on UIC in infants/mothers and BMIC. Comparisons to previous studies in other 
countries were difficult. Based on the interim study results and recent Swiss 
studies in other population groups, it is questionable if infants, especially BF 
ones, and mothers in Switzerland have an adequate iodine intake. It remains to 
evaluate the final study results and to do further research to ensure that Swiss 
infants and mothers are iodine-sufficient and in order to define a UIC reference 
range in infants. Mothers should be well informed about the important role of 
iodine for themselves and their infants and about its dietary sources. In addition, 
iodine supplementation may be recommended to lactating mothers. 
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8. ZUSAMMENFASSUNG 
Jod ist essentiell für eine optimale geistige und körperliche Entwicklung von 
Säuglingen/Kleinkindern. Eine ungenügende Jodaufnahme verursacht so 
genannte Jodmangel-Störungen und kann bei Säuglingen/Kleinkindern zu 
irreversiblen Schädigungen führen. Da > 90% des mit der Nahrung 
aufgenommenen Jods über die Niere ausgeschieden werden, ist der Median 
der Jodkonzentration im Urin (JKU) der empfohlene Indikator zur Bestimmung 
des Jodstatus einer Bevölkerung. Allerdings wurde derjenige Median der JKU, 
welcher auf eine ausreichende Jodzufuhr bei unter 2-Jährigen hinweist, 2007 
von der WHO in Frage gestellt. Zur Etablierung eines verlässlichen 
Referenzbereichs für das Monitoring der JKU bei Säuglingen/Kleinkindern, sind 
mehr Studien von Ländern mit optimaler Jodversorgung erforderlich. In der 
Schweiz wurde die Jodversorgung von der WHO als optimal eingestuft. Daher 
war das Ziel der vorliegenden Studie die JKU bei gesunden 6- und 12-
monatigen Kindern sowie deren Müttern in einer national repräsentativen 
Querschnittstudie in der Schweiz zu untersuchen (Rekrutierung in 
Kinderarztpraxen). Ein weiteres Ziel war die Ermittlung der Jodzufuhr der Kinder 
sowie die Untersuchung des Einflusses unterschiedlicher Ernährungsweisen 
auf die JKU der Kinder. Um diese Ziele zu erreichen wurde die 
Jodkonzentration in Spoturinproben von Kindern und deren Müttern 
(modifizierte Sandell-Kolthoff Methode) sowie in Muttermilch und 
Säuglingsnahrung (beide ICP-MS) gemessen. Die Jodaufnahme der Kinder 
wurde mit einem, von den Müttern selbständig auszufüllenden, 24h-
Ernährungsfragebogen retrospektiv erfasst. Die vorliegende Diplomarbeit 
beinhaltet den Aufbau und die Durchführung der Studie, die 
Zwischenauswertung von Urinproben von 339 Kindern und 343 Müttern, von 
119 Muttermilchproben und 22 Säuglingsnahrungsproben sowie deren 
Betrachtung unter verschiedenen Aspekten (wie Geschlecht, Anthropometrie, 
Nationalität, Region, Jahreszeit, Ernährungsweise und Soziodemographie) und 
die Entwicklung des Ernährungsfragebogens und einer Säuglingsnahrungs-
Datenbank.  
Der Median der JKU der Kinder war 93 μg/l (6-monatige: 88 μg/l, 12-monatige: 
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104 μg/l) und derjenige der Mütter war 81 μg/l (Stillende: 71 μg/l, Nicht-
Stillende: 96 μg/l). Der Median der Jodkonzentration in Muttermilch betrug 51 
μg/kg. Der Jodgehalt der Säuglingsnahrungsprodukte war korrekt deklariert. 
Gestillte Kinder/stillende Mütter hatten signifikant niedrigere JKU im Vergleich 
zu den anderen Kindern/Müttern. Signifikant höhere JKU wurden bei Kindern 
festgestellt, welche Säuglingsmilchnahrung oder Salz (in selbstgemachter 
Beikost) erhielten und bei Kindern mit ausländischer Nationalität oder aus der 
Region Tessin. Die JKU von gestillten Kindern korrelierte positiv mit der 
Jodkonzentration in Muttermilch (sig.). 
Die Zwischenresultate der Studie waren niedriger als in der Literatur 
vorgeschlagene Werte für ein Land mit optimaler Jodversorgung. Gemäss dem 
derzeitigen WHO Cut-off von ≥ 100 μg/l würden die gemessenen medianen 
JKU auf einen leichten Jodmangel hinweisen. Dies war die erste nationale 
Studie in der Schweiz zur Jodversorgung von Säuglingen/Kleinkindern und 
Müttern. Vergleiche mit früheren Studien aus anderen Ländern waren 
schwierig. Anhand der Zwischenresultate der Studie und kürzlich 
durchgeführten Studien bei anderen Personengruppen in der Schweiz ist es 
fragwürdig, ob Säuglinge/Kleinkinder, besonders gestillte, und deren Mütter in 
der Schweiz eine ausreichende Jodzufuhr haben. Es bleibt die Auswertung der 
Endergebnisse der Studie abzuwarten und es bedarf weiterer Untersuchungen, 
um sicher zu stellen, dass Säuglinge/Kleinkinder und Mütter in der Schweiz 
ausreichend mit Jod versorgt sind und um einen Referenzbereich für die JKU 
bei Säuglingen/Kleinkindern festlegen zu können. Mütter sollten gut informiert 
werden über die bedeutende Rolle von Jod für sie selbst und ihr Kind und über 
dessen Nahrungsquellen. Zusätzlich könnte stillenden Müttern eine 
Supplementation mit Jod empfohlen werden. 
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10. APPENDIX  
Appendix 1: „Verordnung des EDI über Speziallebensmittel“ (817.022.104) 
(from 25.11.2005, state 01.01.2009) (EDI, 2005b) 
 
Definition of infant formula („Säuglingsanfangsnahrung“): 
„Art. 1728 Säuglingsanfangsnahrung: Definition und Anforderungen 
1 Säuglingsanfangsnahrung sind Lebensmittel, die für die besondere Ernährung von 
gesunden Säuglingen (Kinder unter zwölf Monaten) während der ersten Lebensmonate 
bestimmt sind und für sich allein den Ernährungsbedürfnissen dieser Säuglinge bis zur 
Einführung angemessener Beikost genügen.“ 
 
Definition of follow-on formula („Folgenahrung”): 
„Art. 1832 Folgenahrung: Definition und Anforderungen 
1 Folgenahrung sind Lebensmittel, die für die besondere Ernährung von gesunden 
Säuglingen, die älter als sechs Monate sind, ab Einführung einer angemessenen 
Beikost, und für Kleinkinder (Kinder zwischen einem und drei Jahren) bestimmt sind 
und den grössten flüssigen Anteil einer nach und nach abwechslungsreicheren Kost 
dieser Säuglinge darstellen.“ 
 
Definition of cereal-based and other complementary food  
„Art. 19 Getreidebeikost und andere Beikost für Säuglinge und Kleinkinder 
1 Getreidebeikost und andere Beikost für Säuglinge und Kleinkinder sind Lebensmittel, 
die den besonderen Ernährungsbedürfnissen von gesunden Säuglingen und 
Kleinkindern zwischen vier Monaten und drei Jahren entsprechen und bestimmt sind: 
a. während der Entwöhnungsperiode der Säuglinge; 
b. als Beikost für Kleinkinder; oder 
c. für deren allmähliche Umstellung auf normale Kost. 35 
2 Nicht als andere Beikost gilt Milch, die für Säuglinge und Kleinkinder bestimmt 
ist. 
3 Getreidebeikost darf angeboten werden als: 
a. einfaches Getreideprodukt, das mit Milch oder anderen geeigneten nahrhaften 
Flüssigkeiten zubereitet ist oder damit zubereitet werden muss; 
b. Getreideprodukt mit zugegebenen proteinreichen Lebensmitteln, das mit Wasser 
oder anderen proteinfreien Flüssigkeiten zubereitet ist oder damit zubereitet werden 
muss; 
c. Teigwaren, die nach dem Kochen in siedendem Wasser oder anderen geeigneten 
Flüssigkeiten verzehrt werden; 
d. Zwiebacks und Biskuits (Kekse), die entweder direkt oder nach dem Zerkleinern 
unter Zusatz von Wasser, Milch oder anderen geeigneten Flüssigkeiten verzehrt 
werden.“ 
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Appendix 2: Plan of feeding for new-born baby, infant and little child up to 36 
months. Source: (Swiss pediatric society, 2002) 
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Appendix 3: Studies on UIC in infants and young children – worldwide – conducted between 1989 and 2009 
 
Country 
Date 
of 
study 
Level of 
study 
1 
(Location) 
Age 
group 
Sample 
description 
Sample 
size 
(M/F) 
Median  
UIC 
infants  
[μg/l] 
Mean 
UIC 
infants 
[μg/l] 
Prevalence % 
UIC 
mothers 
[μg/l] 
UIC 
analysis 
2
 
Comment 
Country 
class. 
iodine  
intake 
(1993 – 
2006) 
3
 
Ref < 
20  
< 
50 
< 
100 
< 
200 
> 
300  
μg/l 
EUROPE 
                
Switzer-
land 
1997 R 
(Bernese 
Region) 
0-5 y 
(random 
selectio
n) 
 
 
6-12yr 
 
13-20yr 
 
21-35 yr 
 
36-50 yr 
All 
 
Boys 
 
Girls 
 
All 
 
women 
 
women 
 
women 
31 
 
14 
 
17 
 
47 
 
24 
 
44 
 
72 
108 
 
110 
 
105 
 
110 
 
90 
 
91 
 
93 
 
- - 
 
- 
 
- 
 
 
- 
 
- 
 
- 
 
- 
9 
 
- 
 
- 
 
 
8 
 
- 
 
- 
 
- 
41 
 
- 
 
- 
 
 
40 
 
- 
 
- 
 
- 
- 
 
- 
 
- 
 
 
- 
 
- 
 
- 
 
- 
- 
 
- 
 
- 
 
 
- 
 
- 
 
- 
 
- 
- S-K Salt 
iodization 
15 ppm. 
 
Women 
are not 
mothers of 
children in 
the study. 
Ade-
quate 
(2004) 
SAC: 
141 μg/l 
(Als 
et al., 
2000
b) 
Armenia 1997 N 0-5 y All 
 
6-24 mo 
 
25-59 mo 
2559 
 
139.5 
(73, 250
 a
) 
- - 
 
 
- 
 
- 
- 
 
 
- 
 
- 
31.7 
 
 
37.5 
 
28.8 
- 
 
 
- 
 
- 
- 
 
 
- 
 
- 
- 
Goiter 
rate: 33% 
thyroid 
palpable, 
6% goiter 
Commer
cial 
colorime
tric kit by 
Dunn et 
al., 1993 
66% of 
study 
household
s used 
iodized 
salt 
 
Exces-
sive 
(2005) 
SAC: 
313 μg/l 
(Ross
i and 
Branc
a, 
2003) 
2
4
5
 
246  
 
 
 
  
Country 
Date 
of 
study 
Level of 
study 
1 
(Location) 
Age 
group 
Sample 
description 
Sample 
size 
(M/F) 
Median  
UIC 
infants  
[μg/l] 
Mean 
UIC 
infants 
[μg/l] 
Prevalence % 
UIC 
mothers 
[μg/l] 
UIC 
analysis 
2
 
Comment 
Country 
class. 
iodine  
intake 
(1993 – 
2006) 
3
 
Ref < 
20  
< 
50 
< 
100 
< 
200 
> 
300  
μg/l 
Austria 1989 
P 
R 
(Vienna 
area) 
4 wk -
16 y 
All 
 
1-12 mo 
 
 
1-3 y 
 
124 
(68/56) 
- 
 
400** 
(156,635
b
) 
 
177** 
(135,409
 b
) 
- - 
 
 
- 
 
 
 
- 
 
- 
 
 
- 
 
 
 
- 
 
- 
 
 
- 
 
 
 
- 
 
- 
 
 
- 
 
 
 
- 
 
- 
 
 
- 
 
 
 
- 
 
- S-K ** Values 
are 
declared as 
μg iodine/g 
creatinine. 
Ade-
quate 
(1994) 
SAC: 
111 μg/l 
(Blum
el et 
al., 
1989) 
Belgium 2001 
P 
L 
(Brussel) 
6 mo - 
3 y 
All 
(healthy) 
111 
(58/53) 
 
Urine 
sample
s: 244 
101 - 3 21 49 81 - - S-K Intervention 
Study: 
Values from 
baseline; 
Delange 
classified 
this value 
as iodine-
deficient 
In-
sufficient 
(1998) 
SAC:  
80 μg/l 
(Dela
nge 
et al., 
2001) 
Czech 
Republic 
1994 
-2002 
N 0-8 y 0-4 y 
 
 
 
4-8 y 
 
 
 
0-1 y 
 
 
1-5 y 
1050 
(550/ 
500) 
 
1300 
(600/ 
700) 
 
 
- 
 
 
 
- 
 
 
 
104 
 
 
114 
- 
 
 
 
- 
 
 
 
129 
 
 
136 
- 
 
 
 
 
- 
 
 
 
 
- 
 
 
 
- 
- 
 
 
 
 
- 
 
 
 
 
- 
 
 
 
- 
- 
 
 
 
 
- 
 
 
 
 
- 
 
 
 
- 
- 
 
 
 
 
- 
 
 
 
 
- 
 
 
 
- 
- 
 
 
 
 
- 
 
 
 
 
- 
 
 
 
- 
- S-K All values 
read from 
graphs. 
In the 
same 
study UIC 
of SAC 
was 
around: 
113 μg/l, 
adults 98 
μg/l 
Ade-
quate 
(2000 P) 
SAC: 
199 μg/l 
Since 
1997 
table salt 
iodization 
20-34 
ppm 
(voluntary
) 
(Bilek 
et al., 
2005) 
2
4
6
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Country 
Date 
of 
study 
Level of 
study 
1 
(Location) 
Age 
group 
Sample 
description 
Sample 
size 
(M/F) 
Median  
UIC 
infants  
[μg/l] 
Mean 
UIC 
infants 
[μg/l] 
Prevalence % 
UIC 
mothers 
[μg/l] 
UIC 
analysis 
2
 
Comment 
Country 
class. 
iodine  
intake 
(1993 – 
2006) 
3
 
Ref < 
20  
< 
50 
< 
100 
< 
200 
> 
300  
μg/l 
France  1994 
P 
R  
(Paris 
area) 
10 mo 
- 4 y 
10 mo 
 
 
2 y 
 
 
4 y 
456 
 
 
368 
 
 
398 
181 
(64,390
 c
) 
 
134 
(54,345
 c
) 
 
116 
(57,291
 c
) 
 
- 0 
 
 
 
0 
 
 
 
0 
0.7 
 
 
 
3.5 
 
 
 
2 
18.0 
 
 
 
31.7 
 
 
 
37.2 
- - - Method 
of Riley 
and 
Gochma
n, 1964 
UI  > 600 
µg/l 
excluded 
Insufficie
nt 
(1996) 
Adults: 
85 μg/l 
(Valei
x et 
al., 
1994) 
France 2000, 
2001 
R  
(Nord-
Pas-de-
Calais) 
10 d - 
6 y 
(health
y) 
All 
 
 
0-6 mo 
 
6-24 mo 
 
24-6 y 
BM (excl.) 
 
 
FM 
 
 
Cow milk 
160  
(93/67) 
 
54 
 
58 
 
48 
10 
 
 
68 
 
 
80 
196 
(4-1042
 d
) 
 
183 
 
160 
 
261 
206 
 
(124,296 
b
) 
 
165 
(87,244 
b
) 
 
220 
(110,327 
b
) 
 
- 
 
 
 
 
 
 
 
234 ± 
47 
 
175 ± 
81 
 
224 ± 
80 
2 
 
 
2 
 
3 
 
2 
------ 
- 
 
 
- 
 
 
 
- 
7 
 
 
4 
 
10 
 
8 
------ 
- 
 
 
- 
 
 
 
- 
24 
 
 
17 
 
31 
 
23 
------ 
20 
 
 
29 
 
 
 
15 
- 
 
 
- 
 
- 
 
- 
------ 
- 
 
 
- 
 
 
 
- 
- 
 
 
- 
 
- 
 
- 
------ 
- 
 
 
- 
 
 
 
- 
- Spectro-
photo-
metric 
10 % of 
infants UI 
> 400 μg/l. 
Feeding 
mode: 
50% cow 
milk, 42 % 
FM, 6% 
BM, 1% 
no milk; 
 
Insufficie
nt 
(1996) 
Adults: 
85 μg/l 
(Poue
ssel 
et al., 
2003) 
2
4
7
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Country 
Date 
of 
study 
Level of 
study 
1 
(Location) 
Age 
group 
Sample 
description 
Sample 
size 
(M/F) 
Median  
UIC 
infants  
[μg/l] 
Mean 
UIC 
infants 
[μg/l] 
Prevalence % 
UIC 
mothers 
[μg/l] 
UIC 
analysis 
2
 
Comment 
Country 
class. 
iodine  
intake 
(1993 – 
2006) 
3
 
Ref < 
20  
< 
50 
< 
100 
< 
200 
> 
300  
μg/l 
France  2005 R 
(Nord-
Pas-de-
Calais) 
1 mo – 
1y 
All  6 mo 
(1.5-12mo) 
Hospitalize
d infants, 
not healthy. 
93% FM, 
3% BF, 2% 
cow milk, 
2% n/a. 
 
95 
(59/36) 
328 
(12-1580 
d
) 
 
338 
 
5 11 20 - - - Specto-
photo-
metric 
25 % of 
infants UI 
> 400 μg/l. 
TSH > 5 
mU/l: 
12%, no 
correlation 
with UI. 
Insufficie
nt 
(1996) 
Adults: 
85 μg/l 
(Poue
ssel 
et al., 
2008) 
Germany 1993 L  
(Düssel-
dorf) 
4.-5. 
mo 
(health
y) 
All 
 
 
Breastmilk 
 
 
Hypoaller-
genic 
formula 
 
Commer-
cial formula 
78 
(44/34) 
 
29 
 
 
23 
 
 
 
26 
- 
 
 
36  
(2-550
 d
) 
 
64  
(11-780
 d
) 
 
 
60  
(7-590
 d
) 
 
- - 
 
 
 
- 
 
 
 
- 
 
 
 
 
- 
- 
 
 
 
- 
 
 
 
- 
 
 
 
 
- 
- 
 
 
 
- 
 
 
 
- 
 
 
 
 
- 
- 
 
 
 
- 
 
 
 
- 
 
 
 
 
- 
- 
 
 
 
- 
 
 
 
- 
 
 
 
 
- 
- Cer-
arsenit-
method 
by 
Wawsch
inek et 
al., 1985 
Not all FM 
were 
fortified 
with 
iodine. 
Ade-
quate 
(1999) 
SAC: 
148 μg/l 
(Man
z et 
al., 
1993) 
2
4
8
 
Continuation of Appendix 3 
  
 
249 
Country 
Date 
of 
study 
Level of 
study 
1 
(Location) 
Age 
group 
Sample 
description 
Sample 
size 
(M/F) 
Median  
UIC 
infants  
[μg/l] 
Mean 
UIC 
infants 
[μg/l] 
Prevalence % 
UIC 
mothers 
[μg/l] 
UIC 
analysis 
2
 
Comment 
Country 
class. 
iodine  
intake 
(1993 – 
2006) 
3
 
Ref < 
20  
< 
50 
< 
100 
< 
200 
> 
300  
μg/l 
Germany 2003 
- 
2006 
N 0-17y All 
 
 
0-2 y 
 
Boys 0 y 
 
Girls 0 y 
 
Boys 1 y 
 
Girls 1 y 
 
Boys 2 y 
 
Girls 2 y 
17‟641 
(8985/86
56) 
- 
 
- 
 
- 
 
- 
 
- 
 
- 
 
- 
117 
 
 
- 
 
133 
 
100 
 
117 
 
82 
 
113 
 
92 
 
- - 
 
 
 
12.7 
* 
- 
 
- 
 
- 
 
- 
 
- 
 
- 
- 
 
 
 
24.5 
 
- 
 
- 
 
- 
 
- 
 
- 
 
- 
- 
 
 
 
47.7 
 
- 
 
- 
 
- 
 
- 
 
- 
 
- 
- 
 
 
 
- 
 
- 
 
- 
 
- 
 
- 
 
- 
 
- 
- 
 
 
 
7.3 
 
- 
 
- 
 
- 
 
- 
 
- 
 
- 
- S-K UI data 
read from 
bar chart 
 
UI  > 600 
µg/l 
excluded. 
* < 25 µg/l 
 
80-90% of 
German 
household
s use 
iodized 
salt. 
Ade-
quate 
(1999) 
SAC: 
148 μg/l 
(Tha
mm 
et al., 
2007) 
Italy 1999 
P 
R  
(Hill, 
seas, 
mountain 
& plain 
area) 
1 mo 
 
 
 
3-5 d 
 
8-10 y 
All 
 
 
 
All 
 
All 
241 
(132/ 
109) 
 
384 
 
847 
69 
(12,21
e
) 
 
 
68  
(10, 192 
e
) 
121  
(39, 244 
e
) 
 
- - 34 
 
 
 
 
35.9 
 
 
13.9 
63 
 
 
 
 
67.7 
 
 
47.8 
-  Within 
same 
study: 
women 
after 
delivery: 
median 
55 µg/l 
S-K UI  > 600 
µg/l 
excluded. 
 
Insufficie
nt  
(1992-
1999) 
SAC:  
94 μg/l 
(Rap
a et 
al., 
1999) 
2
4
9
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Country 
Date 
of 
study 
Level of 
study 
1 
(Location) 
Age 
group 
Sample 
description 
Sample 
size 
(M/F) 
Median  
UIC 
infants  
[μg/l] 
Mean 
UIC 
infants 
[μg/l] 
Prevalence % 
UIC 
mothers 
[μg/l] 
UIC 
analysis 
2
 
Comment 
Country 
class. 
iodine  
intake 
(1993 – 
2006) 
3
 
Ref < 
20  
< 
50 
< 
100 
< 
200 
> 
300  
μg/l 
Turkey 2003 
P 
L 
(Ankara) 
Infants  
 
 
 
 
 
 
 
Newbor
ns (full 
term) 
All 
 
Group 1 
 
 
Group 2 
 
 
All 
 
Group 1 
 
Group 2 
50 
 
 
 
 
 
 
 
40 
 
 
- 
 
 
- 
 
 
 
- 
 
- 
 
 
 
128.4 ± 
34.8 
 
130.0 ± 
18.7 
 
 
 
120.5 
 
126.0 
- 
 
 
- 
 
 
- 
 
 
 
 
- 
 
 
- 
- 
 
 
- 
 
 
- 
 
 
 
 
- 
 
 
- 
- 
 
 
- 
 
 
- 
 
 
 
 
- 
 
 
- 
- 
 
 
- 
 
 
- 
 
 
 
 
- 
 
 
- 
- 
 
 
- 
 
 
- 
 
 
 
 
- 
 
 
- 
- Modified  
S-K 
Intervention 
study: UI 
values from 
baseline. 
No life-
threat.disea
ses, 
malnutr., 
major 
congen. 
abnorm., 
thyroid 
affect. 
Drugs 
 
 
Insufficie
nt  
(2002) 
SAC:  
75 μg/l 
(Yilm
az et 
al., 
2003) 
EASTERN MEDITERRANEAN 
              
Sudan 1994 R  
(Blue Nile 
area) 
1-6 y All 
(4.7 ± 1.6 
yr) 
 
Boys   
 
 
 
Girls 
191 
 
 
 
96 
 
 
 
95 
100.3 
(88,124
 e
) 
 
 
119.3 
(91,160 
e
) 
 
 
91.4 
(69,116 
e
) 
 
 
- 
 
 
 
 
- 
 
 
 
 
- 
- 
 
 
 
 
- 
 
 
 
 
- 
- 
 
 
 
 
- 
 
 
 
 
- 
- 
 
 
 
 
- 
 
 
 
 
- 
80.7 
 
 
 
 
76.0 
 
 
 
 
82.6 
- 
 
 
 
 
- 
 
 
 
 
- 
- Method 
describe
d in 
Bourdou
x, 1988 
Goiter rate 
(all): 22.3%;  
high 
anemia and 
vitamin A 
deficiency 
prevalence; 
high 
goitrogen 
consumptio
n (millet) 
Insufficie
nt 
(1997) 
SAC:  
75 μg/l 
------------ 
no 
iodized 
salt  
(Elno
ur et 
al., 
2000) 
2
5
0
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Country 
Date 
of 
study 
Level of 
study 
1 
(Location) 
Age 
group 
Sample 
description 
Sample 
size 
(M/F) 
Median  
UIC 
infants  
[μg/l] 
Mean 
UIC 
infants 
[μg/l] 
Prevalence % 
UIC 
mothers 
[μg/l] 
UIC 
analysis 
2
 
Comment 
Country 
class. 
iodine  
intake 
(1993 – 
2006) 
3
 
Ref < 
20  
< 
50 
< 
100 
< 
200 
> 
300  
μg/l 
AMERICAS                 
Mexico 1999 R  
(North, 
Center, 
Mexico 
City and 
South) 
0.5-4 y All 18 No data - 0 0 17 - - - S-K Table salt 
iodization 
mandatory 
by law 
since > 50 
yr 
More 
than 
ade-
quate 
(1999) 
SAC: 
235 μg/l 
 
 
 
 
 
 
(Villal
pand
o et 
al., 
2003) 
Vene-
zuela 
1999 R (Mérida 
(Zone of 
the 
Andes)) 
1 mo – 
4 y 
Healthy 
 
 
 
116 
 
 
- 308 ± 
155 
 
0 0 0 - - - S-K - More 
than 
ade-
quate 
(2000/1) 
SAC: 
286 μg/l 
 
 
 
 
 
(Paoli
-
Valeri 
et al., 
2003) 
2
5
1
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Country 
Date 
of 
study 
Level of 
study 
1 
(Location) 
Age 
group 
Sample 
description 
Sample 
size 
(M/F) 
Median  
UIC 
infants  
[μg/l] 
Mean 
UIC 
infants 
[μg/l] 
Prevalence % 
UIC 
mothers 
[μg/l] 
UIC 
analysis 
2
 
Comment 
Country 
class. 
iodine  
intake 
(1993 – 
2006) 
3
 
Ref < 
20  
< 
50 
< 
100 
< 
200 
> 
300  
μg/l 
AFRICA                 
Nigeria 1996 
P 
L  
(Ibadan, 
South-
western 
Nigeria) 
9-18 
mo 
(almost 
excl. 
BF, 
healthy) 
All 
 
 
MUAC * > 
13.5cm 
 
 
MUAC < 
13.5cm 
 
* MUAC = mid-
upper arm 
circumference 
 
68 
(38/30) 
 
47 
 
 
 
21 
 
- 
 
 
- 
 
 
 
- 
99 ± 7 
 
 
99 ± 7 
 
 
 
97 ± 7 
- 
 
 
 
 
- 
 
 
 
- 
- 
 
 
 
 
- 
 
 
 
- 
- 
 
 
 
38.3 
 
 
 
 
38.1 
- 
 
 
 
 
- 
 
 
 
- 
- 
 
 
 
 
- 
 
 
 
- 
Mean: 
145  ± 14 
(n = 68) 
Alternati
ve A of  
S-K 
(Dunn et 
al, 1993) 
Study in a 
goiter-
non-
endemic 
area 
(<5%).  
Low socio-
economic 
group. 
 
Ade-
quate 
(2004/5) 
SAC: 
130 μg/l 
(Akan
ji et 
al., 
1996) 
Reunion 
Island 
1997  R  
(Cirque 
de 
Salazie, 
mountain
ous area) 
6-30 
mo 
All 28  
 
120 - - 14.8 40.7 - - Women of 
childbearin
g age in 
same 
study: 
median 
42 μg/l 
(n = 52) 
S-K 
auto-
analyzer 
Goiter 
rate: 
infants 
0%, 
SAC 12%, 
women 
38%. 
Low 
iodization 
level in 
analyzed 
salt 
samples. 
 
No WHO 
data. 
 
Median 
SAC in 
present 
study: 
78 μg/l 
(n = 91) 
(Jaffi
ol et 
al., 
1997) 
2
5
2
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Country 
Date 
of 
study 
Level of 
study 
1 
(Location) 
Age 
group 
Sample 
description 
Sample 
size 
(M/F) 
Median  
UIC 
infants  
[μg/l] 
Mean 
UIC 
infants 
[μg/l] 
Prevalence % 
UIC 
mothers 
[μg/l] 
UIC 
analysis 
2
 
Comment 
Country 
class. 
iodine  
intake 
(1993 – 
2006) 
3
 
Ref < 
20  
< 
50 
< 
100 
< 
200 
> 
300  
μg/l 
SOUTH-EAST ASIA                
India 2006 
P 
L  
(New 
Delhi) 
- Exclusively
breast-fed, 
healthy 
175 162 - - - 21 - - Median: 
124 μg/l 
(n =175) 
No data Only 
abstract. 
96% of 
analyzed 
salt 
samples 
were 
adequate. 
iodized    
> 15 ppm 
 
Ade-
quate 
(1993-
2002) 
SAC: 
133 μg/l 
(Gupt
a et 
al., 
2006) 
Indo-
nesia 
2007 
P 
R (Central 
Java) 
6-12 
mo 
 
(infants 
deficient 
in 
multiple 
micronu
trients) 
All 
 
 
Group 1 
 
 
Group 2 
 
 
Group 3 
 
 
Placebo 
group 
 
133 
(133/0) 
 
31 
 
 
32 
 
 
39 
 
 
31 
- 
 
 
138 
 
 
171  
 
 
168 
 
 
170 
 
174 
 
 
169  
± 109 
 
180 
± 102 
 
182 ± 
109 
164  
 ± 79 
0 
 
 
 
- 
 
 
- 
 
 
- 
 
 
- 
6.8 
 
 
 
- 
 
 
- 
 
 
- 
 
 
- 
24.1 
 
 
 
- 
 
 
- 
 
 
- 
 
 
- 
- 
 
 
 
- 
 
 
- 
 
 
- 
 
 
- 
11.3  S-K Intervention 
study: UI 
values from 
baseline. 
 
92.5% of 
infants are 
breast-fed 
> 4 times 
per day, 
one third 
received 
FM 
More 
than 
ade-
quate 
(2003) 
SAC: 
229 μg/l 
(Wija
ya-
Erhar
dt et 
al., 
2007) 
2
5
3
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Country 
Date 
of 
study 
Level of 
study 
1 
(Location) 
Age 
group 
Sample 
description 
Sample 
size 
(M/F) 
Median  
UIC 
infants  
[μg/l] 
Mean 
UIC 
infants 
[μg/l] 
Prevalence % 
UIC 
mothers 
[μg/l] 
UIC 
analysis 
2
 
Comment 
Country 
class. 
iodine  
intake 
(1993 – 
2006) 
3
 
Ref < 
20  
< 
50 
< 
100 
< 
200 
> 
300  
μg/l 
WESTERN-PACIFIC                
China 2005 
P 
R  
(11 
provinces) 
0-2 y Urban sites 
 
Rural sites 
1295 
 
1258 
235.5 
 
247.3 
- 
 
- 
- 
 
 
- 
- 
 
 
- 
- 
 
 
- 
- 
 
 
- 
- 
 
 
- 
Median 
lactating 
mothers: 
188.6 
(urban), 
192.1 
(rural) 
μg/l 
Modified  
S-K 
Mandatory 
salt 
iodization 
35 ppm 
More 
than 
ade-
quate 
(2005) 
SAC: 
246 μg/l 
(Yan 
et al., 
2005) 
China 2009 
P 
R  
(regions 
where 
iodized 
salt since 
2000) 
0-1 y All n/a 233 - - - - - - Lactating 
women: 
BF < 6 
mo: 126 
μg/l;  
BF > 6 
mo: 145 
μg/l  
No data Only 
abstract; 
Universal 
salt 
iodization 
program in 
place > 
90% 
coverage 
since 2000 
More 
than 
ade-
quate 
(2005) 
SAC: 
246 μg/l 
(Wan
g et 
al., 
2009) 
Malaysia 1996 
P 
L 
(Menjiling 
Mengkak, 
rural, 
goitrous 
area) 
0-6 y From 
Menjiling 
 
From 
Mengkak 
 
 
32 
 
 
33 
10.6 
 
 
28.1 
 
 
- 87.5 
 
 
 
12 
100 
 
 
 
70 
100 
 
 
 
97 
0 
 
 
 
- 
0 
 
 
 
- 
Median 
women 
15-40 yr: 
11.3 
resp. 
36.8 μg/l 
(n = 53 
resp. 48) 
S-K Intervention 
study: UI 
values from 
baseline  
Prevalence
s read from 
bar chart 
 
Insufficie
nt 
(1995) 
SAC:  
91 μg/l 
(Foo 
et al., 
1996) 
2
5
4
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Country 
Date 
of 
study 
Level of 
study 
1 
(Location) 
Age 
group 
Sample 
description 
Sample 
size 
(M/F) 
Median  
UIC 
infants  
[μg/l] 
Mean 
UIC 
infants 
[μg/l] 
Prevalence % 
UIC 
mothers 
[μg/l] 
UIC 
analysis 
2
 
Comment 
Country 
class. 
iodine  
intake 
(1993 – 
2006) 
3
 
Ref < 
20  
< 
50 
< 
100 
< 
200 
> 
300  
μg/l 
New 
Zealand 
1998 
-1999 
L  
(Christ-
church, 
Dunedin, 
Invercar-
gill: 3 
cities) 
6-24 
mo 
(healthy
) 
All 
 
 
Breast-fed 
 
 
Formula-fed 
 
 
BF and FM 
 
 
No BM, no 
FM 
230 
(131/99) 
 
43 
 
 
51 
 
 
17 
 
 
119 
67  
(37-115
 d
) 
 
44 
(23-82
 d
) 
 
99  
(68-167
 d
) 
 
59 
(39-103 
d
) 
 
59 
(36-112 
d
) 
 
 
 
40 * 
 
 
105 
 
 
56 
 
 
56 
11.7 
 
 
- 
 
 
- 
 
 
- 
 
 
- 
37.0 
 
 
51.2 
 
 
13.7 
 
 
47.1 
 
 
39.5 
67.4 
 
 
83.7 
 
 
51.0 
 
 
70.6 
 
 
66.4 
- 
 
 
- 
 
 
- 
 
 
- 
 
 
- 
- 
 
 
- 
 
 
- 
 
 
- 
 
 
- 
- S-K * geometric 
mean 
 
Mean UIC 
of formula-
fed children 
sig. higher 
than other 
feeding 
groups. 
 
BMIC 
mothers: 22 
μg/l  
Insufficie
nt 
(2002) 
SAC:  
66 μg/l 
(Skea
ff et 
al., 
2005) 
1
 L = local, R = regional, N = national 
2
 S-K = (modified) Sandell-Kolthoff reaction 
3
 Classification of the country according to the WHO Global Database on Iodine Deficiency and median UIC of the age group that was reported together 
with the classification in the WHO database (de Benoist et al., 2008; WHO Nutrition, 2008a; WHO Nutrition, 2008b). 
a 
20th percentile, 80th percentile; 
b  
Quartile 1 and quartile 3; 
c  
5th percentile, 95th percentile; 
d 
 Highest and lowest value of UI (range); 
e 
10th percentile, 
90th percentile; 
f 
 95 % CI 
 
 
 
2
5
5
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Appendix 4: Studies on BMIC – in Switzerland and worldwide (selection) - conducted between 1998 and 2009 
 
Country 
Date 
of 
study 
Level of 
study 
1 
(Location) 
Age 
women 
BM sample 
description 
Sample 
size 
Median  
BMIC  
[μg/l] or 
[μg/kg] 
Mean 
BMIC 
[μg/l] or 
[μg/kg] 
(± SD) 
BMIC 
analysis 
2
 
UI 
Lactating 
women 
[μg/l] 
Median 
UI 
infants 
[μg/l] 
Comment 
Country 
class. 
iodine  
intake 
(1993 – 
2006) 
3
 
Ref 
EUROPE 
             
Switzer-
land 
1992/
93 
L  
(Berne) 
n/a 
 
 
5
th
 – 12
th
 
day after 
birth 
38 
 
98 - - - - - 
Ade-
quate 
(2004) 
SAC: 
141 μg/l 
4 
Switzer-
land 
1993/
94 
L  
(Basel) 
n/a 
 
5
th
 – 12
th
 
day after 
birth 
23 82 - - - - - 4 
Switzer-
land 
1994 L  
(Solothurn) 
n/a 
 
3 – 6 days 
after birth 
30 - 78  
± 59 
Modified 
S-K 
- 66 ± 33 * 
(newborn
s) 
* mean ± SD (Hoang 
Truong 
et al., 
1997) 
Switzer-
land 
1998/
99 
L  
(Basel) 
n/a 
 
> 12
th
 day 
after birth 
52 68 - ICP-MS 
(personal 
comm.  M. 
Haldiman
n, FOPH) 
- - - 4 
Belgium 1999-
2000 
L  
(Brussels) 
n/a 
 
Day 5 after 
delivery 
58 78 98  
± 5 
n/a 
 
- 86  
(newborns
) 
Newborns 
concluded as 
iodine-
deficient 
In-
sufficient 
(1998) 
SAC:  
80 μg/l 
(Ciarde
lli et 
al., 
2002) 
2
5
6
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Country 
Date 
of 
study 
Level of 
study 
1 
(Location) 
Age 
women 
BM sample 
description 
Sample 
size 
Median  
BMIC  
[μg/l] or 
[μg/kg] 
Mean 
BMIC 
[μg/l] or 
[μg/kg] 
(± SD) 
BMIC 
analysis 
2
 
UI 
Lactating 
women 
[μg/l] 
Median 
UI 
infants 
[μg/l] 
Comment 
Country 
class. 
iodine  
intake 
(1993 – 
2006) 
3
 
Ref 
Denmark 2004 
P 
R 
(5 cities in 
Denmark) 
Mean 
27 yr 
5 days 
after 
delivery 
Non-
smoker 
(n = 90) 
 
Smokers 
(n = 50) 
- 53.8 
b 
* 
(49.4-
58.5 
d
) 
 
26.0 
b 
* 
(23.2-
29.1 
d
) 
 
* p < 
0.001 
S-K 
after 
alkaline 
ashing 
40.8 
b
 
(6-665 
a
) 
 
 
40.1 
b
 
(9-143 
a
) 
50.4 
b 
* 
(46.0-
55.1 
d
) 
 
33.3 
b 
* 
(29.9-
37.2 
d
) 
 
* p = 
0.005 
(neonates) 
Healthy 
women, 
study before 
introduction 
of iodized 
salt, majority 
of women 
from 
moderately 
iodine-
deficient 
areas 
In-
sufficient 
(1997-8) 
Adults: 
61 μg/l 
 
(Laurb
erg et 
al., 
2004) 
Germany 2005 
P 
L  
(Jena) 
18-39 y 1
st
 – 5
th
 day 
(n =24), 6
th
 
– 10
th
 day 
(n = 8) 
Iodine 
supplement * 
 
 
No iodine 
supplement 
 
32 
 
 
 
 
20 
 
 
12 
156 
(33–348 
a
) 
 
 
 
151 
 
 
176 
169 ± 88 
 
 
 
 
160 ± 91 
 
 
184 ± 84 
ICP-MS - - * supple-
ments during 
pregnancy: 
175 µg I/day 
(average ) 
Ade-
quate 
(1999) 
SAC:  
148 μg/l 
(Bader 
et al., 
2005) 
Germany 2009 
P 
- - 3
rd
 – 7
th
 
day after 
birth 
- 52 
(20-230 
a
) 
- S-K - - All women 
supplemente
d with 150 
µg I /day 
during 
pregnancy 
 
Ade-
quate 
(1999) 
SAC:  
148 μg/l 
(Gärtn
er and 
Arbeits
kreis 
Jodma
ngel, 
2009) 
 
2
5
7
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Country 
Date 
of 
study 
Level of 
study 
1 
(Location) 
Age 
women 
BM sample 
description 
Sample 
size 
Median  
BMIC  
[μg/l] or 
[μg/kg] 
Mean 
BMIC 
[μg/l] or 
[μg/kg] 
(± SD) 
BMIC 
analysis 
2
 
UI 
Lactating 
women 
[μg/l] 
Median 
UI 
infants 
[μg/l] 
Comment 
Country 
class. 
iodine  
intake 
(1993 – 
2006) 
3
 
Ref 
Spain 2007 
P 
L 
(Santiago) 
- Collected in 
hospital after 
delivery 
14 - 144 ± 
93.2 
ICP-MS - - - Ade-
quate 
(1995-
2002) 
SAC: 109 
μg/l  
 
(Ferna
ndez-
Sanch
ez et 
al., 
2007) 
AMERICAS 
            
USA 2003 R 
(15 US 
states) 
-  - 
 
23 33.5 * 63.3 * 
(4.5-
184.5 
a
) 
Chromat
ography/ 
ICP-MS 
- - * Iodide 
 
Also 
perchlorate 
assessed 
 
Healthy 
lactating 
volunteers 
More 
than 
adequate 
(2001-02) 
SAC:  
249 μg/l  
 
 
(Kirk et 
al., 
2005) 
USA 2007 
P 
R 
(6 US 
states) 
- - 108 of 10 
women 
 
55.2 *  
(3.1-334) 
87.9 ± 
80.9  * 
Ion-
chromato
graphy-
MS 
- - * Iodide 
 
Non- 
smokers. 
Also 
perchlorate/t
hiocyanate 
assessed 
More 
than 
adequate 
(2001-02) 
SAC:  
249 μg/l   
(Kirk et 
al., 
2007) 
2
5
8
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Country 
Date 
of 
study 
Level of 
study 
1 
(Location) 
Age 
women 
BM sample 
description 
Sample 
size 
Median  
BMIC  
[μg/l] or 
[μg/kg] 
Mean 
BMIC 
[μg/l] or 
[μg/kg] 
(± SD) 
BMIC 
analysis 
2
 
UI 
Lactating 
women 
[μg/l] 
Median 
UI 
infants 
[μg/l] 
Comment 
Country 
class. 
iodine  
intake 
(1993 – 
2006) 
3
 
Ref 
USA 2002-
2006 
R 
(Boston-
area) 
19-45y 
 
 
10-250 days 
postpartum 
57 155  
(2.7-1968 
a
) 
205  
± 271 
Spectrop
hotometri
cal, 
modified 
method 
of 
Benotti 
et al. 
 
 
 
114 
c 
(25-920 
a
) 
- Healthy 
lactating 
volunteers 
More 
than 
adequate 
(2001-02) 
SAC:  
249 μg/l   
(Pearc
e et al., 
2007) 
USA 2008 
P 
L 
(Arlington) 
24-34 y 55-253 days 
postpartum 
447 
samples 
of 13 
women 
43 
(1-1200 
a
) 
120  
± 75 
ICP-MS 110 
c 
(26-630 
a
) 
 
(n = 117  
24-h urine 
samples) 
 
 
 
- Non- 
smokers. 
 
More 
than 
adequate 
(2001-02) 
SAC:  
249 μg/l   
(Dasgu
pta et 
al., 
2008) 
USA 2009 
P 
R 
(Rio 
Grande 
Valley, 
Texas) 
20-38 y 30-45 days 
postpartum 
 
75-90 days 
postpartum 
30 
 
 
17 
- 47.8  
± 17.1 
 
42.3 
± 8.71 
NAA - - Healthy, 
Mexican-
American, 
low-income; 
24-h recall: 
iodine  intake 
34 – 50% of 
DRI 
 
 
 
More 
than 
adequate 
(2001-02) 
SAC:  
249 μg/l   
(Hanna
n et al., 
2009) 
2
5
9
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Country 
Date 
of 
study 
Level of 
study 
1 
(Location) 
Age 
women 
BM sample 
description 
Sample 
size 
Median  
BMIC  
[μg/l] or 
[μg/kg] 
Mean 
BMIC 
[μg/l] or 
[μg/kg] 
(± SD) 
BMIC 
analysis 
2
 
UI 
Lactating 
women 
[μg/l] 
Median 
UI 
infants 
[μg/l] 
Comment 
Country 
class. 
iodine  
intake 
(1993 – 
2006) 
3
 
Ref 
EASTERN-MEDITERRANEAN           
Iran 2003 L 
(City of 
Gorgan) 
Mean 
25.6 y 
30-180 days 
postpartum 
100 93.5 
(17-696 
a
) 
 
117  
± 101 
(97.3,13
7.2 
e
) 
S-K 259 
c
 
(35-519 
a
) 
- Iodine-
sufficent 
area, salt 
iodized; 
Healthy 
women, non-
smokers 
 
Ade-
quate 
(2000-1) 
SAC:  
165 μg/l 
(Bazraf
shan et 
al., 
2005) 
Iran 2004-
05 
L  
(Teheran) 
18-36 y 12 ± 4 days 
postpartum 
42 148 
(45-750 
a
) 
176  
± 120 
S-K 107 
c 
(20-710 
a
) 
271 
(57-800 
a
) 
(newborn) 
Healthy 
women, non-
smokers; 
Exclusively 
BF 
 
(Ordoo
khani 
et al., 
2007) 
WESTERN-PACIFIC 
           
Australia 2000 L 
(Sydney) 
33 ± 4.5 3-9 days 
postpartum 
49 84  
(25-234 
a
) 
103.6  
± 59.5 
ICP-MS 46.0 
c 
(4-140 
a
) 
- TSH infants 
measured 
6% > 5mU/l 
 
BMIC 
considered 
as 
moderately 
ID 
 
Ade-
quate 
(2003-4) 
SAC:  
104 μg/l 
(Chan 
et al., 
2003) 
2
6
0
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Country 
Date 
of 
study 
Level of 
study 
1 
(Location) 
Age 
women 
BM sample 
description 
Sample 
size 
Median  
BMIC  
[μg/l] or 
[μg/kg] 
Mean 
BMIC 
[μg/l] or 
[μg/kg] 
(± SD) 
BMIC 
analysis 
2
 
UI 
Lactating 
women 
[μg/l] 
Median 
UI 
infants 
[μg/l] 
Comment 
Country 
class. 
iodine  
intake 
(1993 – 
2006) 
3
 
Ref 
China 2005 
P 
R  
(11 
provinces) 
n/a All from 
mothers with 
infants 0-2 y 
 
Urban sites 
 
Rural sites 
710 
 
 
 
364 
 
346 
145.7 
 
 
 
135.9 
 
157.5 
- S-K  
 
 
 
188.6 
c 
 
192.1 
 
 
 
 
235.5 
 
247.3 
 
Mandatory 
salt 
iodization 35 
ppm 
More 
than ade-
quate 
(2005) 
SAC: 246 
μg/l 
(Yan et 
al., 
2005) 
China 2009 
P 
R  
(regions 
where 
iodized salt 
since 2000) 
n/a All 
 
BF < 6 mo 
 
BF > 6 mo 
n/a 163 - n/a  
 
126 
c
 
 
145 
c 
233 Only 
abstract; 
Universal 
salt 
iodization 
program in 
place > 90% 
coverage 
since 2000 
 
More 
than ade-
quate 
(2005) 
SAC: 246 
μg/ 
(Wang 
et al., 
2009) 
New 
Zealand 
1998 -
1999 
L  
(Christ-
church, 
Dunedin, 
Invercar-
gill: 3 
cities) 
n/a With children 
aged 6-24 
mo 
39 - 22  
(18, 26 
e
) 
S-K - 67  
(37-115
 a
) 
 
BF: 44 
(23-82
 a
) 
 
FF: 99  
(68-167
 a
) 
Healthy 
infants 
 
Mean UIC of 
formula-fed 
children sig. 
higher than 
other feeding 
groups. 
 
Insufficie
nt 
(2002) 
SAC:  
66 μg/l 
(Skeaff 
et al., 
2005) 
1
 L = local, R = regional, N = national 
2
 S-K = (modified) Sandell-Kolthoff reaction; ICP-MS = Inductively Coupled Plasma Mass Spectrometry; NAA = neutron activation analysis 
2
6
1
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3
 Classification of the country according to the WHO Global Database on Iodine Deficiency and median UIC of the age group that was reported together 
with the classification in the WHO database (de Benoist et al., 2008; WHO Nutrition, 2008a; WHO Nutrition, 2008b). 
4
 Ref: (Facheinheit Lebensmittel und Gebrauchsgegenstände des Bundesamtes für Gesundheit, 2000) 
a 
Highest and lowest value of UI (range); 
b
 geometric mean; 
c
 median; 
d
 SEM range; 
e 
95 % CI 
 
 
 
 
 
 
2
6
2
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Appendix 5: Instruction about materials and study procedure for the pediatric 
practices – German 
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Appendix 6: Information sheet for the parents – German 
 
 
268   Appendix 
 
 
 
University of Vienna  Nadja Wüst 
 
 
 
 
 Appendix 
 
 
 
University of Vienna  Nadja Wüst 
 
269 
Appendix 7: Individual registration form – German 
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Appendix 8: Explanation sheet for individual registration form (infant feeding) – 
German 
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Appendix 9: Manual for the parents for the sample collection at home – German 
 
 
 Appendix 
 
 
 
University of Vienna  Nadja Wüst 
 
273 
 
 
274   Appendix 
 
 
 
University of Vienna  Nadja Wüst 
 
 
 
 
 Appendix 
 
 
 
University of Vienna  Nadja Wüst 
 
275 
 
 
 
276   Appendix 
 
 
 
University of Vienna  Nadja Wüst 
 
 
Appendix 10: Questionnaire to the pediatrician after study completion – German 
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Appendix 11: Dietary questionnaire (first) – German 
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Appendix 12: Defined quantities of foods on pictures in the dietary questionnaire 
(see dietary questionnaire, page 3) 
 
Kind of food Measuring unit 
Defined 
quantity [g] 
Data 
source 
a
 
 
 Bread (“Ruchbrot”) A (= medium slice) 40 1 
 B (= ½ medium slice) 20 2 
 C (= ¼ medium slice) 10 2 
 Bread roll (“Weggli”) A (= medium slice) 60 1 
 B (= ½ medium slice) 30 2 
 C (= ¼ medium slice) 15 2 
 Hard / Semi-hard cheese  A (= medium slice) 25 1 
 B (= ½ medium slice) 12.5 2 
 C (= ¼ medium slice) 6.25 2 
 Soft cheese A (= medium slice) 30 1 
 B (= ½ medium slice) 15 2 
 C (= ¼ medium slice) 7.5 2 
a 
Data source: 1 = Quantity definitions in EBISpro 
 2 = Calculated from measuring unit A 
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Appendix 13: Defined measurement units for data entry of dietary 
questionnaires 
 
Type of 
food 
Food Measuring unit 
Defined 
weight [g] 
Data source 
Bread/ 
rusks/ 
biscuits 
Bread   see Appendix 12   
Microc (Migros) slice 5 1 
Pancroc Weizen 
(Roland) 
slice 
6 Producer  
Rice cake piece 9 1 
Rusk (Stück) piece 5 1, 2 
Crispbread piece 9 2 
Biscuit (Petit Beurre) piece 7 5 
Cereal-
products 
Cereal teaspoon, medium 3 5 
 tablespoon, medium 8.5 3 
Cereal, instant  tablespoon, level 2.5 3 
Semolina (raw) teaspoon, medium 4 5 
 tablespoon, medium 12 5 
Semolina (cooked) teaspoon 8 5 
 tablespoon 24 5 
Semolina porridge ladle 100 1 
Rice (raw) teaspoon 5 2 
 tablespoon 15 2 
Rice (cooked) teaspoon, medium 6 5 
 tablespoon, medium 20 5 
Egg spaetzle piece 2 5 
 tablespoon 16 5 
Elbow pasta (raw) tablespoon 11 5 
Elbow pasta (cooked) tablespoon 13 5 
100g raw elbow pasta  cooked  230 4 
Penne pasta  piece, small, raw 1.2 5 
 piece, small, cooked 2.2 5 
 tablespoon, raw 9.5 5 
 tablespoon, cooked 13 5 
100g raw penne pasta  cooked  260 4 
Vegetables String beans tablespoon 20 1 
Fennel piece, small 175 3 
 piece, medium 200 1 
Cucumber slice, thin 3 1 
 slice, medium 12 5 
 slice, thick 18 1 
Carrot piece, small 50 5 
 piece, medium 80 2 
Carrot (fresh, cooked) tablespoon 28 1 
Potato (cooked, peeled) piece, small 70 2 
 piece, medium 90 2 
Potato puree teaspoon, medium 
heaped  9.5 5 
 
tablespoon, medium 
heaped 27 5 
 tablespoon, heaped 35 3 
 tablespoon, level 15 3 
Vegetable puree teaspoon, medium 8 5 
 
tablespoon, medium 
heaped 22 5 
288   Appendix 
 
 
 
University of Vienna  Nadja Wüst 
 
 
Type of 
food 
Food Measuring unit 
Defined 
weight [g] 
Data source 
Vegetables Vegetable puree tablespoon, heaped 35 3 
 tablespoon, level 15 3 
Kohlrabi piece, medium 160 3 
Sweet corn tablespoon, heaped 25 1 
Beet root piece, medium/normal 150 1 
Spinach tablespoon 30 1 
Tomato puree tablespoon 20 1 
Tomato sauce tablespoon 20 1 
Zucchini  slice, medium, raw 10 5 
 tablespoon, raw 20 5 
 tablespoon, cooked 25 1 
Onion teaspoon 5 2 
Fruits 
 
Apple/pear  piece, small 90 1 
 piece, medium 135 1 
 piece, large 180 1 
 slice, medium 21 5 
Banana (mini)  piece 40 1 
Banana piece, medium/normal 125 Mean of 1, 2 
Banana (cooked) tablespoon 30 1 
Blueberry piece 3 1 
Raspberry piece 5 1 
Mandarin piece, medium 50 Mean of 1, 2 
 
slice 6 Deduced 
form piece 
Orange piece, medium 150 1 
Raisin teaspoon 7 2 
 tablespoon 20 2 
Grape piece 4.5 Mean of 1, 2 
Plum piece, medium 35 1 
Apricot piece, medium 45 1 
Peach piece, medium 110 1 
Orange/apple juice teaspoon 5 5 
 tablespoon 10 5 
Fruit puree teaspoon, medium 9.5 5 
 
tablespoon, 
small/level 18 5 
 tablespoon, medium 25 5 
 tablespoon, heaped 35 3 
Nuts Walnut piece 3 Mean of 1, 2 
Milk-
products 
Hard/semi hard cheese see  Appendix 12   
Cheese (grated) teaspoon 3 2 
 tablespoon 9 2 
Soft cheese see  Appendix 12   
Cream cheese/curd teaspoon, medium 12.5 2 
 teaspoon, heaped 15 5 
 tablespoon, medium 25 2 
 tablespoon, heaped 30 1 
 spread, medium 15 1 
Cottage cheese teaspoon, heaped 10.5 5 
 tablespoon, heaped 26 5 
Yoghurt teaspoon, medium 8.5 5 
 tablespoon, medium 22 5 
 cup/jar 180 1 
Curd cup, small 125 1 
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Type of 
food 
Food Measuring unit 
Defined 
weight [g] 
Data source 
Milk-
products 
Curd cup, large 140 1 
Petit Suisse (low fat 
curd) 
cup 100 Producer 
(Coop) 
Fruchtzwerge/Danonino cup 50 Producers 
Cream teaspoon 5 2 
 tablespoon 13 2 
Fat/oil Butter teaspoon 5 1 
 tablespoon 10 2 
 spread, thin 5 1 
Oil teaspoon 5 1, 3 
 tablespoon 10 1, 3 
Egg Egg medium 55 1 
Meat 
(-products) 
Meat (braised, pureed) tablespoon 8.5 3 
 piece 22.5 3 
Bratwurst piece 120 5 
 slice 8 5 
Sauces Meat sauce tablespoon 20 1 
Curry sauce  tablespoon 12 1 
Sugar/ 
sweets 
Jam/honey teaspoon 10 2 
 tablespoon 20 2 
Sugar teaspoon 5 2 
 tablespoon 15 2 
Salt salt pinch of salt 0.25 5 
* 
Data sources: 1 = EBISpro; 2 = Swiss Food Composition Database (Infanger, 2004);  
3 = (Wachtel, 1990); 4 = (Zacharias and Deutsche Gesellschaft für 
Hauswirtschaft, 1992); 5 = defined by ETH Zürich  
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Appendix 14: “Schweizer Berufsnomenklatur, SBN 2000” & UNESCO 
“International Standard Classification of Education” (ISCED) 
 
 “Schweizer Berufsnomenklatur, SBN 2000” (Bundesamt für Statistik, 2000) 
The SBN classifies professions into the following 9 groups of occupation: 
1. Agricultural and forestry occupations, professions of stock-breeding 
2. Production occupations in industry and commerce (excl. construction) 
3. Technical and computer science professions 
4. Professions of the construction industry and mining 
5. Trade and transport professions 
6. Professions of the hotel/restaurant industry and for the provision of personal 
services 
7. Occupations of management and administration, banking and insurance 
industry and the legal system 
8. Health, educational and cultural professions, scientists 
9. Non-classifiable data 
 
 
UNESCO “International Standard Classification of Education” (ISCED)  
(UNESCO Institute for Statistics, 2006)  
The levels are defined as following: 
1 = Primary education or first stage of basic education (compulsory school) 
2 = Lower secondary or second stage of basic education (I) (compulsory 
school) 
3 = (Upper) secondary education (II): 3A: „Matura“, 3B: „Fachmittelschule“, 3C: 
Vocational education 
4 = Post-secondary non-tertiary education  
5 = First stage of tertiary education: 5A: University/university of applied sciences 
(“Hochschule”), 5B: Higher vocational education (“Höhere Berufsbildung”),  
6 = Second stage of tertiary education (doctorate) 
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Appendix 15: Z-scores of child growth references (calculated with WHO Anthro 
program) 
Z-scores 
        
Boys and girls 
Age 
groups n 
% <  
-3SD 
% <  
-2SD 
% > 
+1SD 
% > 
+2SD 
% > 
+3SD Mean SD 
Weight-for-
length/height 
(WHZ) (%) 
Total 339 0 2.1 14.7 2.1 0.6 0.06 0.98 
6-mo 179 0 2.2 10.6 2.2 0.6 -0.1 0.96 
12-mo 160 0 1.9 19.4 1.9 0.6 0.24 0.97 
Length/height-for-
age (HAZ) (%) 
Total 339 0 2.1 
   
0.12 1.06 
6-mo 179 0 1.7 
   
0.12 1.04 
12-mo 160 0 2.5       0.13 1.08 
Weight-for-age 
(WAZ) (%) 
Total 339 0 0.9 
   
0.06 0.93 
6-mo 179 0 0.6 
   
-0.09 0.9 
12-mo 160 0 1.3       0.23 0.94 
BMI-for-age  
(BAZ) (%) 
Total 339 0 2.7 13 2.7 0.6 -0.01 1 
6-mo 179 0 3.4 7.8 2.2 0.6 -0.21 0.96 
12-mo 160 0 1.9 18.8 3.1 0.6 0.22 0.99 
Boys 
                  
Weight-for-
length/height 
(WHZ) (%) 
Total 181 0 1.7 16 1.7 0.6 0.05 0.99 
6-mo 88 0 2.3 10.2 1.1 0 -0.21 0.95 
12-mo 93 0 1.1 21.5 2.2 1.1 0.3 0.97 
Length/height-for-
age (HAZ) (%) 
Total 181 0 1.7 
   
0.16 1.1 
6-mo 88 0 1.1 
   
0.11 1.05 
12-mo 93 0 2.2       0.21 1.16 
Weight-for-age 
(WAZ) (%) 
Total 181 0 0 
   
0.08 0.97 
6-mo 88 0 0 
   
-0.17 0.89 
12-mo 93 0 0       0.32 0.98 
BMI-for-age  
(BAZ) (%) 
Total 181 0 2.8 15.5 2.2 0.6 -0.01 1.01 
6-mo 88 0 4.5 8 1.1 0 -0.31 0.95 
12-mo 93 0 1.1 22.6 3.2 1.1 0.27 0.99 
Girls 
                  
Weight-for-
length/height 
(WHZ) (%) 
Total 158 0 2.5 13.3 2.5 0.6 0.06 0.97 
6-mo 91 0 2.2 11 3.3 1.1 0 0.96 
12-mo 67 0 3 16.4 1.5 0 0.15 0.98 
Length/height-for-
age (HAZ) (%) 
Total 158 0 2.5 
   
0.08 1 
6-mo 91 0 2.2 
   
0.13 1.03 
12-mo 67 0 3       0 0.97 
Weight-for-age 
(WAZ) (%) 
Total 158 0 1.9 
   
0.04 0.89 
6-mo 91 0 1.1 
   
-0.01 0.9 
12-mo 67 0 3       0.11 0.88 
BMI-for-age  
(BAZ) (%) 
Total 158 0 2.5 10.1 3.2 0.6 0 0.99 
6-mo 91 0 2.2 7.7 3.3 1.1 -0.11 0.97 
12-mo 67 0 3 13.4 3 0 0.14 1 
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Appendix 16: UIC [µg/l] of infants by pediatric practice 
 
Region 
Practice 
No. 
6-mo 
[n] 
12-mo 
[n] 
Total 
[n] 
UIC of infants [µg/l] 
Median Min Max 
Lake Geneva  12 3 1 4 76.3 47.3 110.7 
Espace 
Mittelland 
13 4 1 5 85.6 26.6 112.7 
14 10 6 16 67.5 21.9 210.0 
17 10 4 14 67.4 34.8 291.3 
Northwestern 
Switzerland 
2 9 5 14 110.9 32.4 745.0 
3 13 18 31 94.7 11.4 763.1 
16 5 4 9 71.2 18.5 271.5 
Zurich 
1 14 11 25 101.7 17.4 219.9 
5 8 5 13 112.0 20.4 452.1 
7 2 0 2 182.9 21.8 344.0 
11 2 4 6 76.4 26.8 180.8 
Eastern 
Switzerland 
4 31 30 61 82.6 6.4 370.6 
9 3 11 14 112.6 31.0 306.6 
18 8 9 17 68.8 30.8 190.8 
Central 
Switzerland 
6 30 32 62 97.5 15.8 417.1 
10 19 10 29 101.2 42.7 372.6 
Ticino 8 8 9 17 184.3 51.9 504.0 
TOTAL 
 
179 160 339 93.2 6.4 763.1 
2
9
2
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Appendix 17: UIC [µg/l] of mothers by pediatric practice 
 
Region 
Practice 
No. 
Non-
lactating [n] 
Lactating [n] 
Total 
[n] 
UIC of mothers [µg/l] 
Median Min Max 
Lake Geneva  12 2 2 4 50.6 16.7 143.7 
Espace 
Mittelland 
13 1 4 5 58.5 32.3 310.1 
14 11 5 16 117.2 33.1 230.7 
17 7 7 14 91.2 16.6 244.4 
Northwestern 
Switzerland 
2 14 2 16 100.1 6.4 403.0 
3 22 11 33 69.1 25.2 305.4 
16 4 5 9 146.2 10.0 243.3 
Zurich 
1 15 10 25 88.3 20.5 232.5 
5 7 6 13 55.4 24.5 159.8 
7 1 1 2 146.0 132.1 159.9 
11 6 0 6 112.6 28.6 149.6 
Eastern 
Switzerland 
4 38 23 61 71.5 9.1 312.1 
9 9 5 14 101.7 9.7 138.9 
18 12 5 17 51.1 20.2 174.6 
Central 
Switzerland 
6 37 24 61 100.2 11.0 213.3 
10 14 15 29 64.1 12.2 191.4 
Ticino 8 12 6 18 104.8 64.3 142.7 
TOTAL 
 
212 131 343 81.1 6.4 403.0 
2
9
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Appendix 18: BMIC [µg/kg] of mothers by pediatric practice 
 
Region 
Practice 
No. 
6-mo 
[n] 
12-mo 
[n] 
Total 
[n] 
BMIC [µg/kg] 
Median Min Max 
Lake Geneva  12 2 0 2 58.8 57.8 59.8 
Espace 
Mittelland 
13 4 0 4 52.9 25.9 68.4 
14 4 1 5 41.8 18.5 112.3 
17 5 2 7 56.7 35.6 84.5 
Northwestern 
Switzerland 
2 2 0 2 44.1 37.3 50.8 
3 6 4 10 58.8 36.1 127.1 
16 3 2 5 60.0 18.6 147.7 
Zurich 
1 8 1 9 46.7 10.7 74.3 
5 2 0 2 34.1 28.1 40.0 
7 1 0 1 41.7 41.7 41.7 
11 0 0 0 -- -- -- 
Eastern 
Switzerland 
4 19 3 22 57.7 15.5 128.2 
9 3 2 5 38.2 32.1 65.8 
18 5 0 5 31.3 18.0 55.1 
Central 
Switzerland 
6 17 3 20 44.0 23.9 108.3 
10 13 2 15 63.5 21.2 123.5 
Ticino 8 1 4 5 64.6 24.9 145.1 
TOTAL 
 
95 24 119 51.2 10.7 147.7 
2
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   Matura Typus B (Latein) 
 • 1988-1994  Grundschule, Zürich 
 
Berufserfahrung 
 
 • 04/2008- Labor für Humanernährung, ETH Zürich,  
  09/2009 Aufbau und Durchführung einer nationalen Studie zur  
  Jodversorgung von Säuglingen und Müttern in der Schweiz 
 • Sommer 2007 Labor für Humanernährung, ETH Zürich,   
  7 Wochen Praktikum im Bereich Mikronährstoffe 
 • 05-07,  „HELENA-Projekt“, Medizinische Universität Wien, 
   10/2007 Mitarbeit bei Datenerhebung in Schulen & Dateneingabe 
 • 01/2007- „Nutrition Day 2007“, AKE Wien, 
    03/2007 Mitarbeit bei Datenerhebung & -auswertung 
 • Herbst 2005- Novartis Oncology Wien,  
   Sommer 2006 laufende Mitarbeit im Produkt-Management 
 • Herbst 2005  Beratung auf der „Fem Vital“-Messe für Nestlé, Wien 
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 • Sommer 2005 Institut für Ernährungsbiologie, ETH Zürich, 
   5 Wochen Unterstützung bei einer Humanstudie (Praktikum) 
 • Sommer 2005/ Beratung auf der Baby-Expo für Nestlé Alété/Beba,  
   2006 Wien und Graz 
 • Sommer 2004 -  Application Group, Nestlé Wien, laufende Mitarbeit 
    Sommer 2005  
 • Sommer 2004 Application Group, Nestlé Wien,1 Monat Praktikum 
 • Sommer 2002  Klinik Bethanien Zürich, 2 Monate Spitalpraktikum 
 • Frühling 2002  Ernährungsberatung, Bethanien/ Triemli Spital Zürich,  
  2 mal 3 Tage Schnupperpraktikum 
 • Sommer 2001 Architekturbüro, Vasconi Associés Architectes Paris,  
  3 Monate Praktikum 
 • Winter 2001  Architekturbüro, atelier ww Zürich, 3 Monate Praktikum 
 
Weiterbildung 
 
• Ernährung: Theorie und Praxis der Lebensmittelsensorik, April 2010,  
 VEÖ-success-Workshop, Wien 
 „Richtig essen von Anfang an“, Januar 2010, Tagung,  
 AGES-Akademie, Wien 
 XII. Dreiländertagung, September 2008, SGE, DGE, ÖGE, 
 Zürich 
 Theory and Practice of Nutritional Science, SS 2008,  
 ETH Zürich 
 Nutrition and Chronic Disease, SS 2008, ETH Zürich 
 
 • Englischkurse: Universität für Bodenkultur Wien, WS 2007,  
  Englisch Kommunikationskurs 
  Englisch Language Centre Boston, 1 Monat Sommer 2006 
  Australienaufenthalt, 6 Wochen Herbst 2001 
  Interlingua Jersey, 2 Wochen Juli 1999 
  
 • Französischkurse: Institut Français de Vienne, WS 2003, 
  Konversationskurs 
  Alliance Française Paris, 3 Monate Sommer 2001 
  ‚Diplôme de Langue Française‟ 
 
Zusatzqualifikationen 
 
Fremdsprachen • Englisch: sehr gut (mündlich und schriftlich) 
  • Französisch: sehr gut (mündlich und schriftlich) 
  • Italienisch: gute Grundkenntnisse 
 
EDV-Kenntnisse  • Word, Excel, Outlook, PowerPoint, SPSS, Endnote, EBISpro 
